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Riassunto dell’ attività svolta 
I mitocondri sono organelli cellulari che partecipano attivamente alla produzione di 
energia, la trasduzione del segnale e l'apoptosi. Essi sono caratterizzati da una struttura 
sofisticata indispensabile per ospitare le molteplici funzioni mitocondriali. Una membrana 
esterna definisce il confine del organello e il citoplasma, mentre una membrana interna 
compartimentalizza lo spazio interno in spazio intermembrane, matrice e cristae. Le 
cristae sono i siti di fosforilazione ossidativa e sono separate dallo spazio intermembrana 
da strette giunzioni tubolari (Frey and Mannella, 2000; Vogel et al., 2006).  
Durante la morte cellulare programmata la forma e l’ ultrastruttura mitocondriale 
cambiano. Queste alterazioni morfologiche che comprendono l'ampliamento delle 
giunzioni strette delle cristae - il cosiddetto "rimodellamento di cristae" - contribuisce alla 
mobilitazione del citocromo c, e il suo rilascio completo dallo spazio intermembrana al 
citoplasma (Scorrano et al., 2002). 
Ricerche genetiche e biochimiche sui meccanismi molecolari della modificazione 
mitocondriale durante l'apoptosi hanno svelato che la proteina della membrana 
mitocondriale interiore, optic atrophy (OPA1) è un regolatore chiave del rimodellamento 
delle cristae. OPA1 forma vari complessi che mantengono le giunzioni delle cristae 
regolando così la quantità del citocromo c che è disponibile nello spazio intermembrana 
per il suo rilascio nel citoplasma dopo la permeabilizzazione della membrana 
mitocondriale esterna. Su stimolo apoptotico, i complessi di alto peso molecolare (high 
molecular weight, HMW) contenenti OPA1 sono interrotti, con l'allargamento 
concomitante delle giunzioni e il rilascio del citocromo c (Frezza et al., 2006; Cogliati et al., 
2013). È interessante notare che questi gruppi sono composti da forme transmembrana 
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(lunghe) e forme solubili (corte) di OPA1 e la loro dimensione è compresa tra i 500 e gli 
800 KDa, come giudicato da elettroforesi su gel blu nativo e per dimensione cromatografia 
di esclusione. Questa dimensione suggerisce che essi contengono anche altre proteine 
oltre che OPA1, la cui identità e funzione deve essere esaminata. 
Lo scopo della mia tesi di dottorato è di esplorare la composizione dei complessi-OPA1 
contenenti, e di caratterizzare la funzione delle parti di OPA1 identificate nella fisiologia 
mitocondriale e nella morte cellulare. 
Elettroforesi tridimensionale su gel di poliacrilammide blu nativo (BN-PAGE) (3D BN-BN-
SDS PAGE) seguita da semi-quantitativa LC/MS analisi di mitocondri normali e apoptotici 
di fegato di topo, effettuata nel nostro laboratorio, ha rivelato una coorte di proteine 
putative presenti nei complessi OPA1–contenenti la cui distribuzione cambia durante la 
morte cellulare programmata. Per identificare meglio i partner putativi per OPA1 abbiamo 
inoltre eseguito un semi-quantitativa LC/MS analisi in su gel BlueNative dei mitocondri 
murini cardiaci. Inoltre, abbiamo impiegato etichettatura a isotopo stabile con aminoacidi 
(SILAC) (Ong and Mann, 2007) in fibroblasti di topo adulto (MAFS), in combinazione con 
2D BN-BN PAGE e LC/MS. Per distinguere le proteine che sono regolate particolarmente 
durante il rimodellamento delle cristae, con questi due approcci abbiamo confrontato la 
popolazione mitocondriale normale con le popolazioni mitocondriali stimolate con BID, 
un fattore pro-apoptotico tagliato proteoliticamente dal caspasi 8, in forma wild type 
(cBIDwt) o con mutazione che compromette il rimodellamento delle cristae (cBIDKKAA) 
(Cogliati et al., 2013). I risultati ottenuti dalle tre strategie high throughput sono stati 
analizzati per ottenere gli elenchi definitivi dei potenziali interattori di OPA1 e il coorte 
delle proteine che sono ridotte o aumentate in modo significativo nei vari complessi 
multimerici di OPA1 durante il rimodellamento delle cristae. La scoperta degli stessi 
 
 
8 
 
interattori di OPA1 con le varie tecniche hanno dimostrato indipendenza dal tipo di 
tessuto, cosa che mostra che i nostri metodi hanno il livello di specificità necessario per l’ 
ispezione dei complessi OPA1 nella vita e morte cellulare. 
Tra le proteine identificate, la nostra attenzione è stata catturata da due componenti del 
complesso MICOS: Mic60 e Mic19. Il “Mitochondrial contact site and cristae organizing 
system” (MICOS) è una grande struttura proteica eterooligomerica, che regola la 
biogenesi delle giunzioni delle cristae. Tuttavia, il regolatore principale delle cristae OPA1 
non fa parte del complesso MICOS e la sua esatta composizione, l'architettura e le funzioni 
nel lievito e nei mammiferi sono ancora sotto esame. 
In tutti e tre gli approcci di proteomica e dopo immunoblotting con gel Blue Native, il 
componente principale di MICOS, Mic60, è stato individuato in complessi ad alto peso 
molecolare con simile mobilità elettroforetica a quelli di OPA1. Al fine di svelare il 
potenziale crosstalk tra OPA1 e Mic60, abbiamo effettuato analisi biochimiche e genetiche 
in situazione di ablazione di OPA1 o/e Mic60 e dimostrato che le due proteine 
interagiscono nelle membrane mitocondriali interne (inner mitochondrial membranes-
IMM) e sono essenziali nella formazione dei complessi OPA1/Mic60. Esperimenti di 
microscopia elettronica hanno rivelato che questi complessi sono essenziali nella 
formazione della giunzione delle cristae, ma non per specificare la larghezza del loro 
lumen o la giunzione del loro foro. 
Inoltre, abbiamo dimostrato che i complessi Mic60/OPA1 sono eliminati da cBIDwt ma non 
dal suo mutante cBIDKKAA, indicando un nuovo ruolo di Mic60 che riguarda il 
rimodellamento apoptotico delle cristae. E’ da notare che l'analisi bioinformatica ha 
mostrato una divergenza strutturale tra gli ortologi di Mic60 tra lievito e mammiferi, 
spiegando potenzialmente le ulteriori funzioni Mic60 sin dall'inizio dell'evoluzione. Allo 
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stesso modo, abbiamo anche dimostrato che Mic19 fa parte di complessi ad alto peso 
molecolare presenti durante la  ristrutturazione delle cristae, aumentando la possibilità 
che il Mic19 dei mammiferi potrebbe anche regolare la biogenesi dei mitocondri 
attraverso il pathway di OPA1. 
Oltre ai componenti di MICOS, abbiamo voluto, inoltre, indagare un'altra proteina trovata 
significativamente ridotta durante l’ apoptosi. Questa proteina è chiamata ossido nitrico-
associato 1 (nitric oxide-associated 1, NOA1). La coesistenza di NOA1 e OPA1 negli stessi 
complessi è stata confermata con metodi biochimici in BMH mitocondri crosslinked, così 
come dopo co-immunoprecipitazione. Questi dati iniziali, insieme al fatto che la funzione 
di questa proteina era all’ oscuro sino ad ora, ci hanno spinto a studiare ulteriormente il 
suo ruolo nei mitocondri e la sua relazione con OPA1 nel controllo della morfologia 
mitocondriale e nel rimodellamento delle criste. 
Per far luce al collegamento funzionale tra le due proteine di interesse, abbiamo utilizzato 
MEF carenti di NOA1 dove abbiamo sorprendentemente osservato un aumento di OPA1, 
sia a livello di proteine che a livello di trascrizione. Inoltre, mentre NOA1 era assente nelle 
Opa1-/- MEF, il suo livello è tornato alla normalità quando è stata reintrodotta OPA1, 
suggerendo un interazione genetica tra le due. 
Successivamente, al fine di ottenere informazioni sul ruolo di NOA1 nei mitocondri, 
abbiamo analizzato Noa1-/- MEF mediante microscopia confocale ed elettronica. I 
mitocondri di cellule Noa1-/- sono frammentati e hanno alterazioni ultrastrutturali. È 
interessante notare che l' iperespressione di OPA1 ha corretto l’ ultrastruttura 
mitocondriale aberrante in misura simile a quella di reintroduzione di NOA1, sostenendo 
ulteriormente l'ipotesi di una interazione funzionale OPA1-NOA1. 
Dati i difetti strutturali mitocondriali, abbiamo ipotizzato che l’ ablazione di NOA1 colpisca 
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anche funzioni mitocondriali. Infatti, analisi Seahorse ha mostrato una respirazione 
mitocondriale compromessa in cellule mancanti NOA1, coerente con quello che era già 
stato pubblicato. Analisi SDS e Blue Native hanno rivelato una notevole diminuzione nei 
livelli delle proteine delle varie subunità di OXPHOS e un difetto nel assemblaggio dei 
complessi respiratori mancanti NOA1. Sorprendentemente, il numero di copie di DNA 
mitocondriale (mtDNA) era inalterato, mentre la riduzione della proteina non era limitata 
alle proteine codificate da DNA mitocondriale. Di conseguenza, si suggerisce che 
l'instabilità generale delle proteine OXPHOS è probabilmente dovuta all’ incapacità dei 
complessi della catena respiratoria ad essere assemblati correttamente, potenzialmente 
spiegando le disfunzioni bioenergetiche. 
Funzionalmente, le cellule Noa1-/- crescevano più lentamente rispetto a quelle WT con 
medio contenente galattosio, e dopo 2 giorni non erano in grado di tollerare deprivazione 
di glucosio, suggerendo un ruolo potenziale di NOA1 nella crescita cellulare dipendente 
da mitocondri. A causa del fatto che OPA1 è una proteina antiapoptotica e i suoi complessi 
sono interrotti dopo stimoli apoptotici, abbiamo voluto studiare il suo partner, NOA1, nel 
corso dell’ apoptosi. Come per OPA1, i complessi di NOA1 che hanno la stessa motilità 
elettroforetica dopo crosslink come quelli di OPA1 sono similmente interrotti su 
rimodellamento delle criste indotto da cBID. Oltre a ciò, durante l'apoptosi, è probabile 
una scissione proteolitica di NOA1, che potrebbe essere un potenziale meccanismo per 
l'eliminazione di complessi NOA1-OPA1 subito dopo la stimolazione della morte cellulare. 
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Summary 
In conclusione, il nostro studio ha svelato la composizione dei complessi OPA1 che 
vengono eliminati durante l'apoptosi. Abbiamo scoperto un crosstalk tra i principali 
regolatori della biogenesi delle cristae, OPA1 e Mic60 e caratterizzato il ruolo di Mic60 
durante il rimodellamento apoptotico delle cristae. Inoltre, abbiamo scoperto un nuovo 
giocatore nella manutenzione della forma delle cristae, nel loro rimodellamento e nella 
respirazione mitocondriale, NOA1, che agisce nello stesso pathway di OPA1. 
Mitochondria are cellular organelles participating actively in energy production, signal 
transduction and apoptosis. They are characterized by a sophisticated structure essential 
for hosting the multiple mitochondrial functions. An outer membrane defines the border 
of the organelle and the cytoplasm, while an inner membrane compartmentalizes the 
internal space into intermembrane space, matrix and cristae. Cristae are the sites of 
oxidative phosphorylation and are separated from the intermembrane space by narrow 
tubular cristae junctions (Frey and Mannella, 2000; Vogel et al., 2006). 
During programmed cell death mitochondrial shape and ultrastructure change. These 
morphological alterations that include the widening of the narrow cristae junctions – the 
so-called “cristae remodeling” – contribute to the mobilization of the cristae-endowed 
cytochrome c to the intermembrane space and its complete release to the cytosol 
(Scorrano et al., 2002).  
Genetic and biochemical research on the molecular mechanisms of mitochondrial 
structure modifications during apoptosis unveiled that the inner mitochondrial 
membrane dynamin-related protein, Optic atrophy 1 (OPA1) is a key regulator of cristae 
remodeling. OPA1 forms multiple complexes that maintain the cristae junctions close; 
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thereby regulating how much cytochrome c is available in the intermembrane space for 
release in the cytosol upon permeabilization of the outer mitochondrial membrane. Upon 
apoptotic stimulus, the high molecular weight (H.M.W) OPA1-containing complexes are 
disrupted, with concomitant enlargement of the cristae junctions and cytochrome c 
release (Frezza et al., 2006; Cogliati et al., 2013). Interestingly, these assemblies are 
composed by the transmembrane (long) and soluble (short) OPA1 forms and their size 
ranges from 500 to 800 KDa, as judged by blue native gel electrophoresis and by size 
exclusion chromatography. This size suggests that they contain proteins other than OPA1, 
whose identity and function calls for investigation. 
The aim of my PhD thesis is to explore the composition of the OPA1-containing complexes, 
as well as to characterize the function of identified OPA1 partners in mitochondrial 
physiology and cell death. 
Three dimensional BlueNative-BlueNative-SDS PAGE (3D BN-BN-SDS PAGE) followed by 
semi-quantitative LC/MS analysis of normal and apoptotic mouse liver mitochondria, 
carried out in our lab, revealed a cohort of candidate proteins present in the OPA1-
containing complexes whose distribution changes during programmed cell death. To 
further mark off the number of candidate OPA1 partners, we additionally performed a 
semi-quantitative LC/MS analysis in blue native PAGE of mouse heart mitochondria. 
Furthermore, we employed stable isotope labeling by amino acids (SILAC) (Ong and Mann, 
2007) in mouse adult fibroblasts (MAFs), combined with blue native PAGE and LC-MS/MS. 
In order to distinguish the proteins that are regulated specifically during cristae 
remodeling, in the two latter approaches we compared a normal mitochondrial 
population with mitochondrial populations stimulated with the wild type pro-apoptotic 
caspase 8 cleaved BID (cBIDwt) or a cristae remodeling incompetent mutant of cBID 
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(cBIDKKAA) (Cogliati et al., 2013). The resulted hits of all the three high throughput 
strategies were analyzed collectively to obtain the final lists of potential OPA1 interactors 
and the subset of proteins that significantly decrease or increase in the various multimeric 
OPA1 complexes in the course of cristae remodeling. The discovery of the same OPA1 
interactors between the techniques indicated a tissue-independency and that our 
methods had the level of definition required to inspect OPA1 complexes in cell life and 
death. 
Among the identified proteins, our attention was firstly caught by two MICOS complex 
members: Mic60 and Mic19. “Mitochondrial contact site and cristae organizing system” 
(MICOS) is a large heterooligomeric protein structure, which regulates cristae junction 
biogenesis. Nevertheless, the master regulator of cristae shape OPA1 is not part of MICOS 
and its exact composition, architecture and functions in yeast and mammals are still under 
active investigation.  
In all the three proteomic approaches and after immunoblotting of Blue Native PAGE the 
core component of MICOS, Mic60, was retrieved in high molecular weight complexes with 
similar electrophoretic mobility as those of OPA1. In order to unravel the potential 
crosstalk between OPA1 and Mic60, we performed biochemical and genetic analysis in 
OPA1 or/and Mic60 ablation and demonstrated that the two IMM proteins interact and 
are indispensable for the Mic60/OPA1 complexes formation. Functionally, electron 
microscopy revealed that these complexes are essential for cristae junction formation, 
but not for specifying the width of the cristae lumen or the cristae junction mouth.  
Moreover, we showed that the Mic60/OPA1 complexes are eliminated by cBIDwt but not 
by its mutant cBIDKKAA, indicating a novel role of Mic60 that regards apoptotic cristae 
remodeling. Worth noting, bioinformatics analysis uncovered a structural divergence in 
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the transmembrane and middle domains between yeast and mammalian Mic60 
orthologues, potentially explaining the additional Mic60 functions at the outset of 
evolution. Similarly, we also demonstrated that Mic19 is part of high molecular weight 
complexes, which are targeted during cristae remodeling, raising the possibility that 
mammalian Mic19 might also regulate mitochondria biogenesis through the OPA1 
pathway. 
Besides MICOS components, we, additionally, wished to investigate another identified 
protein that was significantly reduced in apoptosis. This protein is christened nitric oxide-
associated 1 (NOA1). The co-existence of NOA1 and OPA1 in the same complexes was 
confirmed biochemically in BMH crosslinked mitochondria, as well as after co-
immunoprecipitation. These initial data, along with the obscure exact function of this 
newly characterized protein, prompted us to further investigate its role in mitochondria 
and its relationship with OPA1 in the control of mitochondrial morphology and cristae 
remodeling.  
To shed light on the functional link between the two proteins of interest, we used NOA1 
deficient MEFs where we surprisingly observed an upregulation of OPA1, both at the 
protein and at the transcript level. In addition, NOA1 was absent in Opa1-/- MEFs, while its 
level went back to normal when OPA1 was re-introduced, suggesting a genetic interaction 
between the two.  
Next, in order to gain an insight into the role of NOA1 in mitochondria, we analyzed NOA1 
deficient MEFs by confocal and electron microscopy. Mitochondria of Noa1-/- cells were 
fragmented and displayed ultrastructural changes. Interestingly, overexpression of OPA1 
corrected the aberrant mitochondrial ultrastructure at a similar extent as upon re-
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introduction of NOA1, further supporting the hypothesis of an OPA1-NOA1 functional 
interplay.  
Given the mitochondrial structural defects, we hypothesized that NOA1 ablation affected 
also mitochondrial functions. Indeed, Seahorse analysis showed impaired mitochondrial 
respiration in NOA1 lacking cells, consistent with previously published reports. SDS and 
blue native PAGE revealed a notable decrease of OXPHOS subunits protein levels and a 
defect on respiratory complexes assembly in NOA1 deficiency. Remarkably, mtDNA copy 
number was unaltered, while the protein reduction was not restricted to mtDNA encoded 
proteins. Consequently, we suggest that the general instability of OXPHOS proteins is 
probably due to the inability of the respiratory chain complexes to properly assemble, 
potentially explaining the bioenergetic dysfunction. 
Functionally, Noa1-/- cells grew slower than WT in galactose-containing medium and after 
two days they were unable to tolerate glucose deprivation, suggesting a potential role of 
NOA1 in mitochondrial-dependent cell growth. Due to the fact that OPA1 is an anti-
apoptotic protein whose complexes are disrupted after apoptotic stimulation, we aimed 
to study its partner, NOA1, in the course of apoptosis. Like OPA1, NOA1 complexes that 
have the same electrophoretic motility after crosslinking as those of OPA1 are similarly 
disrupted upon cBID induced cristae remodeling. On top of this, during apoptosis, NOA1 
is likely proteolyticallly cleaved, which could be a potential mechanism for the elimination 
of NOA1/OPA1-contining complexes early in cell death stimulation. 
In conclusion, our study unraveled the composition of OPA1 complexes that are 
eliminated during apoptosis. We uncovered a crosstalk between the core cristae 
biogenesis regulators, OPA1 and Mic60, and characterized the role of Mic60 during 
apoptotic cristae remodeling. Moreover, we discovered a novel player of cristae shape 
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maintenance, cristae remodeling and mitochondrial respiration, NOA1, that acts in the 
same pathway as OPA1.  
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1. General Introduction 
Mitochondria are fundamental organelles in life and death of eukaryotic cells, 
participating in multiple cellular processes. They are the energy production “factories”, 
they are involved in apoptosis regulation, calcium homeostasis, signaling pathways, cell 
cycle and growth control and reactive oxygen species production. Dysfunctional 
mitochondria are implicated in ageing and several human pathologies, including cancer, 
neurodegenerative diseases, metabolic disorders, diabetes and inflammatory conditions. 
Mitochondrial shape is extremely complex and dynamic, constantly changing to support 
the various functions in response to the cellular demands. The organelles are bordered by 
two distinct membranes; the outer mitochondrial membrane (IMM), that separates them 
from the cytosol, and the inner mitochondrial membrane (IMM) that constitutes the site 
of oxidative phosphorylation (Palade, 1952). The latter can be further subdivided into two 
different compartments, the inner boundary membrane and the cristae. Electron 
tomography allowed the visualization of the 3D mitochondrial ultrastructure identifying 
the cristae as pleomorphic bag like structures connected by a bottleneck called cristae 
junction to the inner boundary membrane (Frey and Mannella, 2000). The respiratory 
complexes are accumulated in the membranes of these structures, as a consequence the 
vast majority of cytochrome c resides in the cristae space (Vogel et al., 2006).  
During apoptosis, soluble mitochondrial components among which cytochrome c, are 
released to the cytosol, to amplify the apoptotic pathway. A dramatic cristae structure 
rearrangement occurs early upon apoptotic stimulation. These morphological alterations 
are described with the term “cristae remodeling” and include the widening of the cristae 
junctions as well as the individual cristae fusion (Scorrano et al., 2002). A key regulator of 
cristae remodeling is the mitochondrial shaping GTPase, Optic atrophy 1 (OPA1).  OPA1 
resides in multiple complexes, which keep the cristae junction close, whilst they are 
targeted and eliminated during cell death. In this thesis, we focus on the identification 
and characterization of OPA1 partners that collaborate to regulate the cristae shape 
before and after the apoptotic cristae remodeling.  
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1.1 Mitochondria, the multifunctional organelles 
Mitochondria are double-membrane organelles where various vital cellular processes are 
carried out. They are the site of cellular respiration, where the majority of ATP is 
generated. According to the chemiosmotic theory, the enzymatic respiratory complexes 
sitting in the inner mitochondrial membrane (IMM), pump protons across the membrane 
during the transfer of electrons from NADH and FADH2 downhill their redox potentials to 
molecular O2, thus generating an electrochemical gradient. The free energy stored in this 
electrochemical gradient drives the F1F0-ATP-synthase to generate ATP. The whole 
process is named oxidative phosphorylation (OXPHOS), because oxygen is the final 
electron acceptor and the ultimate reaction is the phosphorylation of ADP to produce ATP 
(Mitchell and Moyle, 1967).  
The OXPHOS system consists of five enzymatic complexes: NADH-Q oxidoreductase, 
succinate-Q reductase, Q-cytochrome c oxidoreductase, cytochrome c oxidase and ATP 
synthase, which are also called Complex I, II, III, IV and V, respectively. In 2000, the past 
understanding of the organization in discrete complexes was replaced unambiguously by 
the view of a higher order organization in supramolecular assemblies, thanks to analysis 
with Blue-Native gel electrophoresis (BN-PAGE) (Schagger and Pfeiffer, 2000). These 
structures, named “respirosomes” or “respiratory supercomplexes” (RSC) and composed 
by CI, CIII and CIV, enhance the efficiency of electron transfer rate, provide a kinetic 
advantage and limit reactive oxygen species (ROS) production from CI. More than that, 
the dynamic nature of the superassemblies provides an advantage for mitochondria to 
adapt to changing energy demands (Acin-Perez et al., 2008; Genova and Lenaz, 2014). 
In addition to their role in cellular metabolism, mitochondria participate in the 
synchronization of Ca2+ waves inside the different intracellular compartments, thus 
regulating multiple calcium-dependent signaling pathways, such as apoptosis (Jouaville et 
al., 1995; Rizzuto et al., 2003; Rimessi et al., 2008). In particular, they can uptake, 
transiently store and release calcium, making them good “cytosolic buffers” for this ion 
type (Brighton and Hunt, 1974). Besides their indirect role in apoptosis through calcium 
regulation, mitochondria also actively take part in programmed cell death by receiving 
diverse cytosolic signals and, as a response, releasing back cofactors so as to amplify the 
apoptotic pathway (Wang, 2001).  Aging and a plethora of human disorders, including 
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cancer, neurodegenerative diseases and neuropathy, are consequences of or aggravated 
by mitochondrial dysfunction, indicating the importance of proper mitochondrial 
functioning for the cell and the whole organism homeostasis (Schapira, 2006).  
 
1.2 Mitochondrial DNA (mtDNA) 
Mitochondria contain their own genome in multiple copies. Mitochondrial DNA (mtDNA) 
is circular, and according to the theory of endosymbiosis, originates evolutionary from the 
bacterial genome (Margulis, 1971). In humans, mtDNA encodes 13 polypeptides (subunits 
of respiratory complexes; seven subunits of complex I, one of complex III, three of 
complex IV and two subunits of ATP-synthase), as well as 22 transfer RNAs and two 
ribosomal RNAs (16S rRNA and 12S rRNA), which are required for mitochondrial 
translation (Fernandez-Silva et al., 2003). DNA in mammalian mitochondria is not naked; 
instead, it is organized with proteins in structural units named nucleoids (SOTELO and 
PORTER, 1959; Barat et al., 1985). Transcription factor A (TFAM) is the main packaging 
polypeptide and with one molecule of mtDNA, it composes the structural unit of nucleoid 
(Kukat et al., 2015; Kukat et al., 2011). Apart from TFAM, a number of proteins such as 
mitochondrial DNA replication, transcription and translation factors (mtSSB, EFTu, POLG1 
and Twinkle), proteases (Lon), scaffold proteins (ATAD3, Prohibitin) and members of 
signaling pathways, have been proposed to interact with the nucleoids (Gilkerson et al., 
2013).  
Although the number of mitochondrial proteins encoded by the mitochondrial genome is 
small in relation to those encoded by the nuclear genome (around 1500 proteins), mtDNA 
integrity and its normal expression is essential for the assembly and function of 
respiratory chain. Any aberration of the mtDNA stability can be detrimental for the cellular 
function. Genetic defects affecting its integrity and expression are the cause of various 
human diseases (Szklarczyk et al., 2014).  
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1.3 Mitochondrial shape and ultrastructure  
Mitochondria are bordered by two distinct phospholipids membranes – the outer 
mitochondrial membrane (OMM), which is permeable to small molecules, and the 
impermeable inner mitochondrial membrane (IMM) (Fig 1). The compartment between 
the two membranes is called intermembrane space (IMS) and the space enclosed by the 
IMM is called matrix. The IMM folds into a complex network of tubules and lamellae that 
protrude into the matrix, the so-called cristae; thus, the IMM is approximately 5 times 
larger than OMM. The area surrounded by the IMM of one crista is the cristae lumen, 
while the part of the IMM that is not invaginated to form cristae and lies parallel to the 
OMM is defined as inner boundary membrane (IBM) (Vogel et al., 2006). Cristae are 
connected to IBM by narrow tubular structures of varying length, the so-called cristae 
junctions (CJ). In steady-state the diameter of CJ ranges from approximately 20 to 30 nm, 
a size that is regulated to allow the flow of metabolites from the cristae invagination to 
the IMS and vice versa (Mannella et al., 1994; Scorrano et al., 2002).  
 
1.4 The dynamic nature of mitochondrial shape 
Mitochondrial diameter ranges from 0.5 to 1.0 µm and their shape varies from small 
spheres to interconnected tubules (Bereiter-Hahn and Voth, 1994). Because of this 
heterogeneous morphology, this organelle was christened “mitochondrion”, a term which 
originates from the Greek words “µίτος, mitos” (thread) and “χονδρίον, chondrion” 
Figure 1. Mitochondrial structure. Schematic representation of mitochondrial structure (on the left). 
Electron microscopy image of a mitochondrion from mouse embryonic fibroblasts (on the right). OMM: 
outer mitochondrial membrane. IMM: inner mitochondrial membrane. IMS: intermembrane space. 
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(grain). Although initially mitochondria were considered as static organelles - due to the 
limitation of conventional electron microscopy - confocal live-cell imaging with 3D 
reconstruction and electron tomography appeared to be promising visualization tools to 
unravel the plasticity of those organelles (Dimmer and Scorrano, 2006).  
The dynamic nature of mitochondria derives from their ability to constantly undergo 
events of fusion and division, as well as to redistribute inside the cell along cytoskeleton 
tracks (van der Bliek et al., 2013). Occasionally, two mitochondria encounter each other 
and fuse, end to end or head to side. On the other hand, one tubule may undergo fission 
processes to give rise to two or more smaller mitochondria. Fusion and fission often occur 
in short time intervals within the same group of mitochondria. Additionally, movement of 
the organelles may occur upon their association with microtubules of the cytoskeleton or 
after intrinsic events by themselves. Given the complex structure and the fundamental 
roles of mitochondria, as well as the high frequency of the dynamic events, these 
processes should be tightly regulated by sophisticated machineries, in order to coordinate 
networks of organelles with double lipid bilayers (Fig 2). 
 
 
Figure 2. Mitochondrial fusion (a) and fission (b) in mammalian cells. Continual cycles of fusion and fission 
result in the intermixing of the mitochondrial population in the cell. OM fusion is mediated by mitofusin 1 
(MFN1) and MFN2, which are dynamin-related GTPases at the OM. IM fusion is mediated by the dynamin-
related protein optic atrophy 1 (OPA1). The opposing process of mitochondrial fission (see the figure, part 
b) requires the recruitment of dynamin-related protein 1 (DRP1) from the cytosol to the mitochondrial OM. 
Assembly of DRP1 on the mitochondrial surface causes constriction of the mitochondria and eventual 
division of the organelle into two separate entities. Four DRP1 receptors exist in mammals — mitochondrial 
fission 1 (FIS1), mitochondrial fission factor (MFF), Mitochondrial dynamics protein of 49 kDa (MID49) and 
MID51 — and these are located on the mitochondrial OM. Adapted from (Mishra and Chan, 2014). 
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1.4.1 Mechanisms of mitochondrial division 
The control of mitochondria dynamics is mediated by a group of “mitochondria shaping 
proteins”, whose number is growing in the last years. The majority of these proteins 
belong to the dynamin-superfamily, which consists of large GTPases capable to facilitate 
membrane tubulation and/or scission (Praefcke and McMahon, 2004).  
 
1.4.1.1 Key player of fission machinery - DRP1 
One of the proteins involved in mitochondrial fission is dynamin-like-protein (Dlp)1p 
DLP1/DRP1 and its specific function is conserved from yeast to mammals (Smirnova et al., 
2001; Ingerman et al., 2005). Structurally, DRP1 possesses a. an N-terminal GTPase 
domain, which is considered to provide mechanical force, b. a dynamin-like middle 
domain, c. an Insert-B domain, which contains a motif essential for binding to adaptors 
and d. a C-terminal GTPase effector domain (Yoon et al., 2001; Okamoto and Shaw, 2005; 
Bui et al., 2012). DRP1 localizes predominately in the cytosol in the form of dimers or 
tetrameres, but it can be recruited to mitochondria upon dephosphorylation by 
calcineurin, in order to exert its function by GTP hydrolysis (Yoon et al., 2001; Cereghetti 
et al., 2008). There it self-assembles into large oligomeric structures forming spirals 
around the constriction OMM sites (Ingerman et al., 2005). It has been proposed that the 
fission sites are determined by the position of endoplasmic reticulum tubules around 
mitochondria (Friedman et al., 2011).  
 
1.4.1.2 Coplayers of DRP1 
DRP1 binds to several OMM anchored adaptors, including FIS1, MFF and MIEF1, however 
their roles and relevance for the initiation of mitochondrial division are not clear. 
Mitochondrial fission factor (MFF) is a protein anchored to the OMM via its C-tail and it 
interacts with DPR1 in vitro and in vivo. Overexpression of MFF correlates with increased 
DRP1 translocation to mitochondria along with extensive organelle division, while its 
downregulation leads to mitochondrial elongation, suggesting its essential DRP1-
dependent role in fission (Otera et al., 2010). 
FIS1 is another C-tail anchored OMM protein, which was initially considered as the only 
DRP1 adaptor in yeast and human cells, regulating mitochondrial morphology (Yoon et al., 
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2003; Stojanovski et al., 2004). Nevertheless, its direct role in DRP1 recruitment to the 
OMM is questioned in vivo by other reports (Lee et al., 2004; Suzuki et al., 2003); hence, 
its exact function remains an enigma. 
More recently two novel molecules influencing mitochondrial fission have been 
identified; the OMM proteins Mitochondrial dynamics 51 (MiD51, aka mitochondrial 
elongation factor 1, MIEF1) and Mitochondrial dynamics 49 (MiD49).  Palmer et al 
proposed that MiD49/51 is able to recruit DRP1 on mitochondria, yet in a non-functional 
form, thereby inhibiting fission and shifting the balance towards mitochondrial elongation 
(Lee et al., 2004; Palmer et al., 2011). Zhao et al suggested that, besides recruiting and 
inhibiting DRP1 activity, MIEF1 promotes in parallel mitochondrial fusion in an active, 
Mfn2-independent manner (Zhao et al., 2011). Further studies are essential to clarify 
MIEF1 roles in mitochondrial dynamics.   
The mitochondrial fission machinery contains other proteins, including GDAP1, endophilin 
B1, sascin and LRRK2, though their role is still not fully characterized. Ganglioside-induced 
differentiation-associated protein 1 (GDAP1) is located in the OMM, from where it induces 
mitochondrial fragmentation in cooperation with DRP1 (Lee et al., 2004; Niemann et al., 
2005). Endophilins are fatty acyl transferases that participate in membrane scission, 
altering the membrane curvature possibly via a direct interaction with lipids (Schmidt et 
al., 1999; Gad et al., 2000). Endophilin B1 moves from cytosol to mitochondria during 
apoptosis, and changes in its protein levels result in morphological alterations. 
Experiments where DRP1 and endophilin B1 have been concomitantly downregulated 
indicate that the latter acts downstream of the former (Karbowski et al., 2004; Lee et al., 
2004; Schmidt et al., 1999).  Another candidate component of the mitochondrial scission 
machinery is a large multi-domain protein, named sascin. A study on a mouse model 
where sascin is knocked-out shed light on its role in mitochondrial dynamics; cells lacking 
sascin displayed a similar abnormal mitochondrial phenotype to the one observed in DRP1 
deficiency. The two proteins colocalize in the fission foci, while a direct interaction was 
validated with immunoprecipitation. All the data of this report revealed a regulation of 
DRP1 by sascin (Girard et al., 2012). A similar role to the one of sascin has been attributed 
to the large kinase, leucine-rich repeat kinase 2 (LRRK2). LRRK2 mediates DRP1 
recruitment to mitochondria by a direct interaction, resulting in the induction of 
mitochondrial fragmentation (Wang et al., 2012).  
 
 
25 
 
Although several reports have identified regulators of OMM fission, less attention has 
been given to the division of the inner mitochondrial membrane. One could think that the 
scission of both membranes is coordinated by the same proteins. On the other hand, 
distinct mitochondrial shaping proteins residing in the IMM could potentially control its 
fission, like the yeast protein MDM33 (Messerschmitt et al., 2003).   
 
1.4.1.3 Regulation of DRP1 
Apart from the multiple and dynamic proposed protein interactions, mitochondrial 
division is also regulated by a variety of post-translational modifications of the key player 
DRP1. Among these modifications we find the already mentioned (de)phosphorylation, as 
well as SUMOylation, S-nitrosylation, ubiquitination and O-GlcNAcylation.  
Phosphorylation of DRP1 is mediated by PKA at its residues Ser637 and Ser656, to inhibit 
its GTPase activity and block fission, while a third residue Ser585 can be phosphorylated 
by Cdk1 during mitosis in order to promote mitochondrial fragmentation. 
Dephosphorylation at Ser637 is carried out by the Ca2+-dependent phosphatase 
calcineurin, which normally interacts with DRP1. This is a consequence of increased 
cytosolic Ca2+ concentration (such as in case of mitochondrial depolarization) and results 
in DRP1 translocation to mitochondria with subsequent fission events (Jahani-Asl and 
Slack, 2007; Taguchi et al., 2007; Chang and Blackstone, 2007; Cereghetti et al., 2008; 
Jahani-Asl and Slack, 2007; Lee et al., 2004; Schmidt et al., 1999). Very recently, the 
phosphorylation of DRP1 was shown to be controlled by DAP3 - a protein that resides in 
the mitochondrial matrix, raising the question of whether this effect is direct (Xiao et al., 
2015). Overall, the phosphorylation status of Drp1 can determine the shape of 
mitochondria during the changing cellular conditions. 
Moreover, DRP1 activity is controlled by SUMOylation, during which a small SUMO 
protein binds to its substrate through the mitochondrial-anchored SUMO E3 ligase 
(MAPL); thus DRP1 is protected by ubiquitination, stabilized, associated to mitochondria, 
favoring mitochondrial division (Braschi et al., 2009; Wasiak et al., 2007).  In contrast, 
ubiquitination targets DRP1 for degradation by the proteasome. March5 is a 
mitochondrial-associated RING-finger E3 ubiquitin ligase, which ubiquitinates DRP1 at the 
OMM. However, the effect of this regulation on mitochondrial morphology is still 
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controversial (Karbowski et al., 2007). Finally yet importantly, two more modifications 
occur in the polypeptidic sequence of DRP1. First, the GED domain residue Cys644 can be 
S-nitrosylated upon nitric oxide production in neuronal injury, enhancing its GTPase 
activity and subsequently its fission capacity (Cho et al., 2009). Second, O-Glc-NAcylation 
of Thr-585 and Thr-586 in the insert B-domain significantly decreases Ser637 DRP1 
phosphorylation in cardiac myocytes, driving DRP1 translocation and mitochondrial 
fragmentation. All these multi-site posttranslational modifications on the key regulator of 
fission suggest a tight control of mitochondrial morphology (Gawlowski et al., 2012; 
Wasiak et al., 2007). The exact mechanisms by which these modulations are orchestrated 
remain still obscure. 
 
1.4.2 Mechanisms of mitochondrial fusion 
Similar to mitochondrial fission, fusion of the outer and inner mitochondrial membranes 
is mediated by dynamin-like GTPases, which are analyzed in the next paragraphs.  
 
1.4.2.1 Key players of fusion machinery  
1.4.2.1.1 Fzo1/Mitofusins 
The first identified protein to be implicated in fusion was the D. melanogaster Fuzzy 
onions 1 protein (Fzo1), a large GTPase whose activity is required for the elongation of 
mitochondria during spermatogenesis (Hales and Fuller, 1997). Further studies 
demonstrated a genetic and functional conservation of this mitochondrial-shaping 
protein across the species. The yeast orthologue Fzo1p contains an N-terminal GTPase, 
exposed to the cytosol, four coiled-coil domains and two adjacent transmembrane 
domains that span the OMM. Lack of Fzo1 leads to mitochondrial fragmentation, mtDNA 
loss and absence of IMM. Anton et al proposed that, in order to execute its fusogenic 
activities, Fzo1 assembles into homo-dimers upon formation of mitochondrial contacts 
facilitating the tethering of the juxtaposed membranes (Fritz et al., 2001; Anton et al., 
2011).  
In mammals, the two broadly, but differentially expressed homologues of Fzo1, Mitofusin 
1 and 2 (Mfn1 and Mfn2) are required for OMM fusion. Mfn1 resides in the OMM and 
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promotes membrane fusion, while Mfn2 localizes to both endoplasmic reticulum and 
mitochondria and is able to tether the two different organelles in trans. Similar to their 
yeast homologues, Mitofusins possess a GTPase domain and a coiled-coil domain (heptad 
repeat domain, HR1) at the N-terminus, protruding towards the cytosol. Mfns are 
anchored to the OMM via two transmembrane domains, which form a U-shape, while 
their C-terminal coiled-coil domain (heptad repeat domain, HR2) faces the cytosol and is 
responsible for the oligomerization (Santel and Fuller, 2001; Santel et al., 2003; Rojo et 
al., 2002). Thanks to their cytoplasmic coiled-coil domains, mitofusins can form homotypic 
(Mfn1-Mfn1, Mfn2-Mfn2) or heterotypic (Mfn2-Mfn1) dimers or complexes, and in that 
way dock two mitochondria to facilitate their fusion. Cells lacking one or both mitofusins 
display a fragmented mitochondrial phenotype, and the Mfn1-null, Mfn2-null or Mfn1/2-
null mice are not viable (Chen et al., 2003; Chen et al., 2005).   
Despite their high degree of structural and functional similarities, mitofusins play 
distinguishable specific roles, with Mfn1 being the core fusion component, exerting the 
higher GTPase activity (Ishihara et al., 2004). Loss of Mfn1 leads to more pronounced 
fusion defects than loss of Mfn2. Accordingly, while Mfn1 is able to rescue completely the 
phenotype of Mfn1 or Mfn2 loss, Mfn2 can only partially correct the mitochondrial 
shaping defects in a Mfn1-/- background, further supporting the central role of Mfn1 (Chen 
et al., 2005).  
The differential functional partners of each protein could further explain differences in 
the function of mitofusins. For instance, only Mfn1 requires adequate levels of OPA1 to 
promote fusion and, conversely, only Mfn1 is implicated in OPA1-driven mitochondrial 
tubulation (Cipolat et al., 2004). Besides OPA1, Mfn1 interacts directly with mitofusin 
binding protein (MIB), controlling mitochondrial morphology by inhibiting mitofusin 
function. Although also Mfn2 coimmunoprecipitates with MIB, it is not yet clear whether 
this interaction is direct or through Mfn1 (Eura et al., 2006).  On the other hand, Mfn2 
interacts specifically with Stomatin-like protein 2 (SLP2) – though without any determined 
role in mitochondrial fusion –  and the Bcl-2 family members Bcl-2 and Bclx. Bak has been 
shown to interact with both mitofusins, but its relative association with each one of them 
is altered during apoptosis (Hajek et al., 2007; Delivani et al., 2006). Finally, Mfn2 
associates with the mitochondrial ubiquitin-ligase membrane-associated ring CH 
(MARCH-V), without being ubiquitinated by this. MARCH-V ubiquitinates the key player of 
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fission machinery, DRP1, indicating that it provides a common regulator of fusion and 
scission yet in a diverse manner (Nakamura et al., 2006).  
 
1.4.2.1.2 Mgm1/OPA1 
Mgm1 is a dynamin-related GTPase that fuses the IMM in yeast. Initially, Mgm1 was 
characterized as a gene important for the maintenance of mitochondrial genome (Jones 
and Fangman, 1992). The protein contains an N-terminal mitochondrial targeting 
sequence (MTS), which is cleaved by matrix-processing peptidase (MPP) after its insertion 
into the organelle. An N-terminal transmembrane serves as a protein anchor to the IMM. 
The other part of Mgm1 consisted of a GTPase domain, a middle domain and two 
hydrophobic segments, is exposed in the IMS (Sesaki et al., 2003; Shepard and Yaffe, 1999; 
Wong et al., 2000). Mgm1 is processed by the rhomboid-related membrane protease 
Pcp1p at steady state; as a result, it appears in two forms: a long form integrated into the 
IMM and a short form lacking the transmembrane domain, located in the IMS. Both Mgm1 
forms are necessary for mitochondrial fusion (Herlan et al., 2003). In addition, Mgm1p 
participates in a complex together with other fusion-promoting proteins - Fzo1p and 
Ugo1p - which as a multimeric unit contributes to the coordination of the simultaneous 
fusion of four mitochondrial membranes in yeast (Wong et al., 2003). 
The orthologue of Mgm1 in mammals was discovered as a product of a gene which is 
mutated in patients with autosomal dominant optic atrophy, hence it was christened 
Optic Atrophy 1 (Opa1) (Alexander et al., 2000). OPA1 gene in humans is built from 30 
exons (Fig. 3), three of which (4, 4b and 5b) are alternatively spliced giving rise to 8 mRNAs 
and polypeptidic variants (Delettre et al., 2001). In spite of the ubiquitous expression, 
patterns vary across tissues, being highly abundant in retina, brain, heart and pancreas. 
Moreover, the relative expression of each isoform also shows tissue specificity (Akepati 
et al., 2008; Delettre et al., 2001).  
At the protein level, although Mgm1 and OPA1 display just 20% amino-acid sequence 
identity, they share highly conserved secondary features (Fig. 3). Specifically, like Mgm1, 
OPA1 possesses an MTS (or MIS) responsible for its targeting to the mitochondria that is 
cleaved upon its import. After MTS, OPA1 contains a putative transmembrane domain 
(exon 1 and 2), which spans the IMM (Delettre et al., 2000; Olichon et al., 2002), a central 
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GTPase and a middle domain. The GTPase domain is crucial for the fusion-promoting 
activity of OPA1 (Cipolat et al., 2004), while the role of OPA1 middle domain is still 
undefined. Considering that in dynamins the middle domain is implicated in higher order 
self-assembly, also OPA1 might form complexes through this domain (Olichon et al., 2007; 
Ramachandran et al., 2007). Additionally, OPA1 has two coiled-coil domains (CC), one 
close to the N-terminus and one in the C-terminus; the latter is considered to function as 
a GTPase effector domain (GED) (Akepati et al., 2008). Both the coiled-coil domains are 
possibly responsible for homotypic or heterotypic protein-protein interactions, and the 
GED domain is also essential for OPA1 fusogenic function (Cipolat et al., 2004). Two 
additional hydrophobic domains (TM2a and TM2b) are present exclusively in the spliced 
exons 4b and 5b. 
Apart from the post-transcriptional regulation, OPA1 is also subject to post-translations 
modifications, mainly due to proteolytic cleavage (Fig. 3). Mitochondrial processing 
peptidase (MPP) acts on the precursor protein to remove MTS upon its targeting into the 
organelle (Ishihara et al., 2006). The result of OPA1 processing at the cleavage site S2 is 
the formation of long and short forms, like in yeast, which can be detected by western 
blotting as five distinct bands ranging from 100 to 80 kDa. The two higher bands are 
considered to be the long forms of the all the splicing isoforms 1, 2, 4 and 7, while the 
three lower molecular weight bands derive from the translation of isoforms 3, 5, 6, 7 and 
8. The long forms are reported to be anchored into the IMM, while the short forms, lacking 
the TM1, are peripherally associated with the membrane facing the IMS (Olichon et al., 
2002; Satoh et al., 2003). Ban and coworkers suggested that the short forms are able to 
associate with cardiolipin in vitro and show an enhanced GTPase activity (Ban et al., 2010). 
The proteases involved in OPA1 cleavage are the rhomboid-related protease presenilin-
associated rhomboid-like (PARL), the inner membrane metalloendopeptidase (OMA1), 
the IMS AAA (i-AAA) protease Yme1L, as well as the matrix AAA (m-AAA) protease subunits 
paraplegin, AFG3L1 and AFG3L2 (Cipolat et al., 2006; Ehses et al., 2009; Griparic et al., 
2007; Song et al., 2007). OPA1 cleavage is either constitutive or inducible. PARL, Yme1l 
and OMA1 cleave OPA1 constitutively to form fusion competent isoforms (long and low 
abundant short). PARL activity on OPA1 is dependent on the phosphorylation status of the 
substrate’s cleavage site, pointing out another layer of OPA1 regulation (Pellegrini and 
Scorrano, 2007), while Yme1l processes exclusively a subset of OPA1 isoforms (Griparic et 
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al., 2007). Besides the cleavage in physiological conditions, OPA1 further processed in 
sites other than S2 in response to apoptotic stimuli or dissipation of membrane potential, 
indicating a dynamic post-translational regulation.  The extensive formation of short OPA1 
forms under these conditions is accompanied by mitochondrial fragmentation, suggesting 
that the long forms are essential for fusion promotion (Ishihara et al., 2006). Inducible 
cleavage in vitro was shown to be mediated by OMA1 (Head et al., 2009). Recently, OMA1 
cleavage of OPA1 was reported also in vivo, under ischemic brain and kidney injury, 
underlining the importance of this regulation as a quality control in pathological 
conditions (Xiao et al., 2014; Baburamani et al., 2015). Moreover, mAAA-protease 
paraplegin has been proposed to cleave OPA1 at the site S1 upon dissipation of membrane 
potential (Ishihara et al., 2006). At last, a novel OPA1 cleavage was identified in 
postprandial liver, that is mediated by an unknown cysteine protease in a Mfn2-
dependent manner, suggesting a more complicated proteolytic mechanism in response 
to metabolic shifts (Sood et al., 2014).  
 
 
Figure 3. Schematic illustration of OPA1 structure. OPA1 displays a mitochondrial import sequence (MIS) 
followed by a predicted transmembrane region (TM1), hydrophobic segments (TM2a and TM2b), as well as 
coiled coil domains (CC), a GTPase domain and a middle domain. TM2a, TM2b and CC0 are found only in 
spliced exons 4b and 5b. OPA1 exons are depicted by double arrows. Inta-mitochondrial proteolytic 
cleavage sites for mitochondrial peptidase (MPP), paraplegin (S1) and YME1L (S2) are indicated above the 
schema. Adapted from (Belenguer and Pellegrini, 2013). 
 
The pro-fusion activity of OPA1 was evident from gene knockout or downregulation. More 
specifically, OPA1 promotes fusion of the IMM, while it does not affect mitochondrial 
docking. Surprisingly, in other reports overexpression of OPA1 led to mitochondrial 
fragmentation, suggesting an opposite function, i.e. fission induction. This observation 
was made only in already elongated mitochondria. However, in such cells mitochondria 
retain their capability to fuse, excluding the possibility that OPA1 additionally mediates 
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fission. Contrary to Mgm1p and mitofusins, OPA1 is not required to be present 
simultaneously in adjacent mitochondria, in order for them to be fused. However, OPA1 
requires MFN1 in order to induce fusion, while Mfn2 is dispensable (Cipolat et al., 2004; 
Griparic et al., 2004; Song et al., 2009). Furthermore, despite some contradictions (Anand 
et al., 2014), it is more likely that both long and short OPA1 forms are essential for the 
accomplishment of its action (Song et al., 2007). Contrary to steady state, stress induced 
mitochondrial hyperfusion relies only on long OPA1 forms (Tondera et al., 2009). 
Additionally, OPA1 regulates mitochondrial ultrastucture maintenance and cristae 
remodeling, independently of its profusion role.  
Recent evidence supports the notion that OPA1 interacts with other proteins, which 
contribute to its fusogenic function, making the picture more complicated.  Apart from 
Mfn1, An et al demonstrated that OPA1 cleavage is controlled by its association with Higd-
1a, which is crucial for proper mitochondrial fusion (An et al., 2013). Moreover, a 
proteomic approach in anti-OPA1 immunoprecipitated mitochondrial extracts from 
Drosophila revealed that dMitofilin (Mic60 orthologue), Hsc70-5 (Mortalin orthologue), 
as well as Marf (Mitofusin orthologue) act as OPA1-like partners, influencing 
mitochondrial morphology (Banerjee and Chinthapalli, 2014). However, the mechanism 
by which they take part in the control of mitochondrial dynamics is not yet clarified. A 
recent study provided evidence that the mitochondrial nucleoside diphosphase kinase 
(NM23-H4), which catalyzes the synthesis of GTP through ATP-driven conversion of GDP, 
provides the fuel for Opa1, enhancing its GTPase activity and thus membrane remodeling 
(Boissan et al., 2014). A few more proteins, specified in the following pages, have been 
proposed to interact with OPA1, regulating though its function on cristae shape. 
Generally, it is obvious that the function of this shaping protein is tightly regulated in 
various levels (transcriptionally, post-transcriptionally, prost-translationally and in a 
protein-protein interaction level), underscoring the significance of its role in the organelle.  
 
1.4.2.1.3 Ugo1 
Ugo1 is another fusion-promoting protein identified in yeast. It is an integral outer 
mitochondrial membrane protein. Its N-terminus is exposed to the cytosol, interacting 
with Fzo1, while its C-terminal faces the IMS and associates with Mgm1. Ugo1p functions 
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as a bridge between Fzo1 and Mgm1, essential for both OMM and IMM fusion (Sesaki and 
Jensen, 2001; Sesaki and Jensen, 2004). Abrams et al characterized a solute carrier 
Slc25a46 as an Ugo1-like protein and showed that it plays a role in mitochondrial 
dynamics. Mutations in Slc25a46 gene are the cause of a spectrum of optic atrophy 
disorders, which have been already associated with OPA1 mutations as well (Abrams et 
al., 2015).  
 
1.4.2.2 Other regulators of fusion 
Fzo1/Mitofusins, Mgm1/OPA1 and Ugo1 are the hitherto well-established fusogenic 
proteins. In the past few years, other proteins have been proposed to participate in the 
control of mitochondrial morphology by promoting fusion. ROMO1 is one of those: its 
silencing leads to mitochondrial fragmentation, loss of cristae, deficient OXPHOS and 
sensitivity to cell death. Norton et al proposed that it acts in the same pathway as OPA1 
and that ROMO1 oligomerization is differentially regulated according to the redox state 
(Norton et al., 2014). Additionally, LETM1 loss results in striking abnormalities in 
mitochondrial morphology, indicating that is a member of the group of mitochondrial 
dynamics regulators (Dimmer et al., 2008). Prohibitin 2 is  another protein that has been 
associated with mitochondrial elongation, as well as in ultrastructure integrity (Kasashima 
et al., 2006). Its exact function is discussed in the following sections.  
 
1.4.2.3 Lipids 
Besides the mitochondrial shaping proteins, recent studies ascribe to non–bilayer-forming 
lipids a role in mitochondrial fusion. In particular, cardiolipin (CL) and 
phosphatidylethanolamine (PE) are required for proper mitochondrial morphology. These 
lipids generate a negative membrane curvature, which facilitates mitochondrial fusion. 
Interestingly, loss of CL and PE in yeast led to mitochondrial fragmentation, along with a 
reduction of the fusion protein Mgm1, interpreting probably the fusion defect. Chan and 
McQuibban proposed that PE influences mitochondrial fusion by regulating biophysical 
properties of the membranes, as well as contributing to the biogenesis of short forms of 
Mgm1. Although the exact mechanisms of action are not fully exploited yet, it is obvious 
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that the delicate functional coordination of lipids and polypeptidic molecules is essential 
for balanced mitochondrial dynamics (Joshi et al., 2012; Chan and McQuibban, 2012).  
 
1.5 The physiological role of mitochondrial dynamics  
Changes in the morphology of mitochondria affect organelle functions, having an impact 
on a wide range of cellular biological processes. In general, mitochondrial dynamics 
provides a mechanism for mitochondrial quality control, keeping the organelles in “good 
shape”. In particular, mitochondrial fusion favors the continuous exchange of 
mitochondrial content, such as mtDNA and metabolites, between different organelle 
units. In that way, a damage in one mitochondrion can be attenuated by its fusion with a 
functional one (Yoneda et al., 1994).  
The link between mitochondrial shaping proteins and mtDNA maintenance was originally 
reported in studies using yeast, showing that functional Fzo1 and Mgm1p are essential for 
the integrity of mitochondrial genome (Guan et al., 1993; Hermann et al., 1998; Rapaport 
et al., 1998). Accordingly, Chen and co-workers observed a lack of mtDNA nucleoids in 
Opa1 null and double Mfn1/2 null cells, suggesting that the mammalian fusion machinery 
is required for the maintenance of the mtDNA organization units (Chen et al., 2007; Chen 
et al., 2010). However, these experiments were conducted in cells with chronic ablation 
of fusogenic proteins and, in contrast, mtDNA copy number is unaltered when OPA1 is 
deleted acutely; hence, the effects on mtDNA stability might be indirect consequences of 
fusion impairment (Cogliati et al., 2013). On the other hand, prevention of mitochondrial 
fission (DRP1 loss of function) is linked to mtDNA loss (Parone et al., 2008). Although there 
are several lines of evidence correlating mitochondrial dynamics to genome stability, this 
link is more likely due to the importance of the balance between fusion and fission events, 
rather than to a selective role of one mitochondrial shaping protein on mtDNA.   
Apart from mtDNA maintenance, several studies have associated the loss of mitochondrial 
shaping proteins to mitochondrial respiration defects. The laboratories of Zorzano and 
Chan, analyzing the effects of Mfn2 mutations or Mfn2 or Opa1 knockdown, observed 
reduced membrane potential and decreased oxygen consumption in these cells (Bach et 
al., 2003; Chen et al., 2005). As far as mitochondrial fission is concerned, its inhibition by 
DRP1 or Fis1 silencing leads to similar bioenergetic defects to those appearing after 
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blockage of fusion regulators, including reduction of respiration rates (Benard et al., 2007; 
Twig et al., 2008). On the other hand, mitochondria overexpressing Mfn2 aggregate in the 
periphery of the nucleus and display an increased membrane potential, while the whole 
cell show an enhanced glucose oxidation. To clarify whether the effects of the 
overexpression were due to increased fusion rates, the researchers performed the same 
analysis with a truncated form of Mfn2 that has no longer the ability to induce fusion. 
Their results suggested that mitochondrial metabolism alterations are not depending on 
the imbalance of mitochondrial dynamics (Pich et al., 2005). In sum, mitochondrial fusion-
fission events might influence the OXPHOS efficiency per se or in indirect manners through 
distinct roles of the mitochondrial shaping proteins (i.e. Mfn2 via regulating the tethering 
of mitochondria to the endoplasmic reticulum, thus controlling calcium influx, Opa1 via 
the regulation of cristae shape, as described in the next chapters). 
Moreover, elongation of healthy mitochondria protects them from clearance by 
autophagy (Gomes et al., 2011). On the other hand, mitochondrial division facilitates the 
mitochondrial biogenesis and the segregation of damaged and dysfunctional 
mitochondria by autophagy (Knott et al., 2008; Twig et al., 2008). Moreover, under stress 
conditions, mitochondrial network is fragmented with parallel changes in the individual 
organelle’s ultrastructure that contribute to the apoptotic pathway, leading to cell death 
(Youle and van der Bliek, 2012). These structural changes upon apoptotic stimulation are 
further described in the following chapters. 
 
1.6 Macromolecular complexes and lipids involved in cristae shape 
integrity 
The cristae are the principal site of oxidative phosphorylation, since its membranes host 
all the complexes implicated in mitochondrial respiration, while the only soluble OXPHOS 
member, cytochrome c, mainly localizes in the area engulfed by cristae (Scorrano et al., 
2002; Gilkerson et al., 2003). Such a highly defined compartmentalization suggests that 
the IMM is organized into cristae to ensure optimal conditions for ATP production 
minimizing the diffusion of metabolites, such as protons and ADP during respiration 
(Demongeot et al., 2007). The shape of cristae changes in response to different 
mitochondrial respiratory states in order to enhance OXPHOS efficiency (Hackenbrock, 
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1966; Mannella et al., 2001; Hackenbrock et al., 1980; Cogliati et al., 2013). Moreover, 
given the fact that factors residing within the folds of IMM, such as cytochrome c, are 
involved in mitochondrial apoptotic pathways (Scorrano et al., 2002), the maintenance of 
an intact ultrastructure is instrumental to protect cells from apoptosis.  
The active modulation of cristae spatial organization is a consequence of spontaneous 
forces, including intrinsic lipid curvature, combined with complex protein interactions and 
binding to other membranes. Regarding the first, the OMM likely serves as a border to 
limit the extension of cristae structures, while the protein-rich matrix determines the 
minimum volume of the inner compartments of the organelles. As far as the lipids and 
protein interactions are concerned, below we describe all the so far identified 
macromolecular factors that affect cristae shape integrity. 
 
1.6.1 MICOS complex 
“Mitochondrial contact site and cristae organizing system” (MICOS) is a large 
heterooligomeric protein structure of the IMM composed by Mic10 (MINOS1), Mic12, 
Mic19 (CHCHD3), Mic25 (CHCHD6), Mic26 (APOO), Mic27 (MOMA1, APOOL) and Mic60 
(Mitofilin) (Fig. 4). Very recently, this complex was described as two independent protein 
assemblies – Mic27/Mic10/Mic12 and Mic60/Mic19 – which are linked via Mic19 (Fig. 5) 
(Friedman et al., 2015a). Moreover, a novel essential MICOS member was identified: the 
protein QIL1 (C19orf70) (Guarani et al., 2015); thus its exact composition and architecture 
are still under active investigation.  A comprehensive evolutionary study revealed a 
widespread conservation of MICOS complex among eukaryotes, but also an origin from 
α-protobacteria – the ancestors of mitochondria. Interestingly, its components are found 
exclusively in organisms with cristae-containing mitochondria (Munoz-Gomez et al., 
2015).  
This whole protein assembly organizes the mitochondrial membranes in terms of inner 
membrane architecture, cristae junction maintenance and IMM-OMM contact sites 
formation (Fig. 4). Genetic ablation of individual MICOS subunits leads to mitochondrial 
fragmentation, cristae junction loss and concentric IMM structures formation. Recently, 
a proposed model in yeast suggested that specifically Mic19 might determine the number 
of cristae junction through its action as a connector of the two independent MICOS 
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subcomplexes found predominantly in different cristae junction. Besides the 
mitochondrial morphology and ultrastructural defects, MICOS disassembly leads to 
reduced respiration, due to faulty OXPHOS complexes distribution and activity. 
Additionally, MICOS dysfunction is correlated to apoptosis impairment and nucleoids 
aggregation (Xie et al., 2007; von der et al., 2011; Alkhaja et al., 2012; Yang et al., 2012; 
Weber et al., 2013; Itoh et al., 2013; Darshi et al., 2011; Friedman et al., 2015b; John et 
al., 2005). Notably, MICOS members have non-redundant functions in yeast since the 
absence of both MICOS subcomplexes leads to more severe morphological and 
respiratory growth defects than deletion of single MICOS subunits or subcomplexes 
(Friedman et al., 2015a).  
 
 
 
Figure 4. A. MICOS complex (Hypothetical model). MICOS complex is required for maintenance of the 
characteristic architecture of inner mitochondrial membrane (IM) and forms contact sites with the outer 
membrane (OM). In budding yeast, six subunits of MICOS have been identified. All subunits are exposed to 
the intermembrane space (IMS), five are integral inner membrane proteins (Mic10, Mic12, Mic26, Mic27, 
and Mic60), and one is a peripheral inner membrane protein (Mic19). The MICOS complex of metazoa 
additionally contains Mic25, which is related to Mic19, yet subunits corresponding to Mic12 and Mic26 have 
not been identified so far. Bold boundary lines indicate MICOS subunits that have been conserved in most 
organisms analyzed. B. Top. Wild-type architecture of the mitochondrial inner membrane with crista 
junctions and cristae. Bottom. This architecture is considerably altered in micos mutant mitochondria: most 
cristae membranes are detached from the inner boundary membrane and form internal membrane stacks. 
Adapted from (Pfanner et al., 2014). 
 
Furthermore, MICOS complex connects the IMM with the OMM through its association 
with the mitochondrial import machinery (SAM and TOM complexes) (Xie et al., 2007), 
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thus displaying an additional, distinct role on mitochondrial protein biogenesis (von der 
et al., 2011). Looking at a higher hierarchical membrane organization, MICOS complex has 
been proposed to consist of a multimeric structure that spans three membranes – the 
endoplasmic reticulum membrane, the OMM and IMM (van der Laan et al., 2012). Apart 
from MICOS, also SAM complex and the endoplasmic reticulum (ER)-mitochondria 
encounter structure (ERMES) participate in this protein machinery - via proposed physical 
and genetic interactions (Hoppins et al., 2011a; Meisinger et al., 2004) -, which likely 
coordinates the inter-organellar organization and communication.  
 
 
Figure 5. The proposed model by Friedman and colleagues. The schematic representation depicts the 
organization and roles of MICOS subcomplexes in budding yeast. Additionally, it indicates the 
interrelationship between MICOS, cardiolipin and respiratory supercomplexes. Adapted by (Friedman et al., 
2015a). 
 
In this Thesis we focus specifically on the major component of MICOS complex, 
consequently a detailed description of its structure and function follows. 
 
Mic60/Mitofilin 
Mic60, also known as Mitofilin/IMMT, Formation of Cristae Junctions (Fcj1) or Heart 
Muscle Protein (HMP) is the largest and one of the core components of MICOS complex. 
Mic60 is a 90kDa protein possessing an N-terminal mitochondrial targeting sequence, a 
transmembrane helix and a C-terminal domain exposed into the IMS; the latter consists 
of a coiled-coil domain and a conserved C-terminal domain (Rabl et al., 2009; Zerbes et 
al., 2012). The same secondary structural sequence is shared between species from yeast 
to human (Rabl et al., 2009; Zerbes et al., 2012). 
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Downregulation of Mic60 results in instability of other MICOS subunits and consequently 
of the whole multiprotein assembly (Li et al., 2015). Mic60-deficient mitochondria of yeast 
and human cells form abnormal interconnected membrane network and cristae 
structures disconnected from the inner boundary membrane, pointing to a conserved 
function of Mic60 on cristae formation and/or maintenance of cristae junctions (Rabl et 
al., 2009; Zerbes et al., 2012; John et al., 2005; Rabl et al., 2009; Zerbes et al., 2012). 
Additionally, downregulation of Mic60 results in OXPHOS defects, abnormal nucleoids 
distribution and impaired mitochondrial translation. The latter link has been explained by 
its interaction with the core nucleoid proteins TFAM and TFB2M (Itoh et al., 2013; Yang et 
al., 2015). Another hypothesis relating Mic60 to mtDNA integrity is its assumed interaction 
with PARP-1 - a nuclear enzyme that translocates in unidentified way inside mitochondria, 
possibly to regulate mtDNA stability (Rossi et al., 2009). Moreover, Mic60  interacts with 
Mic19/Chchd3 – a scaffold protein for MICOS complex, important for Mic60 stability – as 
well as with OPA1, in order to ensure the correct mitochondrial ultrastructure and the 
proper bioenergetic capacity of mitochondria (Darshi et al., 2011). Interestingly, Mic60 
homeostasis is controlled by proteolytic cleavage by the mitochondrial i-AAA protease 
Yme1L (Li et al., 2015). 
Mic60 is reduced by approximately 50% in fetal Down syndrome brain (Myung et al., 2003) 
and is a target antigen in melanoma-associated retinopathy (Pfohler et al., 2007). On top 
of this, Mic60 alterations correlate to various diseases in studies on animal models, 
including cardiomyopathies and neurodegeneration (Van Laar et al., 2008; Omori et al., 
2002; Baseler et al., 2011); thus emphasizing the relevance of cristae network stability for 
cell physiology.  
 
1.6.2 Cardiolipin 
Besides polypeptidic molecules and complexes, also cardiolipin has been associated with 
the modulation of mitochondrial membranes shape, along with mitochondrial fusion, as 
described before. Cardiolipin is a four-tailed phospholipid located predominately in the 
inner mitochondrial membrane, where it is also biosynthesized. This phospholipid has 
been shown to interact non covalently with various proteins, such as the substrate carrier 
proteins (Pebay-Peyroula et al., 2003), cytochrome c (Tyurin et al., 2007) and the 
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respiratory chain complexes (Fry and Green, 1981; Lange et al., 2001; Robinson, 1993), 
playing, therefore, an important role in the complexes activity. On top of this, cardiolipin 
is essential for the respiratory supercomplexes assembly, thus contributing to OXPHOS 
efficiency (Pfeiffer et al., 2003; Zhang et al., 2002). Importantly, cardiolipin is required for 
yeast Mic27/Mic10/Mic12 assembly, suggesting the coordination between lipids and 
proteins for the correct topology of the IMM (Friedman et al., 2015a).  Furthermore, 
cardiolipin is needed for the assembly of the different Mgm1 isoforms in Saccharomyces 
cerevisiae, further supporting the role of this lipid in the modulation of cristae architecture 
(DeVay et al., 2009). Besides mitochondrial respiration, cardiolipin is involved in the 
apoptotic pathway, by providing the platform for action of the proapoptotic proteins BID 
and caspase-8 (Lutter et al., 2000; Gonzalvez et al., 2008).  
From a mechanical point of view, cardiolipin exerts a high-intrinsic-curvature and a 
tendency to form homogeneous clusters that spontaneously localize to curved membrane 
regions of prokaryotic cells in order to stabilize their geometry (Huang et al., 2006). In a 
cell-free, minimal membrane system, cardiolipin is sufficient to form dynamic 
invaginations, similar to cristae, in response to a local pH gradient (Khalifat et al., 2011; 
Khalifat et al., 2008). 
Cardiolipin is post-synthetically modified to produce its mature form. Disturbances in 
cardiolipin maturation are associated with human pathologies, including Barth syndrome 
(Schlame and Ren, 2006), diabetes (Han et al., 2007), heart failure (Sparagna et al., 2007) 
and Parkinson’s disease (Ellis et al., 2005), underlying the important functions of the lipid. 
Barth syndrome is caused by mutations in the gene encoding for the enzyme tafazzin, 
which catalyzes cardiolipin maturation.  Mitochondria of Barth syndrome patients display 
aberrant ultrastructure and disassembled respiratory supercomplexes (Schlame and Ren, 
2006; McKenzie et al., 2006), further supporting the potential function of cardiolipin on 
cristae organization. 
 
1.6.3 ATP-synthase 
Mitochondrial F1F0-ATP-synthase is organized in dimers in the cristae edge, which in turn 
assemble to form oligomers. These long double rows composed by the enzyme dimers 
along the cristae ridges are conserved across species. They were firstly observed by 
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freeze-fracture electron microscopy in Paramecium multimicronucleatum (Allen et al., 
1989) and 3D reconstruction of cryo-electrotomograms confirmed their existence in 
various species, including algae, yeast, plants and mammals (Davies et al., 2012; Strauss 
et al., 2008; Davies et al., 2011). Davies and colleagues suggested that ATP-synthase 
dimers are crucial for cristae morphology, since their formation is the driving force for the 
lipid bilayer bending. This subsequently results to their association into rows due to the 
elastic membrane conformation. Accordingly, the dimer rows favor the positive curvature 
in the cristae tips (Fig. 6). In line with this idea, knocking out either ATP-synthase dimer-
specific subunits e or g, impairing ATP synthase dimerization, leads to onion-like cristae 
structures (Davies et al., 2012; Paumard et al., 2002). In addition, electron 
cryotomography revealed cristae collapse in aging mitochondria, which was accompanied 
by disassembly of ATP-synthase dimers (Daum et al., 2013).  
 
 
Figure 6. Membrane curvature induced by ATP synthase dimers (A) perspective view of a simulated 
membrane patch with an ATP synthase dimer distorting the planar lipid bilayer. (B, C) cross sections through 
the membrane patch in (A) showing the curvature profile of the lipid bilayer in x and y direction. (D) and (E), 
curvature profiles as in (C) for membranes with two or four ATP synthase dimers, side by side. (F) 
perspective view of the row of four dimers shown in (E). Adapted from (Davies et al., 2012). 
 
Apart from the structure and organization of ATP-synthase, also F1F0-ATPase inhibitor 
factor (IF1) has been suggested to determine the cristae shape. When mitochondrial 
respiration is compromised, IF1 negatively regulates the reversed function of ATP-
synthase and, hence, conserves ATP at the expense of Delta(psi). Changes in its levels 
result in alterations in cristae density and oligomerization status of ATP-synthase during 
physiological and pathological conditions (Campanella et al., 2008).   
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Conversely, a study by Bornhövd and colleagues does not prove any direct consequence 
of the destabilization of ATP-synthase rows to cristae morphology. Instead, they proposed 
that mutations in the subunits g and e lead to a reduction of membrane potential due to 
altered inner mitochondrial membrane dynamics, disruption of lipid microdomains and 
subsequent impaired overall flux through the respiratory chain complexes (Bornhovd et 
al., 2006). Consequently, whether the 3D status of ATP-synthase assemblies impact 
directly on cristae curvature is still under debate.  
 
1.6.4 OPA1 complex 
Mgm1p/OPA1 is another protein that regulates cristae shape independently of its 
profusion role (Frezza et al., 2006; Griparic et al., 2004). In both yeast and human cells, 
ablation or mutation of this protein has been associated with cristae disorganization, 
characterized by irregular shape and large cristae junctions, indicating a role in the 
formation and maintenance of cristae.  Interestingly, Amutha et al. demonstrated that 
Mgm1p deficiency additionally correlates to the inability of ATP-synthase to oligomerize. 
Yet, whether this is a cause or the consequence of cristae structure aberrations was not 
clarified (Amutha et al., 2004; Sesaki et al., 2003; Griparic et al., 2004).  
Studies in our laboratory pointed out that mammalian OPA1 controls cristae shape by 
being organized in high molecular weight complexes, which are eliminated upon 
apoptotic stimulation. In particular, OPA1 complexes reside in the cristae junctions 
determining the CJ diameter, as well as cristae lumen width (CLW). Overexpression of 
OPA1 tightens cristae (decreased CLW) whereas, Opa1 depleted cells are more prone to 
cytochrome c release from the cristae into the IMS and eventually to the cytosol, leading 
to increased apoptosis sensitivity. It is worth mentioning that for the formation of OPA1 
complexes both the transmembrane and the soluble form of the dynamin-like protein are 
needed, underlining the importance of OPA1 processing also in cristae biogenesis (Cogliati 
et al., 2013; Frezza et al., 2006; Varanita et al., 2015).  
A similar model has been proposed for yeast Mgm1p by the group of Nunnari  Mgm1p is 
required in trans on mitochondria to maintain their ultrastructure intact, while mutations 
in its GED domain are linked to abnormal cristae structure, suggesting that intermolecular 
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Mgm1 interactions are mechanistically crucial for cristae formation (Meeusen et al., 
2006). 
In spite of the suggested homotypic OPA1 interactions, we cannot exclude the possibility 
that also proteins other than OPA1 are part of these assemblies regulating cristae shape. 
These proteins could act either as OPA1 coplayers to directly function on cristae 
biogenesis or by assisting the complexes formation or even by stabilizing OPA1. Very 
recently, a few lines of evidence supported this hypothesis. Patten et al identified among 
the OPA1 interactors certain mitochondrial solute carriers (SLC25A) , whose ablation or 
inhibition led to loss of the mitochondrial architecture integrity, along with blockage of 
OPA1 oligomerization and function (Patten et al., 2014a). Moreover, Mitofilin (Mic60) and 
Chchd3 (Mic19) have been shown to interact with OPA1 (Darshi et al., 2011). 
 
1.6.5 Prohibitins  
The Prohibitin (PHB) complex is another macromolecular polypeptide assembly in the 
inner mitochondrial membrane, composed by two evolutionary conserved and highly 
homologous proteins, PHB1 and PHB2. Both prohibitins are indispensable for the complex 
formation, which is anchored to the IMM (Artal-Sanz et al., 2003; Tatsuta et al., 2005).  
The ring shape of prohibitins complex could suggest a scaffolding function for proteins or 
lipids (Back et al., 2002; Nijtmans et al., 2000; Browman et al., 2007), essential for the 
modulation of the inner, outer membrane as well as cristae junction organization. Indeed, 
deficiency of PHB2 led to cristae network disorganization and mitochondrial 
fragmentation. These morphological aberrations coincided with excessive OPA1-cleavage, 
increased sensitivity to apoptotic stimulation and impaired cell proliferation, defects that 
were corrected by the reintroduction of a long form of OPA1. Therefore, PHB2 exerts its 
functions on mitochondria via the regulation of OPA1-processing (Merkwirth et al., 2008). 
Another line of evidence supporting this regulation is that PHB1 interacts with SPG7, a 
member of mAAA-protease complex, which is involved in OPA1 proteolytic cleavage 
(Steglich et al., 1999; Duvezin-Caubet et al., 2007).  
Prohibitins are involved also in the biogenesis and assembly of respiratory complexes, via 
their interaction with the protease complex or by a scaffolding action (Steglich et al., 1999; 
Nijtmans et al., 2002). The hypothesis of a scaffold function of prohibitins derives from 
 
 
43 
 
their similarity with a large family of distantly related membrane proteins, the SPFH 
family. Members of this family have been observed in lipid rafts, indicating their scaffold 
action (Tavernarakis et al., 1999; Browman et al., 2007). More specifically, prohibitins 
interact with stomatin-like protein 2, which in turn binds cardiolipin and hence organize 
the respiratory complexes and supercomplexes in an optimal and efficient assembly (Da 
et al., 2008; Christie et al., 2011; Mitsopoulos et al., 2015). Furthermore, a systematic 
study in yeast revealed a genetic interaction between prohibitins and enzymes 
participating in phosphatidylethanolamine (PE) and cardiolipin (CL) biosynthesis. Indeed, 
downregulation of prohibitins in cells with low PE resulted in severe inner membrane 
abnormalities followed by dissipation of membrane potential and cell death (Osman et 
al., 2009). Recently, prohibitin was proposed to interact with DNAJC19 forming a large 
complex to control cardiolipin remodeling. Ablation of any of the components of this 
assembly leads to accumulation of immature cardiolipin, defective cell growth and 
impaired mitochondrial ultrastructure, defects similar to cells from Barth syndrome 
patients (Richter-Dennerlein et al., 2014). All the above data point to a function of 
prohibitins in phospholipid metabolism, which is consistent with its role as a scaffold 
complex. Moreover, prohibitins complex participates in mtDNA maintenance 
(Bogenhagen et al., 2008). Whether this role is due to a direct interaction with mtDNA or 
proteins of the nucleoid structure, like TFAM (Kasashima et al., 2008), or indirect via the 
modulation of the inner membrane structure or lipid composition is still unanswered.    
 
1.6.6 MICS1/GHITM  
Mitochondrial morphology and cristae structure 1 (MICS1), aka TMBIM5 or growth 
hormone-inducible transmembrane protein (GHITM) is a member of Bax inhibitory 
protein-like family. It is ubiquitously expressed in mammalian tissues, and it is 
overexpressed in breast cancers (Reimers et al., 2007; Lisak et al., 2015). MICS1 has seven 
transmembrane domains, which span to the inner mitochondrial membrane, while its 
carboxy-terminal region faces the IMS. As its name points, MICS1 is essential for the 
proper cristae organization, since its downregulation has been associated with less cristae 
and ring-like IMM structures. Similarly to the other members of this family (Bax Inhibitor 
1, Lifeguard and h-GAAP), MICS1 exerts a cytoprotective role through the regulation of 
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cytochrome c release, independently of the modulation of mitochondrial morphology 
maintenance (Oka et al., 2008). Recently, a collective study on Bax inhibitory-like protein 
family revealed a novel function shared between all the members in Ca2+ homeostasis 
(Lisak et al., 2015). However, the precise mechanism of MICS1 action is not clear.   
1.6.7 NOA1 
Nitric Oxide-Associated 1 (NOA1) is a protein highly conserved across bacteria and 
eukaryotes. Although the very first studies on NOA1 orthologues in Helix pomatia and 
Arapidopsis thaliana proposed a catalytic role of NOA1 in NO production, leading the 
authors to christen it as “Nitric Oxide Synthase” (NOS) (Huang et al., 1997; Guo et al., 
2003), this was challenged early after its characterization (Zemojtel et al., 2006a; Moreau 
et al., 2008). Instead, NOA1 is a functional GTPase (Moreau et al., 2008), belonging to the 
circularly permutated GTPase family (Sudhamsu et al., 2008), whose exact function in 
eukaryotes is still obscure. The bacterial homolog of NOA1, YqeH, catalyzes the hydrolysis 
of GTP to GDP in a potassium dependent manner and is essential for Bacilus subtilis 
growth (Anand et al., 2010; Zemojtel et al., 2006b). Its crystal structure, apart from a 
circularly permutated GTPase domain, revealed additionally a peculiar C-terminal β-
domain probably responsible for nucleic acid and peptide recognition (Sudhamsu et al., 
2008). YqeH along with other members of its protein superfamily appeared to be required 
for proper ribosome biogenesis and assembly (Loh et al., 2007; Uicker et al., 2007; Anand 
et al., 2009).  
In eukaryotes, NOA1 contains a classical mitochondrial targeting sequence (MTS) 
(Zemojtel et al., 2006b), but also, according to a recent report, a classical bipartite nuclear 
localization signal (Fig. 7) (Al-Furoukh et al., 2014). In yeast, YOR205C (alternative names: 
mitochondrial GTPase MTG3, AIM40, GEP3, FMP38) was shown to be important for the 
correct assembly of the small mitoribosomal subunit, efficient respiration, as well as 
mtDNA stability (Paul et al., 2012). Two genetic interactome studies in yeast – one in the 
whole mitochondrial genome held in the laboratory of Nunnari J. (Hoppins et al., 2011b) 
and another focused on prohibitins performed by the group of Langer T. (Osman et al., 
2009) – identified YOR205C as a genetic interactor of prohibitins (GEP3), necessary for cell 
survival in the absence of prohibitins. Mutation in its gene correlates to decreased 
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cardiolipin and PE levels. Moreover, GEP3 was associated with mitochondrial genome 
maintenance.  
 
 
 
 
Figure 7. Schematic representation of functional mammalian NOA1 domains. MTS: mitochondrial 
targeting sequence, bZip: basic Leucine zipper domain, NES: nuclear export signal, NLS: nuclear localization 
signal, PLOOP: circularly permutated GTPase domain, TRAP: RNA binding domain, ClpX: ClpX recognition 
motif. Adapted from (Al-Furoukh et al., 2014). 
 
Mammalian NOA1 localizes predominately to mitochondria, being associated with the 
IMM and facing the matrix. The GTPase domain contains a 100-aa insert absent from 
YeqH, which could possibly suggest diversity in its function along evolution. NOA1 is 
ubiquitously expressed in mammalian tissues, being present in a slightly higher level in 
heart, kidney and lung (Tang et al., 2009).  
The significance of this protein’s role for cell survival is underlined by the fact that NOA1 
deficient mice are lethal at midgestation. Interestingly, cells lacking NOA1 exhibit an 
aberrant mitochondrial morphology and cristae structure (Tang et al., 2009; Kolanczyk et 
al., 2011). Like its bacterial homologue, the mammalian NOA1 is essential for the proper 
mitochondrial translation, but also mtDNA maintenance (Kolanczyk et al., 2011; He et al., 
2012). Various lines of evidence from three different groups converge to the role of NOA1 
in mitochondrial metabolism. Tang et al showed reduced mitochondrial oxygen 
consumption when the substrate is only glutamate/malate, as well as an interaction 
between NOA1 and complex I subunits (Tang et al., 2009). On the other hand, Heidler et 
al suggested that NOA1 regulates OXPHOS through its interaction with complex IV and 
RSC facilitating their assembly (Heidler et al., 2011). In the study of Kolanczyk, where the 
knockout NOA1 fibroblasts were generated, a global respiration defect was reported. The 
only complex excluded from the OXPHOS defects was CII, the only one containing 
exclusively nuclear-encoded subunits. Thus, Kolanczyk et al correlated OXPHOS deficiency 
to mitochondrial translation insufficiency (Kolanczyk et al., 2011).  Last but not least, loss 
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of NOA1 was associated with extensive ROS production and oxidative stress, but also 
increased staurosporine-induced apoptosis (Heidler et al., 2011; Kolanczyk et al., 2011).  
Immunoprecipitation followed by stable isotopic labeling by amino acids (SILAC) analysis 
unveiled prohibitin as a potential interactor of mammalian NOA1, a result that is in line 
with the interactome studies on yeast (Heidler et al., 2011; Osman et al., 2009). However, 
the interaction was not confirmed biochemically in mammalian cells. Among the 
suggested candidate interactors of NOA1 is the pro-apoptotic protein death-associated 
protein 3 (DAP3), which is supposed to be a regulator of not only programmed cell death, 
but also mitochondrial dynamics and mitochondrial protein synthesis (Xiao et al., 2015). 
Although it is conceivable that NOA1 plays vital roles for mitochondrial physiology and 
architecture, further investigation is required to unravel its precise function. 
 
1.7 Physiological role of mitochondrial ultrastructure  
The topology of the inner membrane has an impact on specific mitochondrial functions, 
namely metabolism, ROS production and apoptotic signaling. Recently, our laboratory 
provided experimental evidence supporting that the cristae shape influences the 
respiration rate through the regulation of the assembly of the respiratory supercomplexes 
(RCS). More specifically, a mild overexpression of OPA1 caused the tightening of the 
cristae resulting in a higher RCS assembly and hence in an enhanced oxidative 
phosphorylation. These events had a further impact on the cell, since it favored the 
mitochondrial-dependent cell growth (Cogliati et al., 2013). Considering that the cells 
have to respond in the constantly changing metabolic demands of the tissue, it is 
reasonable to hypothesize that, in order to adapt to these, their mitochondria could 
dynamically alter their organization. Indeed, upon starvation or energy substrate 
deprivation, OPA1 oligomerization is rapidly increased to regulate cristae shape and 
improve the bioenergetic status of mitochondria. In this modulation, the OPA1 interactor 
SLC25A is implicated (Patten et al., 2014b).  
Furthermore, oxidative stress causes a reorganization of the IMM of mitochondria of 
protozoans that survive in extreme environments. Under normal conditions, the 
mitochondrial cristae of the amoeba Chaos carolinensis have a tubular shape. This is 
altered remarkably after fasting, leading to the formations of a paracrystalline IMM 
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network with cubic symmetry (Deng et al., 1999). This structural transition coincides with 
increased ROS production, along with breakdown of internal carbon stores. Therefore, it 
was suggested that rearrangement of cristae upon starvation might protect the organelles 
from oxidative damage and, in particular, provide a shelter of RNA while enhancing their 
translation (Deng and Almsherqi, 2015; Deng et al., 2002).  
Last but not least, another example of the correlation between inner membrane dynamics 
and mitochondrial function is the so-called cristae remodeling during apoptosis. Scorrano 
and co-workers demonstrated that stimulation by a truncated form of a pro-apoptotic 
protein, Bid, led to a rapid mitochondrial ultrastructural rearrangement, which was 
characterized by increased interconnectivity of the intracristal spaces and a notable 
widening of the cristae junctions. This dramatic change in the cristae shape is 
accompanied by an enhanced mobilization of the cristae endowed cytochrome c, which 
subsequently amplifies the cytosolic caspase –dependent apoptotic pathway (Scorrano et 
al., 2002). Since my thesis focuses on cristae remodeling during programmed cell death, 
we are dedicating a separate chapter for the detailed analysis of this process.   
Taking into account all the above, interventions of the inner membrane organization 
might serve as a beneficial way to regulate metabolism in pathological situations. 
Interestingly, our lab crossing two animal models characterized by respiratory deficiency 
with mice mildly overexpressing OPA1, demonstrated that amelioration of cristae shape 
can per se counteract mitochondrial dysfunction (Civiletto et al., 2015). 
 
 
Figure 8. Core regulators of mitochondrial morphology and ultrastructure. (a-b) Mitochondrial fusion is facilitated by 
mitofusins and OPA1, and fission by DRP1. (c) OPA1 form complexes determining the shape of cristae junctions. (d) 
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MICOS complex organizes the cristae. (e) Prohibitins participating in the formation of proper mitochondrial architecture. 
(f) ATP synthase dimers stabilize cristae structure by forming the positive membrane curvature. (g) Nucleoids associated 
with ribosomes compose the mitochondrial genome expression machinery, whose optimal function is affected by the 
correct mitochondrial internal organization. The outer mitochondrial membrane is indicating in blue, while the inner 
membrane in green.  
1.8 Diseases associated with aberrant mitochondrial dynamics 
Deregulation of mitochondria-shaping proteins has been associated with a number of 
human pathologies, underscoring the relevance of mitochondrial dynamics in cellular 
functions and tissue homeostasis. Targeting mitochondrial dynamics regulators or 
downstream mitochondrial factors could ameliorate the symptoms or even treat the 
diseases. The broad spectrum of diseases linked to imbalanced fusion and fission or 
aberrant mitochondrial architecture include neuronal and neurodegenerative disorders, 
cancer and diabetes. 
 
1.8.1 Neurodegeneration 
The precise mechanisms underlying neuronal cell loss in neurodegenerative disorders 
remain elusive. Nevertheless, various hints suggest that imbalanced mitochondrial 
dynamics, excessive fission and apoptosis may be liable for some kinds of 
neurodegeneration. 
ADOA 
In 2000, two different research groups identified OPA1 mutations as the cause of 
autosomal dominant optic atrophy (ADOA), which is the most common form of inherited 
optic neuropathy (Alexander et al., 2000; Delettre et al., 2000). ADOA is a clinically 
heterogeneous disease mainly characterized by visual impairment with moderate to 
severe loss of visual acuity, temporal optic disc pallor, blue-yellow dyschromatopsia and 
central scotoma. The penetrance in family members sharing the same mutation and the 
onset of the disease symptoms can vary remarkably (Ferre et al., 2005; Votruba et al., 
1998). From a histopathological point of view, the fundamental pathology shared in all 
the ADOA patients is the degeneration of retinal ganglion cells (RGCs) accompanied by 
optic nerve atrophy (Kjer et al., 1983; Kline and Glaser, 1979). RGCs are the only affected 
cells among the 60 different neuronal cell types found in the retina. Although Opa1 
protein level in the retina are particular high (Alexander et al., 2000) they are not higher 
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in RGCs than in any other retinal cells (Kamei et al., 2005); thus the reason for ADOA 
specificity is still unidentified.  
The hundreds of the different Opa1 mutations published so far – collected in the eOPA1 
database – consist of substitutions, as well as deletions and insertions. They have been 
detected to locate in various regions of the protein, including the GTPase domain, but also 
other functional OPA1 regions (N-terminus, coiled coil domains, middle and GED domain)  
(Ferre et al., 2005). The majority of the mutations lead to a truncated product, which 
probably causes loss of function, suggesting that haploinsufficiency causes the 
pathogenesis of the disease (Marchbank et al., 2002; Pesch et al., 2001). Besides 
haploinsufficiency, some data indicate that the mutated OPA1 might act in a dominant 
negative way by binding to wild-type protein, impairing the mechanoenzymatic activity of 
the protein complex. Alternatively, the missense mutations might ablate the 
oligomerization capacity of OPA1 and hence, affect its functions in membrane fusion 
and/or cristae junction maintenance (Pesch et al., 2001).  
The molecular mechanism explaining ADOA pathogenesis in the presence of Opa1 
mutations is not clear yet. A study in fibroblasts from ADOA patients revealed a 
remarkable sensitivity of these cells to death stimulation, suggesting that possible the 
antiapoptotic function of OPA1 is defective in these pathological cases (Olichon et al., 
2003). Although several studies in human patients point out the common feature of 
mitochondrial fragmentation, contradictory results have been reported in regards to 
mitochondrial respiration dysfunction (Lodi et al., 2004; Spinazzi et al., 2008; Zanna et al., 
2008; Mayorov et al., 2008). Interestingly, a detailed survey in ADOA patients with poor 
or normal vision revealed that mitochondria of the former display abnormalities in 
OXPHOS, while those of the latter show increased respiration, which might act as 
compensation to preserve vision (Van Bergen et al., 2011).  
For further investigation, two ADOA mouse models of the disease have been developed 
in which the animals carry Opa1 mutations in the GTPase domain (missense or nonsense). 
The heterozygous mutant mice display a progressive loss of RGC, abnormalities in the 
number, shape and myelinization of axons, along with visual impairment. RGC of these 
mice show increased autophagy rates, the reason of which is not determined yet (Alavi et 
al., 2007; Davies et al., 2007; White et al., 2009).    
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Charcot-Marie-Tooth Disease Type 2A (CMT2A) 
Charcot-Marie-Tooth neuropathy Type 2A (CMT2A) is another example of a hereditary 
disorder in which mutations on a mitochondrial shaping protein, Mfn2, have been 
identified as the causative factors (Zuchner et al., 2004). Charcot-Marie-Tooth 
neuropathies are inherited in an autosomal dominant way and manifest with clinical 
symptoms like weakness and distal muscle atrophy, as well as sensory loss. Additional 
signs of CMT are decreased reflexes, foot deformities, cranial nerve involvement, scoliosis 
and glaucoma. The pathophysiological basis of type 2 CMT include the chronic axonal 
degeneration and regeneration leading to the loss of sensory and motor axons (Dyck et 
al., 1998; Dyck et al., 2000). 
The detected mutations in the gene of Mfn2 are several and cluster mainly in the region 
that encodes the GTPase domain, without though being limited only in this region (Kijima 
et al., 2005; Lawson et al., 2005; Zuchner et al., 2004). The genetic and clinical 
heterogeneity complicate the investigation of the link between genotype and phenotype, 
and indeed the molecular pathogenesis of CMT2A with Mfn2 mutations is still unclear. 
Mfn2 ablation in a mouse model correlated the lack of mitochondrial fusion with the 
impairment of dendrite outgrowth, spine formation and cell survival. Based on these 
observations, the authors suggested that fusion is crucial for the mitochondrial content 
exchange and the proper organelle distribution in the neurons (Chen et al., 2007). Given 
the distinct role of Mfn2 in tethering ER to mitochondria modulating calcium flux, (de Brito 
and Scorrano, 2008b), an alternative probable pathway implicated in CMT2A 
pathogenesis could be calcium signaling, which is very important for neuronal cells. 
Further studies are required to address the open questions regarding the etiology of this 
neurodegenerative disorder. 
 
Charcot-Marie-Tooth Disease Type 4A (CMT4A) 
Another type of Charcot-Marie-Tooth neuropathy (CMT4A) has been correlated to 
mutations in a member of the fission machinery, GDAP, further supporting the notion that 
a balance between fission and fusion is detrimental for neurons functions (Baxter et al., 
2002; Cuesta et al., 2002). Analyses in a mouse model indicated that loss of functional 
GDAP leads to abnormalities in calcium homeostasis; a probable reason for the 
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pathogenesis of the disease, due to aberration in mitochondrial network (Barneo-Munoz 
et al., 2015). 
 
Abnormal brain development  
In 2007 a mutation in the DRP1 gene was found to be responsible for microcephaly, 
abnormal brain development, optic atrophy and death of a newborn female patient 
(Waterham et al., 2007). Further biochemical investigation on the case revealed that the 
mutation localized in the middle domain of the fission protein and unraveled that this 
domain is crucial for the formation of DRP1 high-assemblies and the subsequent induction 
of mitochondrial division (Chang et al., 2010). 
 
Other neurodegenerative disorders 
Mitochondrial dynamics deregulation has been additionally linked to the most common 
neurodegenerative disorders (Alzheimer’s, Huntington’s and Parkinson’s diseases). Cho 
and colleagues demonstrated that amyloid-β, which is associated with Alzheimer’s 
disease (AD), induces S-nitrosylation of DRP1. Consequently, the mitochondria are 
fragmented and dysfunctional, contributing to the pathogenesis of AD (Cho et al., 2009).  
Our laboratory has demonstrated that mitochondrial fragmentation and cristae 
alterations are two important traits of Huntington’s disease (HD). Increased activity of the 
phosphatase calcineurin dephosphorylates DRP1, leading to its excessive translocation to 
mitochondria followed by fission of the organelles in HD cells. The fragmented 
mitochondria display hypersensitivity to cristae remodeling and apoptosis (Costa et al., 
2010). In a slightly different model, the causative factor of Huntington’s disease, mutated 
Huntingtin has been shown to trigger mitochondrial scission, via its abnormal binding to 
DRP1, stimulating its enzymatic activity. Impairment in mitochondrial dynamics leads 
likewise to defects in the organelles intracellular transport and eventually to cell death in 
an HD rat model and in fibroblast of HD patients (Wang et al., 2009; Song et al., 2011).  
Finally yet importantly, familiar Parkinson’s disease has been linked to mitochondrial 
morphology and function, since two of the basic proteins involved in its pathogenesis, 
Parkin and PINK1, influence the fusion machinery in a Mfn2-dependent manner, as well 
as the degradation of the organelles through mitophagy (Knott and Bossy-Wetzel, 2008). 
On top of this, missense mutations of OPA1 have been found in sporadic Parkinsonism, 
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which were associated with impaired fusion, respiration and increased autophagy and 
mitophagy (Carelli et al., 2015). In line with this discovery, sporadic Parkinson’s disease 
has been correlated to fragmented mitochondrial network, due to abnormal processing 
of OPA1 or to excessive DRP1 translocated in the OMM. Although overexpression of OPA1 
could not correct the mitochondrial dysfunctions, DRP1 knockdown was sufficient to 
rescue the phenotype (Santos et al., 2015). Intriguingly, according to a study in a 
Parkinson’s disease mouse model concluded that inhibition of DRP1 could serve as a 
promising therapeutic strategy for the neuronal disease (Rappold et al., 2014).  
Collectively, disruption of mitochondrial dynamics seems to be a common trait in a variety 
of neurodegenerative disorders and inhibitors of mitochondrial fission/fusion could serve 
as promising therapeutic strategies for them.   
 
1.8.2 Cancer 
Increasing amount of data indicate that mitochondrial dynamics is altered in various types 
of cancer. Clinical studies in lung adenocarcinoma unraveled an overexpression of DRP1 
along with its peculiar localization in the nucleus preventing its translocation to 
mitochondria, rendering resistance of the tumor to cisplatin (Chiang et al., 2009). 
Upregulation of DRP1 expression as well as downregulation of Mfn1 expression has been 
observed in invasive breast malignancies in comparison with non-metastatic tumors. 
Therefore, deregulation of mitochondrial dynamics appears to be implicated in the 
migration of breast tumors (Zhao et al., 2013a). Furthermore, DRP1 upregulation has been 
associated with malignant oncocytic thyroid tumors (Ferreira-da-Silva et al., 2015). In 
addition, another protein of the fission machinery FIS1 is upregulated in some malignant 
subtypes of malignant melanoma (Su et al., 2009). Besides players of fusion and fission, 
also proteins that influence mitochondrial ultrastructure, such as prohibitins, have been 
involved in carcinogenesis (Czarnecka et al., 2006). One could hypothesize that prohibitins 
are implicated in tumorigenesis through their role in regulating the functional processing 
of the anti-apoptotic protein OPA1. However, the topic is not explored yet. Nevertheless, 
there are some lines of evidence indicating that OPA1-dependend cytochrome c release 
and cell death could contribute to malignancies and possibly serve as a target to sensitize 
cancer cells (Zhao et al., 2013b). Given the extremely complex biology of cancers and the 
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multiplicity in the functions of mitochondrial shaping proteins, investigation is needed to 
shed light on the mechanism how mitochondrial dynamics are involved in cell 
transformation and metastasis.  
 
1.8.3 Type I Diabetes 
Type I diabetes is an autoimmune disorder which results from the autoimmune 
destruction of the insulin-producing β cells in the pancreas. Accumulation of glucose in 
blood and urine is a common feature in diabetes and can cause various complications, 
including cardiac dysfunction. Coronary endothelial cells from diabetic mice, as well as 
high-glucose treated neonatal cardiac myocytes possess fragmented mitochondria, 
displaying a downregulation of OPA1 and an upregulation of DRP1 (Makino et al., 2011; 
Makino et al., 2010). On the other hand prohibitin has been shown to have a protective 
role in pancreatic β cells, possibly due to its control of OPA1 processing (Lee et al., 2010). 
 
1.9 Mitochondria as cell death executioners 
Apoptosis is a process crucial for the embryonic development in metazoan, adult tissue 
turnover, as well as for host defense pathways and the protection from cancer. 
Insufficiency or acceleration of apoptosis, is associated with diseases, including cancer, 
autoimmunity or neurodegenerative disorders (Danial and Korsmeyer, 2004). All the 
pathways of apoptosis converge on the activation of caspases, proteases that orchestrate 
the efficient and non-inflammatory demolition of cells. 
The two main pathways leading to caspase activation include: a) the extrinsic route 
initiated by cell surface death receptors leading directly to caspase 8 activation, and b) 
the intrinsic pathway that is regulated by mitochondria. The intrinsic pathway is activated 
after an internal damage, such as DNA damage, lack of nutrients or oxygen (Scaffidi et al., 
1998; Scaffidi et al., 1999). In certain cell types, like hepatocytes, the extrinsic branch is 
not sufficient to directly activate caspases-8; therefore, they require, additionally, a 
mitochondrial amplification loop.  
The discovery by the group of Korsmeyer that the antiapoptotic oncogene Bcl-2 targets 
its product to mitochondria (Hockenbery et al., 1990) strongly suggested that they were 
actively involved in the control of programmed cell death. A few years later, cytochrome 
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c, the only soluble component of the respiratory chain inside the cristae, was proved to 
be required in the cytosol to instigate apoptosis, while presumably, disabling energy 
production from mitochondria (Liu et al., 1996). Indeed, after the activation of both 
pathways, mitochondria release cytochrome c in the cytosol that in complex with APAF-1 
activate caspase 9 by processing, which in turn activates the effector caspase 3, thus 
triggering cell death (Cain et al., 2002; Garrido et al., 2006). Furthermore, several soluble 
factors of mitochondria, other than cytochrome c, have been shown to participate in the 
apoptotic machinery, among which Smac/DIABLO. Nevertheless, whether SMAC acts as 
proapoptotic or antiapoptotic protein is still under debate (Verhagen et al., 2000; Du et 
al., 2000; Martins et al., 2004). Apoptosis-inducing factor (AIF), endonuclease G (EndoG) 
and Omi stress-regulated endoprotease are three other mitochondrial proteins released 
to the cytosol upon apoptosis stimulation, yet they function in a caspase-independent 
manner (Li et al., 2001; Susin et al., 1999; Verhagen et al., 2002). 
The mitochondrial pathway of cell death is finely regulated by the BCL2-family members, 
which comprise a functionally diverse set of proteins with sequence and structural 
similarity. They possess α-helices with sequence conservation in BCL-2 homology (BH) 
domains. These proteins are categorized as pro-survival and pro-apoptotic proteins, 
according to the BH domains they possess. The pro-survival proteins, like BCL-2, BCL-XL 
and BCL-W, exhibit the homology in all BH1 to 4 regions. The pro-apoptotic polypeptides 
lack stringent sequence conservation of the first α-helical BH4 domain and can be further 
subdivided into ‘‘multidomain’’ and ‘‘BH3-only’’ proteins. Multidomain pro-apoptotic 
members, such as BAX and BAK, display sequence conservation in BH1, BH2 and BH3 
domains, while BH3-only members (BIM, BID, BAD, BIK, NOXA, PUMA, Hrk, Bmf) display 
sequence conservation exclusively in the amphipathic α-helical of the BH3 region (Adams 
and Cory, 2001). The multidomain pro-apoptotic members BAX and BAK are required for 
apoptosis execution in response to diverse stimuli, including intrinsic and extrinsic death 
signals, since cells deficient of both proteins show resistance to cell death (Lindsten et al., 
2000; Wei et al., 2001). 
As the anti-apoptotic BCL-2 family members closely resemble the pro-apoptotic members 
in structure, it is proposed that they function as dominant negative inhibitors by binding 
to BAX and BAK and hampering programmed cell death. In agreement with this notion, 
Nouraini and coworkers demonstrated that BAX associates with the anti-apoptotic 
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protein BCL-XL, inserting the BH3 domain in the hydrophobic grove of the latter (Nouraini 
et al., 2000). 
The BH3-only proteins, such as Bid, reside upstream in the pathway and they can directly 
or indirectly activate BAX and BAK (Wei et al., 2000). Death signals trigger their activation 
by transcriptional regulation or post-translational modification to connect proximal 
signals with the cytochrome c release. For example, after activation of CD95 (Fas) or 
TNFR1 death receptors, BID is cleaved and to p15 tBID by caspase 8, thus it is activated. 
The efficiency of the translocation process at the OMM surface can be enhanced by 
modifications such as the N-terminal myristoylation of tBID that follows its cleavage by 
caspase-8 (Luo et al., 1998; Zha et al., 2000; Gross et al., 1999). 
The mechanisms by which activated BH3-only proteins interact with the pro-survival 
members are summarized in two models (Adams and Cory, 2007). 
A. The direct activation mode: certain BH3-only proteins, termed activators, namely 
Bim and tBid, can directly bind to BAX and BAK and promote their activation (Letai 
et al., 2002; Walensky, 2013; Walensky et al., 2004). According to this model, the 
remaining BH3-only proteins, termed sensitizers, bind only to the pro-survival 
proteins and act by displacing any bound BIM or tBID, allowing them to directly 
activate BAX and BAK.  
B. The indirect activation model: all the BH3-only proteins bind solely their pro-
survival relatives; thereby they act by preventing them from countering BAX or 
BAK activation (Willis et al., 2007). In this model, BIM and tBID are potent inducers 
of apoptosis simply because they can engage all the pro-survival proteins. 
 
1.9.1 OMM permeabilization 
Until very recently, it was believed that in healthy cells BAX was exclusively residing into 
the cytosol, while it was actively translocated to mitochondria upon apoptotic stimulation 
(Hsu et al., 1997; Wolter et al., 1997).  However, elegant studies using FLIP (fluorescence 
loss in photobleaching) and FRAP (fluorescence recovery after photobleaching) 
challenged this and proposed that BAX localizes predominantly to mitochondria, but is 
actively retro-translocated by pro-survival proteins to the cytosol (Todt et al., 2013; 
Schellenberg et al., 2013). In such a model, inhibition of retro-translocation causes BAX to 
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accumulate at mitochondria, thereby sensitizing cells to apoptosis. In contrast to BAX, BAK 
was thought to be constitutively anchored into the OMM (Ferrer et al., 2012). A very 
recent study suggests that also BAK shuttles from mitochondria to the cytosol, though 
with a slow pace, resulting in its predominant localization on the organelles membrane 
(Todt et al., 2015). Why these proteins move back and forward in the cellular 
compartments is still an open question. One would speculate that in this way BAX and 
BAK are “ready to attack” after a swift in the balance of kinetics. Alternatively, BAX and 
BAK might have additional functions on different fields of action. Interestingly, BAX is 
involved in mitochondrial fusion and in calcium dynamics on the ER-mitochondria 
interface (Hoppins et al., 2011c; Scorrano et al., 2003). Therefore, the retro-translocation 
might serve as a mechanism to integrate diverse roles of a multifaceted molecule. 
Nevertheless, under physiological conditions, both multidomain pro-apoptotic members 
are found in “harmless” monomers. Upon receipt of death signal BAX and BAK undergo 
major conformational changes, triggered by BH3-only proteins, leading to their activation 
(Dewson et al., 2008; Gavathiotis et al., 2010). Once activated, BAX and BAK have exposed 
hydrophobic regions that need to be buried in a membrane or a protein interface, leading 
to the formation of membrane-spanning high-molecular weight oligomers. Recently, 
Subburaj et al showed that BAX forms dimers in the OMM that further self-assemble into 
multimeres (Subburaj et al., 2015). BAX/BAK oligomerization in the OMM is responsible 
for the membrane permeabilization, which is a crucial step for cytochrome c release to 
the cytosol (Newmeyer and Ferguson-Miller, 2003).  
The exact mechanism by which BAX/BAK mediates the egress of cytochrome c is still 
obscure. A probable scenario is that the BAX/BAK-mediated apoptotic pores in the OMM 
are permeable to cytochrome c and possibly to other IMS pro-apoptotic proteins. 
Alternatively, BAX and BAK cooperate with resident mitochondrial proteins, such as the 
channel VDAC or ANT, triggering permeability transition and subsequently cytochrome c 
release (Marzo et al., 1998; Shimizu et al., 1999). A different model suggests that the 
BAX/BAK-induced permeabilization of OMM is enhanced by various factors, including 
lipids that lead to a disruption of bilayer (Kluck et al., 1999; Kuwana et al., 2002). In any 
case, BAX/BAK permeabilization appears to be an important step for cytochrome c 
release; nonetheless, it is not sufficient for the completion of the process. 
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1.9.2 Alterations in mitochondrial morphology during apoptosis 
One of the major criteria to distinguish apoptosis from necrosis was the morphological 
derangement of mitochondria in the latter, but not in the former. Accordingly, the notion 
that mitochondrial shape changes during programmed cell death was unexplored for 
many years, despite the understanding that soluble components are released from 
mitochondria during apoptosis. Nevertheless, research of the two last decades revealed 
that mitochondrial organization is altered in apoptotic cells. These rearrangements 
include a) the fragmentation of mitochondrial network and b) changes mitochondrial 
membrane topology.  
 
1.9.2.1 Mitochondrial fragmentation 
The first links between mitochondrial fragmentation to apoptosis were provided by 
studies of Martinou et al and Frank et al. DRP1, the key fission regulator, plays a central 
role in this process, since a dominant negative mutant of DRP1 inhibits cell death (Frank 
et al., 2001; Martinou et al., 2000). The importance of apoptotic fission was substantiated 
in the nematode Caenorhabditis elegans, where the homologue of DRP1 is required for 
programmed cell death during development (Jagasia et al., 2005). Upon apoptosis 
induction, DRP1 translocates to mitochondria and forms polypeptidic assemblies in the 
constriction sites, together with the proapoptotic protein BAX and the fusogenic protein 
Mfn2 (Karbowski et al., 2002). The function of this protein association is not fully 
understood.  Yuan and coworkers proposed that DRP1 foci formation into neuronal 
mitochondria precedes BAX translocation and it provides a platform for recruitment of 
apoptosis executors and fusion/fission regulators (Yuan et al., 2007). Conversely, the 
DRP1 dominant negative mutant does not block BAX translocation to mitochondria, 
indicating that the former acts downstream of BAX (Karbowski et al., 2002). However, loss 
of DRP1 prevents cytochrome c release, even though BAX has moved to the mitochondria 
(Lee et al., 2004). Furthermore, BAX activation enhances the stability of DRP1 on 
mitochondria by controlling its SUMOylation (Wasiak et al., 2007). All the above suggest 
that fission and cytochrome c release are subject of regulation of the same protein very 
close in time, but likely as two distinct events. Moreover, FIS1 has been demonstrated to 
act as a pro-apoptotic protein, independently of DRP1, possibly by recruiting proteins in 
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mitochondria (Lee et al., 2004) or by engaging the calcium dependent function of BAX and 
BAK at the endoplasmic reticulum (Alirol et al., 2006). 
Besides the components of fission machinery, also Mfn2 participates in mitochondrial 
related apoptotic events. Mfn2 co-localizes in the foci of DRP1 and BAX in a GTPase 
dependent manner. Overexpression of Mfn2, residing in this foci, induce apoptosis. 
Conversely, when Mfn2 is restricted outside the foci, BAX translocation is inhibited 
(Karbowski et al., 2002; Neuspiel et al., 2005; Huang et al., 2007). Therefore, this protein 
seems to be important for BAX-mediated initiation of cell death, but most likely 
independently of its effects on mitochondrial dynamics. A possible explanation could be 
that there is an increased tethering between ER and mitochondria in the Mfn2-containing 
puncta (de Brito and Scorrano, 2008a), favoring the enrichment of lipids required for BAX-
BAK permeabilization of the OMM in these sites (Kuwana et al., 2002). 
 
1.9.2.2 Cristae remodeling 
Kinetic studies of cytochrome c release in response to any apoptotic stimulation indicated 
that the release is a rapid and single step procedure whose extent is remarkably complete 
(Goldstein et al., 2000). Noteworthy, the narrow IMS contains only 15%-20% of total 
cytochrome c, while the majority of it resides inside the cristae (Frey and Mannella, 2000; 
Bernardi and Azzone, 1981). Accordingly, besides BAX/BAK action and OMM 
permeabilization, another process should occur for the substantial release of cristae-
endowed cytochrome c, prior to any mitochondrial swelling. This pathway involves a 
striking reorganization of the IMM - the so-called cristae remodeling - and contributes to 
the inversion of cristae curvature with a simultaneous mobilization of the cytochrome c 
stored inside the cristae. More specifically, 3D electron tomographic analysis and 
physiological measurements revealed a notable widening of the narrow cristae junctions 
and fusion of independent cristae in isolated mitochondria or intact cells treated with tBID 
(Fig. 9). These morphological alterations in response to death stimulus are time- and 
stimulus concentration-dependent. Remarkably, this process can be inhibited by 
cyclosporine A, which blocks the permeability transition pore, suggesting a correlation 
between cristae remodeling and the opening of the IMM channel. Moreover, cristae 
reorganization early during apoptosis is independent of BH3 domain and of BAX/BAK-
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mediated OMM permeabilization, suggesting that tBID has two distinct targets: a. 
BAX/BAK to mediate the cytochrome c across the OMM and b. an alternative factor that 
facilitates cristae remodeling (Scorrano et al., 2002; Yamaguchi et al., 2008). Apart from 
tBID, also other death stimuli, like BIK, BIM and Fas activation, lead to apoptotic IMM 
remodeling (Germain et al., 2005; Mootha et al., 2001; Yamaguchi et al., 2008). 
 
 
Figure 9. Cristae remodeling during apoptosis. Upon tBID, BIM or BIK stimulation, the narrow cristae 
junctions widen and the independent cristae fuse.  
 
OPA1, as cristae shape and diameter regulator, plays a crucial role during apoptotic cristae 
remodeling. OPA1 resides in high molecular weight complexes, which act as a molecular 
staple between the adjacent cristae membranes and, hence, maintain the cristae 
junctions close. Early after stimulation by tBID, BIM and BNIP3, these complexes are 
targeted, since they rapidly disassemble with a concomitant opening of the cristae 
junctions and the complete cytochrome c release (Fig. 10). Accordingly, high levels of 
OPA1 stabilize the protein assemblies and prevent the mobilization of cytochrome c, while 
silencing of its gene results in an increased cristae junction diameter (Frezza et al., 2006; 
Landes et al., 2010; Yamaguchi et al., 2008).   
OPA1 complexes targeted during apoptosis consist of both the long membrane integral 
forms and the short soluble forms of the protein. Among the proteases involved in the 
processing of OPA1 is the presenilin-associated rhomboid-like (PARL), which specifically 
participates in the control of cristae remodeling, via the balanced generation of OPA1 
soluble forms. Cells lacking PARL display reduced levels of short OPA1 form, along with 
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faster apoptotic cristae rearrangements and cytochrome c mobilization towards the 
cytosol, as well as sensitivity to intrinsic apoptotic stimuli (Cipolat et al., 2006). 
An outstanding question is how OPA1 complexes are disassembled during programmed 
cell death. Yamaguchi et al demonstrated that the elimination of the complexes requires 
the presence of BAK, without its activation, further supporting the notion that cristae 
remodeling is not a direct consequence of OMM permeabilization (Yamaguchi et al., 
2008). Recently, Jiang and coworkers proposed that OPA1 is cleaved by OMA1 upon 
apoptotic stimulation, leading to the disassembly of the complexes and cytochrome c 
release. The authors linked OMA1 activation to the upstream event of BAX and BAK 
oligomerization, thus placing the two distinct pathways into one (Jiang et al., 2014). 
Nevertheless, studies in our lab succeeded in genetically dissecting outer mitochondrial 
membrane permeabilization from cristae remodeling (Cogliati et al., 2013). Cogliati and 
colleagues took advantage of two mutants of the prototypical inducer of cristae 
remodeling, BID: 
a) The already known BIDG94E, which carries a mutation at the BH3 domain and, thus, 
it is unable to induce opening of the permeability transition pore and cytochrome 
c mobilization (Wei et al., 2000). 
b) BIDKKAA that carries two mutations in the highly conserved lysines of its α6 helix. 
This domain shares high homology not only with the transmembrane domains of 
Bnip3 and BimS, that also remodel cristae, but also with mastoparan (a peptide of 
wasp venom, which perturbs mitochondrial inner membrane) (Pfeiffer et al., 
1995; Landes et al., 2010; Yamaguchi et al., 2008; Cogliati et al., 2013).  While 
BIDG94E induces no cytochrome c release, BIDKKAA is able to release 20%-30% more 
cytochrome c than the baseline, which corresponds to the IMS cytochrome c 
stores. In general, BIDKKAA is sufficient to induce BAX and BAK oligomerization, but 
it is incapable to disrupt OPA1 complexes and trigger cristae remodeling (Fig. 10). 
Consequently, BID exerts two distinct functions in mitochondria via two different 
protein domains (Cogliati et al., 2013). 
 
 
 
 
61 
 
 
Figure 10. OPA1 complexes disruption, cristae remodeling and outer membrane permeabilization upon 
cBIDwt stimulation. The mutant cBIDKKAA is sufficient to induce OMM permeabilization, while is it unable to 
dissociate OPA1 complexes and induce cristae remodeling. OMM: outer mitochondrial membrane, IMM: 
inner mitochondrial membrane.  
 
A possible mechanism by which tBID causes cristae remodeling is through its capacity to 
bind selected lipids, i.e. cardiolipin of IMM (Esposti et al., 2001; Gonzalvez et al., 2005). 
According to this hypothesis, cardiolipin per se as well as its oxidation is essential for BID 
induced apoptosis (Lutter et al., 2000; Ott et al., 2002). Recently, another BH3-only 
protein inducer of apoptotic cristae remodeling Bnip3 has been proposed to interact 
OPA1, and hence destabilizing its high molecular weight complexes (Landes et al., 2010). 
This line of evidence supports the notion that also BID potentially interacts directly with 
OPA1 or other protein that incorporates in the complexes targeted during apoptosis, 
exerting its action. 
As judged by blue native PAGE, multiple OPA1 containing complexes exist (Cogliati et al., 
2013), suggesting that other proteins participate in their assembly and elimination upon 
apoptotic stimulation. Moreover, considering that OPA1 is a multifunctional protein, it is 
conceivable that the candidate partners of this protein participate in the regulation of the 
various functions, an hypothesis that calls for investigation. 
 
1.9.2.3 Impact of cristae remodeling on physiology 
In addition to its role in cytochrome c release, cristae remodeling also impairs 
mitochondrial function by the disassembly of respiratory supercomplexes (Cogliati et al., 
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2013). A very recent study of our laboratory shed light into the relevance of apoptotic 
cristae remodeling in vivo using OPA1 transgenic mice as a genetic tool. OPAtg cells 
showed resistance to cristae remodeling and cytochrome c release, as expected. 
Furthermore, OPA1tg mice displayed a protection from cell death upon activation of FAS 
pathway. Experimental evidence from these mice indicated that OPA1-dependent cristae 
remodeling plays a fundamental role in cell death following tissue damage, including 
acute or chronic muscular atrophy, brain and heart ischemia and apoptotic liver damage 
(Varanita et al., 2015). As a result, it has been proposed that cristae remodeling could 
serve as a promising target for pathologies in which cell death due to tissue damage 
occurs. 
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2. Hypothesis and aims of the thesis 
 
Given the relevance of cristae integrity and remodeling during apoptosis in cell physiology 
and pathology, we aimed to provide further insight into their regulation by OPA1. OPA1 
is retrieved in multiple complexes. The size of the OPA1-containing complexes that are 
targeted during apoptosis range from 500 to 800 KDa, as judged by blue native gel 
electrophoresis and by size exclusion chromatography. Therefore, we hypothesized that 
OPA1 is not the only component of the complexes, but instead cooperates with other 
proteins to control cristae remodeling.  
In this thesis, we specifically aimed to identify and characterize biochemically and 
functionally the components of OPA1 complexes targeted during apoptosis. We took 
advantage of three-dimensional Blue Native – Blue Native – SDS electrophoreses that we 
adapted to proteomic strategies, in order to retrieve all the proteins that compose the 
native complexes of interest. Two identified candidate OPA1 interactors were further 
analyzed biochemically in order to explore their role in cristae biogenesis, cristae 
remodeling, mitochondrial morphology and physiology.  
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2.1. A molecular atlas of the Optic atrophy 1 (Opa1) high molecular 
weight complexes targeted during apoptotic cristae remodeling 
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ABSTRACT 
 
Optic Atrophy 1 (OPA1) is a dynamin-like protein of the inner mitochondrial membrane 
that controls cristae shape and remodeling required for complete cytochrome c release. 
The composition of the OPA1 high molecular weight (HMW) complexes disrupted upon 
apoptotic stimulation is unknown. Here we inspected by quantitative and semi-
quantitative proteomic approaches native OPA1-containing complexes of three 
different tissues to create a compendium of the proteins whose distribution is altered 
during apoptotic cristae remodeling. This approach identified members of MICOS 
complexes, the mitochondrial calcium uniporter and its regulators, and proteins with 
undefined biological function, like GHITM. Biochemical analysis of these candidates 
validated our proteomic methods and served as a proof of principle to investigate OPA1 
interactors.  Our results illustrate the dynamicity of individual proteins association and 
of mitochondrial functions during apoptotic cristae remodeling.  
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INTRODUCTION 
Mitochondria are fundamental organelles in life and death of eukaryotic cells, 
participating in multiple cellular processes, including energy production, calcium 
homeostasis, signaling pathways and apoptosis regulation. Their multifunctional 
properties are accompanied by dynamic changes in their complex shape (Vogel et al., 
2006). Continuous cycles of fusion and fission provide a quality control for the organelle 
homeostasis, by controlling their biogenesis and clearance, favoring the exchange of 
mitochondrial content and influencing the efficiency of oxidative phosphorylation 
(Yoneda et al., 1994; Chen and Chan, 2005; Pernas and Scorrano, 2015). During apoptosis 
mitochondrial network fragments, the outer mitochondrial membrane is permeabilized 
and the topology of the inner mitochondrial membrane (IMM) drastically changes 
(Martinou and Green, 2001; Frank et al., 2001; Scorrano et al., 2002). This striking 
reorganization of the IMM, named cristae remodeling, includes the inversion of cristae 
curvature with a simultaneous mobilization of the cytochrome c stored inside the cristae; 
eventually contributing to the amplification of the apoptotic pathway (Scorrano et al., 
2002). 
Optic Atrophy 1 (OPA1), the only pro-fusion dynamin-related protein of the IMM known 
so far, is, additionally, a regulator of cristae shape and diameter, playing a crucial role in 
apoptotic cristae remodeling. OPA1 resides in high molecular weight (HMW) complexes 
that maintain the cristae junctions tight. Early after stimulation by tBID, BIM or BNIP3, 
these complexes disassemble with a concomitant opening of the cristae junctions and 
complete cytochrome c release (Frezza et al., 2006). Notably, separate domains of the 
same stimulus, BID, are responsible for distinct functions: the α6 helix for OPA1 complexes 
disruption and the BH3 domain for the OMM pore formation (Cogliati et al., 2013), 
 
 
69 
 
indicating that OPA1-dependent cristae remodeling and OMM permeabilization are 
molecularly distinguishable events.  
OPA1 complexes targeted during apoptosis contain both the long membrane integral 
forms and the soluble short forms of the protein (Frezza et al., 2006). On top of this, as 
judged by blue native PAGE, multiple OPA1 containing complexes exist with sizes ranging 
from 500 to 800 kDa (Cogliati et al., 2013), suggesting that other proteins participate in 
their assembly and elimination upon apoptotic stimulation. Moreover, considering that 
OPA1 is a multifunctional protein, it is conceivable that the candidate partners of this 
protein participate in the regulation of its various functions. However, our knowledge on 
OPA1 interacting proteins is limited to pull down experiments (Banerjee and Chinthapalli, 
2014; Patten et al., 2014; Darshi et al., 2011a) that do not take into account endogenous 
interactions or the dynamic behavior of these complexes that are targeted during cristae 
shape changes.  
With this in mind, we decided to explore the components of OPA1-containing HMW 
complexes. Using a three-dimensional Blue Native (BN)–BN–SDS electrophoresis 
approach that we adapted to quantitative and semi-quantitative proteomic strategies, we 
restricted our analysis to the proteins that compose the native complexes of interest 
across multiple tissues. We capitalized on a cristae remodeling incompetent mutant cBID 
(cBIDKKAA) to identify proteins that leave the OPA1 complexes only during cristae shape 
changes. Further analysis of four of our candidates confirmed that the proteomic 
approaches applied here are powerful tools to investigate the dynamic OPA1 interactions.   
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RESULTS 
Three dimensional Blue Native – Blue Native – SDS – PAGE allows to investigate OPA1 
complexes 
Blue native electrophoresis (BN-PAGE) of 1.2% digitonin solubilized mitochondrial 
extracts allowed us to identify multiple macromolecular assemblies containing OPA1, 
which span from approximately 250 kDa up to 1000 kDa (Fig. 1A and 1B). Upon treatment 
of isolated mitochondria with the recombinant pro-apoptotic caspase 8-cleaved BID 
(cBID), OPA1 levels in higher molecular weight complexes, i.e. from 480 kDa to 1000 kDa 
significantly decreased (Fig. 1B), indicating that these are particularly targeted during 
programmed cell death. Their size and multiplicity prompted us to hypothesize that 
proteins other than OPA1 whose identity is not known yet participate in the assembly of 
these complexes.  
In order to identify the proteins in a strong association with OPA1 and minimize the false 
positive interactors, we continued with a second dimension blue native electrophoresis 
(2D BN-PAGE). Specifically, we excised the lane of the first dimension BN-PAGE and loaded 
it directly onto a single-well native gel using an electrophoresis buffer which contained 
0.002% of the detergent n-Dodecyl-β-D-maltopyranoside (DDM). The stable native 
complexes ran along a diagonal, while the weak interactors of the protein assemblies 
dissociated and ran faster below the diagonal (Fig. 1A). After immunoblotting we were 
able to detect the more stable OPA1-containing assemblies, indicating that OPA1 
associates strongly with a number of proteins. Notably, these stable complexes were 
diminished in apoptotic (cBID treated) mitochondria (Fig. 1C). 
To separate the individual components of the complexes of interest and further confirm 
the existence of OPA1 in those, we then proceeded to a third dimension denaturating 
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electrophoresis (3rd D SDS-PAGE). Each resulted diagonal of the 2nd D gels was cut in 
thickness of 1 cm and subsequently loaded onto another single-well polyacrylamide gel 
under denaturating conditions (Fig. 1A). Immunodetection allowed us to verify the 
reduction of OPA1 in the stable, higher molecular weight complexes in response to an 
apoptotic stimulus (Fig. 1D).  In conclusion, this 3D BN-BN-SDS-PAGE appears to be a 
useful tool to investigate the dynamic nature of OPA1-containing complexes.  
 
3D BN-BN-SDS-PAGE followed by LC/MS explores OPA1-containing complexes 
composition 
In order to identify the more stable components of the OPA1-containing assemblies, we 
coupled 3D BN-BN-SDS-PAGE to mass spectrometry analysis (Fig. 1A). To this end, we 
isolated mouse liver mitochondria and extracted the membrane complexes with digitonin 
1.2%. The samples were subsequently separated by 3D-BN-BN-SDS-PAGE. The obtained 
gels were stained with Coomassie to visualize the protein complexes (Fig. 1E, 1F and 1G). 
The diagonals of the 2nd D-BN-PAGE were cut into 7 spots (Fig. 1F) and each one of those 
run in an independent SDS electrophoresis. The lane of each 3rd D-SDS PAGE was 
subdivided into small spots, trypsinized and subjected to mass spectrometry (Fig. 1G). The 
identified peptides of each spot were analyzed statistically with Scaffold Software 
(Version 4.0) using the Mouse MitoCarta dataset (Pagliarini et al., 2008) to obtain a cohort 
of 576 different mitochondrial proteins that reside in the multiple spots of the diagonal, 
corresponding to the various molecular weight OPA1-containing complexes (Suppl. Table 
1). Bioinformatics analysis revealed that the candidate partners of OPA1 belong to 13 
biological function categories that include metabolic process, cellular process, 
localization, cellular component organization or biogenesis, biological regulation, 
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developmental process, response to stimulus, immune system process, multicellular 
organismal process, apoptotic process, reproduction, biological adhesion, locomotion 
(Fig. 2A) (http://pantherdb.org/) (Thomas et al., 2003). Intuitive enrichment analysis of 
the cellular component of our hits validated that the vast majority of the proteins reside 
in the mitochondrial inner membrane or matrix (Fig. 
2B) (http://amp.pharm.mssm.edu/Enrichr) (Chen et al., 2013), enhancing the reliability of 
our results. STRING 10 (http://string-db.org/) (Jensen et al., 2009) analysis provided 
information about the evident and predicted functional interactions of the total of our 
identified proteins (Fig. S1).  
In addition, given the multiple functions of OPA1, we aimed to distinguish the candidate 
OPA1 interactors that are specifically regulated during apoptosis. To this end, we 
performed the same proteomic approach in parallel in normal (untreated) and apoptotic 
(cBID treated) mitochondria. The electrophoreses were performed simultaneously for the 
two samples and the obtained diagonals of the 2nd D BN-PAGE were cut into spots of the 
same molecular weight, which were subsequently loaded onto the same SDS gels. This 
strategy provided us with semi-quantitative stoichiometric results of the identified 
proteins whose levels increase or decrease in each spot/complex compared to control 
after cBID treatment (Suppl. Tables 2-8); thus obtaining a measurement of the potential 
changes in the distribution across the different OPA1-containing complexes of each 
candidate interactor during apoptosis. Enrichment analysis on the functional pathways 
revealed that our hits which decrease during apoptosis are mainly involved in TCA cycle, 
mitochondrial translation and organelle biogenesis and maintenance (Fig. 2C), also 
organized in a network of predicted interactions (Figure S2). 
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BN-PAGE-LQ/MS of mouse heart mitochondria identifies OPA1-containing complexes 
targeted during apoptosis 
We next asked whether the composition of the complexes was similar in a tissue where 
OPA1-controlled mitochondria dependent cell death plays a crucial role and we therefore 
turned our attention to heart, protected from ischemia reperfusion damage by moderate 
Opa1 overexpression (Varanita et al., 2015).  In this approach, in order to distinguish the 
proteins that are regulated specifically during cristae remodeling, mitochondria were 
treated with the wild type pro-apoptotic caspase 8 cleaved BID (cBIDwt) or a mutant cBID, 
which is unable to widen cristae junctions and to disrupt OPA1 complexes (cBIDKKAA) 
(Cogliati et al., 2013). Immunoblotting verified that also in the heart OPA1 leaves high 
molecular weights complexes upon cBIDwt, but not cristae remodeling incompetent 
mutant cBIDKKAA (Fig 3A).  
The resulting gel lanes were cut into 26 successive slices starting from the higher 
molecular weights; each slice was trypsinized and subjected to mass spectrometry (Fig. 
3B).  We graphically depicted the MS results as a migration pattern of each identified 
protein, which derived from its values along the whole electrophoretic run. The peaks of 
OPA1 pattern correspond to the molecular weights of the highly immunodetected protein 
in western blotting, strengthening the reliability of this proteomic approach (Fig. 3C). The 
similarity between the migration profiles of each identified protein and OPA1 was 
measured using Pearson correlation coefficient (r), in order to acquire the list of candidate 
hits that are retrieved in the same spots with OPA1 in untreated mitochondria (r ≥ +0.1). 
Filtering our list using the mitochondrial proteomics database Mitominer 
(http://mitominer.mrc-mbu.cam.ac.uk) (Smith and Robinson, 2016), we ended up with 
643 identified proteins that were assigned to mitochondria, a number that corresponded 
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to the 74% of the total of our hits, confirming the high purity of the sample. Our catalog 
included 213 mitochondrial proteins which are likely associated with the various OPA1-
containing complexes in heart (Fig. 4A, Suppl. Table 9). These proteins reside mainly in the 
mitochondrial inner membrane (Fig. 4B) and are classified into 12 categories according to 
their biological function, including metabolic process, cellular process, localization, 
cellular component organization or biogenesis, biological regulation, developmental 
process, response to stimulus, immune system process, multicellular organismal process, 
apoptotic process, reproduction, biological adhesion, locomotion (Fig 4C). Among these 
target proteins, 189 of them had a smaller total score value along the blue native lane 
than in control after cBIDwt treatment, indicating that they were decreased upon 
apoptosis stimulation (Fig. 4D, Suppl. Table 10). Hence, overall the high molecular weight 
complexes were quantitatively reduced. The majority of these polypeptides are involved 
in mitochondrial respiration, mitochondrial translation as well as organelle biogenesis and 
maintenance (Fig. 4E). Interestingly, 128 mitochondrial proteins were reduced only after 
treatment with cBIDwt, but not cBIDKKAA; thus these candidates dissociate from the 
complexes of interest because of apoptotic cristae remodeling and not of OMM 
permeabilization (Fig. 4F, Suppl. Table 11). 
OPA1 interactions are largely tissue independent 
The two different high-throughput approaches allowed us to come up with a subgroup of 
OPA1 interactors which are detected by both strategies deployed so far (142 
mitochondrial proteins, Fig. 5A and C). The presence of common hits in mouse heart and 
liver mitochondria suggested a tissue-independency of OPA1 associations. According to 
their biological function, these proteins are annotated to the following categories: 
metabolic process, cellular process, localization, cellular component organization or 
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biogenesis, biological regulation, developmental process, response to stimulus, immune 
system process, apoptotic process and biological adhesion (Fig. 5B). Among the candidate 
partners of OPA1 common in heart and liver, 43 proteins were reduced from the OPA1-
containing complexes after cBIDwt treatment (Fig. 5D and E). 
 
SILAC allows quantification of proteins leaving OPA1 complexes during apoptosis 
In order to give a quantitative aspect to our analysis, we took advantage of stable isotope 
labeling by amino acids (SILAC) (Ong et al., 2002) which we applied to our experimental 
setting (Fig. 6). We grew two different populations of mouse adult fibroblasts (MAFs) with 
light (containing normal amino acids) or heavy medium (containing 15C labeled Arg and 
Lys). After six cellular doublings, all the proteome incorporated metabolically the 
corresponding amino acids. Isolated mitochondria from one cellular population were 
treated with cBIDwt or cBIDKKAA, whereas mitochondria of the other served as a control-
untreated. Next, the organelles were solubilized using digitonin and equal amounts of 
heavy and light (treated and untreated) mitochondrial extracts were mixed. The samples 
were then separated by BN-PAGE and the higher molecular weights, corresponding to the 
complexes targeted during apoptosis (500-1000 kDa), were cut into seven successive gel 
bands to be trypsinized and analyzed by MS. This strategy allowed us to distinguish 
simultaneously the proteomes of each population (normal or apoptotic) and determine 
their relative abundance by measuring the ratio in peak heights between two forms of the 
same protein in the two cell states. 
This analysis revealed a list of 90 mitochondrial proteins whose levels are significantly 
altered (Z>1.2) after cBIDwt stimulation in respect to the untreated mitochondrial 
population (Fig. 7A). These polypeptides are located mainly in mitochondrial inner 
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membrane (Fig. 7B) and belong to 9 gene ontology entries regarding their biological 
function; metabolic process, cellular process, localization, cellular component 
organization or biogenesis, biological regulation, developmental process, response to 
stimulus, multicellular organismal process, immune system process (Fig. 7C). Among 
those, 49 unique hits were decreased upon apoptosis in the various gel bands (Fig. 7D, E 
and Suppl. Table 12), while 47 were specifically decreased following apoptotic cristae 
remodeling (Fig. 7F and Suppl. Table 13). 
 
Immunodetection after blue native analysis confirms mass spectrometry results  
To validate biochemically the results of the high-throughput approaches, we performed 
blue native electrophoresis in solubilized mitochondria deriving from liver and heart and 
proceeded with western blotting against four identified hits. First, the major member of 
the MICOS complex Mic60 (Mitofilin), being identified by all the three proteomic 
techniques, was selected for further investigation. BN-PAGE and western blotting 
revealed that Mic60 participates in the formation of high molecular weight complexes, 
some of which share similar electrophoretic mobility with OPA1-containing assemblies in 
native conditions (Fig. 8A). In line with our proteomics data (Suppl. Table 11 and 13), the 
OPA1/Mic60 complexes were disassembled after cBIDwt but not after cBIDKKAA treatment, 
as judged by western blotting. In order to further verify our result, we performed 3D BN-
BN-SDS PAGE followed by western blotting and we confirmed that Mic60 is part of the 
HMW OPA1-containing complexes, since their electrophoretic runs overlap. After cBID 
stimulation, the proteins of interest disappear from the high molecular weights (Fig. 8B), 
suggesting their dissociation from the HMW complexes upon apoptosis.  
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Besides MICOS complex, also members of the calcium uniporter of the inner membrane, 
MCU and MICU1, were detected in heart mitochondria (Suppl. Table 9), and specifically in 
the bands 10-13 in the complexes which correspond approximately to the molecular 
weights 500-720 kDa. Biochemical analysis confirmed the existence of these two proteins 
in various independent assemblies with a size range between 300 and 720 kDa (Fig. 8C). 
Last but not least, a protein named Mitochondrial morphology and cristae structure 1 
(MICS1), aka GHITM and retrieved in our complexome approaches (Suppl. Table 9), caught 
our attention, because, although it has been previously correlated to mitochondrial 
ultrastructural maintenance, its exact function is still obscure. Blue native PAGE validated 
the co-existence of GHITM with OPA1 in 600 kDa HMW assemblies, and its slight decrease 
of it specifically after cBIDwt stimulation (Fig. 8C).   
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DISCUSSION 
The comprehensive proteomic study described here yielded insight into the nature and 
composition of the HMW complexes containing the mitochondrial shaping protein, OPA1. 
Taking advantage of the high resolution of blue native electrophoresis (Schagger et al., 
1994), we were able to separate and detect the multiple intact macromolecular 
assemblies in which OPA1 is present. Applying this technique in digitonin-solubilized 
mouse liver and heart mitochondria and coupling it to mass spectrometry unveiled that 
OPA1 resides in these complexes together with a variety of interactors, whose nature is 
independent of the tissue. Overall, identification of the same interactors in the three 
different approaches used in this study indicated that our methods had the level of 
definition required to inspect OPA1 complexes in cell life and death. 
The higher molecular weight complexes of OPA1 are targeted early during apoptosis, 
contributing to cristae remodeling and cytochrome c mobilization (Cogliati et al., 2013). 
Our data from all the high throughput approaches confirmed the elimination of these 
complexes and indicated a general remarkable alteration in their composition and 
organization upon apoptosis. The comparison of the identity and the abundance of the 
OPA1 complexes components in normal and cBID treated mitochondria provided us with 
valuable information about their differential distribution in the presence of an apoptotic 
stimulus. On top of this, our study allowed us to identify the proteins that are specifically 
redistributed during cristae remodeling, suggesting that they play a role mitochondrial 
ultrastructure alterations during programmed cell death. These proteins could possibly 
act either as OPA1 co-players to directly control cristae biogenesis and stability or by 
assisting the complexes formation or even by stabilizing OPA1 under steady state 
conditions. Alternatively, candidate OPA1 partners could probably be direct targets of 
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cBID, thus facilitating the elimination of the protein complexes in order to trigger cristae 
remodeling. 
The power of our high-throughput analyses was validated by blue native PAGE followed 
by western blotting against identified OPA1 complexes constituents. We confirmed that 
Mic60 share common HMW complexes with OPA1, which are significantly eliminated 
upon apoptotic cristae remodeling. Mic60 is the major component of “Mitochondrial 
contact site and cristae organizing system” (MICOS), a machinery that participates in 
cristae biogenesis and maintenance (Harner et al., 2011). Although a possible interaction 
between the MICOS member and OPA1 has been suggested before (Darshi et al., 2011b; 
Banerjee and Chinthapalli, 2014), we indicate that Mic60 can possibly play a role in cristae 
remodeling. An intriguing aspect to be investigated is the mechanism by which the main 
regulators of cristae shape collaborate for the fulfillment of their action.  
Moreover, among the identified proteins that are reduced during cell death, we found 
members of mitochondrial intermembrane space bridging (MIB) complex, namely 
Metaxin-1, Samm50 and Dnajc11. This is another heteromeric protein assembly crucial 
for the preservation of cristae and assembly of respiratory complexes. MIB associates with 
MICOS members (Mic60 and Mic19) (Ott et al., 2012; Huynen et al., 2016); thus, it is 
conceivable that all the multiprotein machineries responsible for cristae organization 
(OPA1 multimers, MICOS and SAM) might crosstalk to achieve a higher hierarchical 
membrane organization under physiological and apoptotic conditions.  
Additionally, various previously characterized OPA1 modulators were retrieved in our 
proteomics analysis and, hence, served as a proof of principle for studying OPA1 co-
players. Particularly, we found that the inner mitochondrial membrane protein important 
for mitochondrial morphology, Letm1 (Dimmer et al., 2008), is specifically eliminated from 
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OPA1-containing complexes in cBID induced cristae remodeling. Letm1 was previously 
described as a regulator of OPA1-mediated fusion as well as apoptosis (Piao et al., 2009). 
Moreover, the mitochondrial nucleoside diphosphase kinase (Nme) that provides the fuel 
for Opa1, enhancing its GTPase activity (Boissan et al., 2014) was found to be dissociated 
from OPA1-complexes only after cBIDwt treatment, indicating an active OPA1 regulation 
by NME in order to promote membrane remodeling. Furthermore, prohibitins, which 
exert their functions on mitochondria via the regulation of OPA1-processing (Merkwirth 
et al., 2008) were detected in the HMW assemblies containing OPA1. Additional proteins 
discovered at our proteomics methods were the proteases OMA1 and Ymel1, which 
cleave the mitochondrial shaping protein, as well as its partner OPA3, whose exact 
function is still elusive. Importantly, Mfn1, the well-characterized partner of OPA1 for its 
profusion action, was retrieved in the OPA1-containing complexes. Nevertheless, 
apoptotic stimulation did not alter its identification levels; hence Mfn1 is not required for 
the anti-apoptotic role of OPA1, which is indeed distinct from its fusogenic function 
(Frezza et al., 2006).  
Patten and coworkers identified certain mitochondrial solute carriers (SLC25A) as OPA1 
interactors, whose ablation or inhibition led to loss of the mitochondrial architecture 
integrity, along with blockage of OPA1 oligomerization and function (Patten et al., 2014). 
In agreement with this study, we detected calcium-binding mitochondrial carriers 
(SLC25A12 and SLC25A13) in the HMW OPA1-containing complexes, which dissociated 
from them in apoptotic cristae remodeling; overall suggesting a direct interplay between 
the solute carriers and OPA1 under apoptotic conditions to mediate membrane 
rearrangements. Besides the calcium carriers, we demonstrated that also the 
multiprotein channel of mitochondrial calcium uniporter (MCU), as well as its regulators 
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MICU1 and Ccdc90a (De Stefani et al., 2011; Raffaello et al., 2013; Vais et al., 2015) resides 
in common complexes with OPA1 and are redistributed during apoptosis. Thus, our data 
indicate a link between mitochondrial calcium homeostasis and cristae morphology in 
steady state and cell death, an interesting correlation that calls for further investigation.   
As evident from clustering analysis and STRING networks in all our approaches, a large 
part of the proteins targeted during apoptosis was represented by oxidative 
phosphorylation (OXPHOS) complexes subunits. Although their direct interaction with 
OPA1 is not proven or expected, their reduction during cristae remodeling is conceivable. 
The OXPHOS members are assembled into complexes and further organized in a higher 
order forming metabolically active supramolecular assemblies, the respiratory 
supercomplexes (Acin-Perez et al., 2008) that are disassembled during cristae remodeling 
(Cogliati et al., 2013), possibly explaining the changes in the distribution of the individual 
components demonstrated by our proteomic approaches. Similarly, we found several 
subunits of ATP synthase (ATP5H, ATP5L, ATP5F1, mtATP8), as well as integral membrane 
proteins loosely associated with complex V (MP68, DAPIT) to leave the HMW complexes 
in cBID stimulated mitochondria. Given the crucial role of ATP-synthase dimerization in 
cristae morphology (Davies et al., 2012), it is likely that complex V disassembles during 
cristae remodeling. An open question is how OPA1-mediated definition of cristae 
junctions and the adjustment of the cristae tips positive curvature by ATP-synthase dimers 
are coordinated. Our study provides hints for understanding the interplay between OPA1 
complexes and ATP-synthase and suggested some candidate mediators for this crosstalk. 
Several members of the mitochondrial translational machinery (ribosome or nucleoid 
subunits, such as Atad3, Mrpl12, Mrpl23, Lonp1) were shown to be regulated upon 
apoptotic cristae remodeling. One can expect a disassembly of the nucleoids after 
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dramatic architectural rearrangements, considering that the translational units are 
associated with the inner mitochondrial membrane. However, we cannot exclude the 
possibility of an indirect link between OPA1 and components of the protein synthesis 
“factory”.  
More interestingly, our lists contained also novel candidate OPA1 partners whose precise 
biological function in mitochondria is still obscure. Among these proteins we distinguished 
Nitric oxide-associated 1 (NOA1), Growth hormone-inducible transmembrane protein 
(GHITM), Death-associated protein 3 (DAP3) and NLR family member X1 (NLRX1); all of 
which are dissociating from the HMW complexes upon cBID treatment.  Previous studies 
have correlated these four proteins to apoptosis and mitochondrial morphology and 
architecture (Oka et al., 2008; Tang et al., 2009; Kolanczyk et al., 2011; Xiao et al., 2015; 
Soares et al., 2014; Imbeault et al., 2014). Our study provides evidence that these proteins 
interact with OPA1 and are implicated in the cristae remodeling pathway. Further 
biochemical experiments will shed light on their exact function on mitochondrial 
remodeling modulation and their interplay with OPA1.  
In conclusion, our mass spectrometry based on blue native PAGE appeared to be an 
optimal technique to identify OPA1 partners and unravel the changes in composition and 
distribution of mitochondrial heteromeric complexes during cristae remodeling. 
Furthermore, we provided hints into the cooperation between the major cristae shape 
determinants (OPA1, MICOS, MIB and ATP-synthase), but also discovered novel candidate 
OPA1-coplayers in cristae shaping in life and death of the cell.   
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EXPERIMENTAL PROCEDURES 
Recombinant Protein Expression 
p7/p15 recombinant BID was produced, purified and cleaved with caspase-8 as previously 
described (Frezza et al., 2006).  
 
Mitochondria isolation, apoptosis stimulation and membrane complexes extraction 
Mitochondria from mouse liver and mouse adult fibroblasts (MAFs) were purified by 
standard differential centrifugation as described in (Frezza et al., 2007). Mouse heart 
mitochondria were isolated from two CD1 wild type mice as described in  (Fernandez-
Vizarra et al., 2010). 
Isolated mitochondria from liver (250 μg), heart (250 μg) or MAFs (150 μg) were treated 
with cBID and cBIDKKAA. The treatment was performed at 25°C in Experimental Buffer (EBc, 
150 mM KCl, 1 mM Pi, 5 mM glutamate, 2.5 mM malate, 10 μM EGTA-Tris and 10 mM 
Tris-MOPS pH 7.4) at a final mitochondrial concentration of 0.5 mg/ml. The treatment was 
terminated by a 10 min centrifugation at 10000 x g at 4°C. The pellet was suspended in 50 
μl of native buffer (Native Sample Buffer, Invitrogen) containing 1.2% digitonin 
(Invitrogen) and 1:100 protease inhibitors cocktail (PIC, Sigma). After 10 min incubation 
on ice, mitochondria were centrifuged at maximal speed in a table bench centrifuge for 
20min, at 4°C, to extract the soluble membrane complexes. Supernatants were 
transferred into a new tube and 2 μl of Native PAGE Sample additive G250 5% (Invitrogen) 
was added before loading onto a native gel.  
 
BN-PAGE and 3D BN-BN-SDS gel electrophoresis (BN-BN-SDS-PAGE) 
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To detect OPA1 complexes, equal volumes of the native samples were loaded onto a 
precast Native 3-12% Bis-Tris gel (Invitrogen). Electrophoresis was performed in the 
presence of cathode (dark blue cathode: 45min; light blue cathode: 90min) and anode 
buffers prepared following manufacturer’s instructions (Invitrogen). When indicated, 
protein complexes were blotted onto a PVDF membrane, which was probed for the 
indicated antibodies, or stained with Coomassie blue. Coomassie stain was composed of 
40% methanol, 10% acetic acid, 0.25 gr Coomassie Brilliant Blue R-250 (Biorad). 
Second BN-PAGE was performed by excising and casting the lane obtained from the first 
BN-PAGE on a single-well native gel (NuPAGE Novex 4-12% Bis-Tris ZOOM gel, Invitrogen). 
In the cathode buffers used 0.02% n-Dodecyl-D-maltoside (DDM, SIGMA) was added. 
Electrophoresis was performed at 125 V for 1 hr 30 min using dark cathode buffer and at 
150 V, overnight using with light cathode buffer. During 2D BN-BN-PAGE, complexes 
resistant to detergent are aligned in a diagonal easily identified by Coomassie contained 
into the running samples. When indicated, the native gel was subjected to western 
blotting to detect OPA1 complexes or stained with homemade Coomassie blue. 
The third dimension SDS-PAGE was performed after excising the diagonal and incubating 
it with reducing solutions RSa for 10 min, RSb for 7 min and RSc for 12 min, in order to 
facilitate the complexes dissociation during the 3D SDS (RSa=1x LDS sample buffer 
(Invitrogen), 4% β-mercaptoethanol, RSb=1x LDS sample buffer (Invitrogen), 1% N N-
dimethylacrylamide (DMA, SIGMA) and RSc=1x LDS sample buffer (Invitrogen), 20% 
ethanol and 0.1% β-mercaptoethanol). After the treatment, the diagonal was loaded onto 
a gel (NuPAGE Novex 4-12% Bis-Tris ZOOM gel, Invitrogen) and run under denaturating 
conditions to separate the individual proteins that were then transferred onto 
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polyvinylidene fluoride (PVDF) membranes and immunodetected for the indicated 
antibodies.  
 
3D BN-BN-SDS gel electrophoresis for semi-quantitative proteomic analysis 
Untreated and cBID treated mitochondria (10 mg/ml) were suspended in buffer D (1 M 6-
aminohexanoic acid, 1.2% V/V digitonin, 50 mM Bis-Tris-HCl, pH 7) and centrifuged. The 
supernatants containing the extracted membrane complexes were collected and 5% Serva 
Blue G dye in 1 M6-aminohexanoic acid was added to 1/3 of the final sample volume. 
Equal amounts (100 mg) of mitochondrial proteins were separated in a homemade 
gradient gel of 3%–13% acrylamide gradient. The lanes of Untreated and cBID samples of 
the first dimension BN-PAGE were excised, casted on top of a native single-well 3%–14% 
gradient gel and run in the presence of 0.002% Dodecyl D Maltoside (DDM, Sigma). The 
resulted diagonals were divided into the same seven spots (“1”, “2”, “4”, “5”, “7”, “10” 
and “11”), cut and treated with 1% SDS and 1% β-mercaptoethanol for 1 hr. Spots of the 
same molecular weight from untreated and cBID treated samples were loaded onto an 
SDS-PAGE and each lane was subdivided into small spots to be analyzed by LC/MS. Gel 
pieces were then digested with modified porcine trypsin (Promega) at a final ratio 1:20 
(trypsin-protein). Digestion proceeded overnight at 37ºC in 100 mM ammonium 
bicarbonate, pH 8.8. The resulting tryptic peptide mixtures were subjected to nano-liquid 
chromatography coupled to mass spectrometry (LC-MS) for protein identification. 
Peptides were injected onto a C-18 reversed phase (RP) nano-column (75 μm I.D. and 50 
cm, Acclaim PepMap100, Thermo Scientific) and analyzed in a continuous acetonitrile 
gradient consisting of 0-30% B in 240 min, 50-90% B in 3 min (B=90% acetonitrile, 0.5% 
acetic acid). A flow rate of ca. 200 nL/min was used to elute peptides from the RP nano-
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column to an emitter nanospray needle for real time ionization and peptide 
fragmentation on an Orbitrap Fusion mass spectrometer (Thermo Fisher, San José, CA, 
USA). For protein identification, tandem mass spectra were extracted and charge state 
deconvoluted by Proteome Discoverer 1.4.0.288 (Thermo Fisher Scientific). All MS/MS 
samples were analyzed using SEQUESTTM (Thermo Fisher Scientific). 
For data analysis the results were processed using the proteome software of Scaffold 
(Version 4.0) using the Mouse MitoCarta dataset (Pagliarini et al., 2008). The protein 
threshold was set at 99%, the minimum number of peptides (to determine if a protein is 
present) at 2 and the peptide threshold at 95%. The results of its sub-spot retrieved in 3rd 
D-PAGE were consolidated for each spot of the 2nd D-PAGE. The fold change was 
quantified to report how much the protein’s level was altered, by calculating the ratio of 
the number of identified peptides in treated over the number of identified peptides in 
untreated. Fold change less than 0.8 was considered significant for the proteins that 
decrease after treatment.  
 
BN-PAGE based semi-quantitative proteomic analysis 
Mitochondrial proteins (250 μg) from two mouse hearts were treated and solubilized as 
described above. Blue Native Electrophoresis (BN-PAGE) was used to separate the native 
membrane complexes in a homemade gradient gel from 4% to 13% acrylamide, 20 x 20 
cm, for control samples and for samples treated with cBID or cBIDKKAA (1 mg of protein per 
sample). The electrophoresis was performed as described for the 1st dimension BN-PAGE. 
Subsequently, gels were stained using GelCode Blue Stain Reagent (Thermo Scientific). 
Each lane was divided and excised in 26 bands covering the whole electrophoretic run. 
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Gel pieces were then digested trypsinized and subjected to mass spectrometry as 
described above.   
Each identified protein displayed a score value for every spot analyzed; thus we resulted 
with a pattern of identification along the whole electrophoretic run for every hit. The 
strength of relation between the patterns of identification of each protein and the one of 
OPA1 was measured using Pearson correlation coefficiency (r). Positive association was 
considered when r ≥ +0.1. The results were filtered for the mitochondrial predicted 
proteins using the proteomics database MitoMiner (http://mitominer.mrc-
mbu.cam.ac.uk) (Smith and Robinson, 2016). The quantification between treated and 
untreated was performed after calculating their fold change by dividing the sum of their 
score values. Proteins that decrease after cBIDwt but increase, remain unaltered, or the 
decrease is less after cBIDKKAA are considered to be reduced only upon cristae remodelling. 
 
SILAC labelling and quantitative proteomic analysis 
Mouse adult fibroblasts (MAFs) were grown separately in DMEM-Flex medium containing 
4.5 g/L glucose, 2 mM glutamine, 10% fetal bovine serum (FBS), 50 U/ml Penicillin, 50 
mg/ml Streptomycin, 50 mg/ml Uridine and Phenol Red supplemented with either light L-
Lysine and L-Arginine or heavy [U-13C6]-L-Lysine HCl and [U-13C6]-L-Arginine (100 mg/L of 
each amino acid) (SILAC Protein Identification and Quantification Media Kit, Invitrogen). 
After 6 doublings cell subpopulations, light and heavy, were harvested and mitochondria 
were isolated separately. In experiment “a” light mitochondria were treated with 20 
pmol/mg cBID for 30 min in EB, and heavy mitochondria were untreated. After 
centrifugation at 10000 x g, 10 min, 4°C, the pellets from both samples were mixed and 
resuspended together in NB indicated above. In experiment “b”, light mitochondria were 
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untreated while heavy mitochondria were treated with 20 pmol/mg cBIDKKAA for 30 min, 
25°C. After centrifugation the samples were mixed and processed as in experiment “a” 
before proceeding with the BN-PAGE. Protein complexes (500 μg) from experiments “a” 
and “b” were loaded in parallel lanes and complexes were separated by BN-PAGE 
electrophoresis. Three lanes from experiment “a” and “b” were stained with Coomassie 
and bands between 600 and 1000kDa (Spot A1-2, A3-4, A5-6 and A7) were excised with a 
scalpel and digested with trypsin. Digestion proceeded overnight at 37ºC in 100 mM 
ammonium bicarbonate, pH 8.8. The resulting tryptic peptide mixtures were subjected to 
nano-liquid chromatography coupled to mass spectrometry (LC-MS) for protein 
identification. Peptides were injected onto a C-18 reversed phase (RP) nano-column (75 
mm I.D. and 50 cm, Acclaim PepMap100, Thermo Scientific) and analyzed in a continuous 
acetonitrile gradient consisting of 0-30% B in 240 min, 50-90% B in 3 min (B=90% 
acetonitrile, 0.5% acetic acid). A flow rate of ca. 200 nL/min was used to elute peptides 
from the RP nano-column to an emitter nanospray needle for real time ionization and 
peptide fragmentation on a Q Exactive mass spectrometer (Thermo Fisher, San José, CA, 
USA). For protein identification, tandem mass spectra were extracted and charge state 
deconvoluted by Proteome Discoverer 1.4.0.288 (Thermo Fisher Scientific). All MS/MS 
samples were analyzed using SEQUESTTM (Thermo Fisher Scientific).  
Change in peptide abundance in the studied complexes was considered when FDRq < 0.05 
and Zq was > 1.2 or < -1.2 after treatment. To calculate the fold change of each protein 
we measured the median of fold change of all the peptides detected corresponding to 
one protein and fold change > 1.2 or < -1.2 was considered significant. Hits that decrease 
with cBIDwt, while no difference or less folds of decrease was observed in the treatment 
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with the mutant cBIDKKAA, were considered as candidate proteins which are reduced 
specifically during apoptotic cristae remodelling.  
 
Bioinformatics Analysis 
For classification according to Gene Ontology and enrichment analysis, our data were 
clustered using the databases Panther (http://pantherdb.org/) (Thomas et al., 2003) and 
Enrichr (http://amp.pharm.mssm.edu/Enrichr) (Chen et al., 2013). For pathway analysis 
the curated database of Reactome was used, which was implemented in Enrichr. To 
construct the interaction networks we used the meta-server STRING 10 (http://string-
db.org/) (Jensen et al., 2009) and the confidence view was selected. Each network node 
represents a protein and the thickness of the edges represents the confidence of a 
predicted functional association. The prediction methods used were: co-occurrence, co-
expression, experiments, databases and text mining. 
 
Antibodies 
For the immunoblots of the Blue Native gels, PVDF membranes were probed with the 
following antibodies: mouse monoclonal anti-OPA1 (1:1000 BD Biosciences), anti-MICU1 
(1:1000 SIGMA), anti-MCU (1:1000 SIGMA), GHITM/MICS1 (1:200, kind gift from 
Toshihiko Oka). The incubation was overnight at 4°C. Isotype matched, horseradish 
peroxidase-conjugated secondary antibodies (GE Healthcare Life Sciences) were 
employed for chemiluminescence detection. 
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FIGURE LEGENDS 
Figure 1. Three dimensional BlueNative-BlueNative-SDS PAGE is a useful tool to 
investigate OPA1 complexes 
A. Schematic representation of the method. Mitochondria were isolated from mouse 
liver and mitochondrial membrane complexes were extracted by solubilization with 
10 min incubation in 1.2% digitonin. The samples were then subjected to 3D-BN-BN-
SDS-PAGE following LC-MS/MS for protein identification in the complexes of interest.  
B. 1st Dimension BN-PAGE and western blotting against OPA1 of untreated (Untr) and 
cBid treated (cBID) mitochondrial membrane extracts. The higher molecular weight 
OPA1 complexes decrease after cBid treatment. Molecular weight markers are 
indicated on the left. 
C. 2nd Dimension BN-PAGE and western blotting against OPA1 of untreated (Untr, left) 
and cBid treated (cBID, right) mitochondrial membrane extracts. Molecular weight 
markers are indicated on the top of the blots. 
D. 3rd Dimension SDS-PAGE and western blotting against OPA1 of untreated (Untr, top) 
and cBid treated samples (cBID, bottom). Molecular weight markers are indicated on 
the left and on the top. 
E. Coomassie staining of 1st Dimension BN-PAGE of untreated (Untr) and cBid treated 
(cBID) mitochondrial membrane extracts. Molecular weight markers are indicated on 
the left. 
F. Coomassie staining of 2nd Dimension BN-PAGE of untreated (Untr, left) and cBid 
treated (cBID, right) mitochondrial membrane extracts. The resulted parallel diagonals 
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were divided into the same seven spots and processed for SDS-PAGE. Molecular 
weight markers are indicated on the top. 
G. Coomassie staining of the 3rd Dimension SDS PAGE. The complexes of a representative 
spot of the 2nd-D BN-PAGE, from both untreated (Untr) and cBid treated samples, were 
separated in their components by SDS PAGE.  The gel was subdivided into various 
spots were subsequently analysed by LC/MS. The resulting identified peptides were 
analyzed with Scaffold Software and Mitocarta Database was used.  
 
Figure 2. Clustering of candidate OPA1 partners in mouse liver mitochondria 
A. Pie showing protein classification of the identified OPA1 partners based on protein 
biological function.  
B. Enrichment bar graph depicting the identified OPA1 partners in its complexes 
classified based on the cellular component.  
C. Enrichment bar graph of the reactome of the identified OPA1 partners in its complexes 
that decrease after cBIDwt treatment. 
 
Figure 3. BN-PAGE - LQ/MS of mouse heart mitochondria identifies OPA1 containing 
complexes targeted during apoptosis 
A. BN-PAGE and western blotting against OPA1 of untreated (Untr), cBidwt and cBIDKKAA 
treated mitochondrial membrane extracts. As a loading control, GRP75 was used.  
B. Coomassie staining of a Blue Native gel lane. The numbers of the spots in which each 
lane was cut are indicated on the left.  
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C. Graphs depicting the score value of the identified OPA1 peptides to each spot of the 
lane in untreated (Untr), cBidwt and cBIDKKAA treated mitochondrial samples. On top of 
each graph the corresponding BN lanes of figure 1A are depicted horizontally in 
analogy to the molecular weights. The smaller the spot number is the higher the 
molecular weight represents. 
 
Figure 4. Clustering of candidate OPA1 partners in mouse heart mitochondria 
A. STRING network of all the identified proteins present in OPA1-containing complexes 
in heart mitochondria. Each network node represents a protein and the thickness of 
the edges represents the confidence of a predicted functional association. 
B. Enrichment bar graph depicting the identified OPA1 partners in its complexes 
according to the cellular component.  
C. Pie showing the gene ontology of all the identified OPA1 partners in its complexes 
according to their biological function. 
D. STRING network of the identified proteins present in OPA1-containing complexes in 
heart mitochondria which decrease after cBIDwt treatment. 
E. Enrichment bar graph of the reactome of the identified OPA1 partners that decrease 
after cBIDwt treatment. 
F. STRING network of the candidate proteins present in OPA1-containing complexes in 
heart mitochondria which are reduced during cristae remodeling. 
Figure 5. Intersection between candidate OPA1 interactors in liver and heart 
A. Intersection between liver and heart OPA1 interactions. 
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B. Pie depicting the classification of the candidate OPA1-containing complexes 
components identified in both heart and liver based on their biological function. 
C. STRING network of the candidate components of OPA1-containing complexes found 
in both liver and heart mitochondria. Each network node represents a protein and the 
thickness of the edges represents the confidence of a predicted functional association. 
D. Enrichment bar graph of the reactome of the identified OPA1 interactors that 
decrease after cBIDwt treatment. 
E. STRING network of the candidate components of OPA1-containing complexes that are 
reduced upon apoptosis in both liver and heart mitochondria. 
 
Figure 6. SILAC allows quantification of proteins leaving Opa1 complexes during 
apoptosis 
Schematic representation of Stable Isotopic Labeling using Amino Acids (SILAC) in OPA1fl/fl 
MAFs followed by blue native PAGE. Gel bands between 600 kDa and 1000 kDa were 
excised and subjected to LC-MS/MS. 
 
Figure 7. Clustering of candidate OPA1 partners in MAFs after SILAC analysis 
A. STRING network of all the candidate components of OPA1-containing complexes, 
regulated upon apoptosis. Each network node represents a protein and the thickness 
of the edges represents the confidence of a predicted functional association. 
B. Enrichment bar graph depicting the identified OPA1 partners in its complexes, 
regulated upon apoptosis, according to the cellular component.  
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C. Pie showing protein classification of the identified OPA1 partners regulated upon 
apoptosis based on protein biological function.  
D. STRING network of the candidate components of OPA1-containing complexes, which 
are reduced upon apoptosis. 
E. Enrichment bar graph of the reactome of the identified OPA1 interactors that 
decrease after cBIDwt treatment. 
F. STRING network of the candidate components of OPA1-containing complexes that are 
reduced upon apoptotic cristae remodeling. 
 
Figure 8. Biochemical validation of components of OPA1-containing complexes  
A. BN-PAGE and western blotting against OPA1 and Mic60 of untreated (-), cBIDwt and 
cBIDKKAA treated mitochondrial membrane extracts deriving from liver. Molecular 
weight markers are indicated on the left.  
B. 3rd Dimension SDS-PAGE and western blotting against OPA1 and Mic60 of untreated 
(Untr) and cBID treated samples (cBIDwt). Molecular weight markers are indicated on 
the top.  
C. BN-PAGE and western blotting against OPA1, MICU1 and MCU in untreated liver 
mitochondria. Molecular weight markers are indicated on the left.  
D. BN-PAGE and western blotting against OPA1 and GHITM of untreated (-), cBIDwt and 
cBIDKKAA treated mitochondrial membrane extracts deriving from heart. Molecular 
weight markers are indicated on the left.  
 
 
 
 
99 
 
 
Figure 1 
  
 
 
100 
 
 
Figure 2 
 
 
101 
 
Figure 3 
  
 
 
102 
 
Figure 4 
 
 
103 
 
 
 
Figure 5 
 
 
104 
 
 
Figure 6 
  
 
 
105 
 
Figure 7 
 
 
106 
 
 
 
 
 
Figure 8 
 
 
107 
 
A molecular atlas of the Optic atrophy 1 (Opa1) high molecular weight complexes 
targeted during apoptotic cristae remodeling 
 
Maria Eugenia Soriano1*, Christina Glytsou1,2*, Enrique Calvo3, Jesùs Vazquez3, Jose 
Antonio Enriquez3, and Luca Scorrano1,2  
Supplemental online material 
 
  
 
 
108 
 
Legends of Supplementary figures 
 
Supplementary Figure S1. Functional network of candidate OPA1 partners in mouse 
liver mitochondria 
STRING network of all the identified proteins retrieved in OPA1-containing complexes in 
liver mitochondria. Each network node represents a protein and the thickness of the 
edges represents the confidence of a predicted functional association. 
 
Supplementary Figure S2. Functional network of candidate OPA1 partners in mouse 
liver mitochondria that are reduced upon apoptosis stimulation 
STRING network of the identified proteins present in OPA1-containing complexes in liver 
mitochondria, which decrease after cBIDwt treatment. Each network node represents a 
protein and the thickness of the edges represents the confidence of a predicted functional 
association. 
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Suppl. Figure S1 
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Suppl. Figure S2 
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Legends of Supplementary tables 
Supplemental table 1 (Related to Fig. 4). List of all the OPA1 interaction partners 
identified in liver.  
Supplemental table 2 (Related to Fig. 4). List of OPA1 interaction partners that decrease 
after cBIDwt treatment in Spot 1. 
Supplemental table 3 (Related to Fig. 4). List of OPA1 interaction partners that decrease 
after cBIDwt treatment in Spot 2. 
Supplemental table 4 (Related to Fig. 4). List of OPA1 interaction partners that decrease 
after cBIDwt treatment in Spot 4. 
Supplemental table 5 (Related to Fig. 4). List of OPA1 interaction partners that decrease 
after cBIDwt treatment in Spot 5. 
Supplemental table 6 (Related to Fig. 4). List of OPA1 interaction partners that decrease 
after cBIDwt treatment in Spot 7. 
Supplemental table 7 (Related to Fig. 4). List of OPA1 interaction partners that decrease 
after cBIDwt treatment in Spot 10. 
Supplemental table 8 (Related to Fig. 4). List of OPA1 interaction partners that decrease 
after cBIDwt treatment in Spot 11. 
Supplemental table 9 (Related to Fig. 7). List of OPA1 interaction partners in heart. 
Pearson: Pearson correlation coefficiency (r). High Pearson correlation coefficiency 
indicates high confidence of association with OPA1.  
Supplemental table 10 (Related to Fig. 7). List of OPA1 interaction partners in heart that 
decrease after cBIDwt treatment. Only fold change < 0.8 is considered to be significant.   
Supplemental table 11 (Related to Fig. 7). List of OPA1 interaction partners in heart that 
decrease during cristae remodeling. 
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Supplemental table 12 (Related to Fig. 8). List of OPA1 interaction partners in MAFs that 
decrease after cBIDwt treatment (identified by SILAC). Only fold change > 1.2 is considered 
to be significant.   
Supplemental table 13 (Related to Fig. 8). List of OPA1 interaction partners in MAFs that 
decrease in the various spots during cristae remodeling (identified by SILAC). Only fold 
change > 1.2 is considered to be significant.    
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Suppl. Table 1. Consolidate list of all the unique proteins identified in 
the different spots (581 proteins) 
A/A 
ACCESSION 
NUMBER 
PROTEIN NAME GENE 
1 Q9WVM8 Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial  Aadat 
2 Q99K67 Alpha-aminoadipic semialdehyde synthase, mitochondrial  Aass 
3 P61922 4-aminobutyrate aminotransferase, mitochondrial  Abat 
4 P41233 ATP-binding cassette sub-family A member 1 Abca1 
5 Q8K449 ATP-binding cassette sub-family A member 9 Abca9 
6 Q9JI39 ATP-binding cassette sub-family B member 10, mitochondrial  Abcb10 
7 P06795 Multidrug resistance protein 1B  Abcb1b 
8 Q9DC29 ATP-binding cassette sub-family B member 6, mitochondrial Abcb6 
9 Q9CXJ4 ATP-binding cassette sub-family B member 8, mitochondrial Abcb8 
10 Q80WJ6 
Multidrug resistance-associated protein 9 (ATP-binding cassette sub-
family C member 12) Abcc12 
11 P48410 
ATP-binding cassette sub-family D member 1 (Adrenoleukodystrophy 
protein) (ALDP) Abcd1 
12 Q61285 
ATP-binding cassette sub-family D member 2 (Adrenoleukodystrophy-
related protein) Abcd2 
13 P55096 
ATP-binding cassette sub-family D member 3 (68 kDa peroxisomal 
membrane protein) (PMP68)  Abcd3 
14 Q99LE6 ATP-binding cassette sub-family F member 2 Abcf2 
15 Q8VCH0 3-ketoacyl-CoA thiolase B, peroxisomal Acaa1b 
16 Q8BWT1 3-ketoacyl-CoA thiolase, mitochondrial  Acaa2 
17 Q5SWU9 Acetyl-CoA carboxylase 1 (ACC1)  Acaca 
18 E9Q4Z2 Acetyl-CoA carboxylase 2  Acacb 
19 Q80XL6 Acyl-CoA dehydrogenase family member 11 (ACAD-11)  Acad11 
20 Q9D7B6 Isobutyryl-CoA dehydrogenase, mitochondrial  Acad8 
21 Q8JZN5 Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) Acad9 
22 P51174 Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) Acadl 
23 P45952 Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (MCAD)  Acadm 
24 Q07417 Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD)  Acads 
25 P50544 Very long-chain specific acyl-CoA dehydrogenase, mitochondrial  Acadvl 
26 Q8QZT1 Acetyl-CoA acetyltransferase, mitochondrial  Acat1 
27 Q91V92 ATP-citrate synthase  Acly 
28 P28271 Cytoplasmic aconitate hydratase (Aconitase)  Aco1 
29 Q99KI0 Aconitate hydratase, mitochondrial (Aconitase) Aco2 
30 Q32MW3 
Acyl-coenzyme A thioesterase 10, mitochondrial (Acyl-CoA 
thioesterase 10)  Acot10 
31 Q9QXD1 Peroxisomal acyl-coenzyme A oxidase 2  Acox2 
32 Q9EPL9 Peroxisomal acyl-coenzyme A oxidase 3  Acox3 
33 Q8VCW8 Acyl-CoA synthetase family member 2, mitochondrial  Acsf2 
34 P41216 Long-chain-fatty-acid--CoA ligase 1  Acsl1 
35 Q9QUJ7 Long-chain-fatty-acid--CoA ligase 4  Acsl4 
36 Q8JZR0 Long-chain-fatty-acid--CoA ligase 5  Acsl5 
37 Q91VA0 Acyl-coenzyme A synthetase ACSM1, mitochondrial Acsm1 
38 Q8K0L3 Acyl-coenzyme A synthetase ACSM2, mitochondrial  Acsm2 
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39 Q3UNX5 Acyl-coenzyme A synthetase ACSM3, mitochondrial  Acsm3 
40 Q99NB1 acetyl-CoA synthetase 2-like Acss1 
41 Q99NB1 Acetyl-coenzyme A synthetase 2-like, mitochondrial Acss1 
42 P60710 Actin, cytoplasmic 1 (Beta-actin)  Actb 
43 Q6NSR3 Uncharacterized aarF domain-containing protein kinase 2 Adck2 
44 Q60936 Atypical kinase ADCK3, mitochondrial  Adck3 
45 Q8R0N6 Hydroxyacid-oxoacid transhydrogenase, mitochondrial (HOT)  Adhfe1 
46 P54822 Adenylosuccinate lyase (ASL)  Adsl 
47 Q920A7 AFG3-like protein 1  Afg3l1 
48 Q8JZQ2 AFG3-like protein 2  Afg3l2 
49 Q9D1E8 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon  Agpat5 
50 O35423 Serine--pyruvate aminotransferase, mitochondrial (SPT)  Agxt 
51 H7BWY3 Alanine--glyoxylate aminotransferase 2, mitochondrial Agxt2 
52 A0JLR7 Ahnak protein (Fragment) Ahnak 
53 B1AU25 Apoptosis-inducing factor 1, mitochondrial Aifm1 
54 Q3TY86 Apoptosis-inducing factor 3  Aifm3 
55 Q9WTP6 Adenylate kinase 2, mitochondrial (AK 2)  Ak2 
56 Q9WTP7 GTP:AMP phosphotransferase AK3, mitochondrial Ak3 
57 O08715 A-kinase anchor protein 1, mitochondrial  Akap1 
58 Q2VEB3 A-kinase anchoring protein beta Akap6 
59 P21300 Aldose reductase-related protein 1  Akr1b7 
60 Q9Z110 Delta-1-pyrroline-5-carboxylate synthase (P5CS)  Aldh18a1 
61 Q9CZS1 Aldehyde dehydrogenase X, mitochondrial  Aldh1b1 
62 Q8R0Y6 Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) Aldh1l1 
63 Q544B1 
Aldehyde dehydrogenase 2, mitochondrial, isoform CRA_b (Aldehyde 
dehydrogenase, mitochondrial) Aldh2 
64 P47738 Aldehyde dehydrogenase, mitochondrial  Aldh2 
65 Q8CHT0 
Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C 
dehydrogenase)  Aldh4a1 
66 Q8BWF0 Succinate-semialdehyde dehydrogenase, mitochondrial  Aldh5a1 
67 Q9EQ20 
Methylmalonate-semialdehyde dehydrogenase [acylating], 
mitochondrial (MMSDH) Aldh6a1 
68 Q9DBF1 
Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA 
dehydrogenase)  Aldh7a1 
69 Q9WUD7 Brain-specific ankyrin-G (Fragment) ANK3 
70 Q5QNR3 Protein Ankrd36 (Fragment) Ankrd36 
71 E9Q414 
Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 
(Apo B-48)] Apob 
72 Q78IK4 
MICOS complex subunit Mic27 (Apolipoprotein O-like) (Protein 
FAM121A) Apool 
73 Q9D7A8 Armadillo repeat-containing protein 1 Armc1 
74 A2VCS7 Armcx4 protein (Fragment) Armcx4 
75 Q9JHE3 Neutral ceramidase (N-CDase) (NCDase) Asah2 
76 Q9D5T0 ATPase family AAA domain-containing protein 1  Atad1 
77 Q925I1 ATPase family AAA domain-containing protein 3 (AAA-ATPase TOB3) Atad3 
78 Q62388 Serine-protein kinase ATM ( Atm 
79 Q03265 ATP synthase subunit alpha, mitochondrial Atp5a1 
80 P56480 ATP synthase subunit beta, mitochondrial  Atp5b 
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81 Q91VR2 
ATP synthase subunit gamma, mitochondrial (F-ATPase gamma 
subunit) Atp5c1 
82 Q9D3D9 ATP synthase subunit delta, mitochondrial (F-ATPase delta subunit) Atp5d 
83 P56382 ATP synthase subunit epsilon, mitochondrial (ATPase subunit epsilon) Atp5e 
84 Q5I0W0 ATP synthase F(0) complex subunit B1, mitochondrial Atp5f1 
85 Q9CQQ7 
ATP synthase F(0) complex subunit B1, mitochondrial (ATP synthase 
subunit b)  Atp5f1 
86 Q9DCX2 ATP synthase subunit d, mitochondrial (ATPase subunit d) Atp5h 
87 Q06185 ATP synthase subunit e, mitochondrial (ATPase subunit e) Atp5i 
88 P97450 ATP synthase-coupling factor 6, mitochondrial (ATPase subunit F6) Atp5j 
89 P56135 ATP synthase subunit f, mitochondrial Atp5j2 
90 Q9CPQ8 ATP synthase subunit g, mitochondrial (ATPase subunit g) Atp5l 
91 Q9DB20 
ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral 
protein) (OSCP) Atp5o 
92 Q9JLZ3 Methylglutaconyl-CoA hydratase, mitochondrial  Auh 
93 Q3UHR0 BAH and coiled-coil domain-containing protein 1 Bahcc1 
94 Q6P3A8 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial  Bckdhb 
95 Q80XN0 D-beta-hydroxybutyrate dehydrogenase, mitochondrial (BDH)  Bdh1 
96 Q8R164 Valacyclovir hydrolase (VACVase) (Valacyclovirase)  Bphl 
97 A2A655 Protein Bptf Bptf 
98 P01027 Complement C3 (HSE-MSF)  C3 
99 P23589 Carbonic anhydrase 5A, mitochondrial  Ca5a 
100 Q80TJ1 
Calcium-dependent secretion activator 1 (Calcium-dependent activator 
protein for secretion 1)  Cadps 
101 P35564 Calnexin Canx 
102 O89110 Caspase-8 (CASP-8)  Casp8 
103 P24270 Catalase  Cat 
104 Q91VT4 Carbonyl reductase family member 4 Cbr4 
105 Q9D5Y1 Coiled-coil domain-containing protein 39 Ccdc39 
106 Q8BI79 Coiled-coil domain-containing protein 40 (Protein links) Ccdc40 
107 P80313 T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)  Cct7 
108 Q155P7 LEK1 Cenpf 
109 Q8VCT4 Carboxylesterase 1D (Carboxylesterase 3)  Ces1d 
110 Q8C6S9 Cilia- and flagella-associated protein 54 Cfap54 
111 Q8BQV2 Choline O-acetyltransferase (Choline acetyltransferase) Chat 
112 Q9CRB9 
MICOS complex subunit Mic19 (Coiled-coil-helix-coiled-coil-helix 
domain-containing protein 3) Chchd3 
113 Q8BJ64 Choline dehydrogenase, mitochondrial (CDH)  Chdh 
114 Q8K3J4 Nicotinic acetylcholine receptor alpha 9 subunit (Fragment) Chrna9 
115 P30275 Creatine kinase U-type, mitochondrial  Ckmt1 
116 Q922J3 CAP-Gly domain-containing linker protein 1  Clip1 
117 O88696 ATP-dependent Clp protease proteolytic subunit, mitochondrial  Clpp 
118 Q8R4N0 
Citrate lyase subunit beta-like protein, mitochondrial (Citrate lyase 
beta-like) (Beta-methylmalate synthase)  Clybl 
119 Q9D5U8 Cyclic nucleotide-binding domain-containing protein 2 Cnbd2 
120 A2AL36 Centriolin (Centrosomal protein 1)  Cntrl 
121 A2AX52 Collagen alpha-4(VI) chain Col6a4 
122 Q8R1S0 Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial  Coq6 
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123 Q8BJ03 Cytochrome c oxidase assembly protein COX15 homolog Cox15 
124 Q9CR63 
Cytochrome c oxidase assembly protein COX16 homolog, 
mitochondrial Cox16 
125 P19783 
Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (Cytochrome 
c oxidase polypeptide IV)  Cox4i1 
126 P12787 
Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c 
oxidase polypeptide Va) Cox5a 
127 P43024 
Cytochrome c oxidase subunit 6A1, mitochondrial (Cytochrome c 
oxidase polypeptide VIa-liver) Cox6a1 
128 P56391 
Cytochrome c oxidase subunit 6B1 (Cytochrome c oxidase subunit VIb 
isoform 1)  Cox6b1 
129 Q9CPQ1 
Cytochrome c oxidase subunit 6C (Cytochrome c oxidase polypeptide 
VIc) Cox6c 
130 P48771 Cytochrome c oxidase subunit 7A2, mitochondrial  Cox7a2 
131 P56393 
Cytochrome c oxidase subunit 7B, mitochondrial (Cytochrome c 
oxidase polypeptide VIIb) Cox7b 
132 P36552 
Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial 
(COX) (Coprogen oxidase)  Cpox 
133 Q9WVJ3 Carboxypeptidase Q  Cpq 
134 Q8C196 Carbamoyl-phosphate synthase [ammonia], mitochondrial  Cps1 
135 P97742 Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) Cpt1a 
136 P52825 Carnitine O-palmitoyltransferase 2, mitochondrial  Cpt2 
137 Q9DC50 Peroxisomal carnitine O-octanoyltransferase (COT)  Crot 
138 Q9CZU6 Citrate synthase, mitochondrial  Cs 
139 Q9CQX2 
Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane 
isoform) Cyb5b 
140 Q9DB73 NADH-cytochrome b5 reductase 1 (b5R.1)  Cyb5r1 
141 Q9D0M3 Cytochrome c1, heme protein, mitochondrial  Cyc1 
142 P00186 Cytochrome P450 1A2  Cyp1a2 
143 Q9DBG1 Sterol 26-hydroxylase, mitochondrial  Cyp27a1 
144 Q05421 Cytochrome P450 2E1  Cyp2e1 
145 P33267 Cytochrome P450 2F2 Cyp2f2 
146 Q64459 Cytochrome P450 3A11  Cyp3a11 
147 Q91WL5 Cytochrome P450 4A12A  Cyp4a12a 
148 Q7TN08 Dapper homolog 2 (mDpr2)  Dact2 
149 Q9ER88 
28S ribosomal protein S29, mitochondrial (Death-associated protein 3) 
(DAP-3) Dap3 
150 P53395 
Lipoamide acyltransferase component of branched-chain alpha-keto 
acid dehydrogenase complex, mitochondrial  Dbt 
151 Q9CWT6 Probable ATP-dependent RNA helicase DDX28  Ddx28 
152 Q9CQ62 2,4-dienoyl-CoA reductase, mitochondrial  Decr1 
153 O35435 Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase)  Dhodh 
154 Q99LB2 Dehydrogenase/reductase SDR family member 4 ) Dhrs4 
155 A2ATU0 
Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, 
mitochondrial  Dhtkd1 
156 Q6PGC1 ATP-dependent RNA helicase Dhx29  Dhx29 
157 Q8K1G9 DEAH (Asp-Glu-Ala-His) box polypeptide 35  Dhx35 
158 Q8BMF4 
Dihydrolipoyllysine-residue acetyltransferase component of pyruvate 
dehydrogenase complex, mitochondrial  Dlat 
159 O08749 Dihydrolipoyl dehydrogenase, mitochondrial  Dld 
160 Q9D2G2 
Dihydrolipoyllysine-residue succinyltransferase component of 2-
oxoglutarate dehydrogenase complex, mitochondrial  Dlst 
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161 Q9DBT9 Dimethylglycine dehydrogenase, mitochondrial  Dmgdh 
162 O08828 Axonemal dynein heavy chain (Fragment) Dnah1 
163 O08825 Dynein heavy chain (Fragment) Dnah10 
164 Q69Z23 Dynein heavy chain 17, axonemal  Dnah17 
165 Q8BW94 Dynein heavy chain 3, axonemal Dnah3 
166 Q8VHE6 Dynein heavy chain 5, axonemal  Dnah5 
167 Q5SX07 Protein Dnah9 Dnah9 
168 Q8BIK4 
Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange 
factor zizimin-1) Dock9 
169 Q9QXB9 Developmentally-regulated GTP-binding protein 2 (DRG-2) Drg2 
170 Q91ZU6 Dystonin (Bullous pemphigoid antigen 1) Dst 
171 Q45VK7 Cytoplasmic dynein 2 heavy chain 1  Dync2h1 
172 Q9CXJ1 Probable glutamate--tRNA ligase, mitochondrial  Ears2 
173 O35459 Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial  Ech1 
174 Q8BH95 Enoyl-CoA hydratase, mitochondrial Echs1 
175 P42125 Enoyl-CoA delta isomerase 1, mitochondrial Eci1 
176 Q9WUR2 Enoyl-CoA delta isomerase 2, mitochondrial Eci2 
177 Q9JHW4 Selenocysteine-specific elongation factor (Elongation factor sec)  Eefsec 
178 Q9DBM2 Peroxisomal bifunctional enzyme (PBE)  Ehhadh 
179 Q80Y81 Zinc phosphodiesterase ELAC protein 2  Elac2 
180 P54320 Elastin (Tropoelastin) Eln 
181 O08600 Endonuclease G, mitochondrial (Endo G)  Endog 
182 Q8R0W0 Epiplakin Eppk1 
183 Q99LC5 Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF) Etfa 
184 Q9DCW4 Electron transfer flavoprotein subunit beta (Beta-ETF) Etfb 
185 Q921G7 
Electron transfer flavoprotein-ubiquinone oxidoreductase, 
mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase)  Etfdh 
186 Q3TC72 Fumarylacetoacetate hydrolase domain-containing protein 2A Fahd2 
187 Q6P9P0 Protein FAM178A Fam178a 
188 Q9CYH2 Redox-regulatory protein FAM213A  Fam213a 
189 P19096 Fatty acid synthase  Fasn 
190 Q922E6 FAST kinase domain-containing protein 2 Fastkd2 
191 Q544X6 ferrochelatase Fech 
192 P97807 Fumarate hydratase, mitochondrial (Fumarase)  Fh 
193 Q8CHD0 MKIAA0826 protein (Fragment) Fryl 
194 Q9CZD3 Glycine--tRNA ligase  Gars 
195 Q99JT1 
Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-
AdT subunit B)  Gatb 
196 Q7TMG8 Glioblastoma amplified sequence Gbas 
197 Q60759 Glutaryl-CoA dehydrogenase, mitochondrial (GCD) Gcdh 
198 Q8K0D5 Elongation factor G, mitochondrial (EF-Gmt) Gfm1 
199 Q8R2Q4 Ribosome-releasing factor 2, mitochondrial (RRF2mt) Gfm2 
200 Q9WU65 Glycerol kinase 2 (GK 2) (Glycerokinase 2) Gk2 
201 Q91W43 Glycine dehydrogenase (decarboxylating), mitochondrial  Gldc 
202 Q571F8 Glutaminase liver isoform, mitochondrial (GLS)  Gls2 
203 P26443 Glutamate dehydrogenase 1, mitochondrial (GDH 1)  Glud1 
204 Q91XE0 Glycine N-acyltransferase (EC 2.3.1.13) Glyat 
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205 Q8QZY2 Glycerate kinase  Glyctk 
206 Q3TNU4 Putative uncharacterized protein ENSP00000382790 homolog Gm3414 
207 Q5FW57 Glycine N-acyltransferase-like protein  Gm4952 
208 P05202 Aspartate aminotransferase, mitochondrial (mAspAT)  Got2 
209 Q61586 Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAT-1)  Gpam 
210 P13707 Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic (GPD-C)  Gpd1 
211 A2AQR0 Glycerol-3-phosphate dehydrogenase  Gpd2 
212 Q64521 Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M)  Gpd2 
213 Q8BGT5 Alanine aminotransferase 2 (ALT2)  Gpt2 
214 P11352 Glutathione peroxidase 1 (GPx-1)  Gpx1 
215 Q8C5Q4 G-rich sequence factor 1 (GRSF-1) Grsf1 
216 P47791 Glutathione reductase, mitochondrial (GR)  Gsr 
217 Q9DCM2 Glutathione S-transferase kappa 1  Gstk1 
218 Q923K4 
tRNA modification GTPase GTPBP3, mitochondrial (GTP-binding protein 
3) Gtpbp3 
219 Q9CY28 GTP-binding protein 8 Gtpbp8 
220 Q8C3X4 Translation factor Guf1, mitochondrial  Guf1 
221 P12265 Beta-glucuronidase  Gusb 
222 Q61425 Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH)  Hadh 
223 Q8BMS1 Trifunctional enzyme subunit alpha, mitochondrial (TP-alpha) Hadha 
224 Q99JY0 Trifunctional enzyme subunit beta, mitochondrial (TP-beta) Hadhb 
225 Q9WU19 Hydroxyacid oxidase 1 (HAOX1)  Hao1 
226 A8DUK7 Beta-globin Hbbt1 
227 Q9D0S9 Histidine triad nucleotide-binding protein 2, mitochondrial (HINT-2) Hint2 
228 Q6GQU1 Hexokinase Hk1 
229 O08528 Hexokinase-2  Hk2 
230 P38060 Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase)  Hmgcl 
231 P54869 
Hydroxymethylglutaryl-CoA synthase, mitochondrial (HMG-CoA 
synthase) Hmgcs2 
232 P52760 Ribonuclease UK114  Hrsp12 
233 Q99N15 
17beta-hydroxysteroid dehydrogenase type 10/short chain L-3-
hydroxyacyl-CoA dehydrogenase  Hsd17b10 
234 P51660 Peroxisomal multifunctional enzyme type 2 (MFE-2)  Hsd17b4 
235 P50171 Estradiol 17-beta-dehydrogenase 8  Hsd17b8 
236 Q61694 3 beta-hydroxysteroid dehydrogenase type 5  Hsd3b5 
237 Q2TPA8 Hydroxysteroid dehydrogenase-like protein 2  Hsdl2 
238 P08113 Endoplasmin (94 kDa glucose-regulated protein) (GRP-94)  Hsp90b1 
239 P20029 78 kDa glucose-regulated protein (GRP-78)  Hspa5 
240 P38647 Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) Hspa9 
241 P63038 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin)  Hspd1 
242 Q64433 10 kDa heat shock protein, mitochondrial (Hsp10)  Hspe1 
243 Q9JIY5 Serine protease HTRA2, mitochondrial Htra2 
244 Q80W93 Hydrocephalus-inducing protein (Protein Hy-3) Hydin 
245 Q9JKR6 Hypoxia up-regulated protein 1 (GRP-170)  Hyou1 
246 Q8BIJ6 Isoleucine--tRNA ligase, mitochondrial  Iars2 
247 Q8R035 Peptidyl-tRNA hydrolase ICT1, mitochondrial  Ict1 
248 P54071 Isocitrate dehydrogenase [NADP], mitochondrial (IDH)  Idh2 
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249 Q9D6R2 Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial  Idh3a 
250 Q91VA7 Isocitrate dehydrogenase [NAD] subunit, mitochondrial  Idh3b 
251 Q91VA7 Isocitrate dehydrogenase [NAD] subunit, mitochondrial Idh3b 
252 Q8BPT6 Mitochondrial inner membrane protease subunit 2 Immp2l 
253 Q8CAQ8 
MICOS complex subunit Mic60 (Mitochondrial inner membrane 
protein) (Mitofilin) Immt 
254 Q6PCQ0 IQ domain-containing protein E Iqce 
255 Q811J3 Iron-responsive element-binding protein 2 (IRE-BP 2)  Ireb2 
256 P11881 Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1)  Itpr1 
257 P70227 Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3)  Itpr3 
258 Q9JHI5 Isovaleryl-CoA dehydrogenase, mitochondrial (IVD)  Ivd 
259 Q99MN1 Lysine--tRNA ligase  Kars 
260 Q03717 
Potassium voltage-gated channel subfamily B member 1 (Voltage-
gated potassium channel subunit Kv2.1)  Kcnb1 
261 Q3UXZ9 Lysine-specific demethylase 5A  Kdm5a 
262 Q9DCY0 Glycine N-acyltransferase-like protein Keg1 Keg1 
263 Q60575 Kinesin-like protein KIF1B Kif1b 
264 Q52KG5 Kinesin-like protein KIF26A Kif26a 
265 Q91WN4 Kynurenine 3-monooxygenase  Kmo 
266 Q8C3Y4 Kinetochore-associated protein 1 Kntc1 
267 P04104 Keratin, type II cytoskeletal 1 (67 kDa cytokeratin)  Krt1 
268 P02535 Keratin, type I cytoskeletal 10 (56 kDa cytokeratin) Krt10 
269 Q9QWL7 Keratin, type I cytoskeletal 17 (Cytokeratin-17)  Krt17 
270 Q922U2 Keratin, type II cytoskeletal 5 (Cytokeratin-5)  Krt5 
271 P50446 Keratin, type II cytoskeletal 6A (Cytokeratin-6A)  Krt6a 
272 Q9CXF0 Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase) Kynu 
273 Q91YP0 L-2-hydroxyglutarate dehydrogenase, mitochondrial  L2hgdh 
274 Q60675 Laminin subunit alpha-2 (Laminin M chain)  Lama2 
275 Q9CPY7 Cytosol aminopeptidase  Lap3 
276 Q8VDC0 Probable leucine--tRNA ligase, mitochondrial  Lars2 
277 O55203 
LIM domain-binding protein 2 (LDB-2) (Carboxyl-terminal LIM domain-
binding protein 1) Ldb2 
278 P16125 L-lactate dehydrogenase B chain (LDH-B)  Ldhb 
279 Q9Z2I0 LETM1 and EF-hand domain-containing protein 1, mitochondrial  Letm1 
280 Q8CGK3 Lon protease homolog, mitochondrial  Lonp1 
281 Q6PB66 Leucine-rich PPR motif-containing protein, mitochondrial  Lrpprc 
282 Q5S006 Leucine-rich repeat serine/threonine-protein kinase 2  Lrrk2 
283 Q64133 Amine oxidase [flavin-containing] A  Maoa 
284 Q8BW75 Amine oxidase [flavin-containing] B  Maob 
285 Q922Q1 Mitochondrial amidoxime reducing component 2 (mARC2)  Marc2 
286 Q8BJ34 Meiosis arrest female protein 1 (Limkain-b1) Marf1 
287 Q68FL6 Methionine--tRNA ligase, cytoplasmic  Mars 
288 Q99MR8 
Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial 
(MCCase subunit alpha)  Mccc1 
289 Q3ULD5 
Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase 
subunit beta)  Mccc2 
290 Q8VI13 MCG117370, isoform CRA_b (MCG5438)  
mCG_117
370 
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291 Q2KHI9 DNA helicase MCM9  Mcm9 
292 P08249 Malate dehydrogenase, mitochondrial  Mdh2 
293 Q8BMF3 NADP-dependent malic enzyme, mitochondrial (NADP-ME)  Me3 
294 Q9DCS3 Trans-2-enoyl-CoA reductase, mitochondrial  Mecr 
295 Q3U2U7 Methyltransferase-like protein 17, mitochondrial  Mettl17 
296 Q811U4 Mitofusin-1  Mfn1 
297 Q80U63 Mitofusin-2  Mfn2 
298 Q61769 Ki-67 protein Mki67 
299 Q99J39 Malonyl-CoA decarboxylase, mitochondrial (MCD)  Mlycd 
300 Q80UM7 Mannosyl-oligosaccharide glucosidase  Mogs 
301 P56379 6.8 kDa mitochondrial proteolipid Mp68 
302 Q9D023 Mitochondrial pyruvate carrier 2 (Brain protein 44) Mpc2 
303 Q3UW66 Sulfurtransferase Mpst 
304 Q8VIK2 Mpv17-like protein 2 Mpv17l2 
305 Q3TBW2 39S ribosomal protein L10, mitochondrial (L10mt) (MRP-L10) Mrpl10 
306 Q9CQF0 39S ribosomal protein L11, mitochondrial (L11mt) (MRP-L11) Mrpl11 
307 Q9DB15 39S ribosomal protein L12, mitochondrial (L12mt) (MRP-L12) Mrpl12 
308 Q9D1P0 39S ribosomal protein L13, mitochondrial (L13mt) (MRP-L13) Mrpl13 
309 Q9D1I6 39S ribosomal protein L14, mitochondrial (L14mt) (MRP-L14) Mrpl14 
310 Q9CPR5 39S ribosomal protein L15, mitochondrial (L15mt) (MRP-L15) Mrpl15 
311 Q99N93 39S ribosomal protein L16, mitochondrial (L16mt) (MRP-L16) Mrpl16 
312 Q9D8P4 39S ribosomal protein L17, mitochondrial (L17mt) (MRP-L17) Mrpl17 
313 Q9CQL5 39S ribosomal protein L18, mitochondrial (L18mt) (MRP-L18) Mrpl18 
314 Q9D773 39S ribosomal protein L2, mitochondrial (L2mt) (MRP-L2) Mrpl2 
315 Q9D1N9 39S ribosomal protein L21, mitochondrial (L21mt) (MRP-L21) Mrpl21 
316 Q8BU88 39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22) Mrpl22 
317 O35972 39S ribosomal protein L23, mitochondrial (L23mt) (MRP-L23)  Mrpl23 
318 Q9CQ06 39S ribosomal protein L24, mitochondrial (L24mt) (MRP-L24) Mrpl24 
319 Q9D1B9 39S ribosomal protein L28, mitochondrial (L28mt) (MRP-L28) Mrpl28 
320 Q9CQL6 39S ribosomal protein L35, mitochondrial (L35mt) (MRP-L35) Mrpl35 
321 Q921S7 39S ribosomal protein L37, mitochondrial (L37mt) (MRP-L37) Mrpl37 
322 Q8K2M0 39S ribosomal protein L38, mitochondrial (L38mt) (MRP-L38) Mrpl38 
323 Q9JKF7 39S ribosomal protein L39, mitochondrial (L39mt) (MRP-L39) Mrpl39 
324 Q5RL20 39S ribosomal protein L43, mitochondrial Mrpl43 
325 Q8K2Y7 39S ribosomal protein L47, mitochondrial (L47mt) (MRP-L47) Mrpl47 
326 Q9CQ40 39S ribosomal protein L49, mitochondrial (L49mt) (MRP-L49) Mrpl49 
327 Q99N94 39S ribosomal protein L9, mitochondrial (L9mt) (MRP-L9) Mrpl9 
328 E9QJS0 28S ribosomal protein S10, mitochondrial Mrps10 
329 Q9DC71 28S ribosomal protein S15, mitochondrial (MRP-S15) (S15mt) Mrps15 
330 Q99N84 28S ribosomal protein S18b, mitochondrial (MRP-S18-b)  Mrps18b 
331 Q924T2 28S ribosomal protein S2, mitochondrial (MRP-S2) (S2mt) Mrps2 
332 Q9CXW2 28S ribosomal protein S22, mitochondrial (MRP-S22) (S22mt) Mrps22 
333 Q8VE22 28S ribosomal protein S23, mitochondrial (MRP-S23) (S23mt) Mrps23 
334 Q9CQV5 28S ribosomal protein S24, mitochondrial (MRP-S24) (S24mt) Mrps24 
335 Q9D125 28S ribosomal protein S25, mitochondrial (MRP-S25) (S25mt) Mrps25 
336 Q80ZS3 28S ribosomal protein S26, mitochondrial (MRP-S26) (S26mt) Mrps26 
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337 Q8BK72 28S ribosomal protein S27, mitochondrial (MRP-S27) (S27mt) Mrps27 
338 Q61733 28S ribosomal protein S31, mitochondrial (MRP-S31) (S31mt)  Mrps31 
339 Q9JIK9 28S ribosomal protein S34, mitochondrial (MRP-S34) (S34mt)  Mrps34 
340 Q8BJZ4 28S ribosomal protein S35, mitochondrial (MRP-S35) (S35mt) Mrps35 
341 Q99N87 28S ribosomal protein S5, mitochondrial (MRP-S5) (S5mt) Mrps5 
342 Q80X85 28S ribosomal protein S7, mitochondrial (MRP-S7) (S7mt) Mrps7 
343 Q9D7N3 28S ribosomal protein S9, mitochondrial (MRP-S9) (S9mt) Mrps9 
344 Q9D6Y7 Mitochondrial peptide methionine sulfoxide reductase  Msra 
345 P00848 ATP synthase subunit a (F-ATPase protein 6) Mtatp6 
346 P03930 ATP synthase protein 8 (A6L) (F-ATPase subunit 8) Mtatp8 
347 Q791T5 Mitochondrial carrier homolog 1 (Mitochondrial carrier-like protein 1) Mtch1 
348 Q791V5 Mitochondrial carrier homolog 2 Mtch2 
349 P00397 Cytochrome c oxidase subunit 1  Mtco1 
350 P00405 Cytochrome c oxidase subunit 2 (Cytochrome c oxidase polypeptide II) Mtco2 
351 P00158 Cytochrome b (Complex III subunit 3) (Complex III subunit III)  Mt-Cyb 
352 Q8R3J4 
Transcription termination factor 3, mitochondrial (Mitochondrial 
transcription termination factor 3) ( Mterf3 
353 Q8R2R6 
Mitochondrial ribosome-associated GTPase 1 (GTP-binding protein 7) 
(Mitochondrial GTPase 1) Mtg1 
354 Q922D8 C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase)  Mthfd1 
355 Q91YJ5 Translation initiation factor IF-2, mitochondrial (IF-2(Mt))  Mtif2 
356 P03888 NADH-ubiquinone oxidoreductase chain 1  Mtnd1 
357 P03893 NADH-ubiquinone oxidoreductase chain 2  Mtnd2 
358 P03899 NADH-ubiquinone oxidoreductase chain 3  Mtnd3 
359 P03911 NADH-ubiquinone oxidoreductase chain 4  Mtnd4 
360 Q9MD82 NADH-ubiquinone oxidoreductase chain 5  mt-Nd5 
361 Q923Z3 Protein MTO1 homolog, mitochondrial Mto1 
362 Q9D1H1 MCG4778 (Protein Muc16) Muc16 
363 P28666 Murinoglobulin-2 (MuG2) Mug2 
364 P16332 Methylmalonyl-CoA mutase, mitochondrial (MCM)  Mut 
365 Q5SV64 Myosin-10 Myh10 
366 Q8C170 Unconventional myosin-IXa (Unconventional myosin-9a) Myo9a 
367 P70670 
Nascent polypeptide-associated complex subunit alpha, muscle-
specific form  Naca 
368 Q8R4H7 N-acetylglutamate synthase, mitochondrial Nags 
369 Q80TN7 
Neuron navigator 3 (Pore membrane and/or filament-interacting-like 
protein 1) Nav3 
370 Q99LC3 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, 
mitochondrial (Complex I-42kD)  Ndufa10 
371 Q7TMF3 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 
(Complex I-B17.2)  Ndufa12 
372 Q9ERS2 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 
(Cell death regulatory protein GRIM-19) (Complex I-B16.6)  Ndufa13 
373 Q9CQ75 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 
(Complex I-B8)  Ndufa2 
374 Q9CQ91 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 
(Complex I-B9) Ndufa3 
375 Q62425 Cytochrome c oxidase subunit NDUFA4 Ndufa4 
376 Q9CQZ5 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 
(Complex I-B14) ( Ndufa6 
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377 Q9Z1P6 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 
(Complex I-B14.5a)  Ndufa7 
378 Q9DCJ5 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 
(Complex I-19kD)  Ndufa8 
379 Q9DC69 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, 
mitochondrial (Complex I-39kD) Ndufa9 
380 Q9CR21 
Acyl carrier protein, mitochondrial (ACP) (CI-SDAP) (NADH-ubiquinone 
oxidoreductase 9.6 kDa subunit) Ndufab1 
381 Q9CWX2 
Complex I intermediate-associated protein 30, mitochondrial (NADH 
dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 1) Ndufaf1 
382 Q9DCS9 
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 
(Complex I-PDSW)  Ndufb10 
383 O09111 
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, 
mitochondrial (Complex I-ESSS) Ndufb11 
384 Q9CPU2 
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, 
mitochondrial (Complex I-AGGG) Ndufb2 
385 Q9CQZ6 
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 
(Complex I-B12) Ndufb3 
386 Q9CQC7 
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 
(Complex I-B15)  Ndufb4 
387 Q9CQH3 
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, 
mitochondrial (Complex I-SGDH) Ndufb5 
388 Q3UIU2 
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 
(Complex I-B17) Ndufb6 
389 Q9CR61 
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 
(Complex I-B18)  Ndufb7 
390 Q9D6J5 
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, 
mitochondrial (Complex I-ASHI)  Ndufb8 
391 Q9CQJ8 
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 
(Complex I-B22)  Ndufb9 
392 Q91VD9 NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial  Ndufs1 
393 Q91WD5 NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial  Ndufs2 
394 Q9DCT2 NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial  Ndufs3 
395 Q9CXZ1 
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial 
(Complex I-18 kDa)  Ndufs4 
396 Q99LY9 
NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 (Complex I-15 
kDa)  Ndufs5 
397 Q9DC70 NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial  Ndufs7 
398 Q8K3J1 NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial  Ndufs8 
399 Q91YT0 NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial  Ndufv1 
400 Q9D6J6 NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial  Ndufv2 
401 A2AQA9 Protein Neb Neb 
402 Q6P5H2 Nestin Nes 
403 Q8BZL1 
Sialidase-4 (EC 3.2.1.18) (N-acetyl-alpha-neuraminidase 4) 
(Neuraminidase 4) Neu4 
404 Q04690 Neurofibromin (Neurofibromatosis-related protein NF-1) Nf1 
405 Q9Z1J3 Cysteine desulfurase, mitochondrial (m-Nfs1)  Nfs1 
406 O55125 Protein NipSnap homolog 1 (NipSnap1) Nipsnap1 
407 Q9CQE1 Protein NipSnap homolog 3B (NipSnap3B) 
Nipsnap3
b 
408 Q91YP2 Neurolysin, mitochondrial  Nln 
409 Q4PLS0 NACHT (Protein Nlrp2) Nlrp2 
410 Q3TL44 NLR family member X1 Nlrx1 
411 Q01768 Nucleoside diphosphate kinase B (NDK B)  Nme2 
412 Q8C1W8 nicotinamide nucleotide transhydrogenase Nnt 
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413 Q9JJG9 Nitric oxide-associated protein 1 Noa1 
414 Q8BHG1 Nardilysin  Nrd1 
415 Q80U93 Nuclear pore complex protein Nup214  Nup214 
416 P29758 Ornithine aminotransferase, mitochondrial  Oat 
417 Q9CRD0 OCIA domain-containing protein 1 Ociad1 
418 Q60597 2-oxoglutarate dehydrogenase, mitochondrial  Ogdh 
419 Q9D8H7 Metalloendopeptidase OMA1, mitochondrial  Oma1 
420 P58281 Dynamin-like 120 kDa protein, mitochondrial  Opa1 
421 Q505D7 Optic atrophy 3 protein homolog Opa3 
422 P11725 Ornithine carbamoyltransferase, mitochondrial  Otc 
423 Q9D0K2 Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial  Oxct1 
424 Q9ESL0 Succinyl-CoA:3-ketoacid coenzyme A transferase 2B, mitochondrial  Oxct2b 
425 Q4KMM3 Oxidation resistance protein 1 (Protein C7) Oxr1 
426 Q8C015 Serine/threonine-protein kinase PAK 7  Pak7 
427 Q05920 Pyruvate carboxylase, mitochondrial  Pc 
428 Q91ZA3 
Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit 
alpha) Pcca 
429 Q99MN9 
Propionyl-CoA carboxylase beta chain, mitochondrial (PCCase subunit 
beta)  Pccb 
430 Q8BP54 Putative uncharacterized protein (Fragment) Pcx 
431 P35487 
Pyruvate dehydrogenase E1 component subunit alpha, testis-specific 
form, mitochondrial  Pdha2 
432 P27773 Protein disulfide-isomerase A3 ( Pdia3 
433 Q4FJR4 
Pdk3 protein (Pyruvate dehydrogenase kinase, isoenzyme 3, isoform 
CRA_b)  Pdk3 
434 Q504M2 MCG53395 (Protein Pdp2) (Uncharacterized protein) Pdp2 
435 Q7TSQ8 
Pyruvate dehydrogenase phosphatase regulatory subunit, 
mitochondrial (PDPr) Pdpr 
436 Q8CIW5 Twinkle protein, mitochondrial  Peo1 
437 Q9Z210 Peroxisomal membrane protein 11B (Peroxin-11B)  Pex11b 
438 Q8BHF7 
CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, 
mitochondrial  Pgs1 
439 P67778 Prohibitin (B-cell receptor-associated protein 32)  Phb 
440 O35129 Prohibitin-2 (B-cell receptor-associated protein BAP37)  Phb2 
441 Q8CCJ9 PHD finger protein 20-like protein 1 Phf20l1 
442 Q6PDH0 
Pleckstrin homology-like domain family B member 1 (Protein LL5-
alpha) Phldb1 
443 Q8BXA7 PH domain leucine-rich repeat-containing protein phosphatase 2  Phlpp2 
444 O35386 Phytanoyl-CoA dioxygenase, peroxisomal  Phyh 
445 Q8K411 Presequence protease, mitochondrial  Pitrm1 
446 Q8BWW9 Serine/threonine-protein kinase N2  Pkn2 
447 Q9D3P8 Plasminogen receptor (KT) (Plg-R(KT)) Plgrkt 
448 O88492 Perilipin-4 (Adipocyte protein S3-12) Plin4 
449 Q3UH93 Plexin-D1 Plxnd1 
450 Q9DC61 Mitochondrial-processing peptidase subunit alpha  Pmpca 
451 Q8K1R3 Polyribonucleotide nucleotidyltransferase 1, mitochondrial Pnpt1 
452 Q75WC0 
DNA polymerase subunit gamma-1 (Polymerase (DNA directed), 
gamma) Polg 
453 Q9QZM2 DNA polymerase subunit gamma-2, mitochondrial  Polg2 
454 P51175 Protoporphyrinogen oxidase (PPO)  Ppox 
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455 A2A7B5 Protein Prdm2 Prdm2 
456 P97313 
DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic 
subunit) Prkdc 
457 Q9WU79 Proline dehydrogenase 1, mitochondrial  Prodh 
458 Q9Z2Y8 Proline synthase co-transcribed bacterial homolog protein Prosc 
459 A2AVJ5 Proline-rich protein 5-like (Protein observed with Rictor-2) (Protor-2) Prr5l 
460 B9EJ35 Protease, serine, 3 Prss3 
461 Q8C0F9 Inactive serine protease 35 Prss35 
462 Q14C51 
Pentatricopeptide repeat domain-containing protein 3, mitochondrial 
(28S ribosomal protein S39, mitochondrial)  Ptcd3 
463 Q8BWM0 Prostaglandin E synthase 2  Ptges2 
464 B9EJA3 
Protein tyrosine phosphatase, receptor type, D (Receptor-type 
tyrosine-protein phosphatase delta) Ptprd 
465 P42925 
Peroxisomal membrane protein 2 (22 kDa peroxisomal membrane 
protein) Pxmp2 
466 Q922W5 Pyrroline-5-carboxylate reductase 1, mitochondrial  Pycr1 
467 Q8BG51 Mitochondrial Rho GTPase 1 (MIRO-1)  Rhot1 
468 Q5ND29 Rab-interacting lysosomal protein Rilp 
469 Q8CG73 
Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like 
protein) Rpgrip1l 
470 Q91YQ5 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 
1  Rpn1 
471 Q9DBG6 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 
2  Rpn2 
472 Q99PL5 Ribosome-binding protein 1 (Ribosome receptor protein) (RRp) (mRRp) Rrbp1 
473 P70272 Skeletal muscle ryanodine receptor (Fragment) ryr1 
474 Q8BGH2 Sorting and assembly machinery component 50 homolog Samm50 
475 Q99LB7 Sarcosine dehydrogenase, mitochondrial (SarDH)  Sardh 
476 A9JQD3 Protein Scn2a1 (Sodium channel Nav1.2) (Fragment) Scn2a1 
477 P32020 Non-specific lipid-transfer protein (NSL-TP)  Scp2 
478 Q8K2B3 
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, 
mitochondrial  Sdha 
479 Q9CQA3 
Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, 
mitochondrial  Sdhb 
480 Q3TGQ4 Putative uncharacterized protein Secisbp2 
481 Q99JR1 Sideroflexin-1 Sfxn1 
482 Q91V61 Sideroflexin-3 Sfxn3 
483 Q925N0 Sideroflexin-5 Sfxn5 
484 Q9CZN7 Serine hydroxymethyltransferase  Shmt2 
485 Q8JZU2 
Tricarboxylate transport protein, mitochondrial (Citrate transport 
protein) Slc25a1 
486 Q9CR62 Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP)  Slc25a11 
487 Q8BH59 
Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial 
aspartate glutamate carrier 1)  Slc25a12 
488 Q9QXX4 
Calcium-binding mitochondrial carrier protein Aralar2 (Citrin) 
(Mitochondrial aspartate glutamate carrier 2) Slc25a13 
489 Q9Z2Z6 
Mitochondrial carnitine/acylcarnitine carrier protein 
(Carnitine/acylcarnitine translocase) (CAC)  Slc25a20 
490 Q9CQS4 Solute carrier family 25 member 46 Slc25a46 
491 P51881 ADP/ATP translocase 2 (ADP,ATP carrier protein 2)  Slc25a5 
492 Q5HZI9 
Solute carrier family 25 member 51 (Mitochondrial carrier triple repeat 
protein 1) Slc25a51 
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493 O35488 Very long-chain acyl-CoA synthetase (VLACS) (VLCS)  Slc27a2 
494 Q4LDG0 Bile acyl-CoA synthetase (BACS)  Slc27a5 
495 Q9D8T7 SRA stem-loop-interacting RNA-binding protein, mitochondrial Slirp 
496 Q04692 
SWI/SNF-related matrix-associated actin-dependent regulator of 
chromatin subfamily A containing DEAD/H box 1  Smarcad1 
497 Q8VE18 Protein SMG8 (Protein smg-8 homolog) Smg8 
498 Q78PY7 
Staphylococcal nuclease domain-containing protein 1 (100 kDa 
coactivator) (p100 co-activator) Snd1 
499 Q9CWK8 Sorting nexin-2 Snx2 
500 P08228 Superoxide dismutase [Cu-Zn]  Sod1 
501 P09671 Superoxide dismutase [Mn], mitochondrial  Sod2 
502 Q62504 Msx2-interacting protein (SMART/HDAC1-associated repressor protein) Spen 
503 Q3ULF4 Paraplegin  Spg7 
504 Q62261 Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin)  Sptbn1 
505 O35411 Beta III spectrin (Fragment) Sptbn2 
506 Q9R112 Sulfide:quinone oxidoreductase, mitochondrial (SQOR)  Sqrdl 
507 Q9WTN3 Sterol regulatory element-binding protein 1 (SREBP-1)  Srebf1 
508 Q8BTI8 Serine/arginine repetitive matrix protein 2 Srrm2 
509 Q924W7 
Suppression of tumorigenicity 5 protein (DENN domain-containing 
protein 2B) St5 
510 P46978 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 
STT3A (Oligosaccharyl transferase subunit STT3A)  Stt3a 
511 Q9Z2I9 Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial Sucla2 
512 Q9WUM5 Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial  Suclg1 
513 Q9Z2I8 Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial  Suclg2 
514 Q8R086 Sulfite oxidase, mitochondrial  Suox 
515 Q80YD1 ATP-dependent RNA helicase SUPV3L1, mitochondrial  Supv3l1 
516 Q7TQH5 Synaptic nuclear envelope 1 Syne1 
517 Q6ZWQ0 Nesprin-2 (Nuclear envelope spectrin repeat protein 2) Syne2 
518 Q8K0Z7 
Translational activator of cytochrome c oxidase 1 (Coiled-coil domain-
containing protein 44) Taco1 
519 P21958 Antigen peptide transporter 1 (APT1) Tap1 
520 Q3UQ84 Threonine--tRNA ligase, mitochondrial  Tars2 
521 Q91YM4 Protein TBRG4 (Transforming growth factor beta regulator 4) Tbrg4 
522 Q9JHF5  V-type proton ATPase subunit a Tcirg1 
523 Q8K3F7 L-threonine 3-dehydrogenase, mitochondrial  Tdh 
524 Q80VL1 
Tudor and KH domain-containing protein (Tudor domain-containing 
protein 2) Tdrkh 
525 O70372 Telomerase reverse transcriptase Tert 
526 Q921I1 Serotransferrin (Transferrin)  Tf 
527 P40630 Transcription factor A, mitochondrial (mtTFA)  Tfam 
528 Q8JZM0 Dimethyladenosine transferase 1, mitochondrial  Tfb1m 
529 B2RY15 Tln2 protein Tln2 
530 Q9CR76 Transmembrane protein 186 Tmem186 
531 Q3UV71 Transmembrane and TPR repeat-containing protein 1 Tmtc1 
532 P83510 Traf2 and NCK-interacting protein kinase  Tnik 
533 Q9DCC8 Mitochondrial import receptor subunit TOM20 homolog  Tomm20 
534 Q9CZW5 Mitochondrial import receptor subunit TOM70  Tomm70a 
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535 P21107 Tropomyosin alpha-3 chain Tpm3 
536 Q9CQN1 Heat shock protein 75 kDa, mitochondrial (HSP 75)  Trap1 
537 Q80UN9 tRNA dimethylallyltransferase, mitochondrial  Trit1 
538 Q3UFY8 
Mitochondrial ribonuclease P protein 1 (Mitochondrial RNase P protein 
1)  Trmt10c 
539 Q8CGV9 Teashirt homolog 3 (Zinc finger protein 537) Tshz3 
540 P52196 Thiosulfate sulfurtransferase (Rhodanese) Tst 
541 A2ASS6 Titin (Connectin) Ttn 
542 P05213 Tubulin alpha-1B chain (Alpha-tubulin 2) Tuba1b 
543 Q7TMM9 Tubulin beta-2A chain Tubb2a 
544 Q9ERD7 Tubulin beta-3 chain Tubb3 
545 Q9D6F9 Tubulin beta-4A chain (Tubulin beta-4 chain) Tubb4a 
546 P99024 Tubulin beta-5 chain Tubb5 
547 Q8BFR5 Elongation factor Tu, mitochondrial Tufm 
548 Q9JMH6 Thioredoxin reductase 1, cytoplasmic (TR)  Txnrd1 
549 A2AN08 E3 ubiquitin-protein ligase UBR4  Ubr4 
550 Q64435 UDP-glucuronosyltransferase 1-6 (UDPGT 1-6)  Ugt1a6 
551 Q62452 UDP-glucuronosyltransferase 1-9 (UDPGT 1-9) Ugt1a9 
552 Q8BWQ1 UDP-glucuronosyltransferase 2A3 (UDPGT 2A3)  Ugt2a3 
553 Q8R084 UDP-glucuronosyltransferase  Ugt2b1 
554 A2RSJ4 UHRF1-binding protein 1-like Uhrf1bp1l 
555 Q8K0T7 Protein unc-13 homolog C (Munc13-3) Unc13c 
556 P25688 Uricase  Uox 
557 Q8R1I1 Cytochrome b-c1 complex subunit 9 (Complex III subunit 9)  Uqcr10 
558 Q9CQB4 Cytochrome b-c1 complex subunit 7 Uqcrb 
559 Q9CZ13 
Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III 
subunit 1)  Uqcrc1 
560 Q9DB77 
Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III 
subunit 2)  Uqcrc2 
561 Q9CR68 Cytochrome b-c1 complex subunit Rieske, mitochondrial  Uqcrfs1 
562 P99028 
Cytochrome b-c1 complex subunit 6, mitochondrial (Complex III 
subunit 6)  Uqcrh 
563 Q9CQ69 Cytochrome b-c1 complex subunit 8 (Complex III subunit 8) Uqcrq 
564 Q78IK2 
Up-regulated during skeletal muscle growth protein 5 (Diabetes-
associated protein in insulin-sensitive tissues) Usmg5 
565 P79457 Histone demethylase UTY  Uty 
566 Q91XL3 UDP-glucuronic acid decarboxylase 1 Uxs1 
567 Q60932 Voltage-dependent anion-selective channel protein 1 (VDAC-1) Vdac1 
568 Q60930 Voltage-dependent anion-selective channel protein 2 (VDAC-2)  Vdac2 
569 Q60931 Voltage-dependent anion-selective channel protein 3 (VDAC-3)  Vdac3 
570 Q5H8C4 Vacuolar protein sorting-associated protein 13A  Vps13a 
571 Q8CC88 von Willebrand factor A domain-containing protein 8 Vwa8 
572 Q4U4S6 Xin actin-binding repeat-containing protein 2 (Beta-xin)  Xirp2 
573 B7ZMP1 Probable Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3)  Xpnpep3 
574 Q8CAV0 Putative ribonuclease Ybey 
575 O88967 ATP-dependent zinc metalloprotease YME1L1  Yme1l1 
576 Q3V2K0 MCG48927 (Uncharacterized protein) 
1700071K
01Rik 
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Suppl. Table 2. Mitochondrial proteins that decrease after cBID 
treatment – Spot 1 
A/A 
ACCESSION 
NUMBER 
PROTEIN NAME GENE 
FOLD 
CHANGE 
1 Q9ER88 28S ribosomal protein S29, mitochondrial (MRP-S29)  Dap3 0 
2 Q91WD5 
NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, 
mitochondrial Ndufs2 0 
3 Q921G7 
Electron transfer flavoprotein-ubiquinone oxidoreductase, 
mitochondrial (ETF-QO)  Etfdh 0 
4 Q8K1R3 Polyribonucleotide nucleotidyltransferase 1, mitochondrial  Pnpt1 0 
5 Q91YP0 L-2-hydroxyglutarate dehydrogenase, mitochondrial  L2hgdh 0 
6 Q8C1W8 nicotinamide nucleotide transhydrogenase Nnt 0 
7 P16125 L-lactate dehydrogenase B chain (LDH-B)  Ldhb 0 
8 P97450 
ATP synthase-coupling factor 6, mitochondrial (ATPase 
subunit F6) Atp5j 0 
9 P06795 Multidrug resistance protein 1B  Abcb1b 0 
10 Q920A7 AFG3-like protein 1  Afg3l1 0 
11 Q9D773 39S ribosomal protein L2, mitochondrial (L2mt) (MRP-L2) Mrpl2 0 
12 Q64133 Amine oxidase [flavin-containing] A  Maoa 0 
13 Q544X6 ferrochelatase Fech 0 
14 Q9DBG1 Sterol 26-hydroxylase, mitochondrial  
Cyp27a
1 0 
15 Q8VCW8 Acyl-CoA synthetase family member 2, mitochondrial  Acsf2 0 
16 Q3UFY8 Mitochondrial ribonuclease P protein 1  
Trmt10
c 0 
17 Q60936 Atypical kinase ADCK3, mitochondrial  Adck3 0 
18 P50544 
Very long-chain specific acyl-CoA dehydrogenase, 
mitochondrial  Acadvl 0.27 
19 Q9DBM2 Peroxisomal bifunctional enzyme (PBE)  Ehhadh 0.33 
20 Q8CHT0 
Delta-1-pyrroline-5-carboxylate dehydrogenase, 
mitochondrial 
Aldh4a
1 0.42 
22 Q6PB66 Leucine-rich PPR motif-containing protein, mitochondrial  Lrpprc 0.60 
23 Q9QXX4 Calcium-binding mitochondrial carrier protein Aralar2 (Citrin)  
Slc25a1
3 0.63 
24 Q03265 ATP synthase subunit alpha, mitochondrial Atp5a1 0.66 
25 Q99KI0 Aconitate hydratase, mitochondrial (Aconitase)  Aco2 0.67 
26 Q9Z2I9 
Succinyl-CoA ligase [ADP-forming] subunit beta, 
mitochondrial  Sucla2 0.67 
27 P55096 ATP-binding cassette sub-family D member 3 Abcd3 0.67 
28 Q61694 3 beta-hydroxysteroid dehydrogenase type 5  Hsd3b5 0.67 
29 Q922U2 Keratin, type II cytoskeletal 5  Krt5 0.71 
30 Q8CGK3 Lon protease homolog, mitochondrial  Lonp1 0.71 
31 P63038 60 kDa heat shock protein, mitochondrial  Hspd1 0.73 
32 P51660 Peroxisomal multifunctional enzyme type 2 
Hsd17b
4 0.75 
33 Q8QZT1 Acetyl-CoA acetyltransferase, mitochondrial  Acat1 0.78 
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Suppl. Table 3. Mitochondrial proteins that decrease after cBID treatment 
– Spot 2 
A/A 
ACCESSION 
NUMBER 
PROTEIN NAME GENE 
FOLD 
CHANGE 
1 Q8VCH0 3-ketoacyl-CoA thiolase B, peroxisomal  Acaa1b 0 
2 P61922 4-aminobutyrate aminotransferase, mitochondrial  Abat 0 
3 Q6NSR3 Uncharacterized aarF domain-containing protein kinase 2 Adck2 0 
4 Q07417 
Short-chain specific acyl-CoA dehydrogenase, mitochondrial 
(SCAD)  Acads 0 
5 P41216 Long-chain-fatty-acid--CoA ligase 1  Acsl1 0 
6 P54822 Adenylosuccinate lyase (ASL)  Adsl 0 
7 Q9D5T0 ATPase family AAA domain-containing protein 1  Atad1 0 
8 Q8CHT0 
Delta-1-pyrroline-5-carboxylate dehydrogenase, 
mitochondrial  Aldh4a1 0 
9 Q9D5T0 ATPase family AAA domain-containing protein 1  Atad1 0 
10 Q8K449 ATP-binding cassette sub-family A member 9 Abca9 0 
11 P48410 ATP-binding cassette sub-family D member 1  Abcd1 0 
12 Q9Z2Z6 Mitochondrial carnitine/acylcarnitine carrier protein  Slc25a20 0 
13 P30275 Creatine kinase U-type, mitochondrial Ckmt1 0 
14 P56393 Cytochrome c oxidase subunit 7B, mitochondrial  Cox7b 0 
15 Q3U2U7 Methyltransferase-like protein 17, mitochondrial  Mettl17 0 
16 O08600 Endonuclease G, mitochondrial (Endo G)  Endog 0 
17 P97807 Fumarate hydratase, mitochondrial (Fumarase)  Fh 0 
18 Q8R2Q4 Ribosome-releasing factor 2, mitochondrial (RRF2mt) Gfm2 0 
19 Q8BGT5 Alanine aminotransferase 2 (ALT2)  Gpt2 0 
20 Q9WU65 Glycerol kinase 2 (GK 2) (Glycerokinase 2)  Gk2 0 
21 P38647 
Stress-70 protein, mitochondrial (75 kDa glucose-regulated 
protein) Hspa9 0 
22 Q8CEW7 Putative uncharacterized protein Zbed5 0 
23 Q8BIJ6 Isoleucine--tRNA ligase, mitochondrial  Iars2 0 
24 Q61425 
Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial 
(HCDH)  Hadh 0 
25 Q9CQ69 Cytochrome b-c1 complex subunit 8 (Complex III subunit 8)  Uqcrq 0 
26 Q8BMF3 NADP-dependent malic enzyme, mitochondrial (NADP-ME)  Me3 0 
27 Q99JY0 Trifunctional enzyme subunit beta, mitochondrial (TP-beta) Hadhb 0 
28 Q5HZI9 
Solute carrier family 25 member 51 (Mitochondrial carrier 
triple repeat protein 1) Slc25a51 0 
29 Q99N84 28S ribosomal protein S18b, mitochondrial  Mrps18b 0 
30 Q9D7N3 28S ribosomal protein S9, mitochondrial (MRP-S9) Mrps9 0 
31 Q923Z3 Protein MTO1 homolog, mitochondrial Mto1 0 
32 Q505D7 Optic atrophy 3 protein homolog Opa3 0 
33 Q9WUR2 Enoyl-CoA delta isomerase 2, mitochondrial  Eci2 0 
34 Q9Z0X1 Apoptosis-inducing factor 1, mitochondrial  Aifm1 0 
35 Q9JIY5 Serine protease HTRA2, mitochondrial  Htra2 0 
36 Q7TSQ8 
Pyruvate dehydrogenase phosphatase regulatory subunit, 
mitochondrial  Pdpr 0 
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37 Q9CR62 Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP)  Slc25a11 0 
38 Q9QXX4 Calcium-binding mitochondrial carrier protein Aralar2 (Citrin) Slc25a13 0 
39 P52196 Thiosulfate sulfurtransferase  Tst 0 
40 Q8JZM0 Dimethyladenosine transferase 1, mitochondrial  Tfb1m 0 
41 B7ZMP1 
Probable Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 
3)  Xpnpep3 0 
42 Q91ZA3 
Propionyl-CoA carboxylase alpha chain, mitochondrial 
(PCCase subunit alpha)  Pcca 0.21 
43 P51660 Peroxisomal multifunctional enzyme type 2  Hsd17b4 0.33 
44 Q9Z2I0 
LETM1 and EF-hand domain-containing protein 1, 
mitochondrial  Letm1 0.33 
45 Q91XE0 Glycine N-acyltransferase Glyat 0.38 
46 P54869 Hydroxymethylglutaryl-CoA synthase, mitochondrial  Hmgcs2 0.43 
47 Q9DBM2 Peroxisomal bifunctional enzyme (PBE) (PBFE) Ehhadh 0.43 
48 Q8JZU2 Tricarboxylate transport protein, mitochondrial  Slc25a1 0.43 
49 Q61694 3 beta-hydroxysteroid dehydrogenase type 5  Hsd3b5 0.50 
50 Q6PB66 Leucine-rich PPR motif-containing protein, mitochondrial  Lrpprc 0.50 
51 Q9CWX2 Complex I intermediate-associated protein 30, mitochondrial Ndufaf1 0.50 
52 Q99JR1 Sideroflexin-1 Sfxn1 0.50 
53 Q60931 
Voltage-dependent anion-selective channel protein 3 (VDAC-
3) Vdac3 0.50 
54 Q9DCY0 Glycine N-acyltransferase-like protein Keg1 Keg1 0.57 
55 Q80XN0 
D-beta-hydroxybutyrate dehydrogenase, mitochondrial 
(BDH) Bdh1 0.63 
56 Q922Q1 Mitochondrial amidoxime reducing component 2 (mARC2) Mosc2 0.63 
57 Q3V2K0 MCG48927 (Uncharacterized protein) 
1700071K01
Rik 0.67 
58 P11725 Ornithine carbamoyltransferase, mitochondrial  Otc 0.67 
59 Q99MN9 Propionyl-CoA carboxylase beta chain, mitochondrial  Pccb 0.67 
60 Q9Z2I8 
Succinyl-CoA ligase [GDP-forming] subunit beta, 
mitochondrial  Suclg2 0.67 
61 Q8R1I1 Cytochrome b-c1 complex subunit 9 (Complex III subunit 9) Uqcr10 0.67 
62 Q9CR68 Cytochrome b-c1 complex subunit Rieske, mitochondrial  Uqcrfs1 0.67 
63 O55125 Protein NipSnap homolog 1 (NipSnap1) Nipsnap1 0.70 
64 Q78IK2 
Up-regulated during skeletal muscle growth protein 5 
(Diabetes-associated protein in insulin-sensitive tissues) Usmg5 0.75 
65 Q5I0W0 ATP synthase F(0) complex subunit B1, mitochondrial Atp5f1 0.77 
 
Suppl. Table 4. Mitochondrial protein  that decrease after cBID treatment 
- Spot 4 
A/A 
ACCESSION 
NUMBER 
PROTEIN NAME GENE 
FOLD 
CHANG
E 
1 Q9D1I6 39S ribosomal protein L14, mitochondrial Mrpl14 0 
2 P54822 Adenylosuccinate lyase (ASL)  Adsl 0 
3 Q9CXJ4 ATP-binding cassette sub-family B member 8, mitochondrial Abcb8 0 
4 Q922D8 
C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF 
synthase)  Mthfd1 0 
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5 Q8BWM0 Prostaglandin E synthase 2  Ptges2 0 
6 Q7TSQ8 
Pyruvate dehydrogenase phosphatase regulatory subunit, 
mitochondrial (PDPr) Pdpr 0 
7 P80313 T-complex protein 1 subunit eta (TCP-1-eta) Cct7 0 
8 Q8BH59 Calcium-binding mitochondrial carrier protein Aralar1  Slc25a12 0.20 
9 Q61694 3 beta-hydroxysteroid dehydrogenase type 5  Hsd3b5 0.25 
10 Q8R3J4 
Transcription termination factor 3, mitochondrial 
(Mitochondrial transcription termination factor 3) Mterf3 0.25 
11 Q6PB66 Leucine-rich PPR motif-containing protein, mitochondrial Lrpprc 0.29 
12 Q8BJZ4 28S ribosomal protein S35, mitochondrial  Mrps35 0.33 
13 Q8CIW5 Twinkle protein, mitochondrial Peo1 0.33 
14 P19783 Cytochrome c oxidase subunit 4 isoform 1, mitochondrial  Cox4i1 0.40 
15 Q8BFR5 Elongation factor Tu, mitochondrial Tufm 0.43 
16 Q3TGQ4 Putative uncharacterized protein Secisbp2 0.43 
17 P05202 Aspartate aminotransferase, mitochondrial (mAspAT)  Got2 0.45 
18 Q9D1N9 39S ribosomal protein L21, mitochondrial (L21mt)  Mrpl21 0.50 
19 Q8JZN5 
Acyl-CoA dehydrogenase family member 9, mitochondrial 
(ACAD-9)  Acad9 0.50 
20 Q91VA0 Acyl-coenzyme A synthetase ACSM1, mitochondrial Acsm1 0.50 
21 Q80XN0 
D-beta-hydroxybutyrate dehydrogenase, mitochondrial 
(BDH)  Bdh1 0.50 
22 P97807 Fumarate hydratase, mitochondrial (Fumarase)  Fh 0.50 
23 Q9D7B6 Isobutyryl-CoA dehydrogenase, mitochondrial  Acad8 0.50 
24 Q922Q1 Mitochondrial amidoxime reducing component 2 (mARC2)  Mosc2 0.50 
25 Q3UFY8 Mitochondrial ribonuclease P protein 1  Trmt10c 0.50 
26 Q8VIK2 Mpv17-like protein 2 Mpv17l2 0.50 
27 Q80WJ6 
Multidrug resistance-associated protein 9 (ATP-binding 
cassette sub-family C member 12) Abcc12 0.50 
28 Q8R4H7 N-acetylglutamate synthase, mitochondrial  Nags 0.50 
29 Q9CRD0 OCIA domain-containing protein 1 Ociad1 0.50 
30 Q8VDC0 Probable leucine--tRNA ligase, mitochondrial  Lars2 0.50 
31 Q91YM4 Protein TBRG4 (Transforming growth factor beta regulator 4) Tbrg4 0.50 
32 Q8BZL1 Sialidase-4  Neu4 0.50 
33 Q9CR76 Transmembrane protein 186 Tmem186 0.50 
34 Q9JI39 ATP-binding cassette sub-family B member 10, mitochondrial  Abcb10 0.60 
35 Q9CQN1 Heat shock protein 75 kDa, mitochondrial (HSP 75)  Trap1 0.60 
36 P08249 Malate dehydrogenase, mitochondrial  Mdh2 0.60 
37 Q8VCW8 Acyl-CoA synthetase family member 2, mitochondrial  Acsf2 0.62 
38 Q9WUM5 
Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, 
mitochondrial  Suclg1 0.64 
39 Q9D3D9 
ATP synthase subunit delta, mitochondrial (F-ATPase delta 
subunit) Atp5d 0.67 
40 Q9DB73 NADH-cytochrome b5 reductase 1 (b5R.1) Cyb5r1 0.67 
41 Q91VD9 
NADH-ubiquinone oxidoreductase 75 kDa subunit, 
mitochondrial  Ndufs1 0.67 
42 A2AVJ5 Proline-rich protein 5-like Prr5l 0.67 
43 Q925N0 Sideroflexin-5 Sfxn5 0.67 
44 Q9CQS4 Solute carrier family 25 member 46 Slc25a46 0.67 
45 Q8CGV9 Teashirt homolog 3 (Zinc finger protein 537) Tshz3 0.67 
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46 Q3ULD5 Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial  Mccc2 0.70 
47 Q60932 Voltage-dependent anion-selective channel protein 1  Vdac1 0.71 
48 P50544 
Very long-chain specific acyl-CoA dehydrogenase, 
mitochondrial  Acadvl 0.73 
49 Q9CZS1 Aldehyde dehydrogenase X, mitochondrial  Aldh1b1 0.75 
50 P19096 Fatty acid synthase Fasn 0.75 
51 P54869 Hydroxymethylglutaryl-CoA synthase, mitochondrial  Hmgcs2 0.75 
52 Q9JHI5 Isovaleryl-CoA dehydrogenase, mitochondrial (IVD)  Ivd 0.75 
53 Q9R112 Sulfide:quinone oxidoreductase, mitochondrial (SQOR) Sqrdl 0.75 
54 Q91XL3 UDP-glucuronic acid decarboxylase 1  Uxs1 0.75 
55 P26443 Glutamate dehydrogenase 1, mitochondrial (GDH 1)  Glud1 0.77 
56 Q9QXX4 Calcium-binding mitochondrial carrier protein Aralar2 (Citrin)  Slc25a13 0.78 
57 Q8CHT0 
Delta-1-pyrroline-5-carboxylate dehydrogenase, 
mitochondrial  Aldh4a1 0.78 
58 Q9CWT6 Probable ATP-dependent RNA helicase DDX28  Ddx28 0.78 
59 Q99JY0 Trifunctional enzyme subunit beta, mitochondrial (TP-beta)  Hadhb 0.79 
Suppl. Table 5. Mitochondrial proteins that decrease after cBID 
treatment - Spot 5 
A/A 
ACCESSION 
NUMBER 
PROTEIN NAME GENE 
FOLD 
CHANGE 
1 Q9DCW5 Caspase-8 (CASP-8)  Casp8 0 
2 Q9D5T0 Choline dehydrogenase, mitochondrial  Chdh 0 
3 Q32MW3 Cytochrome b-c1 complex subunit 6, mitochondrial Uqcrh 0 
4 P43024 Cytochrome c oxidase subunit 6A1, mitochondrial Cox6a1 0 
5 O89110 Cytochrome c oxidase subunit NDUFA4 Ndufa4 0 
6 P99028 
Dihydrolipoyllysine-residue acetyltransferase component 
of pyruvate dehydrogenase complex, mitochondrial  Dlat 0 
7 Q921G7 
Electron transfer flavoprotein-ubiquinone oxidoreductase, 
mitochondrial  Etfdh 0 
8 Q9JJG9 Mitochondrial carrier homolog 2 Mtch2 0 
9 Q8BJ64 Prostaglandin E synthase 2  Ptges2 0 
10 P51175 Protoporphyrinogen oxidase (PPO)  Ppox 0 
11 Q8K0D5 Putative ribonuclease Ybey 0 
12 Q62425 Sorting and assembly machinery component 50 homolog Samm50 0 
13 Q8R1S0 
Ubiquinone biosynthesis monooxygenase COQ6, 
mitochondrial  Coq6 0 
14 Q8C0F9 Inactive serine protease 35 Prss35 0.08 
15 Q8BW75 Amine oxidase  Maob 0.20 
16 Q8K0D5 Elongation factor G, mitochondrial (EF-Gmt)  Gfm1 0.20 
17 Q8BW75 ATPase family AAA domain-containing protein 1 Atad1 0.25 
18 Q8BU88 39S ribosomal protein L22, mitochondrial Mrpl22 0.33 
19 O35386 
Cytochrome c oxidase assembly protein COX16 homolog, 
mitochondrial Cox16 0.33 
20 Q8R1S0 
Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase complex, 
mitochondrial  Dlst 0.33 
21 Q99J39 Malonyl-CoA decarboxylase, mitochondrial (MCD)  Mlycd 0.33 
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22 Q9JHF5  V-type proton ATPase subunit a Tcirg1 0.38 
23 Q8C3X4 Translation factor Guf1, mitochondrial  Guf1 0.40 
24 Q922E6 FAST kinase domain-containing protein 2 Fastkd2 0.44 
25 Q60932 Voltage-dependent anion-selective channel protein 1  Vdac1 0.47 
26 Q99NB1 Acetyl-coenzyme A synthetase 2-like, mitochondrial Acss1 0.50 
27 Q791V5 Acyl-CoA dehydrogenase family member 11  Acad11 0.50 
28 Q9D2G2 Acyl-coenzyme A thioesterase 10, mitochondrial  Acot10 0.50 
29 P56391 Cytochrome c oxidase subunit 6B1  Cox6b1 0.50 
30 P28271 Cytoplasmic aconitate hydratase (Aconitase)  Aco1 0.50 
31 Q8CHT0 
Delta-1-pyrroline-5-carboxylate dehydrogenase, 
mitochondrial (P5C dehydrogenase)  Aldh4a1 0.50 
32 Q80XL6 Glycine N-acyltransferase  Glyat 0.50 
33 Q9CY28 GTP-binding protein 8 Gtpbp8 0.50 
34 Q9CY28 GTP-binding protein 8 Gtpbp8 0.50 
35 Q99MR8 
Methylcrotonoyl-CoA carboxylase subunit alpha, 
mitochondrial  Mccc1 0.50 
36 Q8BHG1 Nardilysin  Nrd1 0.50 
37 Q9JJG9 Nitric oxide-associated protein 1 Noa1 0.50 
38 Q922W5 Phytanoyl-CoA dioxygenase, peroxisomal  Phyh 0.50 
39 Q922W5 Pyrroline-5-carboxylate reductase 1, mitochondrial  Pycr1 0.50 
40 P21958 Antigen peptide transporter 1 (APT1) Tap1 0.55 
41 Q61586 Glycerol-3-phosphate acyltransferase 1, mitochondrial  Gpam 0.55 
42 P12787 Cytochrome c oxidase subunit 5A, mitochondrial Cox5a 0.57 
43 Q3U1C4 MCG1271 (Protein Secisbp2)  Secisbp2 0.57 
44 P55096 ATP-binding cassette sub-family D member 3  Abcd3 0.59 
45 Q9DB77 Cytochrome b-c1 complex subunit 2, mitochondrial  Uqcrc2 0.59 
46 Q8BHF7 
CDP-diacylglycerol--glycerol-3-phosphate 3-
phosphatidyltransferase, mitochondrial  Pgs1 0.60 
47 P97742 Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L)  Cpt1a 0.62 
48 P52825 Carnitine O-palmitoyltransferase 2, mitochondrial Cpt2 0.62 
49 P19783 Cytochrome c oxidase subunit 4 isoform 1, mitochondrial  Cox4i1 0.63 
50 P40630 Transcription factor A, mitochondrial (mtTFA) Tfam 0.63 
51 Q9CZS1 Aldehyde dehydrogenase X, mitochondrial  Aldh1b1 0.64 
52 Q6PB66 Leucine-rich PPR motif-containing protein, mitochondrial  Lrpprc 0.65 
53 Q9CZ13 Cytochrome b-c1 complex subunit 1, mitochondrial  Uqcrc1 0.65 
54 E9QJS0 28S ribosomal protein S10, mitochondrial Mrps10 0.67 
55 Q9CXF0 ATPase family AAA domain-containing protein 3  Atad3 0.67 
56 Q8K449 ATP-binding cassette sub-family A member 9 Abca9 0.67 
57 Q91V92 ATP-citrate synthase  Acly 0.67 
58 Q925I1 Elongation factor G, mitochondrial  Gfm1 0.67 
59 Q91XE0 Kynureninase  Kynu 0.67 
60 Q3UQ84 Threonine--tRNA ligase, mitochondrial  Tars2 0.67 
61 P50544 
Very long-chain specific acyl-CoA dehydrogenase, 
mitochondrial  Acadvl 0.67 
62 Q9Z2I0 
LETM1 and EF-hand domain-containing protein 1, 
mitochondrial  Letm1 0.70 
63 Q9DBM2 Peroxisomal bifunctional enzyme  Ehhadh 0.74 
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64 Q9WUM5 
Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, 
mitochondrial  Suclg1 0.75 
65 P26443 Glutamate dehydrogenase 1, mitochondrial (GDH 1) Glud1 0.77 
66 Q99K67 
Alpha-aminoadipic semialdehyde synthase, mitochondrial 
(LKR/SDH)  Aass 0.78 
67 O35423 Serine--pyruvate aminotransferase, mitochondrial  Agxt 0.78 
 
Suppl. Table 6. Mitochondrial proteins that decrease after cBID 
treatment - Spot 7 
A/A 
ACCESSION 
NUMBER 
PROTEIN NAME GENE 
FOLD 
CHANGE 
1 E9Q414 Apolipoprotein B-100  Apob 0 
2 Q62388 Serine-protein kinase ATM  Atm 0 
3 A2A655 Protein Bptf Bptf 0 
4 A2AX52 Collagen alpha-4(VI) chain Col6a4 0 
5 P00186 Cytochrome P450 1A2 Cyp1a2 0 
6 Q8K1G9 DEAH (Asp-Glu-Ala-His) box polypeptide 35  Dhx35 0 
7 Q9WUR2 Enoyl-CoA delta isomerase 2, mitochondrial  Eci2 0 
8 Q80W93 Hydrocephalus-inducing protein  Hydin 0 
9 Q03717 
Potassium voltage-gated channel subfamily B member 
1  Kcnb1 0 
10 Q3UXZ9 Lysine-specific demethylase 5A  Kdm5a 0 
11 Q8BJ34 Meiosis arrest female protein 1  Marf1 0 
12 Q791T5 Mitochondrial carrier homolog 1 Mtch1 0 
13 P28666 Murinoglobulin-2 (MuG2) Mug2 0 
14 Q8C170 Unconventional myosin-Ixa Myo9a 0 
15 Q6P5H2 Nestin Nes 0 
16 Q4PLS0 NACHT (Protein Nlrp2) Nlrp2 0 
17 Q8BXA7 
PH domain leucine-rich repeat-containing protein 
phosphatase 2  Phlpp2 0 
18 O88492 Perilipin-4 (Adipocyte protein S3-12) Plin4 0 
19 P70670 
Nascent polypeptide-associated complex subunit 
alpha, muscle-specific form  Prkdc 0 
20 B9EJA3 Protein tyrosine phosphatase, receptor type, D  Ptprd 0 
21 Q8CG73 Protein fantom (Nephrocystin-8)  Rpgrip1l 0 
22 Q8K2B3 
Succinate dehydrogenase [ubiquinone] flavoprotein 
subunit, mitochondrial  Sdha 0 
23 Q04692 
SWI/SNF-related matrix-associated actin-dependent 
regulator of chromatin subfamily A containing 
DEAD/H box 1  Smarcad1 0 
24 A2RSJ4 UHRF1-binding protein 1-like Uhrf1bp1l 0 
25 Q4U4S6 Xin actin-binding repeat-containing protein 2 Xirp2 0 
26 Q91VA0 Acyl-coenzyme A synthetase ACSM1, mitochondrial  Acsm1 0.17 
27 Q7TQH5 Synaptic nuclear envelope 1 Syne1 0.17 
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28 Q8CGK3 Lon protease homolog, mitochondrial  Lonp1 0.18 
29 Q571F8 Glutaminase liver isoform, mitochondrial (GLS)  Gls2 0.20 
30 P46978 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit STT3A  Stt3a 0.20 
31 Q922Q1 
Mitochondrial amidoxime reducing component 2 
(mARC2)  Mosc2 0.22 
32 Q9WU19 Hydroxyacid oxidase 1 (HAOX1)  Hao1 0.25 
33 Q9JIY5 
Serine protease HTRA2, mitochondrial (EC 3.4.21.108) 
(High temperature requirement protein A2) (HtrA2) 
(Omi stress-regulated endoprotease) (Serine protease 
25) (Serine proteinase OMI) Htra2 0.25 
34 P70272 Skeletal muscle ryanodine receptor (Fragment) Naca 0.25 
35 P21107 Tropomyosin alpha-3 chain (Gamma-tropomyosin)  Tpm3 0.25 
36 Q69Z23 Dynein heavy chain 17, axonemal    0.25 
37 Q99MR8 
Methylcrotonoyl-CoA carboxylase subunit alpha, 
mitochondrial  Mccc1 0.31 
38 Q5QNR3 Protein Ankrd36 (Fragment) Ankrd36 0.33 
39 P33267 Cytochrome P450 2F2  Cyp2f2 0.33 
40 Q64459 Cytochrome P450 3A11  Cyp3a11 0.33 
41 Q8VHE6 Dynein heavy chain 5, axonemal  Dnah5 0.33 
42 Q8C3Y4 Kinetochore-associated protein 1 Kntc1 0.33 
43 O55125 Protein NipSnap homolog 1 (NipSnap1) Nipsnap1 0.33 
44 P58281 Dynamin-like 120 kDa protein, mitochondrial Opa1 0.33 
45 P27773 Protein disulfide-isomerase A3 Pdia3 0.33 
46 Q8CC88 von Willebrand factor A domain-containing protein 8 Vwa8 0.33 
47 P79457 Histone demethylase UTY    0.33 
48 P51660 Peroxisomal multifunctional enzyme type 2  Hsd17b4 0.38 
49 Q3UHR0 BAH and coiled-coil domain-containing protein 1 Bahcc1 0.40 
50 O08828 Axonemal dynein heavy chain (Fragment)   0.40 
51 O54850 Endonuclease/reverse transcriptase   0.40 
52 Q8BIK4 
Dedicator of cytokinesis protein 9 (Cdc42 guanine 
nucleotide exchange factor zizimin-1)   0.40 
53 Q8K3J4 
Nicotinic acetylcholine receptor alpha 9 subunit 
(Fragment)   0.40 
54 Q9DBG1 Sterol 26-hydroxylase, mitochondrial  Cyp27a1 0.42 
55 Q99K67 
Alpha-aminoadipic semialdehyde synthase, 
mitochondrial (LKR/SDH)  Aass 0.43 
56 P08113 
Endoplasmin (94 kDa glucose-regulated protein) 
(GRP-94)  Hsp90b1 0.44 
57 Q91YQ5 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 1  Rpn1 0.45 
58 B2RY15 Tln2 protein 
  
Tln2 0.50 
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59 Q8CHT0 
Delta-1-pyrroline-5-carboxylate dehydrogenase, 
mitochondrial (P5C dehydrogenase) Aldh4a1 0.50 
60 A2AQR0 Glycerol-3-phosphate dehydrogenase  Gpd2 0.50 
61 Q60675 
Laminin subunit alpha-2 (Laminin M chain) (Laminin-
12 subunit alpha)  Lama2 0.50 
62 Q04690 
Neurofibromin (Neurofibromatosis-related protein 
NF-1) Nf1 0.50 
63 Q99PL5 
Ribosome-binding protein 1 (Ribosome receptor 
protein) Rrbp1 0.50 
64 Q9QXX4 Calcium-binding mitochondrial carrier protein Aralar2  Slc25a13 0.50 
65 O35488 Very long-chain acyl-CoA synthetase (VLACS) Slc27a2 0.50 
66 Q64435 UDP-glucuronosyltransferase 1-6 (UDPGT 1-6)  Ugt1a6a 0.50 
67 Q5H8C4 Vacuolar protein sorting-associated protein 13A  Vps13a 0.50 
68 A2A8E9 
Carnitine O-palmitoyltransferase 2, mitochondrial 
(Fragment) Cpt2 0.55 
69 A2ATU0 
Probable 2-oxoglutarate dehydrogenase E1 
component DHKTD1, mitochondrial  Dhtkd1 0.56 
70 B1AU25 Apoptosis-inducing factor 1, mitochondrial Aifm1 0.57 
71 Q61586 
Glycerol-3-phosphate acyltransferase 1, 
mitochondrial (GPAT-1)  Gpam 0.57 
72 P61922 4-aminobutyrate aminotransferase, mitochondrial Abat 0.58 
73 Q03265 ATP synthase subunit alpha, mitochondrial Atp5a1 0.60 
74 P01027 Complement C3 (HSE-MSF) C3 0.60 
75 Q91VA7 
Isocitrate dehydrogenase [NAD] subunit, 
mitochondrial  Idh3b 0.60 
76 Q91WN4 Kynurenine 3-monooxygenase  Kmo 0.60 
77 P50446 Keratin, type II cytoskeletal 6A (Cytokeratin-6A)  Krt6a 0.60 
78 Q9WU79 Proline dehydrogenase 1, mitochondrial Prodh 0.60 
79 P97313 DNA-dependent protein kinase catalytic subunit    0.60 
80 Q62504 Msx2-interacting protein   0.60 
81 O35423 
Serine--pyruvate aminotransferase, mitochondrial 
(SPT)  Agxt 0.63 
82 P32020 Non-specific lipid-transfer protein (NSL-TP)  Scp2 0.63 
83 Q6PB66 
Leucine-rich PPR motif-containing protein, 
mitochondrial Lrpprc 0.63 
84 Q9D6F9 Tubulin beta-4A chain (Tubulin beta-4 chain) Tubb4a 0.65 
85 Q9CZS1 Aldehyde dehydrogenase X, mitochondrial  Aldh1b1 0.67 
86 Q922J3 CAP-Gly domain-containing linker protein 1  Clip1 0.67 
87 Q05421 Cytochrome P450 2E1  Cyp2e1 0.67 
88 Q9DBM2 Peroxisomal bifunctional enzyme  Ehhadh 0.67 
89 Q61769 Ki-67 protein Ki67 0.67 
90 Q5S006 Leucine-rich repeat serine/threonine-protein kinase 2  Lrrk2 0.67 
91 Q80UM7 Mannosyl-oligosaccharide glucosidase  Mogs 0.67 
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92 A2AQA9 Protein Neb Neb 0.67 
93 Q8CCJ9 PHD finger protein 20-like protein 1 Phf20l1 0.67 
94 Q9DBG6 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 2  Rpn2 0.67 
95 P99024 Tubulin beta-5 chain Tubb5 0.67 
96 Q8BWQ1 UDP-glucuronosyltransferase 2A3 (UDPGT 2A3) Ugt2a3 0.67 
97 Q8R084 UDP-glucuronosyltransferase  Ugt2b1 0.67 
98 Q99KI0 Aconitate hydratase, mitochondrial (Aconitase) Aco2 0.70 
99 Q91WL5 Cytochrome P450 4A12A  Cyp4a12a 0.71 
100 Q05920 Pyruvate carboxylase, mitochondrial    0.73 
101 P05213 Tubulin alpha-1B chain  Tuba1b 0.74 
102 P35564 Calnexin Canx 0.75 
103 Q9WVJ3 Carboxypeptidase Q  Cpq 0.75 
104 Q91ZU6 Dystonin  Dst 0.75 
105 Q3ULD5 
Methylcrotonoyl-CoA carboxylase beta chain, 
mitochondrial  Mccc2 0.75 
106 P16332 Methylmalonyl-CoA mutase, mitochondrial  Mut 0.75 
107 P11725 Ornithine carbamoyltransferase, mitochondrial Otc 0.75 
108 Q9CQN1 Heat shock protein 75 kDa, mitochondrial  Trap1 0.75 
109 Q7TMM9 Tubulin beta-2A chain Tubb2a 0.75 
110 P20029 78 kDa glucose-regulated protein  Hspa5 0.78 
111 Q60932 Voltage-dependent anion-selective channel protein 1  Vdac1 0.78 
 
Suppl. Table 7. Mitochondrial proteins that decrease after cBID 
treatment - Spot 10 
A/A 
ACCESSION 
NUMBER 
PROTEIN NAME GENE 
FOLD 
CHANGE 
1 P55096 ATP-binding cassette sub-family D member 3  Abcd3 0 
2 O35435 
Dihydroorotate dehydrogenase (quinone), mitochondrial 
(DHOdehase)  Dhodh 0 
3 P50544 
Very long-chain specific acyl-CoA dehydrogenase, 
mitochondrial  Acadvl 0 
4 Q5RL20 39S ribosomal protein L43, mitochondrial Mrpl43 0 
5 Q62425 Cytochrome c oxidase subunit NDUFA4 Ndufa4 0 
6 Q9Z2Z6 Mitochondrial carnitine/acylcarnitine carrier protein  Slc25a20 0 
7 Q60930 Voltage-dependent anion-selective channel protein 2  Vdac2 0 
8 P26443 Glutamate dehydrogenase 1, mitochondrial (GDH 1) Glud1 0 
9 Q9D1P0 
39S ribosomal protein L13, mitochondrial (L13mt) (MRP-
L13) Mrpl13 0 
10 Q9D125 28S ribosomal protein S25, mitochondrial (MRP-S25)  Mrps25 0 
11 Q8R4H7 N-acetylglutamate synthase, mitochondrial  Nags 0 
12 Q9DC61 Mitochondrial-processing peptidase subunit alpha  Pmpca 0 
13 Q99MN9 
Propionyl-CoA carboxylase beta chain, mitochondrial 
(PCCase subunit beta)  Pccb 0.09 
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14 P19783 Cytochrome c oxidase subunit 4 isoform 1, mitochondrial  Cox4i1 0.14 
15 Q99JT1 
Glutamyl-tRNA(Gln) amidotransferase subunit B, 
mitochondrial  Gatb 0.20 
16 P54071 Isocitrate dehydrogenase [NADP], mitochondrial  Idh2 0.20 
17 Q99JY0 Trifunctional enzyme subunit beta, mitochondrial Hadhb 0.21 
18 Q9Z2I8 
Succinyl-CoA ligase [GDP-forming] subunit beta, 
mitochondrial  Suclg2 0.25 
19 Q9Z110 Delta-1-pyrroline-5-carboxylate synthase (P5CS)  Aldh18a1 0.25 
20 P38647 
Stress-70 protein, mitochondrial (75 kDa glucose-
regulated protein)  Hspa9 0.25 
21 Q91YJ5 Translation initiation factor IF-2, mitochondrial  Mtif2 0.25 
22 P00405 
Cytochrome c oxidase subunit 2 (Cytochrome c oxidase 
polypeptide II) Mtco2 0.29 
23 O88967 ATP-dependent zinc metalloprotease YME1L1  Yme1l1 0.33 
24 Q60597 2-oxoglutarate dehydrogenase, mitochondrial  Ogdh 0.33 
25 Q61694 3 beta-hydroxysteroid dehydrogenase type 5  Hsd3b5 0.33 
26 Q8JZU2 Tricarboxylate transport protein, mitochondrial  Slc25a1 0.33 
27 Q9CQ91 NADH dehydrogenase Ndufa3 0.33 
28 Q8BPT6 Mitochondrial inner membrane protease subunit 2  Immp2l 0.33 
29 Q925I1 ATPase family AAA domain-containing protein 3 Atad3 0.33 
30 Q924T2 28S ribosomal protein S2, mitochondrial  Mrps2 0.33 
31 Q9DB15 39S ribosomal protein L12, mitochondrial  Mrpl12 0.33 
32 Q9CQE1 Protein NipSnap homolog 3B  
Nipsnap3
b 0.33 
33 P47738 Aldehyde dehydrogenase, mitochondrial  Aldh2 0.33 
34 O35972 39S ribosomal protein L23, mitochondrial Mrpl23 0.33 
35 Q80X85 28S ribosomal protein S7, mitochondrial (MRP-S7)  Mrps7 0.40 
36 Q3UV71 Transmembrane and TPR repeat-containing protein 1 Tmtc1 0.40 
37 Q6PB66 Leucine-rich PPR motif-containing protein, mitochondrial  Lrpprc 0.43 
38 Q8CHT0 
Delta-1-pyrroline-5-carboxylate dehydrogenase, 
mitochondrial  Aldh4a1 0.43 
39 Q8VE22 28S ribosomal protein S23, mitochondrial (MRP-S23)  Mrps23 0.43 
40 Q9ER88 28S ribosomal protein S29, mitochondrial Dap3 0.43 
41 Q9D3D9 ATP synthase subunit delta, mitochondrial  Atp5d 0.44 
42 Q9D3P8 Plasminogen receptor (KT)  Plgrkt 0.50 
43 P51881 ADP/ATP translocase 2 (ADP,ATP carrier protein 2)  Slc25a5 0.50 
44 Q925N0 Sideroflexin-5 Sfxn5 0.50 
45 Q61586 Glycerol-3-phosphate acyltransferase 1, mitochondrial  Gpam 0.50 
46 Q8JZN5 
Acyl-CoA dehydrogenase family member 9, mitochondrial 
(ACAD-9) Acad9 0.50 
47 Q9D7N3 28S ribosomal protein S9, mitochondrial Mrps9 0.50 
48 Q9CRB9 MICOS complex subunit Mic19  Chchd3 0.50 
49 P21300 Aldose reductase-related protein 1  Akr1b7 0.50 
50 Q9CR21 Acyl carrier protein, mitochondrial  Ndufab1 0.50 
51 P30275 Creatine kinase U-type, mitochondrial  Ckmt1 0.50 
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52 P11725 Ornithine carbamoyltransferase, mitochondrial  Otc 0.50 
53 Q60932 Voltage-dependent anion-selective channel protein 1  Vdac1 0.50 
54 P48771 Cytochrome c oxidase subunit 7A2, mitochondrial Cox7a2 0.50 
55 Q99N84 28S ribosomal protein S18b, mitochondrial Mrps18b 0.50 
56 Q9CQ40 39S ribosomal protein L49, mitochondrial (L49mt)  Mrpl49 0.50 
57 P56379 6.8 kDa mitochondrial proteolipid Mp68 0.50 
58 P41216 Long-chain-fatty-acid--CoA ligase 1 Acsl1 0.55 
59 Q9DBM2 Peroxisomal bifunctional enzyme (PBE)  Ehhadh 0.56 
60 P00848 ATP synthase subunit a (F-ATPase protein 6) Mtatp6 0.57 
61 Q9CPQ8 ATP synthase subunit g, mitochondrial (ATPase subunit g) Atp5l 0.57 
62 P54869 Hydroxymethylglutaryl-CoA synthase, mitochondrial  Hmgcs2 0.57 
63 P97742 Carnitine O-palmitoyltransferase 1, liver isoform  Cpt1a 0.57 
64 Q9QXX4 Calcium-binding mitochondrial carrier protein Aralar2  Slc25a13 0.60 
65 Q06185 ATP synthase subunit e, mitochondrial Atp5i 0.60 
66 P56135 ATP synthase subunit f, mitochondrial Atp5j2 0.60 
67 P53395 
Lipoamide acyltransferase component of branched-chain 
alpha-keto acid dehydrogenase complex, mitochondrial  Dbt 0.60 
68 Q9CXJ4 
ATP-binding cassette sub-family B member 8, 
mitochondrial Abcb8 0.60 
69 P63038 60 kDa heat shock protein, mitochondrial  Hspd1 0.60 
70 Q9DC71 28S ribosomal protein S15, mitochondrial  Mrps15 0.60 
71 Q91VR2 ATP synthase subunit gamma, mitochondrial  Atp5c1 0.62 
72 G5E8R3 Pyruvate carboxylase  Pcx 0.63 
73 Q9CQQ7 ATP synthase F(0) complex subunit B1, mitochondrial  Atp5f1 0.63 
74 Q91XL3 UDP-glucuronic acid decarboxylase 1 Uxs1 0.67 
75 Q8K3J1 
NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, 
mitochondrial (EC 1.6.5.3)  Ndufs8 0.67 
76 Q7TMF3 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex 
subunit 12 Ndufa12 0.67 
77 P03899 NADH-ubiquinone oxidoreductase chain 3  Mtnd3 0.67 
78 Q8BHF7 
CDP-diacylglycerol--glycerol-3-phosphate 3-
phosphatidyltransferase, mitochondrial  Pgs1 0.67 
79 Q80XN0 D-beta-hydroxybutyrate dehydrogenase, mitochondrial  Bdh1 0.67 
80 Q99KI0 Aconitate hydratase, mitochondrial (Aconitase)  Aco2 0.67 
81 Q99JR1 Sideroflexin-1 Sfxn1 0.67 
82 Q9CQV5 28S ribosomal protein S24, mitochondrial  Mrps24 0.67 
83 Q8K2M0 39S ribosomal protein L38, mitochondrial  Mrpl38 0.67 
84 Q99N87 28S ribosomal protein S5, mitochondrial  Mrps5 0.67 
85 Q9DCM2 Glutathione S-transferase kappa 1  Gstk1 0.67 
86 Q8BMS1 Trifunctional enzyme subunit alpha, mitochondrial  Hadha 0.68 
87 Q91ZA3 Propionyl-CoA carboxylase alpha chain, mitochondrial  Pcca 0.68 
88 Q8BJZ4 28S ribosomal protein S35, mitochondrial Mrps35 0.70 
89 Q9CXW2 28S ribosomal protein S22, mitochondrial  Mrps22 0.70 
90 Q9D8H7 Metalloendopeptidase OMA1, mitochondrial  Oma1 0.71 
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91 Q80Y81 Zinc phosphodiesterase ELAC protein 2  Elac2 0.71 
92 P51660 Peroxisomal multifunctional enzyme type 2 Hsd17b4 0.71 
93 Q9DBG1 Sterol 26-hydroxylase, mitochondrial  Cyp27a1 0.75 
94 O09111 
NADH dehydrogenase [ubiquinone] 1 beta subcomplex 
subunit 11, mitochondrial  Ndufb11 0.75 
95 P42925 Peroxisomal membrane protein 2  Pxmp2 0.75 
96 P09671 Superoxide dismutase [Mn], mitochondrial  Sod2 0.75 
97 Q8R035 Peptidyl-tRNA hydrolase ICT1, mitochondrial  Ict1 0.75 
98 Q9CPR5 39S ribosomal protein L15, mitochondrial  Mrpl15 0.75 
99 Q9JIK9 28S ribosomal protein S34, mitochondrial Mrps34 0.78 
 
Suppl. Table 8. Mitochondrial proteins that decrease after cBID 
treatment - Spot 11 
A/A 
ACCESSION 
NUMBER 
PROTEIN NAME GENE 
FOLD 
CHANGE 
1 P00397 Cytochrome c oxidase subunit 1  Mtco1 0 
2 Q9CZW5 Mitochondrial import receptor subunit TOM70  Tomm70a 0 
3 Q9D6Y7 Mitochondrial peptide methionine sulfoxide reductase  Msra 0 
4 P43024 Cytochrome c oxidase subunit 6A1, mitochondrial  Cox6a1 0 
5 Q9WU79 Proline dehydrogenase 1, mitochondrial  Prodh 0 
6 Q8K0Z7 Translational activator of cytochrome c oxidase 1  Taco1 0 
7 Q9WVM8 
Kynurenine/alpha-aminoadipate aminotransferase, 
mitochondrial (KAT/AadAT) Aadat 0.17 
8 P52825 Carnitine O-palmitoyltransferase 2, mitochondrial  Cpt2 0.25 
9 Q925N0 Sideroflexin-5 Sfxn5 0.25 
10 Q9CQN1 Heat shock protein 75 kDa, mitochondrial  Trap1 0.25 
11 Q9EQ20 Methylmalonate-semialdehyde dehydrogenase  Aldh6a1 0.31 
12 Q9D0S9 Histidine triad nucleotide-binding protein 2, mitochondrial  Hint2 0.33 
13 Q9Z0X1 Apoptosis-inducing factor 1, mitochondrial  Aifm1 0.38 
14 Q5FW57 Glycine N-acyltransferase-like protein  Gm4952 0.40 
15 Q99LB2 Dehydrogenase/reductase SDR family member 4 Dhrs4 0.42 
16 P42925 Peroxisomal membrane protein 2  Pxmp2 0.43 
17 Q8BFR5 Elongation factor Tu, mitochondrial Tufm 0.45 
18 Q9CPY7 Cytosol aminopeptidase Lap3 0.50 
19 Q2TPA8 Hydroxysteroid dehydrogenase-like protein 2  Hsdl2 0.50 
20 Q571F8 Glutaminase liver isoform, mitochondrial (GLS)  Gls2 0.50 
21 Q9CZU6 Citrate synthase, mitochondrial  Cs 0.50 
22 Q60930 Voltage-dependent anion-selective channel protein 2  Vdac2 0.50 
23 Q9WTP7 GTP:AMP phosphotransferase AK3, mitochondrial Ak3 0.50 
24 Q99J39 Malonyl-CoA decarboxylase, mitochondrial Mlycd 0.50 
25 Q9CQQ7 ATP synthase F(0) complex subunit B1, mitochondrial Atp5f1 0.50 
26 Q7TMG8 Glioblastoma amplified sequence  Gbas 0.50 
27 Q3UW66 Sulfurtransferase Mpst 0.50 
28 Q8BWT1 3-ketoacyl-CoA thiolase, mitochondrial  Acaa2 0.50 
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29 Q9D6Y7 Mitochondrial peptide methionine sulfoxide reductase  Msra 0.50 
30 P23589 Carbonic anhydrase 5A, mitochondrial  Ca5a 0.50 
31 Q9DBG1 Sterol 26-hydroxylase, mitochondrial  Cyp27a1 0.53 
32 Q8R164 Valacyclovir hydrolase  Bphl 0.60 
33 Q99LC5 Electron transfer flavoprotein subunit alpha, mitochondria Etfa 0.63 
34 Q9CQS4 Solute carrier family 25 member 46 Slc25a46 0.63 
35 P41216 Long-chain-fatty-acid--CoA ligase 1  Acsl1 0.63 
36 Q99N15 
17beta-hydroxysteroid dehydrogenase type 10/short chain 
L-3-hydroxyacyl-CoA dehydrogenase  Hsd17b10 0.67 
37 P06795 Multidrug resistance protein 1B  Abcb1b 0.67 
38 Q64521 Glycerol-3-phosphate dehydrogenase, mitochondrial  Gpd2 0.67 
39 Q8BW75 Amine oxidase [flavin-containing] B  Maob 0.67 
40 Q03265 ATP synthase subunit alpha, mitochondrial Atp5a1 0.67 
41 Q6P3A8 
2-oxoisovalerate dehydrogenase subunit beta, 
mitochondrial Bckdhb 0.67 
42 P50544 
Very long-chain specific acyl-CoA dehydrogenase, 
mitochondrial  Acadvl 0.68 
43 Q9DCW4 Electron transfer flavoprotein subunit beta  Etfb 0.69 
44 P00405 Cytochrome c oxidase subunit 2 Mtco2 0.70 
45 Q8BMS1 Trifunctional enzyme subunit alpha, mitochondrial Hadha 0.71 
46 Q8VCW8 Acyl-CoA synthetase family member 2, mitochondrial  Acsf2 0.71 
47 P52196 Thiosulfate sulfurtransferase Tst 0.75 
48 Q9CZS1 Aldehyde dehydrogenase X, mitochondrial Aldh1b1 0.75 
49 O88696 
ATP-dependent Clp protease proteolytic subunit, 
mitochondrial  Clpp 0.75 
50 Q61425 
Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial 
(HCDH)  Hadh 0.75 
51 Q99MR8 
Methylcrotonoyl-CoA carboxylase subunit alpha, 
mitochondrial Mccc1 0.75 
52 Q60931 Voltage-dependent anion-selective channel protein 3  Vdac3 0.75 
53 P61922 4-aminobutyrate aminotransferase, mitochondrial  Abat 0.75 
54 Q922Q1 Mitochondrial amidoxime reducing component 2 (mARC2) Mosc2 0.78 
55 Q9Z2I0 
LETM1 and EF-hand domain-containing protein 1, 
mitochondrial  Letm1 0.80 
56 P12787 Cytochrome c oxidase subunit 5A, mitochondrial  Cox5a 0.83 
57 Q9DCY0 Glycine N-acyltransferase-like protein Keg1 Keg1 0.83 
58 Q9QXX4 
Calcium-binding mitochondrial carrier protein Aralar2 
(Citrin)  Slc25a13 0.84 
59 P11725 Ornithine carbamoyltransferase, mitochondrial  Otc 0.85 
60 P51660 Peroxisomal multifunctional enzyme type 2  Hsd17b4 0.86 
61 Q8BH95 Enoyl-CoA hydratase, mitochondrial  Echs1 0.87 
62 P11352 Glutathione peroxidase 1  Gpx1 0.88 
63 Q6PB66 Leucine-rich PPR motif-containing protein, mitochondrial  Lrpprc 0.88 
64 P19783 Cytochrome c oxidase subunit 4 isoform 1, mitochondrial Cox4i1 0.90 
65 Q9D881 Cytochrome c oxidase subunit 5B, mitochondrial  Cox5b 0.90 
66 P26443 Glutamate dehydrogenase 1, mitochondrial  Glud1 0.91 
67 H7BWY3 Alanine--glyoxylate aminotransferase 2, mitochondrial Agxt2 0.91 
68 P38647 
Stress-70 protein, mitochondrial (75 kDa glucose-regulated 
protein) (GRP-75)  Hspa9 0.92 
69 P54869 Hydroxymethylglutaryl-CoA synthase, mitochondrial  Hmgcs2 0.92 
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70 Q922U2 Keratin, type II cytoskeletal 5  Krt5 0.95 
71 Q9DBT9 Dimethylglycine dehydrogenase, mitochondrial  Dmgdh 0.97 
 
Suppl. Table 9. Mitochondrial proteins associated with OPA1 in steady 
state  
A/A 
ACCESSION 
NUMBER 
PROTEIN NAME GENE 
PEARSO
N 
1 E0CXD1 Dynamin-like 120 kDa protein, mitochondrial Opa1 1 
2 P24270 Catalase Cat 0.960 
3 P47791 Glutathione reductase, mitochondrial Gsr 0.947 
4 E9PZP7 Malic enzyme Me3 0.943 
5 Q8CC88 von Willebrand factor A domain-containing protein 8 Vwa8 0.931 
6 Q8BUY5 Complex I assembly factor TIMMDC1, mitochondrial Timmdc1 0.921 
7 J3QMG3 Voltage-dependent anion-selective channel protein 3 Vdac3 0.918 
8 Q9D6Y7 Mitochondrial peptide methionine sulfoxide reductase Msra 0.916 
9 Q9QYA2 Mitochondrial import receptor subunit TOM40 homolog Tomm40 0.911 
10 Q9CPQ3 Mitochondrial import receptor subunit TOM22 homolog Tomm22 0.911 
11 O35459 Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial Ech1 0.907 
12 Q9JIK9 28S ribosomal protein S34, mitochondrial Mrps34 0.904 
13 B8JJA9 Cytochrome c oxidase subunit 7C, mitochondrial Cox7c 0.904 
14 P56379 6.8 kDa mitochondrial proteolipid Mp68 0.903 
15 Q9CPY7 Cytosol aminopeptidase Lap3 0.902 
16 P55096 ATP-binding cassette sub-family D member 3 Abcd3 0.893 
17 Q61733 28S ribosomal protein S31, mitochondrial Mrps31 0.885 
18 P53395 
Lipoamide acyltransferase component of branched-chain 
alpha-keto acid dehydrogenase complex, mitochondrial Dbt 0.879 
19 P05201 Aspartate aminotransferase, cytoplasmic Got1 0.876 
20 Q3TL44 NLR family member X1 Nlrx1 0.875 
21 E9Q8F4 NAD(P) transhydrogenase, mitochondrial Nnt 0.874 
22 P51660 Peroxisomal multifunctional enzyme type 2 Hsd17b4 0.871 
23 D3Z6B9 Mitochondrial 10-formyltetrahydrofolate dehydrogenase Aldh1l2 0.870 
24 Q9QZH6 
Evolutionarily conserved signaling intermediate in Toll 
pathway, mitochondrial Ecsit 0.853 
25 Q9CZP5 Mitochondrial chaperone BCS1 Bcs1l 0.850 
26 P15532 Nucleoside diphosphate kinase A Nme1 0.847 
27 Q3U3G8 Serine hydrolase-like protein Serhl 0.847 
28 Q9EQ20 
Methylmalonate-semialdehyde dehydrogenase [acylating], 
mitochondrial Aldh6a1 0.841 
29 A2ALN0 ATP-binding cassette sub-family D member 1 Abcd1 0.838 
30 G3UVV4 Hexokinase-1 Hk1 0.836 
31 Q9CQE3 28S ribosomal protein S17, mitochondrial Mrps17 0.835 
32 Q60714 Long-chain fatty acid transport protein 1 Slc27a1 0.835 
33 Q9JKL4 
NADH dehydrogenase [ubiquinone]1 alpha subcomplex 
assembly factor 3 Ndufaf3 0.831 
34 Q60930 Voltage-dependent anion-selective channel protein 2 Vdac2 0.826 
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35 Q8CGK3 Lon protease homolog, mitochondrial Lonp1 0.823 
36 Q91VA7 Isocitrate dehydrogenase [NAD]subunit, mitochondrial Idh3b 0.816 
37 D3YTQ5 Acyl-CoA dehydrogenase family member 11 Acad11 0.815 
38 P63038 60 kDa heat shock protein, mitochondrial Hspd1 0.815 
39 Q9Z2I0 
LETM1 and EF-hand domain-containing protein 1, 
mitochondrial Letm1 0.807 
40 Q8BK72 28S ribosomal protein S27, mitochondrial Mrps27 0.794 
41 P61922 4-aminobutyrate aminotransferase, mitochondrial Abat 0.794 
42 F8WGD9 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon Agpat5 0.790 
43 O08715 A-kinase anchor protein 1, mitochondrial Akap1 0.790 
44 E9QM21 Bcl-2 homologous antagonist/killer Bak1 0.790 
45 P35564 Calnexin Canx 0.790 
46 E9Q3U7 
Cytochrome c oxidase assembly protein COX16 homolog, 
mitochondrial Cox16 0.790 
47 P61804 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit DAD1 Dad1 0.790 
48 O54734 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase 48 kDa subunit Ddost 0.790 
49 Q3U7R1 Extended synaptotagmin-1 Esyt1 0.790 
50 Q9CR59 
Growth arrest and DNA damage-inducible proteins-
interacting protein 1 
Gadd45g
ip1 0.790 
51 D3YX27 Serine protease HTRA2, mitochondrial Htra2 0.790 
52 E0CYL3 Calcium uniporter protein, mitochondrial Mcu 0.790 
53 Q99N84 28S ribosomal protein S18b, mitochondrial Mrps18b 0.790 
54 Q80ZS3 28S ribosomal protein S26, mitochondrial Mrps26 0.790 
55 Q791T5 Mitochondrial carrier homolog 1 Mtch1 0.790 
56 Q9D0F9 Phosphoglucomutase-1 Pgm2 0.790 
57 P61014 Cardiac phospholamban Pln 0.790 
58 Q922Q4 Pyrroline-5-carboxylate reductase 2 Pycr2 0.790 
59 Q3U186 Probable arginine--tRNA ligase, mitochondrial Rars2 0.790 
60 Q9D938 Transmembrane protein 160 
Tmem16
0 0.790 
61 B1AXP6 Mitochondrial import receptor subunit TOM5 homolog Tomm5 0.790 
62 Q9CZW5 Mitochondrial import receptor subunit TOM70 
Tomm70
a 0.790 
63 P68373 Tubulin alpha-1C chain Tuba1c 0.790 
64 O88967 ATP-dependent zinc metalloprotease YME1L1 Yme1l1 0.790 
65 P97449 Aminopeptidase N Anpep 0.790 
66 A2AQ17 
Complex I intermediate-associated protein 30, 
mitochondrial Ndufaf1 0.790 
67 O08807 Peroxiredoxin-4 Prdx4 0.790 
68 Q9D1H6 
NADH dehydrogenase [ubiquinone]1 alpha subcomplex 
assembly factor 4 Ndufaf4 0.784 
69 O55028 
[3-methyl-2-oxobutanoate dehydrogenase 
[lipoamide]]kinase, mitochondrial Bckdk 0.783 
70 D3Z2K2 28S ribosomal protein S14, mitochondrial Mrps14 0.780 
71 F2Z471 Voltage-dependent anion-selective channel protein 1 Vdac1 0.772 
72 Q9CQV5 28S ribosomal protein S24, mitochondrial Mrps24 0.768 
73 Q9CXW2 28S ribosomal protein S22, mitochondrial Mrps22 0.742 
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74 P11679 Keratin, type II cytoskeletal 8 Krt8 0.731 
75 Q64516 Glycerol kinase Gk 0.721 
76 Q9D5T0 ATPase family AAA domain-containing protein 1 Atad1 0.716 
77 Q3URS9 Coiled-coil domain-containing protein 51 Ccdc51 0.710 
78 Q14C51 
Pentatricopeptide repeat domain-containing protein 3, 
mitochondrial Ptcd3 0.710 
79 P08228 Superoxide dismutase [Cu-Zn] Sod1 0.698 
80 Q8BMS1 Trifunctional enzyme subunit alpha, mitochondrial Hadha 0.692 
81 G3UXK7 Cytochrome c-type heme lyase Hccs 0.688 
82 Q9DCM2 Glutathione S-transferase kappa 1 Gstk1 0.686 
83 P52480 Pyruvate kinase PKM Pkm 0.681 
84 G3UZJ4 Peroxiredoxin-5, mitochondrial Prdx5 0.678 
85 H3BKI6 ATPase family AAA domain-containing protein 3 Atad3a 0.677 
86 Q99N87 28S ribosomal protein S5, mitochondrial Mrps5 0.671 
87 Q8BJZ4 28S ribosomal protein S35, mitochondrial Mrps35 0.670 
88 Q9DCX2 ATP synthase subunit d, mitochondrial Atp5h 0.639 
89 P03930 ATP synthase protein 8 mt-Atp8 0.635 
90 Q9D6R2 
Isocitrate dehydrogenase [NAD]subunit alpha, 
mitochondrial Idh3a 0.631 
91 Q8JZN7 Mitochondrial Rho GTPase 2 Rhot2 0.628 
92 P70404 
Isocitrate dehydrogenase [NAD]subunit gamma 1, 
mitochondrial Idh3g 0.622 
93 Q99JY0 Trifunctional enzyme subunit beta, mitochondrial Hadhb 0.621 
94 Q8C3X2 Coiled-coil domain-containing protein 90B, mitochondrial Ccdc90b 0.620 
95 Q91VC9 Growth hormone-inducible transmembrane protein Ghitm 0.592 
96 D3Z7C8 Branched-chain-amino-acid aminotransferase Bcat2 0.576 
97 Q9MD68 Cytochrome c oxidase subunit 1 mt-Co1 0.553 
98 Q9CXD6 Mitochondrial calcium uniporter regulator 1 Mcur1 0.532 
99 Q505D7 Optic atrophy 3 protein homolog Opa3 0.532 
100 P56382 ATP synthase subunit epsilon, mitochondrial Atp5e 0.531 
101 Q9WVJ3 Carboxypeptidase Q Cpq 0.519 
102 Q1XH17 Tripartite motif-containing protein 72 Trim72 0.517 
103 D3YVW0 Metaxin-1 Mtx1 0.516 
104 Q8VCF0 Mitochondrial antiviral-signaling protein Mavs 0.512 
105 Q99J39 Malonyl-CoA decarboxylase, mitochondrial Mlycd 0.510 
106 F6ZKZ3 Sulfide:quinone oxidoreductase, mitochondrial Sqrdl 0.498 
107 Q9CR76 Transmembrane protein 186 
Tmem18
6 0.495 
108 Q8VD26 Transmembrane protein 143 
Tmem14
3 0.484 
109 D3YXS8 Mitochondrial import receptor subunit TOM40B 
Tomm40
l 0.483 
110 Q8JZN5 Acyl-CoA dehydrogenase family member 9, mitochondrial Acad9 0.481 
111 E9Q7L0 Protein Ogdhl Ogdhl 0.477 
112 J3KMM5 Calcium-transporting ATPase Atp2a2 0.472 
113 B0QZS8 
Mitochondrial import inner membrane translocase subunit 
Tim22 Timm22 0.471 
114 Q9CPQ8 ATP synthase subunit g, mitochondrial Atp5l 0.461 
115 P97450 ATP synthase-coupling factor 6, mitochondrial Atp5j 0.458 
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116 P85094 
Isochorismatase domain-containing protein 2A, 
mitochondrial Isoc2a 0.450 
117 Q9QWL7 Keratin, type I cytoskeletal 17 Krt17 0.413 
118 Q9CRB9 MICOS complex subunit Mic19 Chchd3 0.412 
119 P99028 Cytochrome b-c1 complex subunit 6, mitochondrial Uqcrh 0.408 
120 P17182 Alpha-enolase Eno1 0.403 
121 Q8BMF4 
Dihydrolipoyllysine-residue acetyltransferase component of 
pyruvate dehydrogenase complex, mitochondrial Dlat 0.400 
122 D3Z7S4 ATP synthase subunit delta, mitochondrial Atp5d 0.398 
123 P38647 Stress-70 protein, mitochondrial Hspa9 0.395 
124 Q9D7N3 28S ribosomal protein S9, mitochondrial Mrps9 0.390 
125 Q01768 Nucleoside diphosphate kinase B Nme2 0.383 
126 A2ACG7 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 2 Rpn2 0.382 
127 E9Q8B3 DnaJ homolog subfamily C member 11 Dnajc11 0.378 
128 Q9CPX7 28S ribosomal protein S16, mitochondrial Mrps16 0.371 
129 D6RGL7 ATP synthase F(0) complex subunit B1, mitochondrial Atp5f1 0.370 
130 P43023 Cytochrome c oxidase subunit 6A2, mitochondrial Cox6a2 0.366 
131 P10126 Elongation factor 1-alpha 1 Eef1a1 0.366 
132 Q8CGP5 Histone H2A type 1-F 
Hist1h2a
f 0.366 
133 Q6NXH9 Keratin, type II cytoskeletal 73 Krt73 0.366 
134 P00405 Cytochrome c oxidase subunit 2 mt-Co2 0.366 
135 Q9WV85 Nucleoside diphosphate kinase 3 Nme3 0.366 
136 Q01853 Transitional endoplasmic reticulum ATPase Vcp 0.366 
137 Q9D0L4 Uncharacterized aarF domain-containing protein kinase 1 Adck1 0.365 
138 E9Q5B5 Hexokinase-2 Hk2 0.363 
139 Q6PB66 Leucine-rich PPR motif-containing protein, mitochondrial Lrpprc 0.348 
140 Q922U2 Keratin, type II cytoskeletal 5 Krt5 0.328 
141 P51174 Long-chain specific acyl-CoA dehydrogenase, mitochondrial Acadl 0.321 
142 Q9CPU4 Microsomal glutathione S-transferase 3 Mgst3 0.315 
143 P61027 Ras-related protein Rab-10 Rab10 0.307 
144 Q99KD6 Cox7a2l protein Cox7a2l 0.304 
145 E9Q800 MICOS complex subunit Mic60 Immt 0.304 
146 Q61781 Keratin, type I cytoskeletal 14 Krt14 0.304 
147 Q9ESW4 Acylglycerol kinase, mitochondrial Agk 0.301 
148 F8WHP8 ATP synthase subunit f, mitochondrial Atp5j2 0.299 
149 Q9CZS1 Aldehyde dehydrogenase X, mitochondrial Aldh1b1 0.297 
150 G3UYR8 Alpha-aminoadipic semialdehyde dehydrogenase Aldh7a1 0.296 
151 D3YYN7 Sodium/potassium-transporting ATPase subunit alpha-2 Atp1a2 0.296 
152 D3ZFQ8  Cytochrome c-1 (Predicted), isoform CRA_c Cyc1 0.296 
153 E9PWN2 Isoleucine--tRNA ligase, mitochondrial Iars2 0.296 
154 Q9CRB8 Mitochondrial fission process protein 1 Mtfp1 0.296 
155 P35487 
Pyruvate dehydrogenase E1 component subunit alpha, 
testis-specific form, mitochondrial Pdha2 0.296 
156 E9Q933 Transmembrane protein 11, mitochondrial Tmem11 0.296 
157 Q3ULD5 
Methylcrotonoyl-CoA carboxylase beta chain, 
mitochondrial Mccc2 0.291 
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158 P48771 Cytochrome c oxidase subunit 7A2, mitochondrial Cox7a2 0.287 
159 P56392 Cytochrome c oxidase subunit 7A1, mitochondrial Cox7a1 0.286 
160 Q9D312 Keratin, type I cytoskeletal 20 Krt20 0.280 
161 D3Z7V3 Sarcolemmal membrane-associated protein Slmap 0.275 
162 P04919 Band 3 anion transport protein Slc4a1 0.272 
163 Q61102 
ATP-binding cassette sub-family B member 7, 
mitochondrial Abcb7 0.272 
164 P26443 Glutamate dehydrogenase 1, mitochondrial Glud1 0.268 
165 Q9JHW2 Omega-amidase NIT2 Nit2 0.265 
166 P97742 Carnitine O-palmitoyltransferase 1, liver isoform Cpt1a 0.264 
167 Q9CQX2 Cytochrome b5 type B Cyb5b 0.264 
168 O35972 39S ribosomal protein L23, mitochondrial Mrpl23 0.259 
169 Q3TTY5 Keratin, type II cytoskeletal 2 epidermal Krt2 0.256 
170 P07310 Creatine kinase M-type Ckm 0.255 
171 P08113 Endoplasmin Hsp90b1 0.247 
172 Q60597 2-oxoglutarate dehydrogenase, mitochondrial Ogdh 0.243 
173 Q9QXX4 Calcium-binding mitochondrial carrier protein Aralar2 Slc25a13 0.229 
174 A2AKU9 ATP synthase subunit gamma Atp5c1 0.216 
175 P47738 Aldehyde dehydrogenase, mitochondrial Aldh2 0.214 
176 Q921S7 39S ribosomal protein L37, mitochondrial Mrpl37 0.212 
177 Q78IK2 Up-regulated during skeletal muscle growth protein 5 Usmg5 0.206 
178 Q8BWF0 Succinate-semialdehyde dehydrogenase, mitochondrial Aldh5a1 0.203 
179 P58059 28S ribosomal protein S21, mitochondrial Mrps21 0.202 
180 Q9CXT8 Mitochondrial-processing peptidase subunit beta Pmpcb 0.202 
181 Q9CQB4 Cytochrome b-c1 complex subunit 7 Uqcrb 0.196 
182 Q3UER8 Fibrinogen gamma chain Fgg 0.195 
183 P50544 
Very long-chain specific acyl-CoA dehydrogenase, 
mitochondrial Acadvl 0.189 
184 D6RJ70 Kynurenine--oxoglutarate transaminase 3 Ccbl2 0.187 
185 A2A513 Keratin, type I cytoskeletal 10 Krt10 0.180 
186 P59017 Bcl-2-like protein 13 Bcl2l13 0.174 
187 B1AX78 Hydroxysteroid dehydrogenase-like protein 2 Hsdl2 0.171 
188 B1ASZ3 Glycerol kinase Gyk 0.162 
189 Q8BH59 Calcium-binding mitochondrial carrier protein Aralar1 Slc25a12 0.159 
190 A2AFW6 Mitochondrial carrier homolog 2 Mtch2 0.154 
191 Q8CI78 Required for meiotic nuclear division protein 1 homolog Rmnd1 0.149 
192 Q99MR8 
Methylcrotonoyl-CoA carboxylase subunit alpha, 
mitochondrial Mccc1 0.144 
193 Q76LV0 Glutathione peroxidase Gpx4 0.141 
194 P14094 Sodium/potassium-transporting ATPase subunit beta-1 Atp1b1 0.140 
195 Q8BWM0 Prostaglandin E synthase 2 Ptges2 0.137 
196 P12787 Cytochrome c oxidase subunit 5A, mitochondrial Cox5a 0.132 
197 Q9R0H0 Peroxisomal acyl-coenzyme A oxidase 1 Acox1 0.132 
198 Q9CXJ4 
ATP-binding cassette sub-family B member 8, 
mitochondrial Abcb8 0.131 
199 G3X9M0 28S ribosomal protein S29, mitochondrial Dap3 0.129 
200 P00158 Cytochrome b mt-Cytb 0.126 
201 Q9DB15 39S ribosomal protein L12, mitochondrial Mrpl12 0.125 
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202 Q9CPQ1 Cytochrome c oxidase subunit 6C Cox6c 0.117 
203 P04104 Keratin, type II cytoskeletal 1 Krt1 0.116 
204 M0QWX2 Cytochrome c oxidase subunit 4 isoform 1, mitochondrial Cox4i1 0.112 
205 Q62425 Cytochrome c oxidase subunit NDUFA4 Ndufa4 0.111 
206 Q9D881 Protein Gm11273 Cox5b 0.110 
207 E9Q4M4 MICOS complex subunit Mic25 Chchd6 0.107 
208 Q8K0E8 Fibrinogen beta chain Fgb 0.107 
209 Q9WU65 Glycerol kinase 2 Gk2 0.107 
210 E0CXB1 Proteasome subunit alpha type-6 Psma6 0.107 
211 F8WHN1 39S ribosomal protein L15, mitochondrial Mrpl15 0.105 
212 Q9JI39 
ATP-binding cassette sub-family B member 10, 
mitochondrial Abcb10 0.101 
213 Q9CZN7 Serine hydroxymethyltransferase Shmt2 0.101 
 
Suppl. Table 10. Mitochondrial Proteins associated with OPA1 that 
decrease after apoptotic stimulation 
A/A 
ACCESSION 
NUMBER 
PROTEIN NAME GENE 
Fold 
change 
1 P61922 4-aminobutyrate aminotransferase, mitochondrial Abat 0.00 
2 Q61102 ATP-binding cassette sub-family B member 7, mitochondrial Abcb7 0.88 
3 Q9CXJ4 ATP-binding cassette sub-family B member 8, mitochondrial Abcb8 0.99 
4 A2ALN0 ATP-binding cassette sub-family D member 1 Abcd1 0.20 
5 P55096 ATP-binding cassette sub-family D member 3 Abcd3 0.38 
6 D3YTQ5 Acyl-CoA dehydrogenase family member 11 Acad11 0.33 
7 Q8JZN5 Acyl-CoA dehydrogenase family member 9, mitochondrial Acad9 0.63 
8 P51174 Long-chain specific acyl-CoA dehydrogenase, mitochondrial Acadl 0.85 
9 P50544 
Very long-chain specific acyl-CoA dehydrogenase, 
mitochondrial Acadvl 0.91 
10 Q9R0H0 Peroxisomal acyl-coenzyme A oxidase 1 Acox1 0.17 
11 Q9D0L4 Uncharacterized aarF domain-containing protein kinase 1 Adck1 0.80 
12 Q9ESW4 Acylglycerol kinase, mitochondrial Agk 0.33 
13 F8WGD9 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon Agpat5 0.00 
14 O08715 A-kinase anchor protein 1, mitochondrial Akap1 0.00 
15 Q9CZS1 Aldehyde dehydrogenase X, mitochondrial Aldh1b1 0.56 
16 D3Z6B9 Mitochondrial 10-formyltetrahydrofolate dehydrogenase Aldh1l2 0.15 
17 P47738 Aldehyde dehydrogenase, mitochondrial Aldh2 0.64 
18 Q8BWF0 Succinate-semialdehyde dehydrogenase, mitochondrial Aldh5a1 0.60 
19 Q9EQ20 
Methylmalonate-semialdehyde dehydrogenase [acylating], 
mitochondrial Aldh6a1 0.63 
20 P97449 Aminopeptidase N Anpep 0.00 
21 Q9D5T0 ATPase family AAA domain-containing protein 1 Atad1 0.40 
22 H3BKI6 ATPase family AAA domain-containing protein 3 Atad3a 0.81 
23 P14094 Sodium/potassium-transporting ATPase subunit beta-1 Atp1b1 0.92 
24 J3KMM5 Calcium-transporting ATPase Atp2a2 0.89 
25 A2AKU9 ATP synthase subunit gamma Atp5c1 0.73 
26 D3Z7S4 ATP synthase subunit delta, mitochondrial Atp5d 0.82 
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27 P56382 ATP synthase subunit epsilon, mitochondrial Atp5e 0.80 
28 D6RGL7 ATP synthase F(0) complex subunit B1, mitochondrial Atp5f1 0.38 
29 Q9DCX2 ATP synthase subunit d, mitochondrial Atp5h 0.56 
30 P97450 ATP synthase-coupling factor 6, mitochondrial Atp5j 0.80 
31 F8WHP8 ATP synthase subunit f, mitochondrial Atp5j2 0.62 
32 Q9CPQ8 ATP synthase subunit g, mitochondrial Atp5l 0.84 
33 E9QM21 Bcl-2 homologous antagonist/killer Bak1 0.00 
34 D3Z7C8 Branched-chain-amino-acid aminotransferase Bcat2 0.49 
35 O55028 
[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]]kinase, 
mitochondrial Bckdk 0.27 
36 P59017 Bcl-2-like protein 13 Bcl2l13 0.58 
37 Q9CZP5 Mitochondrial chaperone BCS1 Bcs1l 0.28 
38 P35564 Calnexin Canx 0.00 
39 P24270 Catalase Cat 0.34 
40 D6RJ70 Kynurenine--oxoglutarate transaminase 3 Ccbl2 0.28 
41 Q3URS9 Coiled-coil domain-containing protein 51 Ccdc51 0.40 
42 Q8C3X2 Coiled-coil domain-containing protein 90B, mitochondrial Ccdc90b 0.22 
43 Q9CRB9 MICOS complex subunit Mic19 Chchd3 0.90 
44 P07310 Creatine kinase M-type Ckm 0.63 
45 E9Q3U7 
Cytochrome c oxidase assembly protein COX16 homolog, 
mitochondrial Cox16 0.00 
46 M0QWX2 Cytochrome c oxidase subunit 4 isoform 1, mitochondrial Cox4i1 0.55 
47 P12787 Cytochrome c oxidase subunit 5A, mitochondrial Cox5a 0.43 
48 Q9D881 Protein Gm11273 Cox5b 0.50 
49 Q9CPQ1 Cytochrome c oxidase subunit 6C Cox6c 0.40 
50 P56392 Cytochrome c oxidase subunit 7A1, mitochondrial Cox7a1 0.48 
51 P48771 Cytochrome c oxidase subunit 7A2, mitochondrial Cox7a2 0.83 
52 Q99KD6 Cox7a2l protein Cox7a2l 0.69 
53 B8JJA9 Cytochrome c oxidase subunit 7C, mitochondrial Cox7c 0.40 
54 Q9WVJ3 Carboxypeptidase Q Cpq 0.19 
55 Q9CQX2 Cytochrome b5 type B Cyb5b 0.33 
56 Q9D0M3 Cytochrome c1, heme protein, mitochondrial Cyc1 0.69 
57 D3ZFQ8  Cytochrome c-1 (Predicted), isoform CRA_c Cyc1 0.00 
58 P61804 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit DAD1 Dad1 0.00 
59 P53395 
Lipoamide acyltransferase component of branched-chain 
alpha-keto acid dehydrogenase complex, mitochondrial Dbt 0.45 
60 O54734 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase 48 kDa subunit Ddost 0.00 
61 Q8BMF4 
Dihydrolipoyllysine-residue acetyltransferase component of 
pyruvate dehydrogenase complex, mitochondrial Dlat 0.67 
62 E9Q8B3 DnaJ homolog subfamily C member 11 Dnajc11 0.79 
63 O35459 Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial Ech1 0.58 
64 Q9QZH6 
Evolutionarily conserved signaling intermediate in Toll 
pathway, mitochondrial Ecsit 0.00 
65 P17182 Alpha-enolase Eno1 0.80 
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66 Q3U7R1 Extended synaptotagmin-1 Esyt1 0.50 
67 Q9CR59 
Growth arrest and DNA damage-inducible proteins-interacting 
protein 1 Gadd45gip1 0.00 
68 Q91VC9 Growth hormone-inducible transmembrane protein Ghitm 0.00 
69 Q64516 Glycerol kinase Gk 0.26 
70 Q9WU65 Glycerol kinase 2 Gk2 0.00 
71 P26443 Glutamate dehydrogenase 1, mitochondrial Glud1 0.69 
72 P05201 Aspartate aminotransferase, cytoplasmic Got1 0.50 
73 Q76LV0 Glutathione peroxidase Gpx4 0.67 
74 P47791 Glutathione reductase, mitochondrial Gsr 0.67 
75 Q9DCM2 Glutathione S-transferase kappa 1 Gstk1 0.30 
76 Q8BMS1 Trifunctional enzyme subunit alpha, mitochondrial Hadha 0.79 
77 Q99JY0 Trifunctional enzyme subunit beta, mitochondrial Hadhb 0.68 
78 G3UXK7 Cytochrome c-type heme lyase Hccs 0.80 
79 Q8CGP5 Histone H2A type 1-F Hist1h2af 0.00 
80 G3UVV4 Hexokinase-1 Hk1 0.63 
81 E9Q5B5 Hexokinase-2 Hk2 0.18 
82 P51660 Peroxisomal multifunctional enzyme type 2 Hsd17b4 0.38 
83 B1AX78 Hydroxysteroid dehydrogenase-like protein 2 Hsdl2 0.91 
84 P08113 Endoplasmin Hsp90b1 0.61 
85 P38647 Stress-70 protein, mitochondrial Hspa9 0.75 
86 P63038 60 kDa heat shock protein, mitochondrial Hspd1 0.69 
87 E9PWN2 Isoleucine--tRNA ligase, mitochondrial Iars2 0.00 
88 Q9D6R2 Isocitrate dehydrogenase [NAD]subunit alpha, mitochondrial Idh3a 0.96 
89 Q91VA7 Isocitrate dehydrogenase [NAD]subunit, mitochondrial Idh3b 0.57 
90 P70404 
Isocitrate dehydrogenase [NAD]subunit gamma 1, 
mitochondrial Idh3g 0.78 
91 E9Q800 MICOS complex subunit Mic60 Immt 0.86 
92 P85094 Isochorismatase domain-containing protein 2A, mitochondrial Isoc2a 0.87 
93 P04104 Keratin, type II cytoskeletal 1 Krt1 0.78 
94 A2A513 Keratin, type I cytoskeletal 10 Krt10 0.77 
95 Q61781 Keratin, type I cytoskeletal 14 Krt14 0.57 
96 Q9QWL7 Keratin, type I cytoskeletal 17 Krt17 0.53 
97 Q3TTY5 Keratin, type II cytoskeletal 2 epidermal Krt2 0.72 
98 Q922U2 Keratin, type II cytoskeletal 5 Krt5 0.73 
99 P11679 Keratin, type II cytoskeletal 8 Krt8 0.89 
100 Q9CPY7 Cytosol aminopeptidase Lap3 0.38 
101 Q9Z2I0 
LETM1 and EF-hand domain-containing protein 1, 
mitochondrial Letm1 0.48 
102 Q8CGK3 Lon protease homolog, mitochondrial Lonp1 0.49 
103 Q6PB66 Leucine-rich PPR motif-containing protein, mitochondrial Lrpprc 0.60 
104 Q8VCF0 Mitochondrial antiviral-signaling protein Mavs 0.00 
105 Q99MR8 
Methylcrotonoyl-CoA carboxylase subunit alpha, 
mitochondrial Mccc1 0.66 
106 Q3ULD5 Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial Mccc2 0.44 
107 Q9CXD6 Mitochondrial calcium uniporter regulator 1 Mcur1 0.43 
108 E9PZP7 Malic enzyme Me3 0.36 
109 Q9CPU4 Microsomal glutathione S-transferase 3 Mgst3 0.90 
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110 Q99J39 Malonyl-CoA decarboxylase, mitochondrial Mlycd 0.42 
111 P56379 6.8 kDa mitochondrial proteolipid Mp68 0.33 
112 Q9DB15 39S ribosomal protein L12, mitochondrial Mrpl12 0.00 
113 F8WHN1 39S ribosomal protein L15, mitochondrial Mrpl15 0.75 
114 O35972 39S ribosomal protein L23, mitochondrial Mrpl23 0.64 
115 Q921S7 39S ribosomal protein L37, mitochondrial Mrpl37 0.47 
116 Q9CPX7 28S ribosomal protein S16, mitochondrial Mrps16 0.75 
117 Q99N84 28S ribosomal protein S18b, mitochondrial Mrps18b 0.00 
118 P58059 28S ribosomal protein S21, mitochondrial Mrps21 0.50 
119 Q9CXW2 28S ribosomal protein S22, mitochondrial Mrps22 0.29 
120 Q9CQV5 28S ribosomal protein S24, mitochondrial Mrps24 0.33 
121 Q80ZS3 28S ribosomal protein S26, mitochondrial Mrps26 0.00 
122 Q8BK72 28S ribosomal protein S27, mitochondrial Mrps27 0.40 
123 Q61733 28S ribosomal protein S31, mitochondrial Mrps31 0.00 
124 Q9JIK9 28S ribosomal protein S34, mitochondrial Mrps34 0.36 
125 Q99N87 28S ribosomal protein S5, mitochondrial Mrps5 0.67 
126 Q9D7N3 28S ribosomal protein S9, mitochondrial Mrps9 0.70 
127 Q9D6Y7 Mitochondrial peptide methionine sulfoxide reductase Msra 0.64 
128 P03930 ATP synthase protein 8 mt-Atp8 0.65 
129 Q791T5 Mitochondrial carrier homolog 1 Mtch1 0.00 
130 A2AFW6 Mitochondrial carrier homolog 2 Mtch2 0.86 
131 Q9MD68 Cytochrome c oxidase subunit 1 mt-Co1 0.20 
132 P00405 Cytochrome c oxidase subunit 2 mt-Co2 0.00 
133 P00158 Cytochrome b mt-Cytb 0.60 
134 D3YVW0 Metaxin-1 Mtx1 0.65 
135 Q62425 Cytochrome c oxidase subunit NDUFA4 Ndufa4 0.76 
136 A2AQ17 Complex I intermediate-associated protein 30, mitochondrial Ndufaf1 0.00 
137 Q9JKL4 
NADH dehydrogenase [ubiquinone]1 alpha subcomplex 
assembly factor 3 Ndufaf3 0.55 
138 Q9D1H6 
NADH dehydrogenase [ubiquinone]1 alpha subcomplex 
assembly factor 4 Ndufaf4 0.00 
139 Q9JHW2 Omega-amidase NIT2 Nit2 0.63 
140 Q3TL44 NLR family member X1 Nlrx1 0.36 
141 P15532 Nucleoside diphosphate kinase A Nme1 0.20 
142 Q01768 Nucleoside diphosphate kinase B Nme2 0.17 
143 Q9WV85 Nucleoside diphosphate kinase 3 Nme3 0.00 
144 E9Q8F4 NAD(P) transhydrogenase, mitochondrial Nnt 0.51 
145 Q60597 2-oxoglutarate dehydrogenase, mitochondrial Ogdh 0.80 
146 E9Q7L0 Protein Ogdhl Ogdhl 0.53 
147 E0CXD1 Dynamin-like 120 kDa protein, mitochondrial Opa1 0.44 
148 Q505D7 Optic atrophy 3 protein homolog Opa3 0.94 
149 P35487 
Pyruvate dehydrogenase E1 component subunit alpha, testis-
specific form, mitochondrial Pdha2 0.00 
150 Q9D0F9 Phosphoglucomutase-1 Pgm2 0.00 
151 P52480 Pyruvate kinase PKM Pkm 0.14 
152 P61014 Cardiac phospholamban Pln 0.00 
153 Q9CXT8 Mitochondrial-processing peptidase subunit beta Pmpcb 0.63 
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154 G3UZJ4 Peroxiredoxin-5, mitochondrial Prdx5 0.53 
155 Q14C51 
Pentatricopeptide repeat domain-containing protein 3, 
mitochondrial Ptcd3 0.93 
156 Q8BWM0 Prostaglandin E synthase 2 Ptges2 0.86 
157 Q922Q4 Pyrroline-5-carboxylate reductase 2 Pycr2 0.00 
158 P61027 Ras-related protein Rab-10 Rab10 0.50 
159 Q3U186 Probable arginine--tRNA ligase, mitochondrial Rars2 0.00 
160 Q8JZN7 Mitochondrial Rho GTPase 2 Rhot2 0.00 
161 Q8CI78 Required for meiotic nuclear division protein 1 homolog Rmnd1 0.53 
162 A2ACG7 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 2 Rpn2 0.00 
163 Q3U3G8 Serine hydrolase-like protein Serhl 0.33 
164 D6RHN5 Serpin B13 Serpinb13 0.00 
165 Q8BH59 Calcium-binding mitochondrial carrier protein Aralar1 Slc25a12 0.64 
166 Q9QXX4 Calcium-binding mitochondrial carrier protein Aralar2 Slc25a13 0.71 
167 Q60714 Long-chain fatty acid transport protein 1 Slc27a1 0.00 
168 P04919 Band 3 anion transport protein Slc4a1 0.68 
169 P08228 Superoxide dismutase [Cu-Zn] Sod1 0.40 
170 F6ZKZ3 Sulfide:quinone oxidoreductase, mitochondrial Sqrdl 0.43 
171 B0QZS8 
Mitochondrial import inner membrane translocase subunit 
Tim22 Timm22 0.60 
172 Q8BUY5 Complex I assembly factor TIMMDC1, mitochondrial Timmdc1 0.54 
173 Q8VD26 Transmembrane protein 143 Tmem143 0.65 
174 Q9D938 Transmembrane protein 160 Tmem160 0.00 
175 Q9CR76 Transmembrane protein 186 Tmem186 0.50 
176 Q9CPQ3 Mitochondrial import receptor subunit TOM22 homolog Tomm22 0.52 
177 Q9QYA2 Mitochondrial import receptor subunit TOM40 homolog Tomm40 0.43 
178 D3YXS8 Mitochondrial import receptor subunit TOM40B Tomm40l 0.20 
179 B1AXP6 Mitochondrial import receptor subunit TOM5 homolog Tomm5 0.00 
180 Q9CZW5 Mitochondrial import receptor subunit TOM70 Tomm70a 0.00 
181 Q9CQB4 Cytochrome b-c1 complex subunit 7 Uqcrb 0.59 
182 P99028 Cytochrome b-c1 complex subunit 6, mitochondrial Uqcrh 0.43 
183 Q78IK2 Up-regulated during skeletal muscle growth protein 5 Usmg5 0.59 
184 Q01853 Transitional endoplasmic reticulum ATPase Vcp 0.00 
185 F2Z471 Voltage-dependent anion-selective channel protein 1 Vdac1 0.67 
186 Q60930 Voltage-dependent anion-selective channel protein 2 Vdac2 0.66 
187 J3QMG3 Voltage-dependent anion-selective channel protein 3 Vdac3 0.60 
188 Q8CC88 von Willebrand factor A domain-containing protein 8 Vwa8 0.54 
189 O88967 ATP-dependent zinc metalloprotease YME1L1 Yme1l1 0.00 
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Suppl. Table 11. Mitochondrial proteins associated with OPA1 that 
decrease upon apoptotic cristae remodeling 
A/A 
ACCESSION 
NUMBER 
PROTEIN NAME GENE 
1 P61922 4-aminobutyrate aminotransferase, mitochondrial Abat 
2 Q61102 ATP-binding cassette sub-family B member 7, mitochondrial Abcb7 
3 Q9CXJ4 ATP-binding cassette sub-family B member 8, mitochondrial Abcb8 
4 A2ALN0 ATP-binding cassette sub-family D member 1 Abcd1 
5 P55096 ATP-binding cassette sub-family D member 3 Abcd3 
6 D3YTQ5 Acyl-CoA dehydrogenase family member 11 Acad11 
7 Q8JZN5 Acyl-CoA dehydrogenase family member 9, mitochondrial Acad9 
8 Q9D0L4 Uncharacterized aarF domain-containing protein kinase 1 Adck1 
9 Q9ESW4 Acylglycerol kinase, mitochondrial Agk 
10 Q9CZS1 Aldehyde dehydrogenase X, mitochondrial Aldh1b1 
11 D3Z6B9 Mitochondrial 10-formyltetrahydrofolate dehydrogenase Aldh1l2 
12 P47738 Aldehyde dehydrogenase, mitochondrial Aldh2 
13 Q8BWF0 Succinate-semialdehyde dehydrogenase, mitochondrial Aldh5a1 
14 Q9EQ20 
Methylmalonate-semialdehyde dehydrogenase [acylating], 
mitochondrial Aldh6a1 
15 Q9D5T0 ATPase family AAA domain-containing protein 1 Atad1 
16 A2AKU9 ATP synthase subunit gamma Atp5c1 
17 D6RGL7 ATP synthase F(0) complex subunit B1, mitochondrial Atp5f1 
18 Q9DCX2 ATP synthase subunit d, mitochondrial Atp5h 
19 F8WHP8 ATP synthase subunit f, mitochondrial Atp5j2 
20 Q9CPQ8 ATP synthase subunit g, mitochondrial Atp5l 
21 D3Z7C8 Branched-chain-amino-acid aminotransferase Bcat2 
22 O55028 
[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]]kinase, 
mitochondrial Bckdk 
23 P59017 Bcl-2-like protein 13 Bcl2l13 
24 Q9CZP5 Mitochondrial chaperone BCS1 Bcs1l 
25 P24270 Catalase Cat 
26 Q3URS9 Coiled-coil domain-containing protein 51 Ccdc51 
27 Q8C3X2 Coiled-coil domain-containing protein 90B, mitochondrial Ccdc90b 
28 M0QWX2 Cytochrome c oxidase subunit 4 isoform 1, mitochondrial Cox4i1 
29 P12787 Cytochrome c oxidase subunit 5A, mitochondrial Cox5a 
30 Q9D881 Protein Gm11273 Cox5b 
31 Q9CPQ1 Cytochrome c oxidase subunit 6C Cox6c 
32 P56392 Cytochrome c oxidase subunit 7A1, mitochondrial Cox7a1 
33 B8JJA9 Cytochrome c oxidase subunit 7C, mitochondrial Cox7c 
34 Q9WVJ3 Carboxypeptidase Q Cpq 
35 Q9CQX2 Cytochrome b5 type B Cyb5b 
36 D3ZFQ8  Cytochrome c-1 (Predicted), isoform CRA_c Cyc1 
37 Q9D0M3 Cytochrome c1, heme protein, mitochondrial Cyc1 
38 P53395 
Lipoamide acyltransferase component of branched-chain alpha-keto 
acid dehydrogenase complex, mitochondrial Dbt 
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39 O54734 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa 
subunit Ddost 
40 O35459 Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial Ech1 
41 Q9QZH6 
Evolutionarily conserved signaling intermediate in Toll pathway, 
mitochondrial Ecsit 
42 Q64516 Glycerol kinase Gk 
43 Q9WU65 Glycerol kinase 2 Gk2 
44 P26443 Glutamate dehydrogenase 1, mitochondrial Glud1 
45 P05201 Aspartate aminotransferase, cytoplasmic Got1 
46 Q76LV0 Glutathione peroxidase Gpx4 
47 P47791 Glutathione reductase, mitochondrial Gsr 
48 Q8BMS1 Trifunctional enzyme subunit alpha, mitochondrial Hadha 
49 Q99JY0 Trifunctional enzyme subunit beta, mitochondrial Hadhb 
50 G3UXK7 Cytochrome c-type heme lyase Hccs 
51 G3UVV4 Hexokinase-1 Hk1 
52 E9Q5B5 Hexokinase-2 Hk2 
53 P51660 Peroxisomal multifunctional enzyme type 2 Hsd17b4 
54 P38647 Stress-70 protein, mitochondrial Hspa9 
55 P63038 60 kDa heat shock protein, mitochondrial Hspd1 
56 Q91VA7 Isocitrate dehydrogenase [NAD]subunit, mitochondrial Idh3b 
57 E9Q800 MICOS complex subunit Mic60 Immt 
58 P04104 Keratin, type II cytoskeletal 1 Krt1 
59 A2A513 Keratin, type I cytoskeletal 10 Krt10 
60 Q61781 Keratin, type I cytoskeletal 14 Krt14 
61 Q9QWL7 Keratin, type I cytoskeletal 17 Krt17 
62 Q3TTY5 Keratin, type II cytoskeletal 2 epidermal Krt2 
63 Q922U2 Keratin, type II cytoskeletal 5 Krt5 
64 P11679 Keratin, type II cytoskeletal 8 Krt8 
65 Q9CPY7 Cytosol aminopeptidase Lap3 
66 Q9Z2I0 LETM1 and EF-hand domain-containing protein 1, mitochondrial Letm1 
67 Q8CGK3 Lon protease homolog, mitochondrial Lonp1 
68 Q6PB66 Leucine-rich PPR motif-containing protein, mitochondrial Lrpprc 
69 Q8VCF0 Mitochondrial antiviral-signaling protein Mavs 
70 Q99MR8 Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial Mccc1 
71 Q3ULD5 Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial Mccc2 
72 Q9CXD6 Mitochondrial calcium uniporter regulator 1 Mcur1 
73 E9PZP7 Malic enzyme Me3 
74 Q9CPU4 Microsomal glutathione S-transferase 3 Mgst3 
75 Q99J39 Malonyl-CoA decarboxylase, mitochondrial Mlycd 
76 P56379 6.8 kDa mitochondrial proteolipid Mp68 
77 Q9DB15 39S ribosomal protein L12, mitochondrial Mrpl12 
78 O35972 39S ribosomal protein L23, mitochondrial Mrpl23 
79 Q9CXW2 28S ribosomal protein S22, mitochondrial Mrps22 
80 Q8BK72 28S ribosomal protein S27, mitochondrial Mrps27 
81 Q9JIK9 28S ribosomal protein S34, mitochondrial Mrps34 
82 Q9D6Y7 Mitochondrial peptide methionine sulfoxide reductase Msra 
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83 P03930 ATP synthase protein 8 mt-Atp8 
84 A2AFW6 Mitochondrial carrier homolog 2 Mtch2 
85 Q9MD68 Cytochrome c oxidase subunit 1 mt-Co1 
86 P00405 Cytochrome c oxidase subunit 2 mt-Co2 
87 P00158 Cytochrome b mt-Cytb 
88 D3YVW0 Metaxin-1 Mtx1 
89 Q62425 Cytochrome c oxidase subunit NDUFA4 Ndufa4 
90 Q9JKL4 
NADH dehydrogenase [ubiquinone]1 alpha subcomplex assembly 
factor 3 Ndufaf3 
91 Q9D1H6 
NADH dehydrogenase [ubiquinone]1 alpha subcomplex assembly 
factor 4 Ndufaf4 
92 Q9JHW2 Omega-amidase NIT2 Nit2 
93 Q3TL44 NLR family member X1 Nlrx1 
94 P15532 Nucleoside diphosphate kinase A Nme1 
95 Q01768 Nucleoside diphosphate kinase B Nme2 
96 Q9WV85 Nucleoside diphosphate kinase 3 Nme3 
97 E9Q8F4 NAD(P) transhydrogenase, mitochondrial Nnt 
98 Q60597 2-oxoglutarate dehydrogenase, mitochondrial Ogdh 
99 E0CXD1 Dynamin-like 120 kDa protein, mitochondrial Opa1 
100 P52480 Pyruvate kinase PKM Pkm 
101 Q9CXT8 Mitochondrial-processing peptidase subunit beta Pmpcb 
102 G3UZJ4 Peroxiredoxin-5, mitochondrial Prdx5 
103 Q8BWM0 Prostaglandin E synthase 2 Ptges2 
104 P61027 Ras-related protein Rab-10 Rab10 
105 Q3U186 Probable arginine--tRNA ligase, mitochondrial Rars2 
106 Q8JZN7 Mitochondrial Rho GTPase 2 Rhot2 
107 Q8CI78 Required for meiotic nuclear division protein 1 homolog Rmnd1 
108 Q3U3G8 Serine hydrolase-like protein Serhl 
109 Q8BH59 Calcium-binding mitochondrial carrier protein Aralar1 Slc25a12 
110 Q9QXX4 Calcium-binding mitochondrial carrier protein Aralar2 Slc25a13 
111 Q60714 Long-chain fatty acid transport protein 1 Slc27a1 
112 P04919 Band 3 anion transport protein Slc4a1 
113 P08228 Superoxide dismutase [Cu-Zn] Sod1 
114 F6ZKZ3 Sulfide:quinone oxidoreductase, mitochondrial Sqrdl 
115 B0QZS8 Mitochondrial import inner membrane translocase subunit Tim22 Timm22 
116 Q8BUY5 Complex I assembly factor TIMMDC1, mitochondrial Timmdc1 
117 Q8VD26 Transmembrane protein 143 Tmem143 
118 Q9CPQ3 Mitochondrial import receptor subunit TOM22 homolog Tomm22 
119 Q9QYA2 Mitochondrial import receptor subunit TOM40 homolog Tomm40 
120 D3YXS8 Mitochondrial import receptor subunit TOM40B Tomm40l 
121 Q9CZW5 Mitochondrial import receptor subunit TOM70 Tomm70a 
122 Q9CQB4 Cytochrome b-c1 complex subunit 7 Uqcrb 
123 P99028 Cytochrome b-c1 complex subunit 6, mitochondrial Uqcrh 
124 Q78IK2 Up-regulated during skeletal muscle growth protein 5 Usmg5 
125 F2Z471 Voltage-dependent anion-selective channel protein 1 Vdac1 
126 Q60930 Voltage-dependent anion-selective channel protein 2 Vdac2 
127 J3QMG3 Voltage-dependent anion-selective channel protein 3 Vdac3 
 
 
154 
 
128 Q8CC88 von Willebrand factor A domain-containing protein 8 Vwa8 
 
Suppl. Table 12. All the mitochondrial proteins that decrease after 
cBIDwt 
A/A Spot 
Accession 
Number 
Protein Name Gene 
Fold 
change 
1 A1-2 E9Q7L0 Protein Ogdhl Ogdhl 1.304 
2 A1-2 P00507 Aspartate aminotransferase, mitochondrial Got2 1.296 
3 A3-4 P31000 Vimentin Vim 2.426 
4 A3-4 Q8VDD5 Myosin-9 Myh9 2.225 
5 A3-4 Q3TCU5 Tapasin Tapbp 1.755 
6 A3-4 Q99KI0 Aconitate hydratase, mitochondrial Aco2 1.750 
7 A3-4 P48771 
Cytochrome c oxidase subunit 7A2, 
mitochondrial Cox7a2 1.667 
8 A3-4 Q8BMS1 
Trifunctional enzyme subunit alpha, 
mitochondrial Hadha 1.662 
9 A3-4 Q9CQL5 39S ribosomal protein L18, mitochondrial Mrpl18 1.554 
10 A3-4 P27773 Protein disulfide-isomerase A3 Pdia3 1.504 
11 A3-4 Q8BGH2 
Sorting and assembly machinery component 50 
homolog Samm50 1.491 
12 A3-4 P49432 
Pyruvate dehydrogenase E1 component 
subunit beta, mitochondrial Pdhb 1.398 
13 A3-4 P08249 Malate dehydrogenase, mitochondrial Mdh2 1.355 
14 A3-4 D3ZPP9 
Similar to RIKEN cDNA 1110007C09 (Predicted), 
isoform CRA_a BinCARD 1.337 
15 A3-4 Q7TT47 Paraplegin Spg7 1.316 
16 A3-4 P19783 
Cytochrome c oxidase subunit 4 isoform 1, 
mitochondrial Cox4i1 1.295 
17 A3-4 O55143 
Sarcoplasmic/endoplasmic reticulum calcium 
ATPase 2 Atp2a2 1.229 
18 A3-4 Q61833 Ribophorin Rpn2 1.221 
19 A3-4 P08461 
Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase 
complex, mitochondrial Dlat 1.210 
20 A5-6 Q80X68 Citrate synthase Cs 2.479 
21 A5-6 Q63965 Sideroflexin-1 Sfxn1 1.921 
22 A5-6 A9UMV9 RCG37550, isoform CRA_a Ndufa7 1.913 
23 A5-6 P15178 Aspartate--tRNA ligase, cytoplasmic Dars 1.757 
24 A5-6 P68033 Actin, alpha cardiac muscle 1 Actc1 1.727 
25 A5-6 Q8BGH2 
Sorting and assembly machinery component 50 
homolog Samm50 1.510 
26 A5-6 Q9Z1P6 
NADH dehydrogenase [ubiquinone]1 alpha 
subcomplex subunit 7 Ndufa7 1.473 
27 A5-6 P70565 Plakoglobin Jup 1.470 
28 A5-6 F1LW77 
RAB33B, member of RAS oncogene family 
(Predicted), isoform CRA_b Rab33b 1.421 
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29 A5-6 Q8C2Z6 Putative uncharacterized protein Chchd6 1.388 
30 A5-6 Q9D8L3 Translocon-associated protein subunit delta Ssr4 1.369 
31 A5-6 Q5BK63 
NADH dehydrogenase [ubiquinone]1 alpha 
subcomplex subunit 9, mitochondrial Ndufa9 1.356 
32 A5-6 Q8BMR3 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 1 Rpn1 1.328 
33 A5-6 Q8C454 Putative uncharacterized protein Mtx2 1.308 
34 A5-6 Q7TP78 Protein Ndufa8 Ndufa8 1.308 
35 A5-6 Q3UJW1 Putative uncharacterized protein Aldh2 1.266 
36 A5-6 Q9CPP6 
NADH dehydrogenase [ubiquinone]1 alpha 
subcomplex subunit 5 Ndufa5 1.262 
37 A5-6 O55143 
Sarcoplasmic/endoplasmic reticulum calcium 
ATPase 2 Atp2a2 1.248 
38 A5-6 P27773 Protein disulfide-isomerase A3 Pdia3 1.246 
39 A5-6 Q8BFR5 Elongation factor Tu, mitochondrial Tufm 1.235 
40 A5-6 Q61833 Ribophorin Rpn2 1.204 
41 A7 Q99KI0 Aconitate hydratase, mitochondrial Aco2 2.558 
42 A7 Q6P3V9 Ribosomal protein L4 Rpl4 2.549 
43 A7 Q80X68 Citrate synthase Cs 2.406 
44 A7 Q62261 Spectrin beta chain, non-erythrocytic 1 Sptbn1 2.048 
45 A7 P27773 Protein disulfide-isomerase A3 Pdia3 2.027 
46 A7 Q6PHC1 Eno1 protein Eno1 2.023 
47 A7 Q8BMS1 
Trifunctional enzyme subunit alpha, 
mitochondrial Hadha 1.819 
48 A7 Q7TP78 Protein Ndufa8 Ndufa8 1.764 
49 A7 Q60587 
Trifunctional enzyme subunit beta, 
mitochondrial Hadhb 1.650 
50 A7 E9PVS5 MICOS complex subunit Mic60 Mic60 1.380 
51 A7 B1ASE2 ATP synthase subunit d, mitochondrial Atp5h 1.392 
52 A7 P19234 
NADH dehydrogenase [ubiquinone]flavoprotein 
2, mitochondrial Ndufv2 1.323 
53 A7 Q8BFR5 Elongation factor Tu, mitochondrial Tufm 1.299 
54 A7 Q02253 
Methylmalonate-semialdehyde dehydrogenase 
[acylating], mitochondrial Aldh6a1 1.284 
55 A7 P63038 60 kDa heat shock protein, mitochondrial Hspd1 1.280 
56 A7 D3Z0L4 MICOS complex subunit Mic19 Chchd3 1.272 
57 A7 Q03265 ATP synthase subunit alpha, mitochondrial Atp5a1 1.267 
58 A7 Q3UZQ3 Elongation factor 1-alpha Eef1a1 1.264 
59 A7 F1LXA0 Protein LOC100910710 Ndufa12 1.254 
60 A7 A9UMV9 RCG37550, isoform CRA_a Ndufa7 1.252 
61 A7 P00507 Aspartate aminotransferase, mitochondrial Got2 1.231 
62 A7 Q3U9G2 Putative uncharacterized protein Hspa5 1.230 
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Suppl. Table 13. All the proteins that decrease during apoptotic cristae 
remodeling 
A/A Spot 
Accession 
Number 
Protein Name Gene 
1 A1-2 P00507 Aspartate aminotransferase, mitochondrial Got2 
2 A1-2 E9Q7L0 Protein Ogdhl Ogdhl 
3 A3-4 Q99KI0 Aconitate hydratase, mitochondrial Aco2 
4 A3-4 O55143 Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 Atp2a2 
5 A3-4 P56480 ATP synthase subunit beta, mitochondrial Atp5b 
6 A3-4 P19783 Cytochrome c oxidase subunit 4 isoform 1, mitochondrial Cox4i1 
7 A3-4 P48771 Cytochrome c oxidase subunit 7A2, mitochondrial Cox7a2 
8 A3-4 P08461 
Dihydrolipoyllysine-residue acetyltransferase component of 
pyruvate dehydrogenase complex, mitochondrial Dlat 
9 A3-4 Q8BMS1 Trifunctional enzyme subunit alpha, mitochondrial Hadha 
10 A3-4 E9Q800 MICOS complex subunit Mic60 Immt 
11 A3-4 P08249 Malate dehydrogenase, mitochondrial Mdh2 
12 A3-4 Q9CQL5 39S ribosomal protein L18, mitochondrial Mrpl18 
13 A3-4 Q8VDD5 Myosin-9 Myh9 
14 A3-4 P49432 
Pyruvate dehydrogenase E1 component subunit beta, 
mitochondrial Pdhb 
15 A3-4 P27773 Protein disulfide-isomerase A3 Pdia3 
16 A3-4 D3ZPP9 Similar to RIKEN cDNA 1110007C09 (Predicted), isoform CRA_a BinCARD 
17 A3-4 Q61833 Ribophorin Rpn2 
18 A3-4 Q7TT47 Paraplegin Spg7 
19 A3-4 Q3TCU5 Tapasin Tapbp 
20 A3-4 P31000 Vimentin Vim 
21 A5-6 P68033 Actin, alpha cardiac muscle 1 Actc1 
22 A5-6 Q3UJW1 Putative uncharacterized protein Aldh2 
23 A5-6 Q8C2Z6 Putative uncharacterized protein Chchd6 
24 A5-6 Q80X68 Citrate synthase Cs 
25 A5-6 P15178 Aspartate--tRNA ligase, cytoplasmic Dars 
26 A5-6 P70565 Plakoglobin Jup 
27 A5-6 Q8C454 Putative uncharacterized protein Mtx2 
28 A5-6 Q9CPP6 NADH dehydrogenase [ubiquinone]1 alpha subcomplex subunit 5 Ndufa5 
29 A5-6 Q9Z1P6 NADH dehydrogenase [ubiquinone]1 alpha subcomplex subunit 7 Ndufa7 
30 A5-6 Q7TP78 Protein Ndufa8 Ndufa8 
31 A5-6 Q5BK63 
NADH dehydrogenase [ubiquinone]1 alpha subcomplex subunit 9, 
mitochondrial Ndufa9 
32 A5-6 P27773 Protein disulfide-isomerase A3 Pdia3 
33 A5-6 F1LW77 
RAB33B, member of RAS oncogene family (Predicted), isoform 
CRA_b Rab33b 
34 A5-6 Q8BMR3 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 
subunit 1 Rpn1 
35 A5-6 Q61833 Ribophorin Rpn2 
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36 A5-6 Q63965 Sideroflexin-1 Sfxn1 
37 A5-6 Q9D8L3 Translocon-associated protein subunit delta Ssr4 
38 A5-6 Q8BFR5 Elongation factor Tu, mitochondrial Tufm 
39 A7 Q99KI0 Aconitate hydratase, mitochondrial Aco2 
40 A7 Q02253 
Methylmalonate-semialdehyde dehydrogenase [acylating], 
mitochondrial Aldh6a1 
41 A7 Q03265 ATP synthase subunit alpha, mitochondrial Atp5a1 
42 A7 B1ASE2 ATP synthase subunit d, mitochondrial Atp5h 
43 A7 Q8BMK4 Cytoskeleton-associated protein 4 Ckap4 
44 A7 Q80X68 Citrate synthase Cs 
45 A7 Q3UZQ3 Elongation factor 1-alpha Eef1a1 
46 A7 Q6PHC1 Eno1 protein Eno1 
47 A7 P00507 Aspartate aminotransferase, mitochondrial Got2 
48 A7 Q3U9G2 Putative uncharacterized protein Hspa5 
49 A7 P63038 60 kDa heat shock protein, mitochondrial Hspd1 
50 A7 E9PVS5 MICOS complex subunit Mic60 Immt 
51 A7 F1LXA0 Protein LOC100910710 Ndufa12 
52 A7 A9UMV9 RCG37550, isoform CRA_a Ndufa7 
53 A7 Q7TP78 Protein Ndufa8 Ndufa8 
54 A7 Q5BK63 
NADH dehydrogenase [ubiquinone]1 alpha subcomplex subunit 9, 
mitochondrial Ndufa9 
55 A7 P19234 NADH dehydrogenase [ubiquinone]flavoprotein 2, mitochondrial Ndufv2 
56 A7 P27773 Protein disulfide-isomerase A3 Pdia3 
57 A7 Q6P3V9 Ribosomal protein L4 Rpl4 
58 A7 Q8BMR3 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 
subunit 1 Rpn1 
59 A7 Q62261 Spectrin beta chain, non-erythrocytic 1 Sptbn1 
60 A7 Q8BFR5 Elongation factor Tu, mitochondrial Tufm 
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2.2. Mammalian mitochondrial cristae biogenesis is regulated by 
Mitofilin (Mic60)-OPA1 complexes that are eliminated during 
apoptosis 
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ABSTRACT  
Optic atrophy 1 (OPA1) and the core MICOS complex member, Mic60, are inner 
mitochondrial membrane proteins both involved in shaping mitochondrial cristae; 
however, it is unclear whether they cooperate or they operate in independent 
functional pathways. Here using proteomics, biochemical analysis and electron 
microscopy we show that OPA1 and Mic60 interact, composing high molecular weight 
complexes, which are essential for the cristae junction formation and are targeted early 
upon apoptotic cristae remodeling. Similarly, another MICOS component, Mic19, shares 
common complexes, suggesting a novel role of mammalian MICOS on cristae shape 
modulation during programmed cell death. Nevertheless, unlike OPA1, Mic60 does not 
regulate the width of cristae lumen or cristae junction mouth in physiological or 
apoptotic conditions. Overall, our data uncover the interplay between OPA1 and MICOS 
complex for the formation of cristae junctions and dissociate the mechanisms of cristae 
junction biogenesis from the control of cristae lumen width.  
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INTRODUCTION 
Mitochondria regulate the energy status of the cell while coordinating a variety of other 
key cellular processes, like differentiation, intermediary metabolism, calcium 
homeostasis, and cell death (Kasahara et al., 2013). Such multiplicity of functions is 
possible because of the unique ultrastructural complexity of the organelle, organized in 
five sub-compartments: the outer membrane (OMM), the intermembrane space (IMS), 
the inner boundary membrane, the cristae, and the matrix; this organization allows the 
distribution of biochemical processes via the sub-compartmentalization of the proteins 
that attain and regulate them. For instance, the cristae are responsible for mitochondrial 
respiration because they host the oxidative phosphorylation components and create a 
microenvironment that, ultimately, allows their assembly in respiration-competent 
complexes and super-complexes (Acin-Perez et al., 2008; Acin-Perez and Enriquez, 2014). 
Therefore, cristae number and integrity dictate the bioenergetic capacity of the organelle, 
a concept emerged in the late ‘60s through the pioneering work of Charles Hackenbrock 
(Hackenbrock, 1966) and that has been recently validated in vivo using mouse genetic 
models (Cogliati et al., 2013; Varanita et al., 2015) . 
Until recently, the cristae have been considered as a single ultrastructural component of 
the mitochondrion. However, functional and tomography electron microscopy studies 
have revealed a higher degree of structural complexity of this sub-compartment, whose 
function pivots on two key elements: the lumen and the cristae junction (Mannella, 2006; 
Mannella et al., 2013). The lumen is the space inside the invagination of the crista. Here, 
a critical functional element is the distance between the opposing faces of the IMM, the 
cristae lumen width (CLW), which controls RCS assembly and, in turn, mitochondrial 
respiration: the narrower the CLW, the higher the efficiency of oxidative phosphorylation 
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(Cogliati et al., 2013). The cristae junction (CJ) is the site at the top of the crista that 
separates its lumen from the IMS; in tomographic 3D reconstructions the CJ opens to the 
IMS in a 20-30 nm mouth that regulates the flow of metabolites (Mannella et al., 1994; 
Scorrano et al., 2002). During apoptosis the size of this CJ mouth increases, allowing the 
mobilization and passage of cytochrome c (cyt c) from the lumen to the IMS (Frezza et al., 
2006; Scorrano et al., 2002). To date, it remains unclear whether changes in CLW and CJ 
mouth are coupled or independent events; however, their biogenesis and remodeling 
appear to share some common molecular mechanisms because both processes are 
regulated by the dynamin GTPase OPA1. 
The mammalian OPA1 protein regulates steady-state cristae shape and apoptotic 
remodeling. Loss of OPA1 increases CLW, thereby decreasing mitochondrial respiration 
and sensitizing cells to intrinsic pro-apoptotic stimuli; instead, mild OPA1 overexpression 
decreases CL-width and delays CJ bore widening and cytochrome c release during 
apoptosis. OPA1 forms complexes of several hundreds kilo-Daltons that are eliminated 
during apoptosis, a finding that correlates with CLW and CJ bore remodeling during this 
process. In addition to OPA1, the mammalian mitochondrial protein Mic60 has also been 
shown to control cristae biogenesis. Mic60 is a key component of a large protein complex 
named MICOS (Mitochondrial contact site and cristae organizing system), which regulates 
CJ biogenesis from yeast to mammals. Neither OPA1 nor its yeast homolog, Mgm1p, is 
part of the MICOS complex. Therefore, it remains unsolved whether OPA1 and Mic60 
participate in two distinct CJ biogenesis pathways or, instead, if they coordinate different 
steps of a single process that eludes our understanding. 
The MICOS complex has been extensively characterized in yeast, where it exists as two 
independent MICOS sub-complexes: Mic27/Mic10/Mic12 and Mic60/Mic19. These two 
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sub-complexes independently localize to CJ and are connected via Mic19, which regulates 
sub-complex distribution. In mammals, the existence of these two-subcomplexes remains 
unexplored, but a homolog of Mic12 has not been found yet. Further, whereas genetic 
deletion of Mic10 in yeast causes the cristae to become stacked lamellar structures, 
similar to thylakoids in chloroplasts, silencing of its homolog in mammalian cells yields 
mitochondria with normal cristae (Li et al., 2015). These observations suggest that during 
vertebrate evolution the composition and regulation of the MICOS complex has changed, 
possibly to accommodate its recruitment into the process that widens the CJ mouth 
during apoptosis. Consistent with this possibility, silencing of Mic19 or Mic60, but not of 
Mic10, sensitizes cells to stimuli that trigger intrinsic apoptosis, a cellular program that, 
having emerged approx. 500 million years ago, is absent in yeast. 
Here we used a combination of proteomics, electron tomography and functional analyses 
to unravel the crosstalk between OPA1 and the core MICOS complex component Mic60 
in cristae biogenesis and remodeling. Our data indicate that mammalian Mic60 interacts 
with OPA1 to form high molecular weight complexes that are required to form CJs and 
that are eliminated during cristae remodeling to facilitate cytochrome c release during 
apoptosis. Our results identify a crosstalk between the core cristae biogenesis regulators 
and characterize the role of Mic60 during apoptotic cristae remodeling. 
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RESULTS 
Yeast and Mammalian Mic60 are divergent orthologue proteins 
It is well established that CJ remodeling during apoptosis regulates cyt c release, a notion 
that implies the recruitment of CJ proteins like OPA1 in this process at the onset of 
vertebrate evolution, when cyt c became a key activator of programmed cell death. 
However, the contribution of the core cristae biogenesis complex MICOS in cristae 
remodeling remains unresolved. In order to address this question, we first investigated 
whether the structure of yeast Mic60 and that of its vertebrate orthologue were 
conserved. A bioinformatics analysis indicated that the putative transmembrane helix 
(TMH) of yeast and mammalian Mic60 are divergent (Figure 1A). Per se, this finding is not 
unexpected because TMHs are typically poorly conserved; however, it is at odd with the 
fact that whereas the TMH of yeast Mic60 can form a highly structured hydrophobic α–
helix, that of mammalian Mic60 is predicted to be poorly structured and hydrophobic, 
mostly because it contains two clusters of glycine residues. Furthermore, the TMH of 
Mic60 is strictly conserved from fish to man, a fact that supports the relevance of the 
differences between yeast and mammals Mic60 (Supplemental Figure 1A). This indicates 
that, in vertebrates only, the TMH is subjected to structural constraints that cannot be 
linked only to its membrane-anchoring function.  
Evidence indicating that yeast and mammalian Mic60 are structurally unrelated proteins 
can also be inferred by the lack in the yeast protein of sequences that are conversely 
strictly conserved in all the vertebrate ones. These sequences span the middle domain of 
Mic60 and do not display any obvious homology with any other protein encoded by the 
mouse and human genome (Figure 1A and Supplemental Figure 1B), suggesting a strong 
purifying selection during vertebrate evolution. In unconstrained sequences evolving 
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neutrally, very few, if any, invariant residues would be expected to survive the 500 million 
years of evolution separating vertebrate orders, indicating that the conservation of the 
middle Mic60 domain was likely driven by functional constraints. In conclusion, whereas 
the C-terminal domain is conserved in all eukaryotic orthologues of Mic60 (Munoz-Gomez 
et al., 2015), a novel TMH and N-terminal domain emerged at the outset of vertebrate 
evolution (Supplemental Figures 1A and 1B), possibly to recruit Mic60 in a novel pathway 
or to confer to this CJ protein new partners and mechanisms of regulation, calling for an 
analysis of mammalian Mic60 function. 
 
Mammalian Mic60 forms complexes that are eliminated during BID-induced cristae 
remodeling 
Yeast and mammalian Mic60 form high molecular weight complexes (HMWC) (Guarani et 
al., 2015), but whether and how they change during metabolic, physiologic, or 
pathological processes remains unknown. Prompted by our bioinformatics analysis 
indicating a potential role for mammalian Mic60 in a higher eukaryotic process such as 
apoptosis, we decided to address if mammalian Mic60 HMWC change during apoptotic 
cristae remodeling when OPA1 containing HMWC are disassembled. Blue Native Gel 
Electrophoresis (BNGE) confirmed that Mic60 forms HMWC of 600-1000 kDa in purified 
mouse heart and liver mitochondria (Figure 1B). We next asked if these Mic60-containing 
complexes changed during apoptotic-cristae remodeling. To this end, protein complexes 
separated by BNGE from mouse heart mitochondria treated with recombinant BH3-only 
BCL-2 family member apoptosis activator cleaved BID (cBID) or with its cristae remodeling 
incompetent mutant cBIDKKAA (Cogliati et al., 2013) were processed for mass spectrometry 
(MS) analysis. The color contour plot representation of the number of unique Mic60 and 
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Mic19 peptides identified by this semi-quantitative proteomic analysis in the different 
HMWC isolated from normal and apoptotic mitochondria showed that cBID, but not the 
cristae remodeling incompetent cBIDKKAA mutant greatly reduced the amount of Mic60 
across the HMWC analyzed (Figure 1C). A quantitative proteomic analysis of 
mitochondrial complexes isolated from mouse adult fibroblasts (MAFs) after SILAC 
labeling (Supplemental Figure 2) confirmed that cBID, but not cBIDKKAA, caused a 
significant loss of a comprehensive set of Mic60 peptides in most of the Mic60-containing 
complexes (Figures 1D). 
Since mammalian Mic60 interacts with Mic19 to regulate CJ biogenesis, we also asked 
whether Mic19 assembled and responded to apoptosis like Mic60. In BNGE Mic19 indeed 
formed HMWC migrating like the Mic60-containing ones (Figure 1B) and similarly targeted 
during cristae remodeling (Figures 1C and 1E). In conclusion, Mic60 and Mic19, two critical 
components of the mammalian MICOS, assemble into HMWC that are disrupted during 
apoptotic cristae remodeling. 
 
Mic60 and OPA1 are part of the same complexes targeted during cristae remodeling 
The discovery that Mic60 forms complexes that, like those of OPA1, are eliminated during 
cristae remodeling prompted us to investigate whether the two proteins interact and/or 
are part of the same complexes. To this end, we compared by BNGE and crosslinking 
analysis the migration pattern of Mic60- and OPA1-containing complexes.  Interestingly, 
Mic60 and OPA1 were retrieved in HMWC with similar electrophoretic mobility and 
targeted during cBID induced cristae remodeling (Figure 2A and 2D). Then we turned to 
3-dimension BN-BN-SDS-PAGE that allows the identification of proteins in detergent-
resistant complexes (Figure 2B); immunoblotting of the 3rd dimension SDS gel 
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electrophoresis (SDS-GE) indicated that Mic60 was retrieved in the ~720 kDa OPA1 
containing complex targeted during cristae remodeling (Cogliati et al., 2013) (Figure 2C). 
Indeed, a fraction of Mic60 co-immunoprecipitated with OPA1 (Figure 2E), further 
substantiating their interaction.  
Given the physical interaction between Mic60 and OPA1, we next questioned whether 
both proteins are indispensable for Mic60/OPA1 complexes assembly. For this purpose, 
we turned to a genetic analysis to address the impact of Opa1 acute ablation on Mic60-
containing complexes. Upon adenoviral delivery of CRE recombinase to Opa1flx/flx mouse 
adult fibroblasts (MAFs) loss of Opa1 largely abolished the HMW Mic60 complexes (Figure 
2F, 2H and Supplementary Figure 3A); similarly, silencing of Mic60 lowered the amount of 
OPA1 HMWC (Figure 2G, 2I and Supplementary Figure 3B), indicating that the expression 
of both proteins is required for the formation of the Mic60/OPA1 complexes. In 
conclusion, a fraction of Mic60 exists in complex with OPA1 and the two proteins 
cooperatively form complexes eliminated during cristae remodeling. 
 
Mic60 cooperates with OPA1 to regulate cristae biogenesis 
The genetic and physical interaction between Mic60 and OPA1 prompted us to ask 
whether they regulate together cristae biogenesis and morphology. To this end, first we 
compared by electron microscopy (EM) the density of the cristae and of the CJ in Mic60-
silenced cells, in Opa1-ablated cells, and in cells where we simultaneously silenced Mic60 
and ablated Opa1 (Figures 3A-3B). Mic60 silencing or Opa1 deletion reduced by 25% the 
number of cristae, and by 27% the number of CJ per cristae and 20% the number of CJ per 
mitochondrion (Figure 3C-3E); simultaneous silencing/deletion of these proteins does not 
have an additive effect on these parameters (Figure 3C-3E), suggesting that Mic60 and 
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OPA1 act on the same pathway and calling for an epistatic analysis. The results were 
further supported by quantification of the number of CJ per crista in 3D-reconstructed 
electron tomograms (Figures 6A and 6B).  
When we silenced Mic60 in Opa1tg MAFs, which mildly overexpress OPA1 (Figure 4A), 
cristae number and CJ density decreased, regardless of the higher level of expression of 
OPA1 (Figures 4B-4E). However, overexpression of Mic60 increases cristae and CJ density 
in cells expressing OPA1 but not in Opa1-ablated MAFs (Figure 5A-5D). We conclude that 
cristae biogenesis hinges on a mechanism that involves the formation of OPA1/Mic60 
complexes (Figure 2).  
 
Mic60 does not specify the width of the cristae lumen and of the cristae junction mouth  
To investigate how Mic60 silencing reduces CJ density, we addressed whether Mic60 
specifies the width of the cristae lumen and of the mouth of the CJ. To this goal, we 
returned to the Opa1flx/flx MAFs in which we silenced Mic60 in the presence or absence of 
OPA1 expression and measured these two parameters of the cristae. 
Data showed that in the presence of normal levels of OPA1 expression, Mic60 silencing 
has a modest impact on CLW, increasing by 12% the distance between the opposite sides 
of the IMM that form the crista (Figure 3F). Silencing Mic60 in cells with higher level of 
OPA1 expression (Opa1tg MAFs) does not increase CLW (Figure 4F); consistent with this 
observation, Mic60 overexpression per se also has no effect on CLW (Figure 5F). Taken 
together these findings indicate that Mic60 does not have a direct function on specifying 
the CLW, and that this parameter is uncoupled from the mechanism regulating the 
number of cristae and of the CJ.  
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To study the effect of Mic60 on the width of the CJ mouth, we used electron tomography 
combined with 3D reconstruction in the same set of cells used above. Data show that, 
compared to control cells, acute Opa1 ablation increases the width of the CJ mouth by 
30% (37.74 ± 1.57 nm vs. 51.82 ± 2.20 nm (Figure 6A, 6C). Instead, Mic60 silencing does 
not affect it (37.74 ± 1.57 nm vs. 38.48 ± 1.61 nm; Figure 6C), a finding confirmed by 
experiments showing that Mic60 silencing does not mobilize cyt c (Figure 7C). Consistent 
with these observations, we also found that Mic60 silencing and acute ablation of Opa1, 
together, do not exacerbate the phenotype caused by Opa1 deletion alone (Figures 6A, 
6C and 6E). Thus, under steady-state conditions Mic60 does not have a role in specifying 
the size of the CJ bore, a parameter that, instead, appears to be determined by an Opa1-
mediated mechanism that is uncoupled from CJ biogenesis. This model is supported also 
by data showing that Mic60 is not the rate limiting factor that controls the opening of the 
CJ bore during apoptosis (Figure 7A, 7B). 
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DISCUSSION  
The cristae structure is a key parameter that affects the functional status of mitochondria, 
while it is subjected to dynamic changes in response to the cellular metabolic demands 
and apoptotic triggering efficiency (Hackenbrock, 1966; Mannella et al., 2001; Scorrano 
et al., 2002; Cogliati et al., 2013). The main regulators of cristae architecture known so far 
are the multimers of OPA1, MICOS complex and the dimers of ATP-synthase.  
An open question is whether these machineries are coordinated and whether the same 
mechanisms regulate cristae biogenesis and CLW. Loss of Opa1 impacts on both of these 
structural parameters of the organelle. In this study we show that silencing of Mic60 
impacts on cristae biogenesis but not CLW; also, that Mic60 is a new master regulator of 
cristae biogenesis, and that this process requires the co-expression of Mic60 and OPA1 
for the formation of HMW Mic60/OPA1-containing complexes. By implication, these 
findings support a model where the two events impinge on distinct mechanisms and that 
they can be uncoupled; here, an intriguing possibility would be that OPA1 cooperates with 
dimers of the ATPase to regulate CLW, and with Mic60 to regulate cristae biogenesis. 
Mic60 silencing sensitizes cells to intrinsic pro-apoptotic stimuli (John et al., 2005). Our 
data show that this effect is unlikely due to the fact that such stimuli leads to increased CJ 
bore size because in Mic60-silenced MAFs stimulated with tBID, cyt c is mobilized like in 
mock-silenced control cells. Thus, such increased vulnerability to apoptosis could be 
explained by the fact that loss of Mic60 expression blunts CJ biogenesis and reduces 
mitochondrial respiratory capacity. 
Our data show that Mic19 and Mic60 form HMWC that, on BN-PAGE analysis, have the 
same electrophoretic pattern of migration. These complexes are eliminated during cBID-
induced apoptosis like the Mic60/OPA1-containing complexes raising the possibility that 
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mammalian Mic19 might also regulate mitochondria biogenesis through the OPA1 
pathway. 
In conclusion, we dissected the mechanisms for CJ biogenesis and CLW regulation. 
Mic60/OPA1 complexes are indispensable for CJ biogenesis and are targeted during cBID-
induced apoptosis.  
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EXPERIMENTAL PROCEDURES 
 
Cell culture, Transfection and Molecular Biology 
WT, Opa1flx/flx and Opa1tg SV40 transformed mouse adult fibroblast (MAFs) were 
generated from WT, Opa1flx/flx and Opa1tg mice respectively as previously described 
(Cogliati et al., 2013). Cell lines were maintained in Dulbecco’s Modified Eagle Medium 
(DMEM, Invitrogen) supplemented with 10% FBS (Invitrogen), 2 mM Glutamine, 50 U/ml 
Penicillin, 50 μg/ml Streptomycin, 50 μg/ml Uridine, and 0.1 mM non-essential 
aminoacids (Invitrogen). When indicated, glucose was substituted with 0.9 mg/ml 
galactose (Sigma).  
Acute OPA1 ablation in Opa1flx/flx MAFs was obtained by infection with adenovirus 
expressing cytomegalovirus (CMV)-Cre-GFP (Ad-CRE-GFP: 200 pfu/cell). CMV-GFP (Ad-
GFP) expressing adenoviruses was used as control (Vector Biolabs). Experiments were 
performed 48 hr after infection. 
pcDNA6.2-hMic60-V5 vector (human, transcript variant 1 DNA NM_006839.1, subcloned 
by gateway technology from pCMV6-AC donor plasmid to pDEST-V5) was used for Mic60 
overexpression. Lipofectamine was used as transfection reagent following manufacturer’s 
instructions. 
For RNAi experiments, Oligofectamine was used as transfecting reagent and the sequence 
of the siRNA for Mic60 used was the following: 5’- GAACAAAUGGACAGCUUUA-3’. Silencer 
Negative Control siRNA (Ambion, Life technologies) was used as negative control.  
 
 
Recombinant Protein Expression 
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p7/p15 recombinant BID (wild type and mutant) was produced, purified and cleaved with 
caspase-8 as previously described (Frezza et al., 2006).  
 
Mitochondrial isolation and in vitro assays 
Mitochondria from Mouse Adult Fibroblasts (MAFs) and mouse liver and heart tissues 
were isolated by standard differential centrifugation as previously described (Frezza et al., 
2007; Fernandez-Vizarra et al., 2010). 
Mitochondrial treatment with cBID and cBIDKKAA at the concentration indicated in the 
Figure legends were performed in Experimental Buffer (EB) (1 mg/ml) containing 150 mM 
KCl, 10 mM Tris Mops, 10 μM EGTA-Tris, 1 mM Pi, with 5 mM glutamate/ 2.5 mM malate 
as respiration substrate, pH 7.4, 25°C.  
 
BN-PAGE and 3D BN-BN-SDS gel electrophoresis (BN-BN-SDS-PAGE) 
Blue-Native PAGE (BN-PAGE) analysis was done from samples prepared as indicated here. 
Isolated mitochondria from liver (250 μg), heart (250 μg) or MAFs (150 μg) previously 
treated or not as indicated in the figure legends, were resuspended in 50 μl Native 
solubilization buffer (NB) containing Native Page buffer 4X (Invitrogen), 1.25% digitonin 
and 1:100 protease inhibitor cocktail (PIC, SIGMA). After 10 min on ice the samples were 
centrifuged at maximal speed in a table bench centrifuge at 4°C. Supernatants were 
transferred into a new tube and 2 μl of 5% Coomassie G-250 (Invitrogen) was added 
before being loaded onto a precast NativePAGE 3-12% Bis-Tris Gel (Invitrogen) for 
biochemical experiments. Electrophoresis was performed in the presence of cathode 
(dark blue cathode: 45 min; light blue cathode: 90 min) and anode buffers prepared 
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following Invitrogen manufacturing instructions. When indicated, protein complexes 
were blotted onto a PVDF membrane and probed for the indicated antibodies.  
Second BN-PAGE was performed by excising and casting the lane obtained from the first 
BN-PAGE on a single-well native gel (NuPAGE Novex 4-12% Bis-Tris ZOOM gel, Invitrogen). 
In the cathode buffers used 0.02% n-Dodecyl-D-maltoside (DDM, SIGMA) was added. 
Electrophoresis was performed at 125 V for 1 hr 30 min using dark cathode buffer and at 
150 V, overnight using with light cathode buffer. During 2D BN-BN-PAGE, complexes 
resistant to detergent are aligned in a diagonal easily identified by Coomassie contained 
into the running samples.  
The third dimension SDS-PAGE was performed after excising the diagonal and incubating 
it with reducing solutions RSa for 10 min, RSb for 7 min and RSc for 12 min, in order to 
facilitate the complexes dissociation during the 3D SDS (RSa=1x LDS sample buffer 
(Invitrogen), 4% β-mercaptoethanol, RSb=1x LDS sample buffer (Invitrogen), 1% N N-
dimethylacrylamide (DMA, SIGMA) and RSc=1x LDS sample buffer (Invitrogen), 20% 
ethanol and 0.1% β-mercaptoethanol). After the treatment, the diagonal was loaded onto 
a gel (NuPAGE Novex 4-12% Bis-Tris ZOOM gel, Invitrogen) and run under denaturating 
conditions to separate the individual proteins that were then transferred onto 
polyvinylidene fluoride (PVDF) membranes and stained with the indicated antibodies.  
 
BN-PAGE based semi-quantitative proteomic analysis 
Mitochondrial proteins from two mouse hearts were solubilized as described above. Blue 
Native Electrophoresis (BN-PAGE) was used to separate the native membrane complexes 
in a homemade gradient gel from 4% to 13% acrylamide, 20 x 20 cm, for control samples 
and for samples treated with cBID or cBIDKKAA (1 mg of protein per sample). The 
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electrophoresis was performed as described for the 1st dimension BN-PAGE. 
Subsequently, gels were stained using GelCode Blue Stain Reagent (Thermo Scientific). 
Each lane was divided and excised in 26 bands covering the whole electrophoretic run. 
Gel pieces were then digested with modified porcine trypsin (Promega) at a final ratio 
1:20 (trypsin-protein). Digestion proceeded overnight at 37ºC in 100 mM ammonium 
bicarbonate, pH 8.8. The resulting tryptic peptide mixtures were subjected to nano-liquid 
chromatography coupled to mass spectrometry (LC-MS) for protein identification. 
Peptides were injected onto a C-18 reversed phase (RP) nano-column (75 μm I.D. and 50 
cm, Acclaim PepMap100, Thermo Scientific) and analyzed in a continuous acetonitrile 
gradient consisting of 0-30% B in 240 min, 50-90% B in 3 min (B=90% acetonitrile, 0.5% 
acetic acid). A flow rate of ca. 200 nL/min was used to elute peptides from the RP nano-
column to an emitter nanospray needle for real time ionization and peptide 
fragmentation on an Orbitrap Fusion mass spectrometer (Thermo Fisher, San José, CA, 
USA). For protein identification, tandem mass spectra were extracted and charge state 
deconvoluted by Proteome Discoverer 1.4.0.288 (Thermo Fisher Scientific). All MS/MS 
samples were analyzed using SEQUESTTM (Thermo Fisher Scientific). 
 
SILAC labelling and quantitative proteomic analysis 
Mouse adult fibroblasts (MAFs) were grown separately in DMEM medium containing 4.5 
g/L glucose, 2 mM glutamine, 10% fetal bovine serum (FBS), 50 U/ml Penicillin, 50 mg/ml 
Streptomycin, 50 mg/ml Uridine and Phenol Red supplemented with either light L-Lysine 
and L-Arginine or heavy [U-13C6]-L-Lysine HCl and [U-13C6]-L-Arginine (100 mg/L of each 
amino acid) (SILAC Protein Identification and Quantification Media Kit, Invitrogen). After 
6 doublings cell subpopulations, light and heavy, were harvested and mitochondria were 
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isolated separately. In experiment “a” light mitochondria were treated with 20 pmol/mg 
cBID for 30 min in EB, and heavy mitochondria were untreated. After centrifugation at 
10000 x g, 10 min, 4°C, the pellets from both samples were mixed and resuspended 
together in NB indicated above. In experiment “b”, light mitochondria were untreated 
while heavy mitochondria were treated with 20 pmol/mg cBIDKKAA for 30 min, 25°C. After 
centrifugation the samples were mixed and processed as in experiment “a” before 
proceeding with the BN-PAGE. Protein complexes (500 μg) from experiments “a” and “b” 
were loaded in parallel lanes and complexes were separated by BN-PAGE electrophoresis. 
Three lanes from experiment “a” and “b” were stained with Coomassie and bands 
between 600 and 1000 kDa were excised with a scalpel and digested with trypsin. 
Digestion proceeded overnight at 37ºC in 100 mM ammonium bicarbonate, pH 8.8. The 
resulting tryptic peptide mixtures were subjected to nano-liquid chromatography coupled 
to mass spectrometry (LC-MS) for protein identification. Peptides were injected onto a C-
18 reversed phase (RP) nano-column (75 mm I.D. and 50 cm, Acclaim PepMap100, Thermo 
Scientific) and analyzed in a continuous acetonitrile gradient consisting of 0-30% B in 240 
min, 50-90% B in 3 min (B=90% acetonitrile, 0.5% acetic acid). A flow rate of ca. 200 nL/min 
was used to elute peptides from the RP nano-column to an emitter nanospray needle for 
real time ionization and peptide fragmentation on a Q Exactive mass spectrometer 
(Thermo Fisher, San José, CA, USA). For protein identification, tandem mass spectra were 
extracted and charge state deconvoluted by Proteome Discoverer 1.4.0.288 (Thermo 
Fisher Scientific). All MS/MS samples were analyzed using SEQUESTTM (Thermo Fisher 
Scientific). Change in protein abundance in the studied complexes was considered when 
log (light/heavy) was > 1.2 or < -1.2 after treatment. 
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Biochemistry  
Chemical crosslinking was performed by incubating mitochondria (0.5 mg/ml) with 10 mM 
(bismaleimidohexane) (BMH, PIERCE) in EB after the indicated treatments under the 
indicated experimental conditions. After 30 min the reaction was quenched with β-
mercaptoethanol and mitochondria were spun at 12000 rpm, 10 min, 4°C. Then, the pellet 
was solubilized in laemmli buffer 2X and boiled to proceed with protein separation by in 
a 3-8% Tris-Acetate SDS-PAGE. 
Protein levels of Mic60, OPA1, Fb, Mic19, Grp75 or actin were studied after lysis of 
mitochondria or cells with Ripa buffer in presence of proteases inhibitors, 30 min, 4°C. 
After centrifugation at maximal speed for 30 min, protein concentration was determined 
with Bradford reagent (Bio-Rad). The proteins were separated under denaturing 
conditions in 3 8% Tris-Acetate (NuPage, Invitrogen) or 7.5% Tris-Glycine (BioRad) gels, 
transferred onto PVDF membranes (Millipore) and probed using anti-Mic60 polyclonal 
(1:1000, Proteintech), anti-OPA1 monoclonal (1:1000, BD PharMingen), anti-Fp 
(Flavoprotein subunit of succinate dehydrogenase, complex-II) monoclonal (1:1000, 
Abcam), anti-Grp75 polyclonal (1:2000, Santa Cruz), anti-Mic19 polyclonal (1:1000, 
Proteintech), actin (1:15000, Millipore) antibodies. Isotype matched secondary antibodies 
were conjugated to horseradish peroxidase and chemiluminescence was detected with 
ECL (Amersham) using either traditional methods with films (Amersham) or Image Quant 
LAS 4000 (GE Healthcare Life Sciences). 
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Transmission Electron Microscopy, Tomographic Reconstruction, and Mitochondrial 
Morphometry 
Scramble and Mic60-silenced cells were fixed and processed after 48 hr from transfection. 
In the case of cells infected with Ad-EV or Ad-CRE, and cells infected with retrovirus 
expressing tBID, cells were sorted after 24 hr to select GFP positive cells that were seeded 
and fixed for electron microscopy imaging after 48 hr from infection. For overexpression 
experiments the cells were co-transfected with mtRFP and pDEST-Mic60-V5, and after 24 
hr cells were sorted, and RFP positive cells were seeded in 12 wells plates. After 48 hr 
from the transfection cells were fixed for electron microscopy imaging. 
Cells were fixed for 1 hr at 25°C with glutaraldehyde at a final concentration of 1.25% 
(V/V), post-fixed in 1% OsO4, 1.5% K4Fe(CN)6 in 0.1 M sodium cacodylate pH 7.4, stained 
with 0.5% uranyl acetate, dehydrated in ethanol and embedded in Embed 812.  
For electron tomography, 200-250 nm thick sections were collected on formvar-coated 
copper slot grids and gold fiducials (10 nm) were applied on both surfaces of the grids. 
The samples were imaged in a 200 kV Tecnai G2 20 electron microscope (FEI, Eindhoven, 
The Netherlands) at magnification of 25k or 29k resulting in a pixel size of 0.92 nm and 
0.77 nm respectively. Tilted images (+65/-65 according to a Saxton scheme with a starting 
angle of 1.5°) were acquired using Xplorer 3D (FEI, Eindhoven, The Netherlands) with an 
Eagle 2k × 2k CCD camera (FEI, Eindhoven, The Netherlands). Tilted series alignment and 
tomography reconstruction was done with IMOD (Mastronarde, 1997) and segmentation 
and  3D rendering were done with the Reconstruction software (Fiala, 2005). 
Measurements were made by using the software ImageJ and for quantification the z scale 
was stretched with a factor of 1.6 to correct for resin shrinkage (Mastronarde, 1997) 
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Quantitative analysis of the cristae width was performed in electron microscopy images 
with magnification x59000 and by using the Image J software. A number of 3-6 cristae per 
mitochondrion were measured from cells infected with Ad-EV and transfected with 
pcDNA6.2 empty vector (n=233), pcDNA6.2-hMic60-V5 (n=228), scramble siRNA (n=256), 
Mic60 siRNA (n=261), and from cells infected with ad-CRE and transfected with pcDNA6.2 
empty vector (n=169), pcDNA6.2-hMic60-V5 (n=195), scramble siRNA (n=172), Mic60 
siRNA (n=146) 
Quantitative analysis of cristae and cristae junction number per mitochondrion were done 
by using x46000 or x 59000 magnification EM images, in blind by two different operators. 
The sample size is indicated in the figure legend.   
 
Evolution analysis 
Multiple sequence alignment was performed using ClustalW. 
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FIGURE LEGENDS 
Figure 1. Mic60-complexes distribution is altered during cBID-induced cristae 
remodeling  
A. Amino acid sequence alignment of the transmembrane helix of yeast and human 
Mic60, depicting the extent of conservation. Identical amino acids are marked with 
asterisk (*); strongly similar amino acids are marked with colons (:); weekly similar amino 
acids are marked with (.); non conserved amino acids are not marked ( ). The coiled-coil 
domains are highlighted. 
B. BN-PAGE analysis of complexes extracted from mouse liver or heart mitochondria (125 
μg each), transferred onto PVDF membrane and probed with anti-Mic60 or anti-Mic19 
antibodies. 
C. Coomassie staining after BN-PAGE (left panel) of complexes (500 μg) extracted from 
mouse heart mitochondria, untreated (control) or after 20 min of treatment with cBID or 
cBIDKKAA (30 pmol x mg-1 protein) in Experimental buffer (EB). Gel bands were cut following 
the pattern and size indicated with black vertical lines in the Coomassie panel that were 
then analyzed by mass spectrometry. Color-contour plots show the number of peptides 
from Mic60 (middle panel) or Mic19 (right panel) identified by mass spectrometry along 
the BN-PAGE from high (top) to low (bottom) molecular weight. The color code represents 
the peptides’ abundance in each complex either for Mic60 or Mic19 (color scale legend 
on the right of each panel).  
D. Coomassie stained BN-PAGE (left panel) and heat map of samples from SILAC 
experiments “a” and “b” (right panel). Heat map shows the changes in intensity (number 
of peptides) of Mic60 peptides (#1-4) after the indicated treatments normalized to the 
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respective internal control. Color code defines a decrease (green) or increase (red) in 
peptides intensity of treated vs. control sample. 
E. Heat map representation of quantitative changes in Mic19 peptides (#1-3) after the 
indicated treatment vs. the control. Color code defines a decrease (green) or increase 
(red) in peptides intensity of treated versus control sample. Three different samples were 
included in the analysis.  
 
Figure 2. Mic60-OPA1 complexes are targeted by cBID  
A. BN-PAGE of protein complexes (125 μg) extracted from mouse liver mitochondria (250 
μg), untreated or after 30 min treatment with wild type cBID or cBIDKKAA. The gels were 
blotted onto PVDF membranes before probing with the indicated antibodies. Anti-Fp was 
used as protein loading control. 
B. Schematic representation of three dimensional BN-BN-SDS-PAGE analysis of membrane 
complexes isolated from mouse liver mitochondria. DIG: digitonin, DDM: n-Dodecyl-D-
maltoside. 
C. Western blotting of third dimensional SDS PAGE using anti-OPA1 or anti-Mic60 
antibodies.  
D. Chemical crosslinking with BMH of isolated mitochondria from Opa1flx/flx MAFs 
untreated or treated for 15 min with cBID (20 pmol x mg-1) in EB. Where indicated 5 mM 
BMH was added. Equal amounts of proteins (25 μg) were separated in Tris-Acetate 3-8% 
PAGE and transferred onto PVDF membrane before immune-detection with the indicated 
antibodies.  
E. Mic60 and OPA1 co-immunoprecipitate.  Mitochondrial lysates (125 μg) obtained from 
mouse embryonic fibroblasts were immuno-precipitated with anti-OPA1 antibody and 
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bound proteins were separated electrophoretically, blotted and immuno-detected with 
ant-OPA1 and anti-Mic60 antibodies. The Input lane contains 25 μg of the initial 
mitochondrial lysate and the unspecific immune-reactivity between lysate and beads is 
contained in the IP-IgG lane. 
F. BN-PAGE analysis of protein complexes extracted from Opa1flx/flx MAFs mitochondria 
(150 μg) after 48 hr of infection with adenoviruses expressing the indicated insert (Ad-EV, 
empty vector; Ad-CRE, Cre recombinase). Protein complexes were blotted onto PVDF 
membrane and immuno-detected with the indicated antibodies. The same samples were 
run in parallel in the same gel and stained with Coomassie to compare protein loading 
(left panel).  
G. BN-PAGE analysis of protein complexes extracted from Opa1flx/flx MAFs mitochondria 
(150 μg) after 48 hr from transfection with scramble (scr) or Mic60 siRNA oligos. Protein 
complexes were immuno-detected after blotting with the indicated antibodies. Anti-Fp 
was used as protein loading control. 
H. Chemical crosslinking with 5 mM BMH of isolated mitochondria from Opa1flx/flx MAFs 
after 48 hr of infection with adenoviruses expressing the indicated insert (EV, empty 
vector; CRE, Cre recombinase). Equal amounts (25 μg) of proteins were separated in Tris-
Acetate 3-8% PAGE and transferred onto PVDF membrane before immuno-detection with 
anti-Mic60 antibody.  
I. Chemical crosslinking with 5 mM BMH of isolated mitochondria from Opa1flx/flx MAFs 
after 48 hr of transfection with scramble (scr) or Mic60 siRNA oligos. Equal amounts (25 
μg) of proteins were separated by SDS-PAGE and transferred onto PVDF membrane 
before immuno-detection with anti-OPA1 antibody.  
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Figure 3. Mic60 silencing reduces cristae and CJ density  
A. Mic60 and OPA1 protein levels in Opa1flx/flx MAFs transfected with scramble (scr) or 
Mic60 siRNA and after 16 hr infection with the indicated adenoviruses (Ad-EV-GFP or Ad-
CRE-GFP). After 32 hr of infection, cells were lysed and equal amounts of proteins (25 μg) 
were loaded onto an SDS-PAGE, transferred to PVDF membrane and probed with the 
indicated antibodies. Fp protein served as protein loading control. Changes in protein 
expression were quantified by densitometry analysis by normalizing to Fp protein levels. 
Infection efficiency with the indicated adenoviruses was around 80% after counting GFP-
positive cells respect to the total with a Laser Spinning Disk Confocal Andromeda (data 
not shown). 
B. Electron micrographs of mitochondria from Opa1flx/flx MAFs in the experimental 
conditions described in Figure 3A. Cells were sorted for GFP-positive cells, fixed and 
processed for EM analysis. Scale bars represent 200 nm. 
C. Quantification of cristae number per mitochondrion in 70 randomly selected 
mitochondria from each indicated experimental condition. Data represent the mean ± 
SEM of four independent experiments. Paired sample t-test *** p<0.001. 
D. Quantification of CJ number per crista in 143 randomly selected cristae from each 
indicated experimental condition. Data represent the mean ± SEM of four independent 
experiments. Paired sample t-test *** p<0.001. 
E. Quantification of CJ number per mitochondrion in 70 randomly selected mitochondria 
from each experimental condition. Data represent average ± SEM of four independent 
experiments. Paired sample t-test *** p<0.001. 
F. Morphometric analysis of cristae lumen width, CLW, in 60 randomly selected 
mitochondria from each experimental condition. Data represent average ± SEM of four 
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independent experiments (n=120-170 cristae in each condition). Paired sample t-test *** 
p<0.001. 
 
Figure 4. OPA1 overexpression protects from cristae widening but not from loss of 
cristae and CJ density during Mic60 silencing 
A. OPA1 and Mic60 protein levels in wt and Opa1tg MAFs.  Protein samples (25 μg) were 
separated in a Tris-Acetate 3-8% PAGE, blotted onto a PVDF membrane and probed with 
the indicated antibodies. Actin was used as protein loading control. The same procedure 
was followed to detect protein expression levels in wt and Opa1tg MAFs 48 hr post-
transfection with scramble (scr) or Mic60 siRNA oligos. Changes in protein expression 
were quantified by densitometry analysis and normalized to actin protein levels. 
B. Electron micrographs of mitochondria. WT and Opa1tg MAFs were transfected with 
scramble (scr) or Mic60 siRNA oligos and after 48 hr they were fixed to be processed for 
electron microscopy. The scale bars represent 200 nm.  
C. Quantification of cristae number per mitochondrion in 40 randomly selected 
mitochondria in the indicated experimental condition. Data represent average ± SEM of 
three independent experiments. Paired sample t-test *** p<0.001. 
D. Quantification of CJ number per crista in 40 randomly selected cristae in the indicated 
experimental condition. Data represent average ± SEM of four independent experiments. 
Paired sample t-test *p<0.05. 
E. Quantification of CJ number per mitochondrion in 40 randomly selected mitochondria 
in the indicated experimental condition. Data represent average ± SEM of four 
independent experiments. Paired sample t-test *** p<0.001. 
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F. Morphometric analysis of cristae lumen width in 40 randomly selected mitochondria in 
each experimental condition. Data represent average ± SEM of three independent 
experiments. Paired sample t-test *** p<0.001. 
 
Figure 5. Mic60 overexpression increases the number of cristae and CJ only in presence 
of OPA1  
A. Electron micrographs of mitochondria from Opa1flx/flx MAFs infected with the indicated 
adenoviruses (Ad-EV-GFP or Ad-CRE-GFP). 16 hr post-infection cells were co-transfected 
with mt-RFP and Mic60-V5 or empty vector (EV). Then, cells were sorted for RFP –positive 
cells 24 hr post-transfection and seeded in new plates. After 16 hr, cells were fixed to be 
processed for EM analysis. Scale bars represent 500 nm or 2 μm, as indicated. Infection 
efficiency with the indicated adenoviruses was around 80% after counting GFP-positive 
cells respect to the total with a Laser Spinning Disk Confocal Andromeda. 
B. Quantification of cristae number per mitochondrion in 30 randomly selected 
mitochondria from each experimental condition. Data represent average ± SEM of three 
independent experiments. Paired sample t-test *p<0.05. 
C. Quantification of CJ number per crista of 143 randomly selected cristae from each 
experimental condition. Data represent average ± SEM of three independent 
experiments. Paired sample t-test *** p<0.001; ** p<0.01. 
D. Quantification CJ number per mitochondrion in 30 randomly selected mitochondria 
from each experimental condition. Data represent average ± SEM of three independent 
experiments. Paired sample t-test *** p<0.001; *p<0.05. 
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E. Morphometric analysis CLW in 30 randomly selected mitochondria from each 
experimental condition. Data represent average ± SEM of three independent 
experiments. Paired sample t-test *** p<0.001; ** p<0.01. 
 
Figure 6. Mic60 does not regulate CJ mouth width in steady state 
A. Rotations of surface-rendered views of tomographic reconstructions of 
mitochondria from Opa1flx/flx MAFs in the indicated experimental conditions treated and 
processed as indicated in Figure 3A-B. Inner membrane is depicted in orange and cristae 
compartment in cyan. Outer membrane has been peeled out to highlight CJ.  
B. Quantification of CJ number per cristae in the indicated experimental conditions 
described in (A). Data represent average ± SEM of three independent experiments (4 to 9 
different tomograms for each experimental condition). Paired sample t-test *** p<0.001. 
C.-D. Quantification of CJ mouth width in the indicated experimental conditions described 
in (A). Data represent average ± SEM of three independent experiments (4 to 9 different 
tomograms for each experimental condition). Paired sample t-test *** p<0.001; ** 
p<0.01. 
 
Figure 7. Mic60 has no effect in widening the CJ mouth and cytochrome c release during 
apoptosis 
A. Electron micrographs (left panel) and rotations of surface-rendered views of 
tomographic reconstructions (right panel) of mitochondria from Opa1flx/flx MAFs infected 
with the retrovirus pMIG-tBid and transfected with the indicated siRNAs. For EM the scale 
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bars represent 200 nm. In tomographs inner membrane is depicted in orange and cristae 
compartment in cyan. Outer membrane has been peeled out to highlight CJ.  
B. Quantification of CJ mouth width in the indicated experimental conditions. Data 
represent average ± SEM of three independent experiments. Paired sample t-test *** 
p<0.001; ** p<0.01. 
C. Ascorbate/TMPD-driven respiration ratio of mitochondria isolated from Opa1flx/flx 
MAFs transfected with scramble (scr) or Mic60 siRNA oligos. As positive control of 
cytochrome c mobilization, mitochondria were treated with recombinant cBID (10 pmol x 
mg-1 protein). Data represent average ± SEM of three independent experiments.  
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Mammalian mitochondria cristae biogenesis is regulated by Mitofilin (Mic60)-OPA1 
complexes that are eliminated during apoptosis 
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Supplementary experimental procedures 
Virus production and infection 
The retroviral expression vector MSCV-IRES-GFP containing truncated BID (pMIG-tBid) 
was used to generate amphotropic retrovirus expressing tBID as described previously 
(Cogliati et al., 2013). 24 hr post infection the GFP-positive cells were sorted and after 48 
hr they were fixed and processed for EM he efficiency of transduction was around 80-90% 
estimated by counting GFP positive cells with an epifluorescence microscope. 
Experiments were performed 48 hr after infection. 
 
In Vitro Mitochondrial Assays 
Ascorbate/TMPD-driven respiration was determined as previously described by Scorrano 
and coworkers (Scorrano et al., 2002).  
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Supplemental figure legends 
Supplemental Figure 1. 
A. Multiple amino acid sequence alignment of the predicted Mic60 transmembrane 
helix of vertebrates (upper panel) and mammals (lower panel), depicting the extent of 
conservation. Identical amino acids are marked with asterisk (*); strongly similar amino 
acids are marked with colons (:); weekly similar amino acids are marked with (.); non 
conserved amino acids are not marked ( ). The coiled-coil domains are highlighted. 
Conserved clusters of glycine residues are underlined in red.   
B. Organization and alignment of the predicted protein domains of Mic60 
homologues from yeast to human.  
 
Supplemental Figure 2. Schematic representation of SILAC experiment workflow. 
Experiment “a” contains complexes extracted from control and cBID treated 
mitochondria isolated from mouse adult fibroblasts (MAFs) grown in a medium containing 
heavy or light amino acids respectively. Experiment “b” contained complexes extracted 
from control (light) and cBIDKKAA treated (heavy) mitochondria. After BN-PAGE, Coomassie 
stained bands from 500 to 1048 kDa were excised and analyzed by qualitative and 
quantitative mass spectrometry. 
 
Supplemental Figure 3.  
A.B. Equal amounts of proteins (40 μg) from Opa1flx/flx MAFs infected with the indicated 
adenovirus (Ad-EV or Ad-CRE) were separated in Tris-Acetate 3-8% PAGE and 
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immunoblotted with the indicated antibodies. Fp protein was used as protein loading 
control. 
C. Mic60 protein levels of cellular lysates from Opa1flx/flx MAFs 48 hr post-transfection with 
scramble (scr) or Mic60 siRNA oligos. siRNA #1, #2 and #3 represent three different siRNA 
oligos.  
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2.3. Nitric Oxide-Associated 1 (NOA1) is part of the OPA1-containing 
complexes targeted during cell death 
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Abstract 
Apoptotic cristae remodeling is controlled by heteromeric complexes containing Optic 
Atrophy 1 (OPA1) and disrupted by apoptotic stimuli. Composition of these complexes 
and the role of the OPA1 partners in controlling cristae shape are unclear. Here we 
identify nitric oxide-associated 1 (NOA1) as a member of OPA1-containing complexes 
targeted during apoptosis and cooperating with OPA1 in cristae shape regulation. 
Complexomic analysis retrieved NOA1 in heart mitochondria OPA1 containing 
complexes disrupted upon cristae remodeling. The OPA1-NOA1 interaction was 
confirmed biochemically and genetically. NOA1 genetic ablation causes mitochondrial 
fragmentation and cristae disorganization, corrected by NOA1 re-introduction as well 
as by OPA1 overexpression, supporting the OPA1 and NOA1 crosstalk in cristae shape 
morphogenesis. Functionally, NOA1 ablation phenocopies the effect of OPA1 deletion 
on respiratory complexes assembly, oxidative phosphorylation, apoptosis and 
mitochondria-dependent cell growth. Thus NOA1 cooperates with OPA1 in the 
regulation of mitochondrial function and ultrastructure during life and death of the cell.  
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Introduction 
Mitochondria are key organelles for energy production, intermediate metabolism, 
calcium signaling, developmental control and last but not least programmed cell death 
(Dimmer and Scorrano, 2006). Their multiplicity of functions is reflected by their 
extremely complex structure, compartmentalization and dynamic organization. 
Mitochondria possess the outer mitochondrial membrane (OMM), that separates them 
from the cytosol, and the inner mitochondrial membrane (IMM) that encloses the matrix 
and constitutes the site of oxidative phosphorylation. The IMM can be further subdivided 
into two different compartments, the inner boundary membrane (IBM) and the cristae, a 
network of tubules and lamellae connected to the IBM by narrow tubular structures called 
cristae junctions. Dynamic changes in shape contribute to specific mitochondrial 
functions, such as apoptosis amplification (Vogel et al., 2006; Scorrano et al., 2002). 
“Cristae remodeling” indeed describes a set of morphological alterations that occur early 
after apoptotic stimulation and favor the mobilization of the cristae-endowed cytochrome 
c to the intermembrane space and eventually to the cytosol, thereby maximizing the 
efficiency of the intrinsic apoptotic pathway (Scorrano et al., 2002).  
Optic Atrophy 1 (OPA1) is a mitochondrial shaping protein which controls cristae shape 
and remodeling by forming high molecular weight (HMW) complexes in the cristae to 
maintain them tight under physiological conditions. Upon apoptotic stimuli, OPA1-
containing HMW complexes are disrupted with concomitant enlargement of the cristae 
junctions and cytochrome c release (Frezza et al., 2006; Cogliati et al., 2013). Little is 
known on the formation of these HMW, except that both the membrane anchored and 
the soluble forms of OPA1 are needed (Cipolat et al., 2006; Frezza et al., 2006). We 
therefore performed comprehensive proteomic analyses of native liver, fibroblast and 
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heart mitochondrial complexes identifying multiple OPA1 interactors that are targeted 
during apoptosis (Soriano & Glytsou et al., in preparation).  
Among the OPA1 partners we identified a mitochondrial GTPase christened Nitric Oxide-
Associated 1 (NOA1), a highly conserved protein across bacteria and eukaryotes. NOA1 
belongs to the circularly permutated GTPase family (Sudhamsu et al., 2008), but its exact 
molecular action in eukaryotes is still obscure. Its bacterial orthologue, YqeH, along with 
other members of its protein superfamily are required for proper ribosome biogenesis 
and assembly (Loh et al., 2007; Uicker et al., 2007; Anand et al., 2009). In eukaryotes, 
NOA1 contains a classical mitochondrial targeting sequence (MTS) (Zemojtel et al., 2006), 
but also a classical bipartite nuclear localization signal (Al-Furoukh et al., 2014). In yeast, 
the NOA1 orthologue YOR205C (alternative names: mitochondrial GTPase MTG3, AIM40, 
GEP3, FMP38) is important for the correct assembly of the small mitoribosomal subunit, 
efficient respiration, and mtDNA stability (Paul et al., 2012). Two genetic interactome 
studies in yeast identified it as a genetic interactor of prohibitins, essential scaffolds that 
modulate mitochondrial cristae organization (Osman et al., 2009b). Yeast strains lacking 
YOR205C display decreased cardiolipin and PE levels (Hoppins et al., 2011; Osman et al., 
2009a), and Noa1 deletion in mice results in lethality at midgestation. Functional studies 
in mammalian cells suggested that NOA1 is required for mitochondrial protein synthesis, 
ATP production and apoptosis. However, the mechanism by which NOA1 impacts on 
mitochondrial functions is still undefined.  
Here we unravel the physical and functional interaction between OPA1 and NOA1. Our 
data indicate that NOA1, like OPA1, is essential for mitochondrial structure, function and 
mitochondria-dependent cell growth.  
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Results 
NOA1 and OPA1 are retrieved in the same HMW complexes targeted during apoptosis 
Three dimensional BlueNative (BN)-BN-SDS PAGE followed by LC/MS analysis in normal 
and apoptotic mouse liver mitochondria revealed a list of candidate proteins that 
quantitatively change in OPA1-containing complexes during apoptosis (Soriano et al., in 
preparation). Among the identified proteins whose levels are significantly reduced in 
apoptosis, our attention was caught by a protein christened nitric oxide associated 1 
(NOA1). BN-PAGE of digitonin solubilized mitochondrial complexes (Fig. 1A) followed by 
trypsinization, liquid chromatography (LC) and mass spectrometry (MS) allowed us to 
localize OPA1 and NOA1 in the same complexes in mouse heart, brain and a cell line, FC57 
(Fig. 1B). Thus, targeted MS/LC analysis provided further evidence that NOA1 and OPA1 
are found in two common macromolecular assemblies, which correspond to the spots 13-
15 (approximate molecular weight 700-500kD) and 19-24 (approximate molecular weight 
380-240kD). These MS data prompted us to verify biochemically whether OPA1 and NOA1 
share the same complexes. First, we confirmed that overexpressed V5-tagged NOA1 and 
OPA1 could be crosslinked in a complex that is disrupted upon cristae remodeling 
induction by recombinant caspase-8 cleaved BID (cBID) (Frezza et al., 2006) (Fig. 1C, 
arrows). Second, V5-tagged NOA1 expressed in mouse embryonic fibroblasts (MEFs) could 
pull-down OPA1 (Fig. 1D). Third, endogenous OPA1 and NOA1 could be 
immunoprecipitated (Fig. 1E). Thus OPA1 and NOA1 are retrieved in the same complexes 
and physically interact.  
 
mNOA1 resides predominately in the mitochondrial intermembrane space 
Given the dual targeting sequences present in mammalian NOA1, we wished to verify if 
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and where it resided in mitochondria. Confocal imaging indicated that endogenous Noa1 
co-localized with the mitochondrial marker Tim23 in HeLa cells (Bergmann’s co-
localization 78.1%, SEM 0.02, Supplementary Fig. S1A), without being detected into the 
nucleus in steady state conditions. Carbonate extraction in purified mouse liver 
mitochondria showed that mNOA1 is a peripherally associated membrane protein 
(Supplementary Fig. S1B). In order to examine NOA1 submitochondrial localization, we 
performed Proteinase K (PK) accessibility assay. The pattern of NOA1 was superimposable 
to that of OPA1 (Supplementary Fig. S1C), indicating that they share their localization in 
the IMS. Overall, NOA1 is a mitochondrial protein peripherally associated to the IMM 
facing the IMS.  
 
NOA1 and OPA1 genetically interact  
We next aimed to shed more light on the genetic relationship between the two proteins. 
To this end, we capitalized on Noa1-/- MEFs (Kolanczyk et al., 2011). Immunoblotting 
confirmed that NOA1 was absent in Noa1-/- MEFs. When we probed the same lysates for 
OPA1, we surprisingly observed an increase of OPA1 levels. This upregulation was specific, 
because OPA1 levels turned back to normal when NOA1 was reintroduced (Fig. 1F). The 
OPA1 upregulation was due to an increase in its transcript levels as indicated by 
quantitative real-time PCR (Fig. 1G). Reciprocally, NOA1 was absent in Opa1-/- MEFs, and 
its levels turned back to normal upon OPA1 re-introduction (Fig. 1H). Taken together, 
these data indicate that OPA1 and NOA1 interact also genetically. 
 
NOA1 deficiency alters mitochondrial shape and ultrastructure 
Since NOA1 and OPA1 physically and genetically interact, we next analyzed whether 
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changes in NOA1 levels altered mitochondrial morphology and ultrastructure. 3D-
reconstructions of z-stacks of confocal images of wt and Noa1-/- MEFs expressing 
mitochondrial targeted dsRED (mtRFP) showed that mitochondria of Noa1-/- MEFs were 
50% shorter than their wild type counterparts (Fig. 2A,B).  
Mitochondrial fragmentation was accompanied by ultrastructural derangements with 
concentric cristae structures, as indicated by electron microscopy (EM) (Fig. 2C). Noa1-/- 
mitochondria were characterized by increased cristae width lumen (maximal cristae width) 
and fewer cristae junctions (Fig. 2D,E), suggesting that NOA1 participates like OPA1 in 
cristae junction biogenesis and organization. Additional morphometric analysis confirmed 
that mitochondria lacking NOA1 were smaller (Fig. 2F), and that cristae surface to 
mitochondrial area ratio was increased (Fig. 1G). These phenotypes were specific, because 
they were corrected by NOA1 reintroduction in Noa1-/- MEFs (Fig. 1H, I). Interestingly, 
overexpression of OPA1 in cells lacking NOA1 corrected the aberrant mitochondrial 
ultrastructure at a similar extent as upon NOA1 re-introduction (Fig. 1H and 1I), further 
supporting the hypothesis of an OPA1-NOA1 functional interplay in the control of cristae 
shape.  To verify whether these defects were a consequence of chronic Noa1 ablation, we 
turned to acute NOA1 silencing in HeLa cells. Efficient reduction of NOA1 transcript and 
protein levels by siRNA (Fig. S2B,C) resulted in similar cristae shape aberrations (Fig. S2A), 
with a reduction in the number of cristae per mitochondrion and an increase in maximal 
cristae width (Fig. S2D, E).  
To test the consequence of NOA1 overexpression on the mitochondrial shape, MEFs were 
transfected with a plasmid expressing GFP-tagged NOA1 and GFP positive cells were sorted 
cytofluorimetrically and processed to be analyzed by EM. Mitochondria appeared 
elongated in cells overexpressing NOA1, as also confirmed by morphometric analysis 
 
 
212 
 
(Figure S2F,G). Collectively, these data indicate that NOA1 participates in the regulation of 
mitochondrial morphology, ultrastructure and cristae junction biogenesis.  
 
NOA1 is essential for OXPHOS subunits stability and mitochondrial dependent cell 
survival and growth 
Given the mitochondrial structure defects, we hypothesized that NOA1 ablation affects 
also mitochondrial functions. Indeed, Seahorse analysis showed impaired mitochondrial 
respiration in Noa1-/- MEFs (Fig. 3A). Due to the fact that OPA1 is a core regulator of cristae 
shape, a factor that controls the assembly of respiratory supercomplexes and therefore 
OXPHOS efficiency (Cogliati et al., 2013), we hypothesized that likewise, its partner NOA1 
might affect respirasomes formation.  Blue native PAGE of Noa1-/- mitochondrial extracts 
revealed a defect in the assembly even of individual respiratory complexes (Fig. 3B), 
potentially explaining the OXPHOS dysfunction. To understand whether the observed 
respiratory defect was a consequence of mtDNA loss, we measured by qPCR the Sdha 
(nuclear encoded) and Mtco2 (mtDNA encoded) ratio that was unaltered in Noa1-/- cells 
(Fig. 3C), suggesting that mtDNA levels were not affected by loss of Noa1. Alternatively, 
the respiratory defects might be a consequence of abnormal mitochondrial translation. 
While the protein levels of several OXPHOS subunits were decreased in NOA1 deficient 
cells, this reduction was not restricted to mtDNA encoded proteins (like MTCO1 of CIV and 
ND4 of CI), but also to nuclear encoded OXPHOS subunits (NDUFB8 of CI) (Fig. 3D). These 
results suggest a general instability of OXPHOS proteins, probably due to the inability of 
respiratory chain complexes to properly assemble, as a consequence of altered cristae 
shape.   
To understand whether the observed ultrastructural and bioenergetics defects had any 
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functional consequence, we measured growth of Noa1-/- cells in galactose-containing 
medium to force cells to rely on mitochondrial OXPHOS to generate ATP.  Noa1-/- cells not 
only grew slower in galactose-containing medium (Fig. 4A), but they also underwent 
apoptosis, as indicated by flow cytometry analysis (Fig. 4B). Furthermore, Noa1-/- MEFs 
were more sensitive to H2O2 induced apoptosis (Fig. 4C) and NOA1 levels decreased, 
probably as a consequence of NOA1 cleavage (as indicated by the appearance of a novel 
lower MW immunoreactive band) in mitochondria treated with the apoptotic stimulus 
cBID (Fig. 4D). Thus, NOA1 is essential for mitochondrial function, impacting on 
mitochondria-dependent cell growth and viability. 
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Discussion 
Cristae biogenesis, maintenance and dynamics are mainly mediated by protein complexes. 
One of the major regulators is OPA1, which resides in the IMM forming complexes (Frezza 
et al., 2006) along with multiple interactors, among which is NOA1 (Soriano et al., in 
preparation). Here we describe that NOA1 and OPA1 interact physically and functionally. 
NOA1 peripherally associated membrane protein residing inside mitochondria. Worth 
noting, we did not observe any nuclear localization, which was reported previously (Al-
Furoukh et al., 2014). Although NOA1 was previously localized in the mitochondrial matrix 
(Tang et al., 2009), our experiments of protease accessibility place it instead in the IMS, 
where it interacts with both soluble and transmembrane forms of OPA1.  
The HMW complexes, in which OPA1 and NOA1 are retrieved, are targeted during 
apoptosis. Upon apoptosis induction in isolated mitochondria, NOA1 is possibly 
proteolytically cleaved, which could be a potential mechanism for the dissociation of 
OPA1/NOA1 complexes early during cell death stimulation. Similar to OPA1 ablation 
(Frezza et al., 2006), NOA1 loss sensitizes cells to programmed cell death induced by H2O2, 
indicating that it acts as an anti-apoptotic protein. Taken together, we suggest that OPA1 
and NOA1 share common complexes whose integrity is lost early during cell death, 
providing probably a protective mechanism against apoptotic cristae remodeling under 
physiological conditions.   
Not only the two proteins coexist in the same HMW complexes, but they also interact 
genetically and physically. Noteworthy, OPA1 is upregulated in Noa1-/- MEFs, possibly to 
serve as a compensatory response, whereas NOA1 is absent in Opa1-/- cells, indicating that 
the latter is essential for NOA1 stability. 
Electron and confocal microscopy morphometric analysis allowed us to demonstrate that 
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NOA1 plays a key role in mitochondrial morphology and ultrastructure maintenance. Even 
though the phenotypes between Opa1-/- and Noa1-/- MEFs are not identical, mitochondria 
of both genotypes are fragmented and their cristae architecture is severely altered. Similar 
structural defects were observed also upon acute Noa1 ablation, excluding that the cristae 
alterations are a consequence of chronic Noa1 depletion. Interestingly, the ultrastructural 
defects of NOA1 deficient mitochondria can be corrected by the overexpression of OPA1 
further supporting a model in which that the two proteins are functionally linked. 
Since cristae shape regulates the efficiency of mitochondrial respiration (Cogliati et al., 
2013), our prediction was that the Noa1-/- abnormal cristae structure resulted in impaired 
oxidative phosphorylation. Indeed, previous (Kolanczyk et al., 2011; Heidler et al., 2011) 
and our own results confirmed that when NOA1 is lacking mitochondrial respiration is 
defective. However, this was not caused by a reduction in mtDNA copy number (Kolanczyk 
et al., 2011), as it is conversely the case for cells chronically lacking mitochondrial fusion 
proteins (Chen et al., 2010).  NOA1 orthologues in bacteria and yeast are required for 
proper mitoribosome biogenesis and assembly (Loh et al., 2007; Uicker et al., 2007; Anand 
et al., 2009) and mitochondrial translation defects are caused by mammalian NOA1 
ablation (Kolanczyk et al., 2011), possibly explaining the respiration defect observed in 
Noa1-/- cells.  We also found that levels of various OXPHOS subunits are remarkably 
decreased in Noa1-/- cells, but this reduction was global and not restricted to mtDNA 
encoded proteins. Our results suggest that the impaired respiration is a consequence of 
the instability of OXPHOS proteins and not of defective mitochondrial protein-synthesis. 
Interestingly, Blue Native PAGE revealed that respiratory complexes failed to be properly 
assembled in Noa1-/- MEFs, in line with previously published studies (Kolanczyk et al., 2011; 
Heidler et al., 2011) and with the changes observed upon genetic and apoptotic cristae 
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shape alterations (Cogliati et al., 2013). We therefore propose that OXPHOS subunits 
degradation in Noa1-/- cells results from the inability of respiratory chain complexes to 
properly assemble (Acin-Perez et al., 2008). Given that the GTPase domain of mammalian 
NOA1 contains a 100-aa insert absent from the bacterial homologue of NOA1 (YeqH), we 
could possibly suggest a diversity or multiplicity in its function along evolution. Collectively, 
we propose that mammalian NOA1 functions as a regulator of cristae shape, which is 
essential for the appropriate respiratory complexes formation and, thus, the efficient 
bioenergetic activity of mitochondria.  
While upon NOA1 loss mitochondria fragment, NOA1 overexpression causes 
mitochondrial elongation, suggesting that NOA1 directly or indirectly contributes to 
organelle fusion and that NOA1 is a functional partner of OPA1 not only in cristae structure 
maintenance, but also in its profusion role. Further biochemical studies are required to 
test this hypothesis.  
Intriguingly, high-throughput screens in yeast and mammals revealed NOA1 as a potential 
genetic or physical interactor of prohibitins, respectively. Considering that prohibitins 
control mitochondrial ultrastructure via regulating OPA1 processing, it would be 
interesting for the future to unveil the precise relationship between NOA1, OPA1 and 
prohibitins in the course of cristae shape maintenance.  
To sum up, mammalian NOA1 cooperates with OPA1 in the regulation of the mitochondrial 
morphology, cristae shape and cristae remodeling, by participating in the formation of 
common macromolecular assemblies.  NOA1, like its interactor OPA1, is essential for 
cristae integrity, which influences OXPHOS complexes assembly, efficiency and, 
subsequently, mitochondria-dependent cell viability, but it additionally participates in 
programmed cell death execution.  
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Experimental procedures  
 
Cell culture, cell growth experiments and transfections  
Noa1+/+ and Noa1-/- mouse embryonic fibroblasts were maintained in Dulbecco’s Modified 
Eagle Medium (DMEM, Invitrogen) supplemented with 10% fetal bovine serum (FBS, 
Invitrogen), 50 U/ml Penicillin, 50 μg/ml Streptomycin, 0.1 mM non-essential amino acids 
(0.89 g/l L-alanine, 1.32 g/l L-asparagine, 1.33 g/l L-aspartic acid, 1.47 g/l L-glutamic acid, 
0.75 g/l glycine, 1.15 g/l L-proline, 1.05 g/l L-serine, Invitrogen), 50 μg/ml L-uridine, 1 mM 
sodium pyruvate, 10% Amniomax C-100 supplement (Invitrogen). When indicated, 
glucose was substituted with 0.9 mg/ml galactose (Sigma).  
The medium (DMEM) for HeLa was supplemented with 10% of fetal bovine serum (FBS), 
50 U/ml Penicillin, 50 μg/ml Streptomycin, 0.1 mM non-essential amino acids and 2 mM 
glutamine. 
Opa1+/+, Opa1-/-, Opa1-/-::OPA1 mouse embryonic fibroblasts (MEFs) and Opa1flx/flx mouse 
adult fibroblasts (MAFs) were cultured as previously described (Cogliati et al., 2013). All 
the cell lines were cultured at 37°C in a 5% CO2 atmosphere. 
Plasmid transfections were performed using Lipofectamine2000 following manufacturer’s 
instructions (Invitrogen). 
For cell growth, equal numbers of cells were seeded in 12-well plates. Viable cells were 
counted daily for 3 days using a hemocytometer as determined by Trypan Blue exclusion 
and normalized to the initial number of cells.  
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Mitochondria Isolation 
Mitochondria from mouse liver and cell lines were isolated by standard differential 
centrifugation as previously described (Frezza et al., 2007). Mouse heart and brain 
mitochondria were purified as described in (Fernandez-Vizarra et al., 2010). 
 
Molecular biology 
pcDNA3.2-hNOA1-V5 and pcDNA47-hNOA1-GFP were generated by subcloning the 
plasmid pDONR221-hNOA1 (DNASU) into the corresponding vectors (Invitrogen) using the 
Gateway cloning system. Constructs were confirmed by sequencing. pMSCV-OPA1 and 
mitochondrial targeted red fluorescent protein (mtRFP), which corresponds to pDsRed2-
Mito, were previously described (Cipolat et al., 2004).  
 
Biochemistry 
Cell lysis was performed with RIPA buffer (150 mM NaCl, 1% Nonidet P-40, 0.25% 
deoxycholate, 1 mM EDTA, 50 mM Tris, pH 7.4) in the presence of complete protease-
inhibitor mixture (Sigma). Protein concentration was measured by Bradford protein assay 
(Biorad). Proteins (20-30 μg) were separated by 4–12% Tris-MOPS SDS–PAGE or 3%–8% 
Tris-acetate polyacrylamide gels (NuPage, Invitrogen), transferred onto PVDF membranes 
(Millipore) and probed using the following antibodies: mouse monoclonal anti-OPA1 
(1:1000 BD Biosciences), rabbit polyclonal anti-C4orf14 (1:500 Proteintech), rabbit 
polyclonal anti-GRP75 (1:2000 Santa Cruz Biotechnology), rabbit polyclonal anti-VDAC 
(1:1000 Abcam), mouse monoclonal anti-V5 (1:1000 Invitrogen), mouse monoclonal anti-
SDHA (1:5000 Abcam), rabbit polyclonal anti-TOM20 (1:1000 Santa Cruz Biotechnology), 
rabbit polyclonal anti-GAPDH (1:1000 Sigma), rabbit polyclonal anti-ND4 (1:500 Santa 
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Cruz Biotechnology), mouse monoclonal anti-NDUFB8 (1:1000 Abcam), mouse 
monoclonal anti-MTCO1 (1:1000 Abcam), mouse monoclonal anti-cytochrome c (1:1000 
BD Pharmigen), mouse monoclonal anti-ATP5a (1:4000 Abcam) and mouse monoclonal 
anti-actin clone C4 (1:10000 Millipore). Isotype matched, horseradish peroxidase-
conjugated secondary antibodies (GE Healthcare Life Sciences) were used followed by 
detection of chemiluminescence using the ECL western blotting substrate (Life 
Technologies) and ImageQuant LAS 4000 (GE Healthcare Life Sciences). 
For protein crosslinking, mitochondria (0.5 mg/ml) purified from MAFs were treated, 
when indicated, with 50 pmol cBID per mg in experimental buffer (E.B., 150 mM KCl, 10 
mM Tris-Mops pH 7.4, 10 μM EGTA-Tris, 1 mM Pi and 5/2.5 mM Glutamate/Malate) for 
30 min at room temperature agitating. The reaction was quenched with a centrifugation 
at 10000 x g. Subsequently, mitochondria were resolved in 10 mM bismaleimidohexane 
(BMH, PIERCE) in E.B., incubated with the crosslinker for 1 hr at 25°C, spun and dissolved 
in SDS-PAGE loading buffer (NuPage, Invitrogen). Mitochondrial proteins (20 μg) were 
separated on 7% Tris-acetate polyacrylamide gels (NuPage, Invitrogen) and western 
blotting was performed as described before. 
 
Immunoprecipitation 
For immunoprecipitations, MEFs transfected with pcDNA3.2-hNOA1-V5 were lysed in PBS 
0.1% Triton-X 100 supplemented with a protease inhibitor cocktail (PIC, Sigma-Aldrich). 
Equal amounts of lysates (150 μg) were diluted 1:5 in PBS with PIC and pre-cleared with 
10 μl of Dynabeads (Magnetic beads, ThermoFisher). Dynabeads were blocked with PBS 
1% BSA, 10% FBS for 5 min and then incubated with the indicated antibody (1:50, 30 min, 
25°C). Then, pre-cleared extracts were precipitated in the Dynabeads-antibody complex 
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for 1 hr at 25°C. Precipitates were washed extensively three times in lysis buffer and 
bound complexes were eluted with 2× SDS-PAGE sample buffer (NuPAGE, Invitrogen), 
boiled and analyzed by immunoblotting. As a negative control lysates were incubated with 
plain Dynabeads in the absence of any antibody. 
 
Blue Native PAGE for respiratory supercomplexes  
5 x 106 cells were spun down, washed and resuspended in 400 μl of 4% digitonin in PBS 
with the addition of protease inhibitor cocktail (PIC, SIGMA) and incubated on ice for 
10min. The samples were centrifuged at 10000 x g for 10 min at 4°C, washed with cold 
PBS and centrifuged again. The pellet was suspended in 100 μl of native buffer (Native 
sample buffer (Invitrogen), 1% Dodecyl D Maltoside (DDM, SIGMA) and PIC (SIGMA), 
incubated 5 min on ice and centrifuged at 22000 x g for 30 min at 4°C to extract the soluble 
complexes. 10 μl of Native PAGE Sample additive G250 5% (Invitrogen) were added into 
the supernatant. Equal volumes were loaded onto a 3-12% Native Bis-Tris gel (Invitrogen). 
 
Recombinant Protein Expression 
p7/p15 recombinant BID was produced, purified and cleaved with caspase-8 as previously 
described (Frezza et al., 2006).  
 
Quantitative RT-PCR 
Total RNA from cultured fibroblasts was extracted using RNeasy Mini Kit (Qiagen) and 
treated with DNAase I (Sigma) for 15 min at room temperature. mRNA was 
retrotranscribed using Superscript III RT–PCR Kit and oligo-(dT)20 primers (Invitrogen). 
Real-time quantitative PCR was performed on a 7900 Genetic Analyzer (Applied 
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Biosystems) using GoTaq Green Master Mix (Promega). Reaction conditions were 
standard (95°C 15 s, 60°C 30 s; 40 cycles). Oligonucleotides used in the reactions were the 
following: 5′-TGACAAACTTAAGGAGGCTGTG-3′ and 5′- CATTGTGCTGAATAACCCTCAA-3′ 
for mouse Opa1, 5′-GTCTCCTGCGACTTCAAC-3′ and 5′-TCATTGTCATACCAGGAAATGAGC-3′ 
for mouse Gapdh, 5′-TGTGATTGAAAACATCTACCTTCCA-3′ and 5′-
TTTAAGCTTGATATCCACTGTGGTGT-3′ for human OPA1, 5′-ATGTCGTAGGAAGAGTTGGA-3′ 
and 5′- GTCAAAGGCAAGTGAATCAG-3′ for human NOA1, 5΄-AACAGCGACACCCACTCCTC-3′ 
and 5΄- CATACCAGGAAATGAGCTTGACAA-3′ for human GAPDH. All the results were 
normalized to GAPDH mRNA expression.  
 
Live Imaging 
To visualize mitochondrial network, 105 cells were seeded onto 25 mm coverslips and 
transfected with mtRFP. 24 hr post-transfection, the coverslips were covered with Hank’s 
Balanced Salt Solution (HBSS) supplemented with 10 mM Hepes and fluorescence signals 
were analyzed using IMIC Andromeda system (Fondis Electronic) equipped with ORCA-
03G Camera (Hamamatsu), a × 60 oil objective (UPLAN × 60 oil, 1.35NA, Olympus), 488 
and 561 nm lasers for excitation and FF01-446/523/600/677 (Semrock) as emission filter. 
Stacks of 10 images separated by 0.5 μm along the z axis were acquired a × 60 objective 
(oil; CFI Plan APO 1.4 NA) and 561 nm (50 mW) excitation (Santo-Domingo et al., 2013). 
3D reconstruction and volume rendering were performed using a plug-in of ImageJ 1.44o 
software (National Institutes of Health). Mitochondrial length was quantified with Image 
J tool ‘Freehand line selection’ by measuring the average mitochondrial major axis length 
of 10 mitochondria per cell in 20 cells per sample.  
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Transmission electron microscopy and mitochondrial morphometry 
Cells were fixed with freshly prepared glutaraldehyde at a final concentration of 1.25% 
(V/V) in 0.1 M Sodium cacodylate trihydrate pH 7.2 for 1 hr at 37ºC and washed in 0.1 M 
Sodium cacodylate trihydrate. Embedding and staining were performed as described in 
(Scorrano et al., 2002). When indicated, cell sorting was performed before fixation. MEFs 
were transfected with pcDNA47-hNOA1-GFP or pcDNA47-GFP and the next day harvested 
and sorted using flow cytometry with FACS Canto (BD Biosciences). The cells expressing 
GFP were cultured into dishes and fixed after 16 hr. For electron microscopy visualization, 
thin sections were imaged on a Tecnai-12 electron microscope (Philips-FEI) at the EM 
Facility of University of Padova. For morphometric analysis, mitochondrial parameters 
were measured using Image J (National Institutes of Health). 
 
Seahorse analysis 
Oxygen consumption rate (OCR, pmol/min) was determined using XF24 Extracellular Flux 
Analyzer and the XF cell mito stress test kit (Seahorse Biosciences). 9000 wt MEFs or 
36000 Noa1-/- MEFs per well were seeded in an XF24 cell culture microplate and, after 24 
hr, the normal medium was exchanged with the Cellular Assay Solution (8.3 g/L DMEM, 5 
g/L Glucose, 0.58 g/L Glutamine, 1 mM Sodium Pyruvate, 0.015 g/L Phenol Red, pH 7.2). 
The assay consisted of oxygen consumption measurements during time starting with the 
basal conditions and followed by sequential injections of Oligomycin 1.3 μM, FCCP 0.4 μM 
and Rotenone 1.0 μM/Antimycin 1.2 μM. Three measurements were performed after 
each compound injection. The analysis was performed simultaneously in the same plate 
for the control and Noa1-/- cells. 
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Measurement of mitochondrial DNA copy number 
Total cellular DNA was isolated from 5 x 106 MEFs using DNeasy Blood & Tissue Kit 
(Qiagen) and was amplified by real time PCR using GoTaq Green Master Mix (Promega) 
following manufacturer’s indications. Reaction conditions were (95°C 15 s, 60°C 60 s; 40 
cycles). The oligodeoxynucleotides used were specific for the mtDNA encoded gene mt-
Co2 (3’- CTACAAGACGCCACAT-5’ and 3’- GAGGGGGAGAGCAAT-5’) and the nuclear 
encoded gene Sdha (3’-TACTACAGCCCCAAGTCT-5’ and 3’- TGGACCCATCTTCTATGC-5’). 
The mtDNA copy number per cell was calculated using Sdha amplification as a reference 
for nuclear DNA content. 
 
Cell viability assay 
For cell death analysis, 1,5x104 MEFs of the indicated genotype were seeded in 12-well-
plates. After 24 hr the medium was changed for fresh glucose- or galactose-containing 
medium. Cells were harvested at the indicated time points and stained with annexin-V 
FITC and propidium iodide (eBiosciences). Cell viability was measured by flow cytometry 
(FACSCalibur, BD Biosciences) as the percentage of annexin-V and PI negative events.  
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Figure legends  
Figure 1. NOA1 and OPA1 interact physically and genetically 
A. Coomassie staining after Blue Native PAGE of digitonin solubilized mitochondrial 
extracts. The picture shows the approximate molecular weight of each of the thirty 
different spots in which Blue Native gel lane was cut, in order to be subjected to 
LC/MS analysis, as shown in the figure 1B.    
B. Graph depicting OPA1 and NOA1 peptides identified along the Blue Native gel lane 
by liquid chromatography and mass spectrometry in mitochondria from mouse 
brain, heart and a cell line (FC57).  
C. Mitochondrial crosslinking. MAFs were transfected with pcDNA3.2-hNOA1-V5. 
After 24 hr mitochondria were isolated, when indicated, treated with 50 pmol/mg 
of cBID for 30 min at room temperature, spun and crosslinked with 10 mM BMH 
for 1 hr at 25°C. Equal amounts of proteins (20 μg) were separated by SDS-PAGE 
and immunoblotted using anti-V5 and anti-OPA1 antibodies. Arrows denote the 
complexes. 
D. NOA1-V5 was immunoprecipitated from MEFs transfected with pcDNA3.2-hNOA1-
V5 and analyzed by SDS-PAGE/immunoblotting as indicated. For input 15 μg of cell 
lysates were loaded. Cell lysates incubated with beads without antibody served as 
a negative control.  
E. OPA1 was immunoprecipitated from MEFs transfected with pcDNA3.2-hNOA1-V5 
and analyzed by SDS-PAGE/immunoblotting as indicated. For input 15 μg of cell 
lysates were loaded. Cell lysates incubated with beads without antibody served as 
a negative control.  
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F. Equal amounts (30 μg) of the whole lysates from Noa1+/+ and Noa1-/- MEFs 
transfected with the plasmids pcDNA3.2-hNOA1-V5 (NOA1-V5) or empty vector 
(EV), when indicated, were separated by SDS PAGE and immunoblotted using anti-
OPA1 and anti-actin. 
G. qPCR analysis of mOPA1 transcript levels of Noa1-/- MEFs, normalized to GAPDH 
and to wt MEFs. Data represent mean ± SEM of three independent experiments. 
H. Equal amounts (30 μg) of the whole lysates from Opa1+/+, Opa1-/- and Opa1-/-::OPA1 
MEFs transfected with the indicated plasmids were separated by SDS PAGE and 
immunoblotted using anti-NOA1 and anti-GAPDH. 
 
Figure 2. NOA1 deficiency alters mitochondrial morphology and ultrastructure 
A. Representative confocal images of MEFs of the indicated genotype transfected with 
mtRFP.  
B. Quantification of the average mitochondrial length. Data represent mean ± SEM of 
three independent experiments (10 mitochondria per cell, 20 cells per sample). 
C. Electron microscopy analysis of Noa1+/+ and Noa1-/- MEFs. The scale bar represents 
500 nm. 
D. Quantification of the number of cristae per mitochondrion in Noa1+/+ and Noa1-/- 
MEFs. Data represent mean ± SDV of 20 randomly selected mitochondria.  
E. Morphometric analysis of the maximal cristae width. Data represent mean ± SDV of 
300 cristae. 
F. Quantification of mitochondrial perimeter in Noa1+/+ and Noa1-/- MEFs. Data 
represent mean ± SEM of three independent experiments (25 mitochondria per 
experiment). 
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G. Morphometric analysis of the ratio cristae surface area to mitochondrial surface area. 
Data represent mean ± SDV of 25 randomly selected mitochondria.  
H. Electron microscopy analysis of Noa1-/- MEFs transfected, where indicated, with 
empty vector (EV), pcDNA3.2-hNOA1-V5 (NOA1) or pMSCV-OPA1 (OPA1). The scale 
bar represents 500 nm. 
I. Morphometric analysis of the cristae width. Data represent mean ± SDV of 514 
cristae. 
 
Figure 3. NOA1 loss leads to a global reduction of mitochondrial respiratory chain 
complexes subunits 
A. Oxygen consumption rate is measured by Seahorse XF Cell Mito Stress Test Kit in 
basal conditions and after the addition of oligomycin 1.3 μM (A), FCCP 0.4 μM (B) 
and rotenone 1 μM/antimycin 1.2 μM (C). The blue horizontal line connotes the 
basal respiration of wt cells. 
B. BN PAGE analysis of OXPHOS proteins in mitochondria from wt and Noa1-/- MEFs. 
Equal amounts (150 μg) of solubilized membrane complexes were separated in 
native conditions, transferred onto PVDF membranes and probed with the 
indicated antibodies. 
C. mtDNA copy number quantification. Total DNA was isolated from the indicated 
cell lines. mtDNA and ncDNA was amplified by RT-PCR using specific primers. The 
mtDNA copy number was normalized to the mtDNA copy number of the 
correspondent WT cell line. Data are average ± SEM of two independent 
experiments.  
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D. Equal amounts (30 μg) of mitochondrial proteins were separated by SDS PAGE, 
transferred onto PVDF membranes and probed with the indicated antibodies 
against various OXPHOS subunits. 
 
Figure 4. NOA1 is required for mitochondrial dependent cell growth and viability 
A. Growth curve. Cells of the indicated genotype were cultured in DMEM 
supplemented with the indicated monosaccharide. Viable cells were counted 
using Trypan blue exclusion and compared to the seeding cell number. Data 
represent the mean ± SEM of three independent experiments.  
B. Cell viability. Cells of the indicated genotype were cultured in DMEM 
supplemented with the indicated monosaccharide. Viable cells were determined 
cytofluorimetrically as the percentage of Annexin-V negative cells. Data represent 
the mean ± SEM of three independent experiments.  
C. Purified mouse liver mitochondria (0.5 mg/ml) were incubated in experimental buffer 
and treated for the indicated time with 20 pmol/mg of cBID at 25°C. Proteins (20 μg) 
were separated with SDS-PAGE and immunoblotted with the indicated antibodies.   
D. Noa1+/+ and Noa1-/- MEFs were treated with 1 mM H2O2 for the indicated times and 
viability was determined cytofluorimetrically as the percentage of Annexin-V and 
Propidium Iodide negative cells. Data represent mean ± SEM of two independent 
experiments.  
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Supplementary experimental procedures 
 
RNA Interference (RNAi) 
RNAi experiments were performed using 200 nM of the sihNOA1 (5’-
GGUCAUACGUUACUCCAGA-3’)dTdT and Oligofectamine (Invitrogen) following 
manufacturer’s instruction. HeLa cells transfected with scrambled siRNA were used as 
control. The cells were analyzed 72 hr after transfection. 
 
Proteinase K accessibility assay  
Purified mouse liver mitochondria (0.5 mg/ml) diluted in isolation buffer (I.B., 0.2 M 
sucrose, 0.1 mM EGTA-Tris, 10 mM Tris/MOPS, pH 7.4) were treated with Proteinase K 
(PK, 5 μg/mg) for 15 min at 4°C. Where indicated, hypotonic rupture of the OMM was 
achieved by diluting the mitochondrial suspension 1:40 in 2 mM or 20 mM HEPES/KOH 
pH 7.4; Triton X-100 was added where indicated at a final concentration of 0.3% (v/v). The 
PK reaction was quenched with 1 mM PMSF for 5 min at 4°C and the samples were spun 
at 4°C, 12000 x g for 10 min. The pellets were resuspended in SDS-PAGE loading buffer 
(NuPAGE, Invitrogen) and 30 μg of protein were separated by SDS–PAGE and 
immunoblotted using the indicated antibodies.   
 
Carbonate extraction 
Carbonate extraction was performed in purified mouse liver mitochondria (0.5 mg/ml) by 
incubation in 0.1 M Na2CO3 pH 11.2 for 30 min, 4°C. Soluble and membrane fractions were 
separated by centrifugation at 24000 x g for 1 h, 4°C. The supernatant was precipitated 
with 10% TCA, 20 min, 4°C, centrifuged at 18000 x g, 30 min, 4°C and the pellet was 
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washed with cold acetone. Equal amounts (10 μg) of proteins from total, pellet or 
supernatant were separated by SDS PAGE and immunoblotted using the indicated 
antibodies. 
 
Analysis of cell death 
Cells of the indicative genotype were treated with 1 mM H2O2. At the indicated time 
points, cells were harvested and stained with Annexin-V FITC (eBiosciences). Cell viability 
was measured by flow cytometry (FACSCalibur, BD Biosciences) as the percentage of 
Annexin-V-negative events. 
 
Immunofluorescence  
HeLa cells grown on glass coverslips were fixed with freshly prepared, ice-cold 3.7% 
formaldehyde in PBS for 30 min, followed by permeabilization with 0.1% Triton X-100 in 
PBS for 10 min. Next, the coverslips were washed with PBS, incubated with blocking buffer 
(10% FBS + 1% BSA in PBS) for 20min and, then, with primary antibodies for 2 hr at room 
temperature. We used antibodies against NOA1 (1:50, Proteintech) and TIM23 (1:50, BD 
Biosciences) diluted in the blocking buffer. The cells were then washed with PBS and 
incubated with the appropriate secondary antibodies labeled with Alexa Fluor 488 (1:300, 
for the antibody against NOA1) or Alexa Fluor 568 (1:1000, for the antibody against 
TIM23) (ThermoFisher) for 1 hour at room temperature. The coverslips were mounted 
with one drop of Prolong gold antifade reagent (Life Technologies). Fluorescence signals 
were analyzed under a Nikon Eclipse TE300 inverted microscope equipped with a 
PerkinElmer Ultraview LCI confocal system. Confocal images of TRIC and FITC fluorescence 
were acquired along the z-axis, deconvolved and 3D reconstructed using the appropriate 
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plugins of ImageJ (National Institutes of Health). Co-localization analysis was performed 
in 3D projections using “Squass” (segmentation and quantification of subcellular shapes) 
software (Rizk et al., 2014) which was implemented into ImageJ. 
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Supplemental figure legends  
Figure S1. NOA1 resides in the inner mitochondrial compartments 
A. Representative confocal images of HeLa cells stained for Tim23 and Noa1. 
Endogenous Noa1 co-localizes with the mitochondrial marker Tim23 (Bergmann’s 
colocalization 78.1%, SEM 0.02).  
B. Carbonate extraction. Purified mouse liver mitochondria (0.5 mg/ml) were 
incubated in 0.1 M Na2CO3 pH 11.2 for 30 min, 4°C. Soluble and membrane 
fractions were separated by centrifugation. Equal amounts (10μg) of proteins from 
total (T), pellet (P) or supernatant (S) were separated by SDS–PAGE and 
immunoblotted using the indicated antibodies. 
C. Proteinase K accessibility assay. Purified mouse liver mitochondria (0.5 mg/ml) 
incubated in isolation buffer (I.B., 0.2 M sucrose, 10 mM Tris/MOPS, 0.1 mM EGTA-
Tris, pH 7.4) were treated as indicated in the figure and 30 μg of protein were 
separated by SDS–PAGE and immunoblotted using the indicated antibodies. PK, 
proteinase K; SW, swelling. 
 
Figure S2. Acute Noa1 ablation or overexpression affect mitochondrial ultrastructure 
A. Representative electron micrographs of HeLa transfected with siRNA targeting hNOA1 
(sihNOA1) or a negative siRNA (scramble). The scale bar represents 500 nm. 
B. qPCR analysis of hNOA1 transcript levels in HeLa transfected with sihNOA1, depicting 
the efficiency of silencing. The data were normalized to GAPDH and to WT MEFs and 
represent the mean ± SEM of three independent experiments. 
C. Western blotting in whole cell lysates from HeLa transfected with scramble or 
sihNOA1.   
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D. Morphometric analysis of the maximal cristae width. Data represent the average ± 
SEM of two independent experiments (320 cristae per experiment).  
E. Quantitative analysis of the number of cristae per mitochondrion. Data represent 
mean ± SEM of three independent experiments (at least 40 mitochondria per 
experiment). 
F. Representative electron micrographs of MEFs transfected with the indicated plasmids, 
sorted in FACS for GFP positive, re-cultured and subsequently fixed. The scale bar 
represents 1 μm. 
G. Morphometric analysis of the mitochondrial perimeter. Data represent mean ± SDV of 
63 randomly selected mitochondria.  
 
  
 
 
240 
 
 
 
 
Suppl. Figure S1 
 
 
 
 
241 
 
Suppl. Figure S2 
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General discussion 
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3. Discussion  
Mitochondrial cristae are the sites of oxidative phosphorylation, since they host all the 
complexes implicated in respiration. The shape of cristae alters dynamically in response 
to the metabolic demands of the cell in order to enhance OXPHOS efficiency 
(Hackenbrock, 1966; Mannella et al., 2001; Hackenbrock et al., 1980; Cogliati et al., 2013). 
Additionally, mitochondrial ultrastructure is subjected to remodeling early during 
apoptosis facilitating the mobilization of cytochrome c; thus amplifying the intrinsic cell 
death program (Scorrano et al., 2002).  The main regulators of cristae architecture known 
so far are the MICOS complex, the dimers of ATP-synthase and the multimers of OPA1. 
Whether and how these machineries are coordinated is still unexplored.  
OPA1 is a pleiotropic protein, that regulates cristae shape and remodeling independently 
of its profusion role (Frezza et al., 2006; Griparic et al., 2004). OPA1 is organized in high 
molecular weight complexes residing in the cristae junctions, while they are eliminated 
after stimulation by the caspase 8-cleaved pro-apoptotic BID (cBID). Using high-
throughput approaches based on blue native PAGE, we demonstrated that OPA1 
associates with multiple proteins to form these macromolecular assemblies. Our 
experimental design allowed us to distinguish the candidate OPA1 interactors that leave 
OPA1 complexes during apoptotic cristae remodeling; hence suggesting that these 
proteins likely participate in the control of cristae rearrangements.  
Among the identified OPA1 interactors, our attention was firstly caught by the two major 
components of MICOS complex, Mic60 and Mic19. Biochemical experiments confirmed 
that OPA1, Mic60 and Mic19 share common complexes that are targeted during 
 
 
244 
 
apoptosis. Further investigation based on electron microscopy and genetics uncovered a 
cooperation between OPA1 and Mic60 for cristae biogenesis regulation. Nevertheless, 
Mic60 is not implicated in the definition of cristae junction diameter, like OPA1. Thus, it is 
conceivable that Mic60 plays a role in apoptosis not by directly widening cristae junctions, 
but indirectly, likely via regulating mitochondrial respiratory capacity. Overall, we propose 
that OPA1 multimers and MICOS are associated physically and functionally, while they 
execute additional distinct functions.  
Furthermore, we focused on another candidate OPA1 co-player, NOA1, whose precise 
function is still undefined. Similarly, performing biochemical analysis, we validated the 
physical and genetic interaction between OPA1 and NOA1. Electron microscopy unveiled 
an interplay between the two proteins in the regulation of cristae shape. We showed that 
NOA1 is required for the effective mitochondrial respiration, as well as apoptosis and 
mitochondria-dependent cell viability and growth. Consequently, our research identified 
NOA1 as a novel partner of OPA1 in mitochondrial ultrastructure and function during life 
and death of the cell. 
Given the fact that NOA1 overexpression leads to mitochondria elongation, we can 
hypothesize that NOA1 is a functional partner of OPA1 not only in cristae structure 
maintenance, but probably also in its profusion role. Considering that, to date, OPA1 is 
the only identified protein that can fuse the inner mitochondrial membrane, the discovery 
of a novel IMM fusogenic polypeptide seems intriguing. We are currently trying to 
establish an in vitro fusion assay, in order to examine the possibility that recombinant 
NOA1 is capable to fuse liposomes or whether it acts through OPA1 pathway. 
In addition, our proteomic approaches detected core and loosely associated members of 
the ATP-synthase to be part of the OPA1-containing complexes, while they were found to 
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be dissociated from them upon cBID-induced cristae remodeling. Elaborate studies have 
indicated that the dimerization of ATP-synthase drives the positive curvature of the cristae 
tip; thus complex V is a main regulator of cristae shape (Davies et al., 2012). The notion 
that OPA1 collaborates with ATP-synthase dimers to control the whole cristae shape in a 
coordinated manner arises our interest and calls for biochemical investigation.  
Overall, our studies on the composition and distribution of OPA1-containing complexes in 
steady state and cristae remodeling could shed light on the pathogenesis of Autosomal 
Dominant Optic Atrophy (ADOA), a pathology where OPA1 is mutated (Alexander et al., 
2000). Additionally, the anti-apoptotic function of OPA1 serves as a fundamental 
protective mechanism in denervation-induced muscular atrophy, ischemic heart and 
brain damage, as well as hepatocellular apoptosis (Varanita et al., 2015). Consequently, 
knowledge deriving from my thesis can contribute to the specificity of potential therapies 
targeting OPA1-dependent cristae remodeling in atrophic, apoptotic, and ischemic tissue 
damage. On the other hand, targeting OPA1 anti-apoptotic action by inhibiting its GTPase 
activity might contribute to anti-cancer therapies via sensitizing transformed cells to 
programmed cell death. Similarly, understanding the interactions of OPA1 can add to the 
specificity of its inhibition and, as a result, to the efficacy of the treatment.  
In general, my Thesis provided hints on the interactions of the cristae shaping IMM 
protein, OPA1, in life and death of the cell.  
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